1	Clinica	NNP	PERSON	Clinica	nn	3	SENT_1	[p1l839t81r919b103],
2	Chimica	NNP	PERSON	Chimica	nn	3	SENT_1	[p1l929t81r1025b103],
3	Acta	NNP	PERSON	Acta	_	0	SENT_1	[p1l1035t82r1087b103],
4	405	CD	NUMBER	405	number	5	SENT_1	[p1l1097t82r1141b103],
5	(	CD	NUMBER	(	dep	3	SENT_1	[p1l1154t81r1234b108],
6	2009	CD	DATE	2009	dep	5	SENT_1	[p1l1154t81r1234b108],
7	)	CD	NUMBER	)	num	8	SENT_1	[p1l1154t81r1234b108],
8	49-52	CD	NUMBER	49-52	dep	3	SENT_1	[p1l1245t82r1320b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l784t191r918b215],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l932t191r989b215],
3	available	JJ	O	available	amod	2	SENT_2	[p1l1003t191r1129b215],
4	at	IN	O	at	_	0	SENT_2	[p1l1142t194r1169b215],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1183t191r1387b215],

1	Clinica	NNP	PERSON	Clinica	nn	3	SENT_3	[p1l817t287r989b334],
2	Chimica	NNP	PERSON	Chimica	nn	3	SENT_3	[p1l1012t287r1221b334],
3	Acta	NNP	PERSON	Acta	_	0	SENT_3	[p1l1241t289r1355b334],

1	—	NN	O	—	nn	2	SENT_4	[p1l15t420r52b438],
2	p	NN	O	p	_	0	SENT_4	[p1l15t420r52b438],
3	;	:	O	;	_	0	SENT_4	[p1l79t420r243b442],
4	,	,	O	,	_	0	SENT_4	[p1l79t420r243b442],
5	=	JJ	O	=	dep	2	SENT_4	[p1l79t420r243b442],
6	:	:	O	:	_	0	SENT_4	[p1l79t420r243b442],
7	.	.	O	.	_	0	SENT_4	[p1l79t420r243b442],

1	—	NN	O	—	_	0	SENT_5	[p1l79t420r243b442],
2	.	.	O	.	_	0	SENT_5	[p1l79t420r243b442],

1	,	,	O	,	_	0	SENT_6	[p1l79t420r243b442],
2	,	,	O	,	_	0	SENT_6	[p1l79t420r243b442],
3	~	NN	O	~	nn	4	SENT_6	[p1l79t420r243b442],
4	j-it	NN	O	j-it	appos	1	SENT_6	[p1l79t420r243b442],
5	:	:	O	:	_	0	SENT_6	[p1l79t420r243b442],
6	journal	NN	O	journal	nn	7	SENT_6	[p1l585t407r709b437],
7	homepage	NN	O	homepage	dep	1	SENT_6	[p1l728t407r923b437],
8	:	:	O	:	_	0	SENT_6	[p1l728t407r923b437],
9	www.elsevier.com/locate/clinchim	NN	O	www.elsevier.com/locate/clinchim	dep	7	SENT_6	[p1l943t407r1583b432],

1	Rifampicin	NN	MISC	rifampicin	dep	117	SENT_7	[p1l6t569r277b625],
2	alters	VBZ	O	alter	dep	117	SENT_7	[p1l299t569r436b614],
3	atorvastatin	NN	O	atorvastatin	dep	117	SENT_7	[p1l459t570r760b614],
4	plasma	NN	O	plasma	dep	117	SENT_7	[p1l782t569r961b625],
5	concentration	NN	O	concentration	dep	117	SENT_7	[p1l983t570r1333b614],
6	on	IN	O	on	dep	117	SENT_7	[p1l1356t582r1418b614],
7	the	DT	O	the	dep	117	SENT_7	[p1l1440t569r1519b614],
8	basis	NN	O	basis	dep	117	SENT_7	[p1l1541t569r1664b614],
9	of	IN	O	of	dep	117	SENT_7	[p1l6t640r58b685],
10	SLCO1B1	NN	O	slco1b1	dep	117	SENT_7	[p1l72t643r280b686],
11	521T	NN	O	521t	dep	117	SENT_7	[p1l306t643r492b686],
12	>	JJR	O	>	dep	117	SENT_7	[p1l306t643r492b686],
13	C	NN	O	c	dep	117	SENT_7	[p1l306t643r492b686],
14	polymorphism	NN	O	polymorphism	dep	117	SENT_7	[p1l514t640r886b697],
15	Yi-Jing	NN	O	yi-jing	dep	117	SENT_7	[p1l6t744r140b787],
16	He	PRP	O	he	dep	117	SENT_7	[p1l157t745r209b778],
17	‘	VBD	O	‘	dep	117	SENT_7	[p1l221t735r272b784],
18	lb	NN	O	lb	dep	117	SENT_7	[p1l221t735r272b784],
19	,	,	O	,	_	0	SENT_7	[p1l221t735r272b784],
20	Wei	NNP	PERSON	Wei	dep	117	SENT_7	[p1l288t743r366b778],
21	Zhang	NNP	PERSON	Zhang	dep	117	SENT_7	[p1l383t743r506b787],
22	3	CD	NUMBER	3	dep	117	SENT_7	[p1l517t742r541b784],
23	,	,	O	,	_	0	SENT_7	[p1l517t742r541b784],
24	Yao	NNP	PERSON	Yao	dep	117	SENT_7	[p1l558t745r627b778],
25	Chen	NNP	PERSON	Chen	dep	117	SENT_7	[p1l645t743r744b778],
26	3	CD	NUMBER	3	dep	117	SENT_7	[p1l756t742r780b784],
27	,	,	O	,	_	0	SENT_7	[p1l756t742r780b784],
28	Dong	NNP	PERSON	Dong	dep	117	SENT_7	[p1l799t745r902b787],
29	Guo	NNP	PERSON	Guo	dep	117	SENT_7	[p1l919t745r997b778],
30	3	CD	NUMBER	3	dep	117	SENT_7	[p1l1010t742r1034b784],
31	,	,	O	,	_	0	SENT_7	[p1l1010t742r1034b784],
32	Jiang-Hua	NNP	PERSON	Jiang-Hua	dep	117	SENT_7	[p1l1047t744r1247b787],
33	Tu	NNP	O	Tu	dep	117	SENT_7	[p1l1263t745r1312b778],
34	3	CD	NUMBER	3	dep	117	SENT_7	[p1l1323t742r1347b784],
35	,	,	O	,	_	0	SENT_7	[p1l1323t742r1347b784],
36	Lin-Yong	NNP	PERSON	Lin-Yong	dep	117	SENT_7	[p1l1366t744r1538b787],
37	Xu	NNP	PERSON	Xu	dep	117	SENT_7	[p1l1554t745r1607b778],
38	3	CD	NUMBER	3	dep	117	SENT_7	[p1l1619t742r1642b784],
39	,	,	O	,	_	0	SENT_7	[p1l1619t742r1642b784],
40	Zhi-Rong	NNP	O	Zhi-Rong	dep	117	SENT_7	[p1l1660t743r1842b787],
41	Tan	NNP	O	Tan	dep	117	SENT_7	[p1l1857t745r1927b778],
42	3	CD	NUMBER	3	dep	117	SENT_7	[p1l1939t742r1962b784],
43	,	,	O	,	_	0	SENT_7	[p1l1939t742r1962b784],
44	Bi-Lian	NNP	O	Bi-Lian	dep	117	SENT_7	[p1l8t797r145b831],
45	Chen	NNP	O	Chen	dep	117	SENT_7	[p1l163t796r262b831],
46	C	NNP	O	C	dep	117	SENT_7	[p1l274t795r296b837],
47	,	,	O	,	_	0	SENT_7	[p1l274t795r296b837],
48	Zhi	NNP	PERSON	Zhi	dep	117	SENT_7	[p1l314t796r376b831],
49	Li	NNP	PERSON	Li	dep	117	SENT_7	[p1l394t797r425b831],
50	3	CD	NUMBER	3	dep	117	SENT_7	[p1l437t795r461b837],
51	,	,	O	,	_	0	SENT_7	[p1l437t795r461b837],
52	Gan	NNP	ORGANIZATION	Gan	dep	117	SENT_7	[p1l479t798r556b831],
53	Zhou	NNP	ORGANIZATION	Zhou	dep	117	SENT_7	[p1l572t796r673b831],
54	3	CD	NUMBER	3	dep	117	SENT_7	[p1l684t795r708b837],
55	,	,	O	,	_	0	SENT_7	[p1l684t795r708b837],
56	Bang-Ning	NNP	O	Bang-Ning	dep	117	SENT_7	[p1l727t797r936b840],
57	Yu	NNP	O	Yu	dep	117	SENT_7	[p1l952t798r1002b831],
58	3	CD	NUMBER	3	dep	117	SENT_7	[p1l1014t795r1038b837],
59	,	,	O	,	_	0	SENT_7	[p1l1014t795r1038b837],
60	Julia	NNP	PERSON	Julia	dep	117	SENT_7	[p1l1051t796r1141b840],
61	l	NN	O	l	dep	117	SENT_7	[p1l1158t796r1392b831],
62	(	CD	NUMBER	(	dep	117	SENT_7	[p1l1158t796r1392b831],
63	irchheiner	NN	O	irchheiner	dep	117	SENT_7	[p1l1158t796r1392b831],
64	b	NN	O	b	dep	117	SENT_7	[p1l1402t788r1429b837],
65	,	,	O	,	_	0	SENT_7	[p1l1402t788r1429b837],
66	Hong-Hao	NNP	PERSON	Hong-Hao	dep	117	SENT_7	[p1l1447t798r1649b840],
67	Zhou	NNP	PERSON	Zhou	dep	117	SENT_7	[p1l1666t796r1766b831],
68	“	CD	NUMBER	“	dep	117	SENT_7	[p1l1778t790r1824b815],
69	"	``	O	"	dep	117	SENT_7	[p1l1778t790r1824b815],
70	*	NN	O	*	dep	117	SENT_7	[p1l1778t790r1824b815],
71	3	CD	NUMBER	3	dep	117	SENT_7	[p1l6t871r15b881],
72	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	dep	117	SENT_7	[p1l26t872r235b899],
73	Research	NNP	ORGANIZATION	Research	dep	117	SENT_7	[p1l245t872r346b894],
74	Institute	NNP	ORGANIZATION	Institute	dep	117	SENT_7	[p1l356t872r457b897],
75	,	,	O	,	_	0	SENT_7	[p1l356t872r457b897],
76	Institute	NNP	ORGANIZATION	Institute	dep	117	SENT_7	[p1l468t872r563b894],
77	of	IN	ORGANIZATION	of	dep	117	SENT_7	[p1l574t872r599b899],
78	Clinical	JJ	ORGANIZATION	clinical	dep	117	SENT_7	[p1l605t872r689b894],
79	Pharmacology	NN	ORGANIZATION	pharmacology	dep	117	SENT_7	[p1l698t872r866b899],
80	,	,	O	,	_	0	SENT_7	[p1l698t872r866b899],
81	Central	NNP	ORGANIZATION	Central	dep	117	SENT_7	[p1l878t872r961b894],
82	South	NNP	ORGANIZATION	South	dep	117	SENT_7	[p1l969t872r1035b894],
83	University	NNP	ORGANIZATION	University	dep	117	SENT_7	[p1l1046t872r1166b899],
84	,	,	O	,	_	0	SENT_7	[p1l1046t872r1166b899],
85	Changsha	NNP	LOCATION	Changsha	dep	117	SENT_7	[p1l1177t872r1293b899],
86	,	,	O	,	_	0	SENT_7	[p1l1177t872r1293b899],
87	Hunan	NNP	LOCATION	Hunan	dep	117	SENT_7	[p1l1304t873r1386b897],
88	,	,	O	,	_	0	SENT_7	[p1l1304t873r1386b897],
89	410078	CD	NUMBER	410078	dep	117	SENT_7	[p1l1397t873r1486b897],
90	,	,	O	,	_	0	SENT_7	[p1l1397t873r1486b897],
91	China	NNP	LOCATION	China	dep	117	SENT_7	[p1l1498t872r1563b894],
92	b	NN	O	b	dep	117	SENT_7	[p1l6t902r16b917],
93	Institute	NNP	ORGANIZATION	Institute	dep	117	SENT_7	[p1l27t907r123b929],
94	of	IN	ORGANIZATION	of	dep	117	SENT_7	[p1l133t907r158b934],
95	Natural	NNP	ORGANIZATION	Natural	dep	117	SENT_7	[p1l164t907r251b929],
96	Products	NNPS	ORGANIZATION	Products	dep	117	SENT_7	[p1l260t907r360b929],
97	and	CC	O	and	dep	117	SENT_7	[p1l370t907r413b929],
98	Clinical	JJ	O	clinical	dep	117	SENT_7	[p1l423t907r508b929],
99	Pharmacology	NN	O	pharmacology	dep	117	SENT_7	[p1l517t907r685b934],
100	,	,	O	,	_	0	SENT_7	[p1l517t907r685b934],
101	University	NNP	ORGANIZATION	University	dep	117	SENT_7	[p1l697t907r813b934],
102	Ulm	NNP	ORGANIZATION	Ulm	dep	117	SENT_7	[p1l824t907r874b932],
103	,	,	O	,	_	0	SENT_7	[p1l824t907r874b932],
104	Germany	NNP	ORGANIZATION	Germany	dep	117	SENT_7	[p1l886t908r991b934],
105	C	NNP	ORGANIZATION	C	dep	117	SENT_7	[p1l6t942r14b952],
106	Xiangya	NNP	ORGANIZATION	Xiangya	dep	117	SENT_7	[p1l23t943r118b970],
107	Hospital	NNP	ORGANIZATION	Hospital	dep	117	SENT_7	[p1l128t943r228b970],
108	,	,	O	,	_	0	SENT_7	[p1l128t943r228b970],
109	Central	NNP	ORGANIZATION	Central	dep	117	SENT_7	[p1l240t943r322b964],
110	South	NNP	ORGANIZATION	South	dep	117	SENT_7	[p1l331t943r396b964],
111	University	NNP	ORGANIZATION	University	dep	117	SENT_7	[p1l408t943r527b970],
112	,	,	O	,	_	0	SENT_7	[p1l408t943r527b970],
113	Changsha	NNP	LOCATION	Changsha	dep	117	SENT_7	[p1l539t943r655b970],
114	,	,	O	,	_	0	SENT_7	[p1l539t943r655b970],
115	Hunan	NNP	LOCATION	Hunan	dep	117	SENT_7	[p1l666t944r748b968],
116	,	,	O	,	_	0	SENT_7	[p1l666t944r748b968],
117	China	NNP	LOCATION	China	_	0	SENT_7	[p1l760t943r825b964],

1	ARTICLE	NN	O	article	_	0	SENT_8	[p1l6t1080r230b1102],
2	INFO	NN	O	info	nn	3	SENT_8	[p1l278t1080r401b1102],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_8	[p1l691t1080r960b1102],

1	Article	NNP	O	Article	nn	2	SENT_9	[p1l6t1157r82b1179],
2	history	NN	O	history	_	0	SENT_9	[p1l92t1157r178b1184],
3	:	:	O	:	_	0	SENT_9	[p1l92t1157r178b1184],
4	Background	NN	O	background	dep	2	SENT_9	[p1l6t1196r169b1226],
5	:	:	O	:	_	0	SENT_9	[p1l6t1196r169b1226],
6	Both	CC	O	both	preconj	7	SENT_9	[p1l190t1196r252b1220],
7	atorvastatin	NN	O	atorvastatin	nsubj	11	SENT_9	[p1l272t1197r432b1220],
8	and	CC	O	and	_	0	SENT_9	[p1l453t1196r502b1220],
9	rifampicin	NN	O	rifampicin	nsubj	11	SENT_9	[p1l522t1196r661b1226],
10	are	VBP	O	be	cop	11	SENT_9	[p1l681t1203r722b1220],
11	substrates	NNS	O	substrate	dep	2	SENT_9	[p1l743t1196r878b1220],
12	of	IN	O	of	_	0	SENT_9	[p1l899t1196r927b1220],
13	OATP1B1	NN	O	oatp1b1	prep_of	11	SENT_9	[p1l944t1197r1063b1220],
14	(	CD	NUMBER	(	num	16	SENT_9	[p1l1088t1196r1200b1226],
15	organic	JJ	O	organic	amod	16	SENT_9	[p1l1088t1196r1200b1226],
16	anion	NN	O	anion	nsubj	18	SENT_9	[p1l1220t1197r1295b1220],
17	transporting	VBG	O	transport	partmod	16	SENT_9	[p1l1315t1196r1484b1226],
18	Received	VBN	O	receive	rcmod	11	SENT_9	[p1l6t1237r111b1259],
19	16	CD	DATE	16	num	22	SENT_9	[p1l128t1238r154b1259],
20	February	NNP	DATE	February	nn	22	SENT_9	[p1l171t1237r277b1264],
21	2009	CD	DATE	2009	num	22	SENT_9	[p1l292t1238r352b1259],
22	polypeptide	NN	O	polypeptide	nsubj	23	SENT_9	[p1l714t1238r874b1269],
23	1B1	NN	O	1b1	xcomp	18	SENT_9	[p1l894t1239r959b1269],
24	)	CD	NUMBER	)	num	23	SENT_9	[p1l894t1239r959b1269],
25	encoded	VBN	O	encode	partmod	23	SENT_9	[p1l979t1238r1093b1263],
26	by	IN	O	by	_	0	SENT_9	[p1l1111t1238r1144b1269],
27	SLCOIBI	NN	O	slcoibus	nn	28	SENT_9	[p1l1160t1240r1271b1263],
28	gene	NN	O	gene	agent	25	SENT_9	[p1l1292t1245r1362b1269],
29	.	.	O	.	_	0	SENT_9	[p1l1292t1245r1362b1269],

1	Rifampicin	NNP	O	Rifampicin	nsubj	5	SENT_10	[p1l1381t1238r1525b1269],
2	is	VBZ	O	be	cop	5	SENT_10	[p1l1544t1239r1563b1263],
3	a	DT	O	a	det	5	SENT_10	[p1l1582t1245r1595b1263],
4	potent	JJ	O	potent	amod	5	SENT_10	[p1l1613t1242r1702b1269],
5	inhibitor	NN	O	inhibitor	_	0	SENT_10	[p1l1719t1238r1837b1263],
6	of	IN	O	of	_	0	SENT_10	[p1l1854t1238r1882b1263],
7	SLCO1B1	NN	O	slco1b1	nn	9	SENT_10	[p1l1896t1240r2007b1263],
8	(	CD	NUMBER	(	num	9	SENT_10	[p1l2030t1239r2100b1269],
9	lC50	NN	O	lc50	prep_of	5	SENT_10	[p1l2030t1239r2100b1269],
10	1.5	CD	NUMBER	1.5	num	9	SENT_10	[p1l2120t1240r2154b1263],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l329t1273r434b1295],
2	in	IN	O	in	_	0	SENT_11	[p1l445t1273r467b1294],
3	revised	JJ	O	revised	amod	4	SENT_11	[p1l477t1273r563b1295],
4	form	NN	O	form	prep_in	1	SENT_11	[p1l574t1273r631b1295],
5	2	CD	DATE	2	dep	4	SENT_11	[p1l641t1274r654b1294],
6	April	NNP	DATE	April	tmod	1	SENT_11	[p1l665t1273r723b1300],
7	2009	CD	DATE	2009	num	6	SENT_11	[p1l734t1274r794b1295],

1	umol/1	NN	O	umol/1	_	0	SENT_12	[p1l6t1319r111b1349],
2	)	CD	NUMBER	)	num	1	SENT_12	[p1l6t1319r111b1349],
3	Accepted	JJ	O	accepted	amod	4	SENT_12	[p1l328t1309r437b1336],
4	2	CD	DATE	2	dep	1	SENT_12	[p1l448t1310r461b1330],
5	April	NNP	DATE	April	tmod	4	SENT_12	[p1l471t1309r530b1336],
6	2009	CD	DATE	2009	num	5	SENT_12	[p1l540t1310r600b1330],

1	Available	JJ	O	available	amod	2	SENT_13	[p1l328t1344r436b1366],
2	online	NN	O	online	_	0	SENT_13	[p1l447t1345r522b1366],
3	14	CD	DATE	14	dep	2	SENT_13	[p1l534t1346r560b1366],
4	April	NNP	DATE	April	tmod	3	SENT_13	[p1l569t1344r628b1371],
5	2009	CD	DATE	2009	num	4	SENT_13	[p1l638t1346r698b1366],

1	and	CC	O	and	cc	9	SENT_14	[p1l6t1437r55b1461],
2	SLCO1B1	NN	O	slco1b1	nn	3	SENT_14	[p1l73t1438r185b1461],
3	521T	NN	O	521t	npadvmod	6	SENT_14	[p1l206t1438r305b1461],
4	>	JJR	O	>	dep	5	SENT_14	[p1l206t1438r305b1461],
5	C	NN	O	c	amod	3	SENT_14	[p1l206t1438r305b1461],
6	functional	JJ	O	functional	amod	8	SENT_14	[p1l324t1437r460b1461],
7	genetic	JJ	O	genetic	amod	8	SENT_14	[p1l479t1437r577b1467],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_14	[p1l596t1437r795b1467],
9	alters	VBZ	O	alter	_	0	SENT_14	[p1l814t1437r887b1461],
10	the	DT	O	the	det	11	SENT_14	[p1l907t1437r950b1461],
11	kinetics	NNS	O	kinetics	dobj	9	SENT_14	[p1l969t1437r1072b1461],
12	of	IN	O	of	_	0	SENT_14	[p1l1092t1437r1120b1461],
13	atorvastatin	NN	O	atorvastatin	prep_of	11	SENT_14	[p1l1136t1437r1297b1461],
14	in	FW	O	in	prep	13	SENT_14	[p1l1317t1437r1340b1461],
15	vivo	FW	O	vivo	pobj	14	SENT_14	[p1l1359t1437r1418b1461],
16	.	.	O	.	_	0	SENT_14	[p1l1359t1437r1418b1461],

1	We	PRP	O	we	nsubj	2	SENT_15	[p1l1437t1438r1481b1461],
2	hypothesize	VBP	O	hypothesize	_	0	SENT_15	[p1l6t1477r168b1507],
3	that	IN	O	that	complm	6	SENT_15	[p1l182t1477r237b1501],
4	rifampicin	NN	O	rifampicin	nsubj	6	SENT_15	[p1l250t1477r388b1507],
5	might	MD	O	might	aux	6	SENT_15	[p1l403t1477r483b1507],
6	inﬂuence	VB	O	inﬂuence	ccomp	2	SENT_15	[p1l497t1477r621b1501],
7	atorvastatin	NN	O	atorvastatin	nn	8	SENT_15	[p1l635t1477r796b1501],
8	kinetics	NNS	O	kinetics	dobj	6	SENT_15	[p1l811t1477r914b1501],
9	in	IN	O	in	_	0	SENT_15	[p1l929t1477r953b1501],
10	a	DT	O	a	det	12	SENT_15	[p1l968t1484r981b1501],
11	SLCO1B1	NN	O	slco1b1	nn	12	SENT_15	[p1l994t1478r1105b1501],
12	polymorphism	NN	O	polymorphism	npadvmod	13	SENT_15	[p1l1124t1477r1322b1507],
13	dependent	JJ	O	dependent	amod	14	SENT_15	[p1l1337t1477r1482b1507],
14	manner	NN	O	manner	prep_in	6	SENT_15	[p1l6t1524r115b1541],
15	.	.	O	.	_	0	SENT_15	[p1l6t1524r115b1541],

1	Keywords	NNPS	O	Keywords	_	0	SENT_16	[p1l6t1574r127b1601],
2	:	:	O	:	_	0	SENT_16	[p1l6t1574r127b1601],
3	SLC01	NN	O	slc01	nn	5	SENT_16	[p1l7t1611r79b1631],
4	B1	NN	O	b1	nn	5	SENT_16	[p1l84t1611r110b1631],
5	Rifampicin	NN	O	rifampicin	dep	1	SENT_16	[p1l7t1645r136b1672],

1	Methods	NNS	O	method	_	0	SENT_17	[p1l6t1767r126b1791],
2	:	:	O	:	_	0	SENT_17	[p1l6t1767r126b1791],
3	Sixteen	CD	NUMBER	sixteen	num	4	SENT_17	[p1l136t1767r232b1791],
4	subjects	NNS	O	subject	nsubj	9	SENT_17	[p1l240t1767r345b1797],
5	with	IN	O	with	_	0	SENT_17	[p1l352t1767r413b1791],
6	known	JJ	O	known	amod	8	SENT_17	[p1l420t1767r511b1791],
7	SLCOIB1	NN	O	slcoib1	nn	8	SENT_17	[p1l516t1768r626b1791],
8	genotypes	NNS	O	genotype	prep_with	4	SENT_17	[p1l635t1770r770b1797],
9	(	VBP	O	(	dep	1	SENT_17	[p1l779t1767r806b1797],
10	6	CD	NUMBER	6	num	13	SENT_17	[p1l779t1767r806b1797],
11	c.	NN	O	c.	nn	13	SENT_17	[p1l813t1768r917b1795],
12	521Tl	NN	O	521tl	nn	13	SENT_17	[p1l813t1768r917b1795],
13	‘	NN	O	‘	dobj	9	SENT_17	[p1l813t1768r917b1795],
14	,	,	O	,	_	0	SENT_17	[p1l813t1768r917b1795],
15	6	CD	NUMBER	6	num	16	SENT_17	[p1l924t1768r939b1791],
16	c.	NN	O	c.	dobj	9	SENT_17	[p1l946t1768r1011b1791],
17	521	CD	NUMBER	521	num	18	SENT_17	[p1l946t1768r1011b1791],
18	TC	NN	O	tc	dep	16	SENT_17	[p1l1015t1768r1048b1791],
19	and	CC	O	and	_	0	SENT_17	[p1l1054t1767r1103b1791],
20	4	CD	NUMBER	4	num	21	SENT_17	[p1l1109t1768r1125b1791],
21	c.	NN	O	c.	dobj	9	SENT_17	[p1l1132t1768r1196b1791],
22	521	CD	NUMBER	521	num	24	SENT_17	[p1l1132t1768r1196b1791],
23	CC	NN	O	cc	nn	24	SENT_17	[p1l1202t1767r1245b1797],
24	)	NN	O	)	nsubjpass	26	SENT_17	[p1l1202t1767r1245b1797],
25	were	VBD	O	be	auxpass	26	SENT_17	[p1l1253t1774r1319b1791],
26	divided	VBN	O	divide	rcmod	21	SENT_17	[p1l1327t1767r1424b1791],
27	into	IN	O	into	_	0	SENT_17	[p1l1432t1767r1482b1791],
28	2	CD	NUMBER	2	num	29	SENT_17	[p1l7t1808r21b1831],
29	groups	NNS	O	group	prep_into	26	SENT_17	[p1l34t1814r124b1837],
30	(	CD	NUMBER	(	num	31	SENT_17	[p1l138t1807r426b1837],
31	atorvastatin	NN	O	atorvastatin	dep	29	SENT_17	[p1l138t1807r426b1837],
32	—	CD	NUMBER	—	num	34	SENT_17	[p1l138t1807r426b1837],
33	placebo	NN	O	placebo	nn	34	SENT_17	[p1l138t1807r426b1837],
34	group	NN	O	group	dep	29	SENT_17	[p1l437t1814r521b1837],
35	,	,	O	,	_	0	SENT_17	[p1l437t1814r521b1837],
36	n	NN	O	n	appos	34	SENT_17	[p1l533t1814r579b1831],
37	:	:	O	:	_	0	SENT_17	[p1l533t1814r579b1831],
38	8	CD	NUMBER	8	dep	29	SENT_17	[p1l587t1808r610b1835],
39	;	:	O	;	_	0	SENT_17	[p1l587t1808r610b1835],
40	atorvastatin	NN	O	atorvastatin	nn	43	SENT_17	[p1l624t1807r935b1837],
41	—	CD	NUMBER	—	num	43	SENT_17	[p1l624t1807r935b1837],
42	rifampicin	NN	O	rifampicin	nn	43	SENT_17	[p1l624t1807r935b1837],
43	group	NN	O	group	dep	29	SENT_17	[p1l946t1814r1029b1837],
44	,	,	O	,	_	0	SENT_17	[p1l946t1814r1029b1837],
45	n	NN	O	n	appos	29	SENT_17	[p1l1042t1807r1122b1837],
46	=	JJ	O	=	amod	48	SENT_17	[p1l1042t1807r1122b1837],
47	8	CD	NUMBER	8	tmod	46	SENT_17	[p1l1042t1807r1122b1837],
48	)	NN	O	)	dep	45	SENT_17	[p1l1042t1807r1122b1837],
49	randomly	RB	O	randomly	advmod	26	SENT_17	[p1l1136t1807r1268b1837],
50	.	.	O	.	_	0	SENT_17	[p1l1136t1807r1268b1837],

1	In	IN	O	in	_	0	SENT_18	[p1l1281t1808r1305b1831],
2	this	DT	O	this	det	5	SENT_18	[p1l1317t1807r1365b1831],
3	2-phase	JJ	O	2-phase	amod	5	SENT_18	[p1l1378t1807r1483b1837],
4	crossover	NN	O	crossover	nn	5	SENT_18	[p1l7t1854r132b1871],
5	study	NN	O	study	prep_in	28	SENT_18	[p1l141t1847r218b1877],
6	,	,	O	,	_	0	SENT_18	[p1l141t1847r218b1877],
7	atorvastatin	NN	O	atorvastatin	nsubjpass	28	SENT_18	[p1l227t1847r384b1871],
8	(	CD	NUMBER	(	num	14	SENT_18	[p1l395t1847r438b1877],
9	40	CD	NUMBER	40	num	14	SENT_18	[p1l395t1847r438b1877],
10	mg	NN	O	mg	nn	14	SENT_18	[p1l448t1854r490b1877],
11	single-oral	JJ	O	single-oral	amod	14	SENT_18	[p1l499t1847r638b1877],
12	dose	NN	O	dose	nn	14	SENT_18	[p1l648t1847r719b1877],
13	)	NN	O	)	nn	14	SENT_18	[p1l648t1847r719b1877],
14	pharmacokinetics	NNS	O	pharmacokinetic	dep	7	SENT_18	[p1l730t1847r965b1877],
15	after	IN	O	after	_	0	SENT_18	[p1l974t1847r1036b1871],
16	co-administration	NN	O	co-administration	prep_after	28	SENT_18	[p1l1044t1847r1280b1871],
17	of	IN	O	of	_	0	SENT_18	[p1l1290t1847r1318b1871],
18	placebo	NN	O	placebo	nn	21	SENT_18	[p1l1324t1847r1424b1877],
19	and	CC	O	and	_	0	SENT_18	[p1l1434t1847r1482b1871],
20	rifampicin	NN	O	rifampicin	conj_and	18	SENT_18	[p1l7t1887r142b1917],
21	(	NN	O	(	prep_of	16	SENT_18	[p1l151t1887r211b1917],
22	600	CD	NUMBER	600	num	23	SENT_18	[p1l151t1887r211b1917],
23	mg	NN	O	mg	nsubjpass	28	SENT_18	[p1l219t1894r261b1917],
24	single-oral	JJ	O	single-oral	amod	26	SENT_18	[p1l267t1887r406b1917],
25	dose	NN	O	dose	nn	26	SENT_18	[p1l413t1887r484b1917],
26	)	NN	O	)	dep	23	SENT_18	[p1l413t1887r484b1917],
27	were	VBD	O	be	auxpass	28	SENT_18	[p1l492t1894r558b1911],
28	measured	VBN	O	measure	_	0	SENT_18	[p1l565t1887r695b1911],
29	for	IN	O	for	_	0	SENT_18	[p1l701t1887r738b1911],
30	up	RB	O	up	quantmod	32	SENT_18	[p1l744t1894r777b1917],
31	to	TO	O	to	dep	32	SENT_18	[p1l784t1890r809b1911],
32	48	CD	NUMBER	48	num	33	SENT_18	[p1l815t1888r847b1911],
33	h	NN	O	h	prep_for	28	SENT_18	[p1l855t1887r871b1911],
34	by	IN	O	by	_	0	SENT_18	[p1l878t1887r910b1917],
35	liquid	JJ	O	liquid	amod	41	SENT_18	[p1l915t1887r990b1917],
36	chromatography	NN	O	chromatography	dep	35	SENT_18	[p1l997t1887r1299b1917],
37	—	CD	NUMBER	—	num	36	SENT_18	[p1l997t1887r1299b1917],
38	mass	NN	O	mass	nn	41	SENT_18	[p1l997t1887r1299b1917],
39	spectrometry	NN	O	spectrometry	nn	41	SENT_18	[p1l1307t1890r1483b1917],
40	(	CD	NUMBER	(	num	41	SENT_18	[p1l6t1927r126b1957],
41	LC	NN	O	lc	agent	28	SENT_18	[p1l6t1927r126b1957],
42	.	.	O	.	_	0	SENT_18	[p1l6t1927r126b1957],

1	—	NN	O	—	_	0	SENT_19	[p1l6t1927r126b1957],
2	.	.	O	.	_	0	SENT_19	[p1l6t1927r126b1957],

1	MS	NN	O	m	_	0	SENT_20	[p1l6t1927r126b1957],
2	)	NN	O	)	dep	1	SENT_20	[p1l6t1927r126b1957],
3	.	.	O	.	_	0	SENT_20	[p1l6t1927r126b1957],

1	In	IN	O	in	_	0	SENT_21	[p1l135t1928r159b1951],
2	the	DT	O	the	det	4	SENT_21	[p1l168t1927r210b1951],
3	third	JJ	ORDINAL	third	amod	4	SENT_21	[p1l219t1927r283b1951],
4	phase	NN	O	phase	prep_in	15	SENT_21	[p1l292t1927r375b1957],
5	,	,	O	,	_	0	SENT_21	[p1l292t1927r375b1957],
6	rifampicin	NN	O	rifampicin	nn	7	SENT_21	[p1l384t1927r519b1957],
7	(	NN	O	(	nsubjpass	15	SENT_21	[p1l530t1927r590b1957],
8	450	CD	NUMBER	450	num	13	SENT_21	[p1l530t1927r590b1957],
9	mg	NN	O	mg	nn	13	SENT_21	[p1l599t1934r641b1957],
10	single-oral	JJ	O	single-oral	amod	13	SENT_21	[p1l650t1927r789b1957],
11	dose	NN	O	dose	nn	13	SENT_21	[p1l798t1927r869b1957],
12	)	NN	O	)	nn	13	SENT_21	[p1l798t1927r869b1957],
13	pharmacokinetics	NNS	O	pharmacokinetic	dep	7	SENT_21	[p1l880t1927r1114b1957],
14	was	VBD	O	be	auxpass	15	SENT_21	[p1l1123t1934r1174b1951],
15	measured	VBN	O	measure	_	0	SENT_21	[p1l1183t1927r1313b1951],
16	additionally	RB	O	additionally	advmod	15	SENT_21	[p1l1322t1927r1483b1957],
17	.	.	O	.	_	0	SENT_21	[p1l1322t1927r1483b1957],

1	Results	NNS	O	result	_	0	SENT_22	[p1l1495t1927r1591b1951],
2	:	:	O	:	_	0	SENT_22	[p1l1495t1927r1591b1951],
3	Rifampicin	NN	O	rifampicin	dep	1	SENT_22	[p1l1604t1927r1745b1957],
4	increased	VBD	O	increase	rcmod	3	SENT_22	[p1l1756t1927r1881b1951],
5	atorvastatin	NN	O	atorvastatin	nn	7	SENT_22	[p1l1892t1927r2049b1951],
6	plasma	NN	O	plasma	nn	7	SENT_22	[p1l2060t1927r2154b1957],
7	concentration	NN	O	concentration	dobj	4	SENT_22	[p1l6t1966r189b1990],
8	in	IN	O	in	_	0	SENT_22	[p1l202t1966r227b1990],
9	accordance	NN	O	accordance	_	0	SENT_22	[p1l240t1966r387b1990],
10	with	IN	O	with	_	0	SENT_22	[p1l399t1966r461b1990],
11	SLCO1B1	NN	O	slco1b1	nn	12	SENT_22	[p1l472t1967r582b1990],
12	521T	NN	O	521t	prep_in_accordance_with	7	SENT_22	[p1l596t1967r694b1990],
13	>	JJR	O	>	amod	15	SENT_22	[p1l596t1967r694b1990],
14	C	NN	O	c	nn	15	SENT_22	[p1l596t1967r694b1990],
15	genotype	NN	O	genotype	dep	12	SENT_22	[p1l707t1969r829b1996],
16	while	IN	O	while	mark	28	SENT_22	[p1l841t1966r915b1990],
17	the	DT	O	the	det	19	SENT_22	[p1l925t1966r967b1990],
18	increasing	VBG	O	increase	amod	19	SENT_22	[p1l977t1966r1112b1997],
19	percentage	NN	O	percentage	nsubj	28	SENT_22	[p1l1120t1970r1265b1997],
20	of	IN	O	of	_	0	SENT_22	[p1l1275t1966r1303b1990],
21	AUCUHS	NN	O	aucuh	nn	22	SENT_22	[p1l1305t1967r1429b1999],
22	)	NN	O	)	prep_of	19	SENT_22	[p1l1305t1967r1429b1999],
23	among	IN	O	among	_	0	SENT_22	[p1l1440t1973r1531b1996],
24	c.	NN	O	c.	nn	25	SENT_22	[p1l1540t1967r1644b1994],
25	521T1	NN	O	521t1	prep_among	22	SENT_22	[p1l1540t1967r1644b1994],
26	"	''	O	"	punct	25	SENT_22	[p1l1540t1967r1644b1994],
27	,	,	O	,	_	0	SENT_22	[p1l1540t1967r1644b1994],
28	c.	VBP	O	c.	dep	15	SENT_22	[p1l1654t1967r1755b1991],
29	521TC	NN	O	521tc	nn	34	SENT_22	[p1l1654t1967r1755b1991],
30	and	CC	O	and	_	0	SENT_22	[p1l1764t1966r1813b1990],
31	c.	NN	O	c.	nn	34	SENT_22	[p1l1823t1967r1887b1991],
32	521	CD	NUMBER	521	num	34	SENT_22	[p1l1823t1967r1887b1991],
33	CC	NN	O	cc	nn	34	SENT_22	[p1l1892t1967r1926b1990],
34	individuals	NNS	O	individual	nsubj	36	SENT_22	[p1l1935t1966r2079b1990],
35	were	VBD	O	be	cop	36	SENT_22	[p1l2089t1973r2154b1990],
36	833	CD	NUMBER	833	ccomp	28	SENT_22	[p1l485t2007r532b2030],
37	:	:	O	:	_	0	SENT_22	[p1l540t2019r562b2031],
38	:	:	O	:	_	0	SENT_22	[p1l540t2019r562b2031],
39	245	CD	PERCENT	245	num	40	SENT_22	[p1l569t2007r636b2030],
40	%	NN	PERCENT	%	dep	7	SENT_22	[p1l569t2007r636b2030],
41	vs	CC	O	vs	_	0	SENT_22	[p1l642t2012r668b2030],
42	468	CD	NUMBER	468	conj_vs	40	SENT_22	[p1l677t2006r728b2030],
43	:	:	O	:	_	0	SENT_22	[p1l736t2019r758b2031],
44	:	:	O	:	_	0	SENT_22	[p1l736t2019r758b2031],
45	233	CD	PERCENT	233	num	46	SENT_22	[p1l766t2006r834b2030],
46	%	NN	PERCENT	%	dep	3	SENT_22	[p1l766t2006r834b2030],
47	vs	CC	O	vs	_	0	SENT_22	[p1l855t2012r881b2030],
48	330	CD	NUMBER	330	dep	3	SENT_22	[p1l902t2006r952b2030],
49	:	:	O	:	_	0	SENT_22	[p1l959t2019r981b2031],
50	:	:	O	:	_	0	SENT_22	[p1l959t2019r981b2031],
51	223	CD	PERCENT	223	num	52	SENT_22	[p1l989t2006r1058b2030],
52	%	NN	PERCENT	%	dep	1	SENT_22	[p1l989t2006r1058b2030],
53	(	CD	NUMBER	(	num	54	SENT_22	[p1l1080t2005r1138b2036],
54	P	NN	O	p	dep	52	SENT_22	[p1l1080t2005r1138b2036],
55	:	:	O	:	_	0	SENT_22	[p1l1080t2005r1138b2036],
56	0.007	CD	NUMBER	0.007	dep	1	SENT_22	[p1l1146t2005r1241b2036],
57	)	NN	O	)	dep	56	SENT_22	[p1l1146t2005r1241b2036],
58	.	.	O	.	_	0	SENT_22	[p1l1146t2005r1241b2036],

1	However	RB	O	however	advmod	7	SENT_23	[p1l1263t2007r1391b2034],
2	,	,	O	,	_	0	SENT_23	[p1l1263t2007r1391b2034],
3	SLCOIBI	NN	O	slcoibus	nn	4	SENT_23	[p1l1411t2006r1524b2030],
4	521T	NN	O	521t	nsubj	7	SENT_23	[p1l1546t2007r1647b2030],
5	>	JJR	O	>	dep	6	SENT_23	[p1l1546t2007r1647b2030],
6	C	NN	O	c	amod	4	SENT_23	[p1l1546t2007r1647b2030],
7	exerted	VBD	O	exert	dep	13	SENT_23	[p1l1667t2005r1769b2030],
8	no	DT	O	no	det	9	SENT_23	[p1l1791t2012r1824b2030],
9	impact	NN	O	impact	dobj	7	SENT_23	[p1l1845t2006r1939b2036],
10	on	IN	O	on	_	0	SENT_23	[p1l1959t2012r1992b2030],
11	rifampicin	NN	O	rifampicin	nn	12	SENT_23	[p1l2013t2005r2154b2036],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_23	[p1l6t2045r241b2075],
13	(	VBP	O	(	_	0	SENT_23	[p1l252t2045r377b2075],
14	P	NN	O	p	dep	15	SENT_23	[p1l252t2045r377b2075],
15	>	JJR	O	>	dobj	13	SENT_23	[p1l252t2045r377b2075],
16	0.05	CD	NUMBER	0.05	num	17	SENT_23	[p1l252t2045r377b2075],
17	)	NN	O	)	nsubj	13	SENT_23	[p1l252t2045r377b2075],
18	.	.	O	.	_	0	SENT_23	[p1l252t2045r377b2075],

1	Conclusions	NNS	O	conclusion	_	0	SENT_24	[p1l6t2084r163b2108],
2	:	:	O	:	_	0	SENT_24	[p1l6t2084r163b2108],
3	These	DT	O	these	det	4	SENT_24	[p1l180t2084r257b2108],
4	results	NNS	O	result	nsubj	5	SENT_24	[p1l275t2084r362b2108],
5	suggested	VBD	O	suggest	dep	1	SENT_24	[p1l381t2084r511b2114],
6	that	IN	O	that	complm	8	SENT_24	[p1l529t2084r582b2108],
7	rifampicin	NN	O	rifampicin	nsubj	8	SENT_24	[p1l600t2084r735b2114],
8	elevated	VBD	O	elevate	ccomp	5	SENT_24	[p1l753t2084r864b2108],
9	the	DT	O	the	det	12	SENT_24	[p1l881t2084r923b2108],
10	plasma	NN	O	plasma	nn	12	SENT_24	[p1l942t2084r1036b2114],
11	concentration	NN	O	concentration	nn	12	SENT_24	[p1l1054t2084r1236b2108],
12	ofatorvastatin	NN	O	ofatorvastatin	dobj	8	SENT_24	[p1l1255t2084r1443b2108],
13	depending	VBG	O	depend	_	0	SENT_24	[p1l1461t2084r1602b2114],
14	on	IN	O	on	prepc_depending_on	8	SENT_24	[p1l1622t2091r1655b2108],
15	SLCO1B1	NN	O	slco1b1	nn	16	SENT_24	[p1l1674t2085r1783b2108],
16	genotype	NN	O	genotype	pobj	8	SENT_24	[p1l1806t2087r1929b2114],
17	and	CC	O	and	_	0	SENT_24	[p1l1949t2084r1998b2108],
18	rifampicin	NN	O	rifampicin	nn	19	SENT_24	[p1l2019t2084r2154b2114],
19	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	22	SENT_24	[p1l1393t2123r1627b2153],
20	were	VBD	O	be	auxpass	22	SENT_24	[p1l1636t2130r1702b2147],
21	not	RB	O	not	neg	22	SENT_24	[p1l1712t2126r1756b2147],
22	altered	VBN	O	alter	conj_and	5	SENT_24	[p1l1764t2123r1855b2147],
23	by	IN	O	by	_	0	SENT_24	[p1l1865t2123r1897b2153],
24	SLC01B1	NN	O	slc01b1	nn	25	SENT_24	[p1l1904t2124r2013b2147],
25	genotype	NN	O	genotype	agent	22	SENT_24	[p1l2025t2126r2154b2153],
26	.	.	O	.	_	0	SENT_24	[p1l2025t2126r2154b2153],

1	1	LS	NUMBER	1	_	0	SENT_25	[p1l11t2453r56b2503],
2	.	.	O	.	_	0	SENT_25	[p1l11t2453r56b2503],

1	Introduction	NN	O	introduction	_	0	SENT_26	[p1l80t2450r476b2502],

1	Atorvastatin	NNP	O	Atorvastatin	nsubj	3	SENT_27	[p1l105t2621r456b2673],
2	is	VBZ	O	be	cop	3	SENT_27	[p1l477t2622r519b2673],
3	one	CD	NUMBER	one	_	0	SENT_27	[p1l540t2636r644b2673],
4	of	IN	O	of	_	0	SENT_27	[p1l664t2620r724b2673],
5	the	DT	O	the	det	10	SENT_27	[p1l737t2621r829b2673],
6	most	RBS	O	most	advmod	7	SENT_27	[p1l850t2629r993b2673],
7	potent	JJ	O	potent	amod	10	SENT_27	[p1l1012t2629r1199b2686],
8	3	CD	NUMBER	3	num	10	SENT_27	[p1l1217t2621r2051b2686],
9	—	NN	O	—	nn	10	SENT_27	[p1l1217t2621r2051b2686],
10	hydroxy	NN	O	hydroxy	prep_of	3	SENT_27	[p1l1217t2621r2051b2686],
11	—	CD	NUMBER	—	number	12	SENT_27	[p1l1217t2621r2051b2686],
12	3	CD	NUMBER	3	num	17	SENT_27	[p1l1217t2621r2051b2686],
13	—	NN	O	—	nn	17	SENT_27	[p1l1217t2621r2051b2686],
14	methylglutaryl	NN	O	methylglutaryl	nn	17	SENT_27	[p1l1217t2621r2051b2686],
15	—	CD	NUMBER	—	num	17	SENT_27	[p1l1217t2621r2051b2686],
16	CoA	NN	O	coa	nn	17	SENT_27	[p1l10t2708r124b2758],
17	reductase	NN	O	reductase	dep	3	SENT_27	[p1l138t2706r412b2758],
18	inhibitors	NNS	O	inhibitor	dep	17	SENT_27	[p1l429t2705r704b2758],
19	for	IN	O	for	_	0	SENT_27	[p1l720t2705r799b2758],
20	treatment	NN	O	treatment	prep_for	18	SENT_27	[p1l813t2713r1101b2758],
21	of	IN	O	of	_	0	SENT_27	[p1l1113t2705r1174b2758],
22	hypercholesterolemia	NN	O	hypercholesterolemia	prep_of	20	SENT_27	[p1l1182t2705r1804b2771],
23	which	WDT	O	which	nsubj	28	SENT_27	[p1l1816t2705r1995b2758],
24	is	VBZ	O	be	cop	28	SENT_27	[p1l2010t2706r2051b2758],
25	an	DT	O	a	det	28	SENT_27	[p1l10t2806r78b2843],
26	important	JJ	O	important	amod	28	SENT_27	[p1l112t2792r402b2856],
27	risk	NN	O	risk	nn	28	SENT_27	[p1l436t2791r541b2843],
28	factor	NN	O	factor	rcmod	3	SENT_27	[p1l574t2791r738b2843],
29	in	IN	O	in	_	0	SENT_27	[p1l772t2792r824b2843],
30	the	DT	O	the	det	31	SENT_27	[p1l859t2791r950b2843],
31	development	NN	O	development	prep_in	28	SENT_27	[p1l985t2791r1365b2856],
32	of	IN	O	of	_	0	SENT_27	[p1l1398t2791r1459b2843],
33	atherosclerosis	NN	O	atherosclerosis	prep_of	31	SENT_27	[p1l1485t2791r1911b2843],
34	and	CC	O	and	_	0	SENT_27	[p1l1946t2791r2051b2843],
35	coronary	JJ	O	coronary	amod	40	SENT_27	[p1l10t2891r264b2941],
36	heart	NN	O	heart	nn	40	SENT_27	[p1l299t2876r449b2928],
37	disease	NN	O	disease	nn	40	SENT_27	[p1l483t2876r690b2928],
38	(	CD	NUMBER	(	num	40	SENT_27	[p1l729t2876r921b2941],
39	CHD	NN	O	chd	nn	40	SENT_27	[p1l729t2876r921b2941],
40	)	NN	O	)	prep_of	31	SENT_27	[p1l729t2876r921b2941],
41	.	.	O	.	_	0	SENT_27	[p1l729t2876r921b2941],

1	Several	JJ	O	several	amod	2	SENT_28	[p1l958t2876r1162b2928],
2	studies	NNS	O	study	nsubj	3	SENT_28	[p1l1198t2876r1398b2928],
3	showed	VBD	O	show	_	0	SENT_28	[p1l1436t2876r1657b2928],
4	that	IN	O	that	complm	47	SENT_28	[p1l1692t2876r1808b2928],
5	organic	JJ	O	organic	amod	6	SENT_28	[p1l1841t2877r2052b2941],
6	anion	NN	O	anion	nsubj	47	SENT_28	[p1l10t2961r170b3012],
7	transporting	VBG	O	transport	partmod	6	SENT_28	[p1l190t2961r548b3026],
8	polypeptide	NN	O	polypeptide	nn	9	SENT_28	[p1l568t2960r909b3026],
9	1B1	NN	O	1b1	dobj	7	SENT_28	[p1l933t2963r1030b3012],
10	(	CD	NUMBER	(	num	12	SENT_28	[p1l1062t2960r1371b3026],
11	OATP1B1	NN	O	oatp1b1	nn	12	SENT_28	[p1l1062t2960r1371b3026],
12	)	NN	O	)	nsubjpass	18	SENT_28	[p1l1062t2960r1371b3026],
13	encoded	VBN	O	encode	partmod	12	SENT_28	[p1l1396t2960r1637b3012],
14	by	IN	O	by	_	0	SENT_28	[p1l1659t2960r1728b3026],
15	SLCOIB1	NN	O	slcoib1	agent	13	SENT_28	[p1l1744t2963r1981b3012],
16	is	VBZ	O	be	auxpass	18	SENT_28	[p1l2010t2961r2051b3012],
17	speciﬁcally	RB	O	speciﬁcally	advmod	18	SENT_28	[p1l11t3045r325b3111],
18	expressed	VBN	O	express	rcmod	9	SENT_28	[p1l345t3045r629b3111],
19	at	IN	O	at	_	0	SENT_28	[p1l652t3053r706b3097],
20	the	DT	O	the	det	22	SENT_28	[p1l726t3045r817b3097],
21	basolateral	JJ	O	basolateral	amod	22	SENT_28	[p1l839t3045r1150b3097],
22	membrane	NN	O	membrane	prep_at	18	SENT_28	[p1l1173t3045r1483b3097],
23	of	IN	O	of	_	0	SENT_28	[p1l1506t3045r1566b3097],
24	hepatocytes	NNS	O	hepatocyte	prep_of	22	SENT_28	[p1l1582t3045r1924b3111],
25	and	CC	O	and	_	0	SENT_28	[p1l1946t3045r2051b3097],
26	genetic	JJ	O	genetic	amod	27	SENT_28	[p1l9t3132r217b3196],
27	variations	NNS	O	variation	nsubjpass	32	SENT_28	[p1l239t3131r522b3183],
28	in	IN	O	in	_	0	SENT_28	[p1l548t3132r602b3182],
29	SLCO1B1	NN	O	slco1b1	prep_in	27	SENT_28	[p1l624t3133r861b3183],
30	have	VBP	O	have	aux	32	SENT_28	[p1l894t3131r1025b3183],
31	been	VBN	O	be	auxpass	32	SENT_28	[p1l1051t3131r1190b3183],
32	shown	VBN	O	show	conj_and	18	SENT_28	[p1l1216t3131r1406b3183],
33	to	TO	O	to	aux	34	SENT_28	[p1l1432t3139r1486b3183],
34	impair	VB	O	impair	xcomp	32	SENT_28	[p1l1513t3132r1701b3196],
35	the	DT	O	the	det	37	SENT_28	[p1l1725t3131r1816b3183],
36	cellular	JJ	O	cellular	amod	37	SENT_28	[p1l1843t3131r2054b3183],
37	uptake	NN	O	uptake	dobj	34	SENT_28	[p1l10t3216r204b3281],
38	of	IN	O	of	_	0	SENT_28	[p1l237t3216r297b3268],
39	its	PRP$	O	its	poss	40	SENT_28	[p1l322t3217r387b3268],
40	substrates	NNS	O	substrate	prep_of	37	SENT_28	[p1l420t3216r708b3268],
41	including	VBG	O	include	_	0	SENT_28	[p1l740t3216r1009b3281],
42	exogenous	JJ	O	exogenous	amod	43	SENT_28	[p1l1039t3231r1342b3281],
43	drugs	NNS	O	drug	prep_including	34	SENT_28	[p1l1375t3216r1533b3281],
44	and	CC	O	and	_	0	SENT_28	[p1l1567t3216r1671b3268],
45	endogenous	JJ	O	endogenous	amod	46	SENT_28	[p1l1704t3216r2051b3281],
46	compounds	NNS	O	compound	prep_including	34	SENT_28	[p1l10t3300r345b3366],
47	[	VBP	O	[	ccomp	3	SENT_28	[p1l366t3300r498b3366],
48	1,2	CD	NUMBER	1,2	number	49	SENT_28	[p1l366t3300r498b3366],
49	]	CD	NUMBER	]	dobj	47	SENT_28	[p1l366t3300r498b3366],
50	.	.	O	.	_	0	SENT_28	[p1l366t3300r498b3366],

1	Naturally	RB	O	naturally	advmod	2	SENT_29	[p1l516t3300r780b3366],
2	occurring	VBG	O	occur	_	0	SENT_29	[p1l794t3301r1067b3366],
3	SNP	NN	ORGANIZATION	snp	nsubjpass	14	SENT_29	[p1l1083t3303r1202b3360],
4	,	,	O	,	_	0	SENT_29	[p1l1083t3303r1202b3360],
5	SLCO1B1	NN	O	slco1b1	nn	6	SENT_29	[p1l1217t3303r1453b3352],
6	521T	NN	O	521t	appos	3	SENT_29	[p1l1474t3303r1687b3352],
7	>	JJR	O	>	amod	8	SENT_29	[p1l1474t3303r1687b3352],
8	C	NN	O	c	dep	6	SENT_29	[p1l1474t3303r1687b3352],
9	(	CD	NUMBER	(	num	11	SENT_29	[p1l1706t3300r2051b3365],
10	Val174Ala	NN	O	val174alum	nn	11	SENT_29	[p1l1706t3300r2051b3365],
11	)	NN	O	)	dep	6	SENT_29	[p1l1706t3300r2051b3365],
12	,	,	O	,	_	0	SENT_29	[p1l1706t3300r2051b3365],
13	was	VBD	O	be	auxpass	14	SENT_29	[p1l8t3400r120b3437],
14	found	VBN	O	find	ccomp	2	SENT_29	[p1l162t3385r329b3437],
15	to	TO	O	to	aux	17	SENT_29	[p1l372t3393r426b3437],
16	be	VB	O	be	auxpass	17	SENT_29	[p1l468t3385r535b3437],
17	associated	VBN	O	associate	xcomp	14	SENT_29	[p1l578t3385r872b3437],
18	with	IN	O	with	_	0	SENT_29	[p1l913t3385r1045b3437],
19	marked	JJ	O	marked	amod	20	SENT_29	[p1l1089t3385r1306b3437],
20	alterations	NNS	O	alteration	prep_with	17	SENT_29	[p1l1349t3385r1652b3437],
21	of	IN	O	of	_	0	SENT_29	[p1l1695t3385r1755b3437],
22	OATP1B1	NN	O	oatp1b1	prep_of	20	SENT_29	[p1l1791t3387r2044b3437],

1	transport	NN	O	transport	nn	2	SENT_30	[p2l9t31r276b89],
2	activity	NN	O	activity	_	0	SENT_30	[p2l314t24r525b89],
3	in	FW	O	in	prep	2	SENT_30	[p2l561t24r611b75],
4	vitro	FW	O	vitro	nn	5	SENT_30	[p2l649t24r775b75],
5	[	FW	O	[	pobj	3	SENT_30	[p2l818t23r906b89],
6	3	CD	NUMBER	3	num	7	SENT_30	[p2l818t23r906b89],
7	]	NN	O	]	dep	5	SENT_30	[p2l818t23r906b89],
8	.	.	O	.	_	0	SENT_30	[p2l818t23r906b89],

1	It	PRP	O	it	nsubjpass	4	SENT_31	[p2l947t27r986b75],
2	has	VBZ	O	have	aux	4	SENT_31	[p2l1024t23r1118b75],
3	been	VBN	O	be	auxpass	4	SENT_31	[p2l1158t23r1296b75],
4	shown	VBN	O	show	_	0	SENT_31	[p2l1336t23r1526b75],
5	that	IN	O	that	complm	13	SENT_31	[p2l1565t23r1680b75],
6	the	DT	O	the	det	8	SENT_31	[p2l1718t23r1809b75],
7	plasma	NN	O	plasma	nn	8	SENT_31	[p2l1849t23r2053b89],
8	concentration	NN	O	concentration	nsubj	13	SENT_31	[p2l10t109r407b160],
9	of	IN	O	of	_	0	SENT_31	[p2l439t108r500b160],
10	pravastatin	NN	O	pravastatin	prep_of	8	SENT_31	[p2l526t109r843b174],
11	was	VBD	O	be	cop	13	SENT_31	[p2l873t124r984b160],
12	1.5	CD	NUMBER	1.5	number	13	SENT_31	[p2l1021t108r1232b161],
13	—	CD	NUMBER	—	ccomp	4	SENT_31	[p2l1021t108r1232b161],
14	fold	NN	O	fold	dep	13	SENT_31	[p2l1021t108r1232b161],
15	increased	VBN	O	increase	partmod	13	SENT_31	[p2l1267t108r1538b160],
16	in	IN	O	in	_	0	SENT_31	[p2l1572t109r1624b160],
17	subjects	NNS	O	subject	prep_in	15	SENT_31	[p2l1658t108r1887b174],
18	with	IN	O	with	_	0	SENT_31	[p2l1919t108r2051b160],
19	SLCO1	NN	O	slco1	nn	20	SENT_31	[p2l6t196r172b246],
20	B1	NN	O	b1	prep_with	17	SENT_31	[p2l181t197r243b245],
21	*	CD	NUMBER	*	number	22	SENT_31	[p2l259t194r318b246],
22	5	CD	NUMBER	5	num	23	SENT_31	[p2l259t194r318b246],
23	haplotype	NN	O	haplotype	dobj	15	SENT_31	[p2l343t194r629b259],
24	compared	VBN	O	compare	_	0	SENT_31	[p2l654t194r939b259],
25	with	IN	O	with	prepc_compared_with	23	SENT_31	[p2l964t194r1097b246],
26	SLCO1B1	NN	O	slco1b1	nn	28	SENT_31	[p2l1118t194r1597b255],
27	*	CD	NUMBER	*	num	28	SENT_31	[p2l1118t194r1597b255],
28	1a	NN	O	1a	pobj	23	SENT_31	[p2l1118t194r1597b255],
29	/	:	O	/	punct	33	SENT_31	[p2l1118t194r1597b255],
30	*	CD	NUMBER	*	num	32	SENT_31	[p2l1118t194r1597b255],
31	1a	NN	O	1a	nn	32	SENT_31	[p2l1118t194r1597b255],
32	individuals	NNS	O	individual	nsubj	33	SENT_31	[p2l1621t194r1935b246],
33	[	VBP	O	[	dep	13	SENT_31	[p2l1963t194r2051b259],
34	4	CD	NUMBER	4	number	35	SENT_31	[p2l1963t194r2051b259],
35	]	CD	NUMBER	]	dobj	33	SENT_31	[p2l1963t194r2051b259],
36	.	.	O	.	_	0	SENT_31	[p2l1963t194r2051b259],

1	Moreover	RB	O	moreover	advmod	11	SENT_32	[p2l10t282r296b339],
2	,	,	O	,	_	0	SENT_32	[p2l10t282r296b339],
3	2-fold	RB	O	2-fold	advmod	4	SENT_32	[p2l327t279r497b331],
4	higher	JJR	O	higher	amod	6	SENT_32	[p2l528t279r714b344],
5	blood	NN	O	blood	nn	6	SENT_32	[p2l741t279r901b331],
6	concentration	NN	O	concentration	nsubjpass	11	SENT_32	[p2l932t280r1329b331],
7	of	IN	O	of	_	0	SENT_32	[p2l1359t279r1419b331],
8	simvastatin	NN	O	simvastatin	nn	9	SENT_32	[p2l1442t280r1769b331],
9	acid	NN	O	acid	prep_of	6	SENT_32	[p2l1798t279r1912b331],
10	was	VBD	O	be	auxpass	11	SENT_32	[p2l1941t294r2052b331],
11	observed	VBN	O	observe	_	0	SENT_32	[p2l10t363r269b415],
12	in	IN	O	in	_	0	SENT_32	[p2l290t364r344b415],
13	SLCO1B1	NN	O	slco1b1	nn	14	SENT_32	[p2l361t366r598b415],
14	c.	NN	O	c.	prep_in	11	SENT_32	[p2l625t366r765b416],
15	521	CD	NUMBER	521	num	17	SENT_32	[p2l625t366r765b416],
16	CC	NN	O	cc	nn	17	SENT_32	[p2l776t366r849b415],
17	individuals	NNS	O	individual	nsubj	18	SENT_32	[p2l869t363r1182b415],
18	[	VBP	O	[	rcmod	14	SENT_32	[p2l1207t363r1294b429],
19	5	CD	NUMBER	5	number	20	SENT_32	[p2l1207t363r1294b429],
20	]	CD	NUMBER	]	dobj	18	SENT_32	[p2l1207t363r1294b429],
21	.	.	O	.	_	0	SENT_32	[p2l1207t363r1294b429],

1	*	NN	O	*	_	0	SENT_33	[p2l52t628r73b652],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_33	[p2l107t628r453b680],
3	author	NN	O	author	dobj	2	SENT_33	[p2l472t628r635b670],
4	.	.	O	.	_	0	SENT_33	[p2l472t628r635b670],

1	Tel.	NNP	O	Tel.	_	0	SENT_34	[p2l652t628r746b670],
2	:	:	O	:	_	0	SENT_34	[p2l652t628r746b670],
3	+86 731 4805379	CD	NUMBER	+86 731 4805379	dep	1	SENT_34	[p2l990t630r1209b676],[p2l773t630r874b672],
4	;	:	O	;	_	0	SENT_34	[p2l990t630r1209b676],
5	fax	NN	O	fax	dep	1	SENT_34	[p2l1232t628r1315b670],
6	:	:	O	:	_	0	SENT_34	[p2l1232t628r1315b670],
7	+86 731 4487233	CD	NUMBER	+86 731 4487233	dep	5	SENT_34	[p2l1559t630r1777b670],[p2l1342t630r1443b672],
8	.	.	O	.	_	0	SENT_34	[p2l1559t630r1777b670],

1	E-mail	NN	O	e-mail	nn	2	SENT_35	[p2l105t704r254b746],
2	address	NN	O	address	_	0	SENT_35	[p2l272t704r456b746],
3	:	:	O	:	_	0	SENT_35	[p2l272t704r456b746],
4	hhzhou@public.cs.hn.cn	NN	O	hhzhou@public.cs.hn.cn	nn	6	SENT_35	[p2l476t704r1040b756],
5	(	CD	NUMBER	(	num	6	SENT_35	[p2l1062t704r1200b756],
6	H.	NNP	O	H.	dep	2	SENT_35	[p2l1062t704r1200b756],
7	.	.	O	.	_	0	SENT_35	[p2l1062t704r1200b756],

1	—	NN	O	—	_	0	SENT_36	[p2l1062t704r1200b756],
2	.	.	O	.	_	0	SENT_36	[p2l1062t704r1200b756],

1	H.	NNP	PERSON	H.	nn	3	SENT_37	[p2l1062t704r1200b756],
2	Zhou	NNP	PERSON	Zhou	nn	3	SENT_37	[p2l1219t704r1372b756],
3	)	NNP	O	)	_	0	SENT_37	[p2l1219t704r1372b756],
4	.	.	O	.	_	0	SENT_37	[p2l1219t704r1372b756],

1	0009-8981	CD	DURATION	0009-8981	_	0	SENT_38	[p2l9t845r262b885],
2	/	:	O	/	punct	1	SENT_38	[p2l273t842r322b892],
3	$	$	MONEY	$	nsubj	5	SENT_38	[p2l273t842r322b892],
4	—	CD	MONEY	—	num	3	SENT_38	[p2l344t868r369b872],
5	see	VBP	O	see	dep	1	SENT_38	[p2l391t855r464b885],
6	front	JJ	O	front	amod	7	SENT_38	[p2l485t843r600b885],
7	matter	NN	O	matter	nsubj	14	SENT_38	[p2l619t849r778b885],
8	©	CD	NUMBER	©	num	13	SENT_38	[p2l796t846r834b885],
9	2009	CD	DATE	2009	num	13	SENT_38	[p2l854t845r971b885],
10	Elsevier	NNP	O	Elsevier	nn	13	SENT_38	[p2l993t843r1176b885],
11	B.V.	NNP	O	B.V.	nn	13	SENT_38	[p2l1196t846r1280b885],
12	All	NNP	O	All	nn	13	SENT_38	[p2l1300t843r1363b884],
13	rights	NNS	O	rights	dep	7	SENT_38	[p2l1384t843r1517b895],
14	reserved	VBD	O	reserve	ccomp	5	SENT_38	[p2l1539t843r1750b885],
15	.	.	O	.	_	0	SENT_38	[p2l1539t843r1750b885],

1	doi	FW	O	doi	_	0	SENT_39	[p2l9t913r710b965],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_39	[p2l9t913r710b965],
3	/	:	O	/	punct	5	SENT_39	[p2l9t913r710b965],
4	j.	NN	O	j.	nn	5	SENT_39	[p2l9t913r710b965],
5	CCa	NN	O	cca	dep	2	SENT_39	[p2l9t913r710b965],
6	.2009.04.003	CD	NUMBER	.2009.04.003	dep	2	SENT_39	[p2l9t913r710b965],

1	©	RB	O	©	advmod	7	SENT_40	[p2l1042t997r1086b1041],
2	2009	CD	DATE	2009	num	6	SENT_40	[p2l1110t996r1245b1041],
3	Elsevier	NNP	MISC	Elsevier	nn	6	SENT_40	[p2l1270t994r1482b1041],
4	B.V.	NNP	MISC	B.V.	nn	6	SENT_40	[p2l1504t997r1602b1042],
5	All	NNP	MISC	All	nn	6	SENT_40	[p2l1625t994r1698b1041],
6	rights	NNS	O	rights	nsubj	7	SENT_40	[p2l1722t994r1876b1054],
7	reserved	VBD	O	reserve	_	0	SENT_40	[p2l1901t994r2146b1042],
8	.	.	O	.	_	0	SENT_40	[p2l1901t994r2146b1042],

1	In	IN	O	in	_	0	SENT_41	[p2l149t1297r205b1346],
2	human	JJ	O	human	amod	3	SENT_41	[p2l235t1294r446b1347],
3	liver	NN	O	liver	prep_in	6	SENT_41	[p2l476t1294r618b1355],
4	,	,	O	,	_	0	SENT_41	[p2l476t1294r618b1355],
5	atorvastatin	NN	O	atorvastatin	nsubj	6	SENT_41	[p2l649t1295r1007b1347],
6	undergoes	VBZ	O	undergo	_	0	SENT_41	[p2l1037t1294r1349b1360],
7	extensive	JJ	O	extensive	amod	8	SENT_41	[p2l1381t1295r1662b1347],
8	metabolism	NN	O	metabolism	dobj	6	SENT_41	[p2l1693t1294r2048b1347],
9	by	IN	O	by	_	0	SENT_41	[p2l2077t1294r2149b1360],
10	cytochrome	NN	O	cytochrome	nn	11	SENT_41	[p2l48t1380r405b1446],
11	P450	NN	O	p450	prep_by	6	SENT_41	[p2l453t1382r764b1441],
12	—	CD	NUMBER	—	num	13	SENT_41	[p2l453t1382r764b1441],
13	3A4	NN	O	3a4	tmod	11	SENT_41	[p2l453t1382r764b1441],
14	,	,	O	,	_	0	SENT_41	[p2l453t1382r764b1441],
15	which	WDT	O	which	nsubj	16	SENT_41	[p2l811t1380r997b1433],
16	catalyzes	VBZ	O	catalyze	rcmod	13	SENT_41	[p2l1045t1380r1317b1446],
17	2	CD	NUMBER	2	num	19	SENT_41	[p2l1365t1383r1396b1432],
18	active	JJ	O	active	amod	19	SENT_41	[p2l1445t1381r1621b1433],
19	metabolites	NNS	O	metabolite	dobj	16	SENT_41	[p2l1668t1380r2038b1441],
20	,	,	O	,	_	0	SENT_41	[p2l1668t1380r2038b1441],
21	2hydroxy	JJ	O	2hydroxy	amod	24	SENT_41	[p2l2085t1383r2146b1432, p2l49t1465r682b1532],
22	—	NN	O	—	nn	24	SENT_41	[p2l2085t1383r2146b1432, p2l49t1465r682b1532],
23	atorvastatin	NN	O	atorvastatin	nn	24	SENT_41	[p2l2085t1383r2146b1432, p2l49t1465r682b1532],
24	acid	NN	O	acid	dobj	16	SENT_41	[p2l716t1465r835b1518],
25	and	CC	O	and	_	0	SENT_41	[p2l870t1465r980b1518],
26	4	CD	NUMBER	4	num	29	SENT_41	[p2l1013t1465r1686b1532],
27	—	NN	O	—	nn	29	SENT_41	[p2l1013t1465r1686b1532],
28	hydroxyatorvastatin	NN	O	hydroxyatorvastatin	nn	29	SENT_41	[p2l1013t1465r1686b1532],
29	acid	NN	O	acid	dobj	16	SENT_41	[p2l1720t1465r1840b1518],
30	from	IN	O	from	_	0	SENT_41	[p2l1875t1465r2018b1518],
31	the	DT	O	the	det	32	SENT_41	[p2l2051t1465r2147b1518],
32	acid	NN	O	acid	prep_from	16	SENT_41	[p2l48t1551r168b1604],
33	and	CC	O	and	_	0	SENT_41	[p2l193t1551r302b1604],
34	the	DT	O	the	det	37	SENT_41	[p2l326t1551r421b1604],
35	inactive	JJ	O	inactive	amod	37	SENT_41	[p2l447t1552r680b1604],
36	lactone	NN	O	lactone	nn	37	SENT_41	[p2l704t1551r921b1604],
37	forms	NNS	O	form	conj_and	32	SENT_41	[p2l945t1551r1116b1604],
38	of	IN	O	of	_	0	SENT_41	[p2l1142t1551r1204b1604],
39	atorvastatin	NN	O	atorvastatin	prep_of	37	SENT_41	[p2l1221t1552r1579b1604],
40	[	CD	NUMBER	[	number	41	SENT_41	[p2l1606t1551r1752b1618],
41	6,7	CD	NUMBER	6,7	num	42	SENT_41	[p2l1606t1551r1752b1618],
42	]	NN	O	]	dep	37	SENT_41	[p2l1606t1551r1752b1618],
43	.	.	O	.	_	0	SENT_41	[p2l1606t1551r1752b1618],

1	Inhibitors	NNS	O	inhibitor	nsubj	12	SENT_42	[p2l1778t1551r2067b1604],
2	of	IN	O	of	_	0	SENT_42	[p2l2092t1551r2154b1604],
3	CYP3A4	NN	O	cyp3a4	prep_of	1	SENT_42	[p2l49t1640r304b1699],
4	,	,	O	,	_	0	SENT_42	[p2l49t1640r304b1699],
5	mibefradil	NN	O	mibefradil	conj_and	3	SENT_42	[p2l355t1638r691b1699],
6	,	,	O	,	_	0	SENT_42	[p2l355t1638r691b1699],
7	itraconazole	NN	O	itraconazole	conj_and	3	SENT_42	[p2l741t1638r1122b1691],
8	and	CC	O	and	_	0	SENT_42	[p2l1171t1638r1282b1691],
9	clarithromycin	NN	O	clarithromycin	conj_and	3	SENT_42	[p2l1333t1638r1804b1704],
10	,	,	O	,	_	0	SENT_42	[p2l1333t1638r1804b1704],
11	markedly	RB	O	markedly	advmod	12	SENT_42	[p2l1855t1638r2148b1704],
12	increased	VBN	O	increase	_	0	SENT_42	[p2l49t1723r333b1776],
13	plasma	NN	O	plasma	nn	14	SENT_42	[p2l365t1724r578b1790],
14	exposure	NN	O	exposure	dobj	12	SENT_42	[p2l608t1739r881b1790],
15	to	TO	O	to	_	0	SENT_42	[p2l911t1731r969b1776],
16	atorvastatin	NN	O	atorvastatin	prep_to	12	SENT_42	[p2l1000t1724r1358b1776],
17	in	FW	O	in	prep	12	SENT_42	[p2l1389t1725r1441b1776],
18	vivo	FW	O	vivo	nn	19	SENT_42	[p2l1470t1725r1586b1777],
19	[	FW	O	[	pobj	17	SENT_42	[p2l1622t1723r1714b1790],
20	8	CD	NUMBER	8	num	21	SENT_42	[p2l1622t1723r1714b1790],
21	]	NN	O	]	dep	19	SENT_42	[p2l1622t1723r1714b1790],
22	.	.	O	.	_	0	SENT_42	[p2l1622t1723r1714b1790],

1	Besides	IN	O	besides	_	0	SENT_43	[p2l1747t1724r1968b1777],
2	P450	NN	O	p450	nn	3	SENT_43	[p2l1999t1726r2146b1776],
3	enzymes	NNS	O	enzyme	prep_besides	13	SENT_43	[p2l48t1825r327b1876],
4	,	,	O	,	_	0	SENT_43	[p2l48t1825r327b1876],
5	drug	NN	O	drug	appos	3	SENT_43	[p2l354t1810r674b1876],
6	—	CD	NUMBER	—	num	8	SENT_43	[p2l354t1810r674b1876],
7	drug	NN	O	drug	nn	8	SENT_43	[p2l354t1810r674b1876],
8	interactions	NNS	O	interaction	nsubjpass	13	SENT_43	[p2l700t1811r1054b1863],
9	of	IN	O	of	_	0	SENT_43	[p2l1082t1810r1144b1863],
10	atorvastatin	NN	O	atorvastatin	prep_of	8	SENT_43	[p2l1163t1811r1522b1863],
11	are	VBP	O	be	auxpass	13	SENT_43	[p2l1548t1825r1639b1863],
12	also	RB	O	also	advmod	13	SENT_43	[p2l1665t1810r1780b1863],
13	reported	VBN	O	report	_	0	SENT_43	[p2l1808t1810r2066b1876],
14	at	IN	O	at	_	0	SENT_43	[p2l2092t1818r2148b1863],
15	the	DT	O	the	det	16	SENT_43	[p2l48t1896r143b1949],
16	level	NN	O	level	prep_at	13	SENT_43	[p2l182t1896r321b1949],
17	of	IN	O	of	_	0	SENT_43	[p2l360t1896r422b1949],
18	hepatic	JJ	O	hepatic	amod	19	SENT_43	[p2l453t1896r674b1962],
19	transporters	NNS	O	transporter	prep_of	16	SENT_43	[p2l710t1904r1093b1962],
20	.	.	O	.	_	0	SENT_43	[p2l710t1904r1093b1962],

1	Lau	NNP	PERSON	Lau	nsubj	4	SENT_44	[p2l1133t1899r1235b1949],
2	et	FW	O	et	nn	3	SENT_44	[p2l1272t1904r1329b1949],
3	al.	FW	O	al.	dep	1	SENT_44	[p2l1366t1896r1429b1949],
4	found	VBN	O	find	_	0	SENT_44	[p2l1469t1896r1642b1949],
5	that	IN	O	that	complm	8	SENT_44	[p2l1681t1896r1802b1949],
6	rifampicin	NN	O	rifampicin	nsubj	8	SENT_44	[p2l1838t1896r2147b1962],
7	effectively	RB	O	effectively	advmod	8	SENT_44	[p2l48t1981r358b2048],
8	decreased	VBD	O	decrease	ccomp	4	SENT_44	[p2l379t1981r678b2034],
9	the	DT	O	the	det	11	SENT_44	[p2l702t1981r797b2034],
10	hepatic	JJ	O	hepatic	amod	11	SENT_44	[p2l822t1981r1042b2048],
11	uptake	NN	O	uptake	dobj	8	SENT_44	[p2l1065t1981r1269b2048],
12	and	CC	O	and	_	0	SENT_44	[p2l1292t1981r1401b2034],
13	efﬂux	NN	O	efﬂux	conj_and	11	SENT_44	[p2l1426t1981r1597b2034],
14	of	IN	O	of	_	0	SENT_44	[p2l1617t1981r1680b2034],
15	atorvastatin	NN	O	atorvastatin	prep_of	11	SENT_44	[p2l1696t1982r2054b2034],
16	by	IN	O	by	_	0	SENT_44	[p2l2077t1981r2149b2048],
17	inhibiting	VBG	O	inhibit	prepc_by	8	SENT_44	[p2l49t2067r343b2134],
18	the	DT	O	the	det	20	SENT_44	[p2l386t2067r482b2120],
19	transport	NN	O	transport	nn	20	SENT_44	[p2l527t2075r808b2134],
20	activity	NN	O	activity	dobj	17	SENT_44	[p2l852t2068r1074b2134],
21	of	IN	O	of	_	0	SENT_44	[p2l1118t2067r1180b2120],
22	Oatp	NN	O	oatp	prep_of	20	SENT_44	[p2l1218t2070r1358b2134],
23	and	CC	O	and	_	0	SENT_44	[p2l1405t2067r1514b2120],
24	MRP2	NN	O	mrp2	prep_of	20	SENT_44	[p2l1561t2070r1733b2120],
25	in	IN	O	in	_	0	SENT_44	[p2l1781t2068r1836b2120],
26	rats	NNS	O	rat	prep_in	17	SENT_44	[p2l1882t2075r1990b2120],
27	and	CC	O	and	_	0	SENT_44	[p2l2037t2067r2146b2120],
28	OATP1	NN	O	oatp1	nn	29	SENT_44	[p2l49t2156r235b2207],
29	B1	NN	O	b1	prep_in	17	SENT_44	[p2l248t2157r313b2206],
30	in	IN	O	in	_	0	SENT_44	[p2l340t2155r395b2206],
31	humans	NNS	O	human	prep_in	17	SENT_44	[p2l415t2154r654b2207],
32	[	CD	NUMBER	[	number	33	SENT_44	[p2l675t2153r875b2220],
33	9	CD	NUMBER	9	num	34	SENT_44	[p2l675t2153r875b2220],
34	—	NN	O	—	dep	31	SENT_44	[p2l675t2153r875b2220],
35	11	CD	NUMBER	11	num	36	SENT_44	[p2l675t2153r875b2220],
36	]	NN	O	]	dep	34	SENT_44	[p2l675t2153r875b2220],
37	.	.	O	.	_	0	SENT_44	[p2l675t2153r875b2220],

1	Moreover	RB	O	moreover	advmod	6	SENT_45	[p2l895t2157r1196b2215],
2	,	,	O	,	_	0	SENT_45	[p2l895t2157r1196b2215],
3	atorvastatin	NN	O	atorvastatin	nsubjpass	6	SENT_45	[p2l1216t2155r1574b2207],
4	has	VBZ	O	have	aux	6	SENT_45	[p2l1593t2154r1691b2207],
5	been	VBN	O	be	auxpass	6	SENT_45	[p2l1709t2154r1854b2207],
6	shown	VBN	O	show	_	0	SENT_45	[p2l1873t2154r2072b2207],
7	to	TO	O	to	aux	11	SENT_45	[p2l2090t2162r2146b2207],
8	be	VB	O	be	cop	11	SENT_45	[p2l48t2240r117b2293],
9	both	CC	O	both	preconj	11	SENT_45	[p2l135t2240r272b2293],
10	a	DT	O	a	det	11	SENT_45	[p2l290t2255r321b2293],
11	substrate	NN	O	substrate	xcomp	6	SENT_45	[p2l339t2240r613b2293],
12	and	CC	O	and	_	0	SENT_45	[p2l632t2240r741b2293],
13	inhibitor	NN	O	inhibitor	conj_and	11	SENT_45	[p2l761t2240r1023b2293],
14	of	IN	O	of	_	0	SENT_45	[p2l1040t2240r1102b2293],
15	P-glycoprotein	NN	O	p-glycoprotein	nn	17	SENT_45	[p2l1113t2240r1552b2306],
16	(	CD	NUMBER	(	num	17	SENT_45	[p2l1573t2240r1759b2306],
17	P-gp	NN	O	p-gp	prep_of	11	SENT_45	[p2l1573t2240r1759b2306],
18	)	CD	NUMBER	)	number	19	SENT_45	[p2l1573t2240r1759b2306],
19	[	CD	NUMBER	[	dep	17	SENT_45	[p2l1785t2239r1913b2306],
20	12	CD	NUMBER	12	num	21	SENT_45	[p2l1785t2239r1913b2306],
21	]	NN	O	]	dep	19	SENT_45	[p2l1785t2239r1913b2306],
22	.	.	O	.	_	0	SENT_45	[p2l1785t2239r1913b2306],

1	Being	VBG	O	be	cop	4	SENT_46	[p2l1933t2241r2100b2306],
2	a	DT	O	a	det	4	SENT_46	[p2l2117t2255r2147b2293],
3	probe	NN	O	probe	nn	4	SENT_46	[p2l49t2325r221b2392],
4	drug	NN	O	drug	partmod	14	SENT_46	[p2l268t2325r407b2392],
5	of	IN	O	of	_	0	SENT_46	[p2l453t2325r516b2378],
6	P	NN	O	p	nn	8	SENT_46	[p2l556t2328r705b2392],
7	—	CD	NUMBER	—	num	8	SENT_46	[p2l556t2328r705b2392],
8	gp	NN	O	gp	prep_of	4	SENT_46	[p2l556t2328r705b2392],
9	,	,	O	,	_	0	SENT_46	[p2l556t2328r705b2392],
10	digoxin	NN	O	digoxin	nn	12	SENT_46	[p2l753t2325r977b2392],
11	plasma	NN	O	plasma	nn	12	SENT_46	[p2l1022t2325r1236b2392],
12	concentrations	NNS	O	concentration	nsubj	14	SENT_46	[p2l1283t2326r1731b2378],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_46	[p2l1780t2325r2149b2392],
14	increased	VBD	O	increase	_	0	SENT_46	[p2l49t2412r333b2465],
15	when	WRB	O	when	advmod	19	SENT_46	[p2l356t2412r526b2465],
16	atorvastatin	NN	O	atorvastatin	nsubj	19	SENT_46	[p2l549t2413r908b2465],
17	was	VBD	O	be	cop	19	SENT_46	[p2l928t2427r1043b2465],
18	co	JJ	O	co	amod	19	SENT_46	[p2l1068t2412r1560b2465],
19	—	NN	O	—	advcl	14	SENT_46	[p2l1068t2412r1560b2465],
20	administered	VBN	O	administer	partmod	19	SENT_46	[p2l1068t2412r1560b2465],
21	[	CD	NUMBER	[	num	23	SENT_46	[p2l1588t2412r1714b2478],
22	13	CD	NUMBER	13	num	23	SENT_46	[p2l1588t2412r1714b2478],
23	]	NN	O	]	dobj	20	SENT_46	[p2l1588t2412r1714b2478],
24	.	.	O	.	_	0	SENT_46	[p2l1588t2412r1714b2478],

1	Conﬂicting	VBG	O	conﬂicting	amod	2	SENT_47	[p2l149t2497r474b2564],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_47	[p2l497t2497r737b2564],
3	exist	VBP	O	exist	_	0	SENT_47	[p2l761t2498r902b2550],
4	regarding	VBG	O	regard	xcomp	3	SENT_47	[p2l924t2497r1213b2564],
5	the	DT	O	the	det	7	SENT_47	[p2l1235t2497r1330b2550],
6	hepatic	JJ	O	hepatic	amod	7	SENT_47	[p2l1354t2497r1574b2564],
7	uptake	NN	O	uptake	dobj	4	SENT_47	[p2l1596t2497r1800b2564],
8	of	IN	O	of	_	0	SENT_47	[p2l1824t2497r1886b2550],
9	rifampicin	NN	O	rifampicin	prep_of	7	SENT_47	[p2l1903t2497r2147b2564, p2l48t2585r149b2637],
10	.	.	O	.	_	0	SENT_47	[p2l1903t2497r2147b2564, p2l48t2585r149b2637],

1	Tirona	NNP	O	Tirona	nsubj	4	SENT_48	[p2l181t2585r374b2637],
2	et	FW	O	et	nn	3	SENT_48	[p2l407t2592r463b2637],
3	al.	FW	O	al.	dep	1	SENT_48	[p2l495t2584r559b2637],
4	demonstrated	VBD	O	demonstrate	_	0	SENT_48	[p2l593t2584r1013b2637],
5	that	IN	O	that	complm	8	SENT_48	[p2l1046t2584r1167b2637],
6	OAT	NN	O	oat	nn	7	SENT_48	[p2l1199t2586r1320b2637],
7	P1B1	NN	O	p1b1	nsubj	8	SENT_48	[p2l1323t2587r1464b2636],
8	displayed	VBD	O	display	ccomp	4	SENT_48	[p2l1505t2584r1789b2650],
9	far	RB	O	far	advmod	10	SENT_48	[p2l1823t2584r1903b2637],
10	greater	JJR	O	greater	amod	11	SENT_48	[p2l1933t2592r2149b2650],
11	capability	NN	O	capability	dobj	8	SENT_48	[p2l48t2670r342b2736],
12	for	IN	O	for	_	0	SENT_48	[p2l380t2670r464b2723],
13	rifampicin	NN	O	rifampicin	nn	14	SENT_48	[p2l502t2670r811b2736],
14	transport	NN	O	transport	prep_for	8	SENT_48	[p2l850t2678r1130b2736],
15	than	IN	O	than	mark	26	SENT_48	[p2l1168t2670r1303b2723],
16	OATP1B3	NN	O	oatp1b3	nn	17	SENT_48	[p2l1343t2672r1613b2723],
17	(	NN	O	(	nsubj	26	SENT_48	[p2l1659t2670r1800b2736],
18	also	RB	O	also	advmod	19	SENT_48	[p2l1659t2670r1800b2736],
19	known	VBN	O	know	partmod	17	SENT_48	[p2l1842t2670r2048b2723],
20	as	IN	O	as	_	0	SENT_48	[p2l2088t2685r2146b2723],
21	OATP8	NN	O	oatp8	nn	22	SENT_48	[p2l49t2755r268b2821],
22	)	NN	O	)	prep_as	19	SENT_48	[p2l49t2755r268b2821],
23	in	IN	O	in	_	0	SENT_48	[p2l299t2756r355b2808],
24	Hela	NN	LOCATION	helum	nn	25	SENT_48	[p2l382t2755r516b2808],
25	cells	NNS	O	cell	prep_in	22	SENT_48	[p2l542t2755r671b2808],
26	[	VBP	O	[	advcl	8	SENT_48	[p2l701t2755r828b2822],
27	14	CD	NUMBER	14	num	28	SENT_48	[p2l701t2755r828b2822],
28	]	CD	NUMBER	]	dobj	26	SENT_48	[p2l701t2755r828b2822],
29	.	.	O	.	_	0	SENT_48	[p2l701t2755r828b2822],

1	However	RB	O	however	advmod	6	SENT_49	[p2l856t2758r1136b2816],
2	,	,	O	,	_	0	SENT_49	[p2l856t2758r1136b2816],
3	Vavricka	NNP	PERSON	Vavricka	nsubj	6	SENT_49	[p2l1162t2755r1421b2808],
4	et	FW	O	et	nn	5	SENT_49	[p2l1447t2763r1504b2808],
5	al.	FW	O	al.	dep	3	SENT_49	[p2l1529t2755r1592b2809],
6	found	VBN	O	find	_	0	SENT_49	[p2l1621t2755r1794b2808],
7	out	IN	O	out	prt	6	SENT_49	[p2l1821t2763r1920b2808],
8	that	IN	O	that	complm	18	SENT_49	[p2l1945t2755r2066b2808],
9	in	IN	O	in	mark	12	SENT_49	[p2l2091t2756r2147b2808],
10	Xenopus	NN	O	xenopus	nn	11	SENT_49	[p2l42t2844r292b2908],
11	laevis	NN	O	laevi	nsubj	12	SENT_49	[p2l326t2841r487b2894],
12	oocytes	VBZ	O	oocyte	advcl	18	SENT_49	[p2l520t2849r744b2907],
13	expression	NN	O	expression	nn	14	SENT_49	[p2l779t2842r1101b2908],
14	system	NN	O	system	dobj	12	SENT_49	[p2l1136t2849r1359b2908],
15	,	,	O	,	_	0	SENT_49	[p2l1136t2849r1359b2908],
16	OATP1B3	NN	O	oatp1b3	nsubj	18	SENT_49	[p2l1393t2844r1663b2894],
17	predominantly	RB	O	predominantly	advmod	18	SENT_49	[p2l1699t2841r2148b2908],
18	mediated	VBD	O	mediate	ccomp	6	SENT_49	[p2l49t2927r330b2980],
19	the	DT	O	the	det	21	SENT_49	[p2l364t2927r459b2980],
20	hepatic	JJ	O	hepatic	amod	21	SENT_49	[p2l494t2928r714b2994],
21	uptake	NN	O	uptake	conj_and	21	SENT_49	[p2l747t2928r950b2994],
22	of	IN	O	of	_	0	SENT_49	[p2l984t2927r1046b2980],
23	rifampicin	NN	O	rifampicin	prep_of	21	SENT_49	[p2l1073t2927r1382b2994],
24	and	CC	O	and	_	0	SENT_49	[p2l1415t2927r1524b2980],
25	to	TO	O	to	_	0	SENT_49	[p2l1558t2936r1615b2980],
26	a	DT	O	a	det	28	SENT_49	[p2l1649t2943r1680b2980],
27	less	JJR	O	less	amod	28	SENT_49	[p2l1714t2927r1820b2981],
28	extent	NN	O	extent	prep_to	21	SENT_49	[p2l1855t2936r2046b2981],
29	by	IN	O	by	_	0	SENT_49	[p2l2077t2928r2149b2994],
30	OATP1B1	NN	O	oatp1b1	prep_by	28	SENT_49	[p2l49t3016r313b3066],
31	[	CD	NUMBER	[	number	32	SENT_49	[p2l351t3013r477b3080],
32	15	CD	NUMBER	15	num	33	SENT_49	[p2l351t3013r477b3080],
33	]	NN	O	]	dep	21	SENT_49	[p2l351t3013r477b3080],
34	.	.	O	.	_	0	SENT_49	[p2l351t3013r477b3080],

1	The	DT	O	the	det	3	SENT_50	[p2l502t3013r612b3066],
2	molecular	JJ	O	molecular	amod	3	SENT_50	[p2l640t3013r942b3066],
3	base	NN	O	base	_	0	SENT_50	[p2l966t3013r1098b3067],
4	for	IN	O	for	_	0	SENT_50	[p2l1125t3013r1209b3066],
5	rifampicin	NN	O	rifampicin	nn	6	SENT_50	[p2l1234t3013r1543b3080],
6	uptake	NN	O	uptake	prep_for	3	SENT_50	[p2l1569t3013r1773b3080],
7	from	IN	O	from	_	0	SENT_50	[p2l1801t3013r1944b3066],
8	portal	NN	O	portal	prep_from	3	SENT_50	[p2l1970t3013r2146b3080],

1	50	CD	NUMBER	50	_	0	SENT_51	[p2l377t3156r405b3177],
2	Y.	NNP	O	Y.	dep	1	SENT_51	[p2l1133t3156r1173b3182],
3	.	.	O	.	_	0	SENT_51	[p2l1133t3156r1173b3182],

1	—	NN	O	—	_	0	SENT_52	[p2l1133t3156r1173b3182],
2	.	.	O	.	_	0	SENT_52	[p2l1133t3156r1173b3182],

1	j.	NN	O	j.	_	0	SENT_53	[p2l1133t3156r1173b3182],
2	He	PRP	O	he	dep	1	SENT_53	[p2l1184t3156r1215b3177],
3	et	FW	O	et	nn	4	SENT_53	[p2l1225t3158r1247b3177],
4	al.	FW	O	al.	dep	2	SENT_53	[p2l1256t3155r1280b3177],
5	/	:	O	/	punct	8	SENT_53	[p2l1293t3156r1302b3180],
6	Clinica	NNP	PERSON	Clinica	nn	8	SENT_53	[p2l1315t3155r1392b3177],
7	Chimica	NNP	PERSON	Chimica	nn	8	SENT_53	[p2l1403t3155r1494b3177],
8	Acta	NNP	PERSON	Acta	dep	4	SENT_53	[p2l1503t3156r1554b3177],
9	405	CD	NUMBER	405	number	10	SENT_53	[p2l1564t3156r1607b3177],
10	(	CD	NUMBER	(	dep	8	SENT_53	[p2l1619t3155r1698b3182],
11	2009	CD	DATE	2009	dep	10	SENT_53	[p2l1619t3155r1698b3182],
12	)	CD	NUMBER	)	num	13	SENT_53	[p2l1619t3155r1698b3182],
13	49-52	CD	NUMBER	49-52	dep	1	SENT_53	[p2l1709t3156r1782b3177],

1	vein	NN	O	vein	nsubjpass	9	SENT_54	[p2l8t3295r137b3349],
2	into	IN	O	into	_	0	SENT_54	[p2l179t3295r297b3349],
3	hepatocytes	NNS	O	hepatocyte	prep_into	1	SENT_54	[p2l339t3294r704b3363],
4	in	IN	O	in	_	0	SENT_54	[p2l746t3295r802b3348],
5	humans	NNS	O	human	prep_in	3	SENT_54	[p2l844t3294r1087b3349],
6	is	VBZ	O	be	auxpass	9	SENT_54	[p2l1129t3295r1173b3349],
7	not	RB	O	not	neg	9	SENT_54	[p2l1216t3302r1316b3349],
8	completely	RB	O	completely	advmod	9	SENT_54	[p2l1355t3294r1695b3363],
9	elucidated	VBN	O	elucidate	_	0	SENT_54	[p2l1733t3294r2049b3349],
10	at	IN	O	at	_	0	SENT_54	[p2l2091t3302r2148b3349],
11	present	JJ	DATE	present	prep_at	9	SENT_54	[p2l10t3391r253b3452],
12	.	.	O	.	_	0	SENT_54	[p2l10t3391r253b3452],

1	However	RB	O	however	advmod	5	SENT_55	[p2l295t3386r580b3447],
2	,	,	O	,	_	0	SENT_55	[p2l295t3386r580b3447],
3	common	JJ	O	common	amod	4	SENT_55	[p2l623t3399r892b3438],
4	agreement	NN	O	agreement	nsubj	5	SENT_55	[p2l932t3391r1262b3452],
5	exists	VBZ	O	exist	_	0	SENT_55	[p2l1300t3384r1471b3438],
6	that	IN	O	that	complm	11	SENT_55	[p2l1512t3383r1635b3438],
7	rifampicin	NN	O	rifampicin	dep	11	SENT_55	[p2l1675t3383r1989b3452],
8	is	VBZ	O	be	cop	11	SENT_55	[p2l2030t3384r2074b3438],
9	a	DT	O	a	det	11	SENT_55	[p2l2116t3399r2147b3438],
10	potent	JJ	O	potent	amod	11	SENT_55	[p2l10t3481r210b3541],
11	blocker	NN	O	blocker	dep	5	SENT_55	[p2l232t3472r458b3527],
12	of	IN	O	of	_	0	SENT_55	[p2l481t3472r544b3527],
13	OATP1B1	NN	O	oatp1b1	prep_of	11	SENT_55	[p2l561t3475r830b3527],
14	[	CD	NUMBER	[	num	13	SENT_55	[p2l866t3472r1106b3541],
15	14	CD	NUMBER	14	num	18	SENT_55	[p2l866t3472r1106b3541],
16	—	NN	O	—	nn	18	SENT_55	[p2l866t3472r1106b3541],
17	16	CD	NUMBER	16	num	18	SENT_55	[p2l866t3472r1106b3541],
18	]	NN	O	]	nsubj	11	SENT_55	[p2l866t3472r1106b3541],
19	.	.	O	.	_	0	SENT_55	[p2l866t3472r1106b3541],

1	The	DT	O	the	det	3	SENT_56	[p2l109t3561r219b3616],
2	primary	JJ	O	primary	amod	3	SENT_56	[p2l236t3562r477b3630],
3	goal	NN	O	goal	nsubj	7	SENT_56	[p2l489t3561r612b3630],
4	of	IN	O	of	_	0	SENT_56	[p2l629t3561r691b3616],
5	this	DT	O	this	det	6	SENT_56	[p2l700t3561r808b3616],
6	study	NN	O	study	prep_of	3	SENT_56	[p2l827t3561r992b3630],
7	was	VBD	O	be	_	0	SENT_56	[p2l1005t3577r1121b3616],
8	to	TO	O	to	aux	9	SENT_56	[p2l1137t3570r1194b3616],
9	demonstrate	VB	O	demonstrate	xcomp	7	SENT_56	[p2l1211t3561r1590b3616],
10	if	IN	O	if	mark	12	SENT_56	[p2l1608t3561r1652b3616],
11	SLCO1B1	NN	O	slco1b1	nn	12	SENT_56	[p2l1657t3564r1904b3616],
12	521T	NN	O	521t	advcl	9	SENT_56	[p2l1925t3564r2147b3616],
13	>	JJR	O	>	dep	14	SENT_56	[p2l1925t3564r2147b3616],
14	C	NN	O	c	amod	12	SENT_56	[p2l1925t3564r2147b3616],

1	polymorphism	NN	O	polymorphism	nsubj	2	SENT_57	[p3l10t17r452b85],
2	had	VBD	O	have	_	0	SENT_57	[p3l474t17r582b72],
3	an	DT	O	a	det	4	SENT_57	[p3l605t33r676b72],
4	impact	NN	O	impact	dobj	2	SENT_57	[p3l697t18r903b85],
5	on	IN	O	on	_	0	SENT_57	[p3l922t33r996b72],
6	atorvastatin	NN	O	atorvastatin	nn	9	SENT_57	[p3l1018t17r1722b85],
7	—	CD	NUMBER	—	num	9	SENT_57	[p3l1018t17r1722b85],
8	rifampicin	NN	O	rifampicin	nn	9	SENT_57	[p3l1018t17r1722b85],
9	interaction	NN	O	interaction	prep_on	4	SENT_57	[p3l1745t18r2069b72],
10	in	IN	O	in	_	0	SENT_57	[p3l2091t18r2146b71],
11	humans	NNS	O	human	prep_in	2	SENT_57	[p3l10t106r264b161],
12	.	.	O	.	_	0	SENT_57	[p3l10t106r264b161],

1	The	DT	O	the	det	2	SENT_58	[p3l279t106r390b161],
2	dependence	NN	O	dependence	nsubjpass	16	SENT_58	[p3l408t106r772b174],
3	of	IN	O	of	_	0	SENT_58	[p3l790t105r852b161],
4	the	DT	O	the	det	6	SENT_58	[p3l862t106r958b161],
5	plasma	NN	O	plasma	nn	6	SENT_58	[p3l976t106r1190b174],
6	concentration	NN	O	concentration	prep_of	2	SENT_58	[p3l1206t106r1622b161],
7	of	IN	O	of	_	0	SENT_58	[p3l1639t105r1702b161],
8	rifampicin	NN	O	rifampicin	prep_of	6	SENT_58	[p3l1712t105r2019b174],
9	and	CC	O	and	_	0	SENT_58	[p3l2036t106r2145b161],
10	SLCO1B1	NN	O	slco1b1	nn	11	SENT_58	[p3l10t197r267b249],
11	521T	NN	O	521t	conj_and	6	SENT_58	[p3l293t197r516b249],
12	>	JJR	O	>	amod	14	SENT_58	[p3l293t197r516b249],
13	C	NN	O	c	nn	14	SENT_58	[p3l293t197r516b249],
14	genotype	NN	O	genotype	dep	11	SENT_58	[p3l535t202r814b263],
15	was	VBD	O	be	auxpass	16	SENT_58	[p3l833t210r949b249],
16	tested	VBN	O	test	_	0	SENT_58	[p3l971t194r1151b249],
17	simultaneously	RB	O	simultaneously	advmod	16	SENT_58	[p3l1174t194r1641b263],
18	.	.	O	.	_	0	SENT_58	[p3l1174t194r1641b263],

1	2	LS	NUMBER	2	_	0	SENT_59	[p3l8t360r50b402],
2	.	.	O	.	_	0	SENT_59	[p3l8t360r50b402],

1	Materials	NNPS	O	Materials	_	0	SENT_60	[p3l71t358r312b401],
2	and	CC	O	and	_	0	SENT_60	[p3l332t358r428b401],
3	methods	NNS	O	method	conj_and	1	SENT_60	[p3l449t358r675b401],

1	2.1	CD	NUMBER	2.1	_	0	SENT_61	[p3l6t506r80b548],
2	.	.	O	.	_	0	SENT_61	[p3l6t506r80b548],

1	Subjects	NNS	O	subject	_	0	SENT_62	[p3l102t504r294b558],

1	After	IN	O	after	_	0	SENT_63	[p3l109t650r226b693],
2	genotyping	VBG	O	genotype	prepc_after	23	SENT_63	[p3l238t650r501b704],
3	a	DT	O	a	det	4	SENT_63	[p3l515t662r540b693],
4	total	NN	O	total	dobj	2	SENT_63	[p3l554t650r656b693],
5	of	IN	O	of	_	0	SENT_63	[p3l672t650r721b693],
6	111	CD	NUMBER	111	num	11	SENT_63	[p3l732t652r798b693],
7	unrelated	JJ	O	unrelated	amod	11	SENT_63	[p3l820t650r1041b693],
8	Chinese	JJ	MISC	chinese	amod	11	SENT_63	[p3l1056t650r1236b693],
9	healthy	JJ	O	healthy	amod	11	SENT_63	[p3l1252t650r1425b704],
10	male	JJ	O	male	amod	11	SENT_63	[p3l1439t650r1551b693],
11	volunteers	NNS	O	volunteer	prep_of	4	SENT_63	[p3l1565t650r1809b693],
12	aged	JJ	O	aged	amod	11	SENT_63	[p3l1824t650r1932b704],
13	20	CD	NUMBER	20	tmod	12	SENT_63	[p3l1948t652r2005b693],
14	:	:	O	:	_	0	SENT_63	[p3l2016t656r2056b696],
15	I	PRP	O	I	dep	11	SENT_63	[p3l2016t656r2056b696],
16	:	:	O	:	_	0	SENT_63	[p3l2016t656r2056b696],
17	2	CD	NUMBER	2	num	18	SENT_63	[p3l2069t652r2095b693],
18	y	NN	O	y	dep	11	SENT_63	[p3l2110t663r2145b704],
19	,	,	O	,	_	0	SENT_63	[p3l2110t663r2145b704],
20	16	CD	NUMBER	16	num	21	SENT_63	[p3l12t723r62b765],
21	subjects	NNS	O	subject	appos	11	SENT_63	[p3l77t721r261b775],
22	were	VBD	O	be	auxpass	23	SENT_63	[p3l274t734r390b765],
23	recruited	VBN	O	recruit	_	0	SENT_63	[p3l404t721r611b765],
24	in	IN	O	in	_	0	SENT_63	[p3l626t722r669b764],
25	this	DT	O	this	det	26	SENT_63	[p3l682t721r765b765],
26	study	NN	O	study	prep_in	23	SENT_63	[p3l780t721r908b775],
27	including	VBG	O	include	_	0	SENT_63	[p3l921t721r1137b775],
28	6	CD	NUMBER	6	num	31	SENT_63	[p3l1149t723r1176b765],
29	SLCO1B1	NN	O	slco1b1	nn	31	SENT_63	[p3l1187t723r1379b765],
30	c.	NN	O	c.	nn	31	SENT_63	[p3l1398t723r1580b771],
31	521TT	NN	O	521tt	prep_including	26	SENT_63	[p3l1398t723r1580b771],
32	,	,	O	,	_	0	SENT_63	[p3l1398t723r1580b771],
33	6	CD	NUMBER	6	num	35	SENT_63	[p3l1594t723r1621b765],
34	c.	NN	O	c.	nn	35	SENT_63	[p3l1635t723r1813b765],
35	521TC	NN	O	521tc	prep_including	26	SENT_63	[p3l1635t723r1813b765],
36	and	CC	O	and	_	0	SENT_63	[p3l1826t721r1911b765],
37	4	CD	NUMBER	4	num	38	SENT_63	[p3l1924t723r1954b764],
38	c.	NN	O	c.	prep_including	26	SENT_63	[p3l1966t723r2079b765],
39	521	CD	NUMBER	521	num	41	SENT_63	[p3l1966t723r2079b765],
40	CC	NN	O	cc	nn	41	SENT_63	[p3l2087t723r2147b765],
41	subjects	NNS	O	subject	nsubjpass	23	SENT_63	[p3l10t792r194b847],
42	who	WP	O	who	nsubj	45	SENT_63	[p3l210t792r314b836],
43	did	VBD	O	do	aux	45	SENT_63	[p3l330t792r403b836],
44	not	RB	O	not	neg	45	SENT_63	[p3l420t799r497b836],
45	differ	VB	O	differ	rcmod	41	SENT_63	[p3l512t792r635b836],
46	signiﬁcantly	RB	O	signiﬁcantly	advmod	45	SENT_63	[p3l650t792r931b847],
47	in	IN	O	in	_	0	SENT_63	[p3l946t793r989b835],
48	age	NN	O	age	nn	52	SENT_63	[p3l1005t805r1083b847],
49	and	CC	O	and	_	0	SENT_63	[p3l1099t792r1185b836],
50	body	NN	O	body	conj_and	48	SENT_63	[p3l1201t792r1317b847],
51	mass	NN	O	mass	nn	52	SENT_63	[p3l1332t805r1448b836],
52	index	NN	O	index	prep_in	45	SENT_63	[p3l1466t792r1595b836],
53	as	IN	O	as	mark	54	SENT_63	[p3l1609t805r1655b836],
54	presented	VBN	O	present	advcl	45	SENT_63	[p3l1672t792r1901b847],
55	in	IN	O	in	_	0	SENT_63	[p3l1918t793r1962b835],
56	Table	NNP	O	Table	prep_in	54	SENT_63	[p3l1974t792r2096b836],
57	1	CD	NUMBER	1	num	56	SENT_63	[p3l2115t795r2145b836],
58	.	.	O	.	_	0	SENT_63	[p3l2115t795r2145b836],

1	The	DT	O	the	det	3	SENT_64	[p3l7t863r93b906],
2	genotyping	NN	O	genotyping	nn	3	SENT_64	[p3l112t863r375b917],
3	analyses	NNS	O	analysis	nsubjpass	10	SENT_64	[p3l394t863r587b917],
4	of	IN	O	of	_	0	SENT_64	[p3l608t863r657b906],
5	SLCO1B1	NN	O	slco1b1	nn	6	SENT_64	[p3l667t865r859b906],
6	521T	NN	O	521t	prep_of	3	SENT_64	[p3l882t865r1056b906],
7	>	JJR	O	>	dep	8	SENT_64	[p3l882t865r1056b906],
8	C	NN	O	c	amod	6	SENT_64	[p3l882t865r1056b906],
9	were	VBD	O	be	auxpass	10	SENT_64	[p3l1073t875r1190b906],
10	performed	VBN	O	perform	_	0	SENT_64	[p3l1211t863r1456b917],
11	as	IN	O	as	mark	12	SENT_64	[p3l1476t875r1522b906],
12	described	VBN	O	describe	advcl	10	SENT_64	[p3l1543t863r1765b906],
13	in	IN	O	in	_	0	SENT_64	[p3l1786t863r1829b906],
14	our	PRP$	O	we	poss	19	SENT_64	[p3l1849t875r1929b906],
15	previous	JJ	O	previous	amod	19	SENT_64	[p3l1947t863r2146b917],
16	study	NN	O	study	nn	19	SENT_64	[p3l10t934r138b988],
17	[	NN	O	[	nn	19	SENT_64	[p3l163t934r258b988],
18	17	CD	NUMBER	17	num	19	SENT_64	[p3l163t934r258b988],
19	]	NN	O	]	prep_in	12	SENT_64	[p3l163t934r258b988],
20	.	.	O	.	_	0	SENT_64	[p3l163t934r258b988],

1	Each	DT	O	each	det	2	SENT_65	[p3l282t934r390b978],
2	participant	NN	O	participant	poss	5	SENT_65	[p3l414t935r697b988],
3	's	POS	O	's	_	0	SENT_65	[p3l414t935r697b988],
4	healthy	JJ	O	healthy	amod	5	SENT_65	[p3l722t934r895b988],
5	status	NN	O	status	nsubjpass	7	SENT_65	[p3l917t941r1051b978],
6	was	VBD	O	be	auxpass	7	SENT_65	[p3l1074t947r1165b978],
7	determined	VBN	O	determine	_	0	SENT_65	[p3l1189t934r1459b978],
8	by	IN	O	by	_	0	SENT_65	[p3l1484t934r1540b988],
9	medical	JJ	O	medical	amod	10	SENT_65	[p3l1563t934r1744b978],
10	history	NN	O	history	agent	7	SENT_65	[p3l1768t934r1936b988],
11	,	,	O	,	_	0	SENT_65	[p3l1768t934r1936b988],
12	physical	JJ	O	physical	amod	13	SENT_65	[p3l1961t934r2146b988],
13	examination	NN	O	examination	conj_and	10	SENT_65	[p3l9t1005r309b1055],
14	,	,	O	,	_	0	SENT_65	[p3l9t1005r309b1055],
15	routine	JJ	O	routine	amod	16	SENT_65	[p3l330t1005r497b1048],
16	blood	NN	O	blood	conj_and	10	SENT_65	[p3l517t1004r647b1048],
17	and	CC	O	and	_	0	SENT_65	[p3l668t1004r753b1048],
18	urine	NN	O	urine	nn	19	SENT_65	[p3l775t1005r895b1048],
19	tests	NNS	O	test	conj_and	10	SENT_65	[p3l915t1011r1031b1055],
20	,	,	O	,	_	0	SENT_65	[p3l915t1011r1031b1055],
21	and	CC	O	and	_	0	SENT_65	[p3l1052t1004r1137b1048],
22	electrocardiography	NN	O	electrocardiography	conj_and	10	SENT_65	[p3l1158t1004r1627b1059],
23	.	.	O	.	_	0	SENT_65	[p3l1158t1004r1627b1059],

1	All	DT	O	all	det	2	SENT_66	[p3l1645t1005r1708b1048],
2	subjects	NNS	O	subject	nsubjpass	15	SENT_66	[p3l1729t1004r1913b1059],
3	were	VBD	O	be	auxpass	5	SENT_66	[p3l1933t1017r2050b1048],
4	not	RB	O	not	neg	5	SENT_66	[p3l2070t1011r2147b1048],
5	allowed	VBN	O	allow	_	0	SENT_66	[p3l9t1076r191b1120],
6	to	TO	O	to	aux	7	SENT_66	[p3l207t1083r251b1120],
7	smoke	VB	O	smoke	xcomp	5	SENT_66	[p3l269t1076r430b1126],
8	,	,	O	,	_	0	SENT_66	[p3l269t1076r430b1126],
9	consume	VB	O	consume	dep	7	SENT_66	[p3l447t1089r656b1120],
10	coffee	NN	O	coffee	dobj	9	SENT_66	[p3l672t1076r808b1120],
11	or	CC	O	or	_	0	SENT_66	[p3l824t1089r874b1120],
12	alcohol	NN	O	alcohol	conj_or	10	SENT_66	[p3l887t1076r1052b1120],
13	and	CC	O	and	_	0	SENT_66	[p3l1069t1076r1153b1120],
14	were	VBD	O	be	auxpass	15	SENT_66	[p3l1168t1089r1285b1120],
15	instructed	VBN	O	instruct	conj_and	5	SENT_66	[p3l1301t1076r1534b1120],
16	to	TO	O	to	aux	17	SENT_66	[p3l1550t1083r1595b1120],
17	abstain	VB	O	abstain	xcomp	15	SENT_66	[p3l1611t1076r1777b1120],
18	from	IN	O	from	_	0	SENT_66	[p3l1793t1076r1904b1120],
19	any	DT	O	any	det	20	SENT_66	[p3l1919t1089r2002b1131],
20	drugs	NNS	O	drug	prep_from	17	SENT_66	[p3l2017t1076r2146b1131],
21	for	IN	O	for	_	0	SENT_66	[p3l9t1146r74b1190],
22	at	IN	DURATION	at	quantmod	24	SENT_66	[p3l84t1153r128b1190],
23	least	JJS	DURATION	least	mwe	22	SENT_66	[p3l140t1146r246b1190],
24	1	CD	DURATION	1	prep_for	20	SENT_66	[p3l260t1149r278b1190],
25	week	NN	NUMBER	week	tmod	17	SENT_66	[p3l296t1147r423b1190],
26	before	IN	O	before	_	0	SENT_66	[p3l434t1146r579b1190],
27	taking	VBG	O	take	prepc_before	17	SENT_66	[p3l591t1147r737b1201],
28	part	NN	O	part	dobj	27	SENT_66	[p3l748t1153r843b1201],
29	in	IN	O	in	_	0	SENT_66	[p3l854t1147r897b1190],
30	this	DT	O	this	det	31	SENT_66	[p3l909t1146r992b1190],
31	trial	NN	O	trial	prep_in	27	SENT_66	[p3l1005t1146r1106b1190],
32	.	.	O	.	_	0	SENT_66	[p3l1005t1146r1106b1190],

1	The	DT	O	the	det	2	SENT_67	[p3l1117t1147r1203b1190],
2	investigation	NN	O	investigation	nsubjpass	4	SENT_67	[p3l1216t1147r1514b1201],
3	was	VBD	O	be	auxpass	4	SENT_67	[p3l1523t1159r1614b1190],
4	approved	VBN	O	approve	_	0	SENT_67	[p3l1626t1146r1844b1201],
5	by	IN	O	by	_	0	SENT_67	[p3l1856t1147r1913b1201],
6	the	DT	O	the	det	8	SENT_67	[p3l1924t1147r1998b1190],
7	Ethics	NNPS	ORGANIZATION	Ethics	nn	8	SENT_67	[p3l2011t1146r2146b1190],
8	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_67	[p3l9t1219r267b1261],
9	of	IN	ORGANIZATION	of	_	0	SENT_67	[p3l279t1218r328b1261],
10	Central	NNP	ORGANIZATION	Central	nn	12	SENT_67	[p3l334t1218r498b1261],
11	South	NNP	ORGANIZATION	South	nn	12	SENT_67	[p3l511t1218r644b1261],
12	University	NNP	ORGANIZATION	University	prep_of	8	SENT_67	[p3l655t1219r899b1272],
13	,	,	O	,	_	0	SENT_67	[p3l655t1219r899b1272],
14	Xiangya	NNP	ORGANIZATION	Xiangya	nn	15	SENT_67	[p3l909t1219r1096b1272],
15	School	NNP	ORGANIZATION	School	appos	12	SENT_67	[p3l1108t1218r1259b1261],
16	of	IN	ORGANIZATION	of	_	0	SENT_67	[p3l1271t1218r1320b1261],
17	Medicine	NNP	ORGANIZATION	Medicine	prep_of	15	SENT_67	[p3l1327t1218r1550b1268],
18	,	,	O	,	_	0	SENT_67	[p3l1327t1218r1550b1268],
19	and	CC	O	and	_	0	SENT_67	[p3l1563t1218r1649b1261],
20	subjects	NNS	O	subject	nsubj	21	SENT_67	[p3l1662t1218r1847b1272],
21	gave	VBD	O	give	conj_and	4	SENT_67	[p3l1858t1230r1964b1272],
22	written	VBN	O	write	amod	24	SENT_67	[p3l1974t1219r2147b1261],
23	informed	VBN	O	inform	amod	24	SENT_67	[p3l9t1289r222b1333],
24	consent	NN	O	consent	dobj	21	SENT_67	[p3l239t1296r422b1333],
25	before	IN	O	before	_	0	SENT_67	[p3l436t1289r581b1333],
26	study	NN	O	study	nn	27	SENT_67	[p3l599t1289r727b1344],
27	enrollment	NN	O	enrollment	prep_before	21	SENT_67	[p3l741t1289r1008b1333],
28	.	.	O	.	_	0	SENT_67	[p3l741t1289r1008b1333],

1	2.2	CD	NUMBER	2.2	_	0	SENT_68	[p3l6t1444r87b1485],
2	.	.	O	.	_	0	SENT_68	[p3l6t1444r87b1485],

1	Study	NNP	O	Study	_	0	SENT_69	[p3l109t1441r243b1496],
2	design	NN	O	design	dep	1	SENT_69	[p3l263t1441r411b1496],

1	In	IN	O	in	_	0	SENT_70	[p3l111t1590r157b1630],
2	this	DT	O	this	det	3	SENT_70	[p3l172t1587r260b1631],
3	trial	NN	O	trial	prep_in	13	SENT_70	[p3l275t1587r385b1637],
4	,	,	O	,	_	0	SENT_70	[p3l275t1587r385b1637],
5	16	CD	NUMBER	16	num	6	SENT_70	[p3l400t1590r453b1631],
6	volunteers	NNS	O	volunteer	nsubjpass	13	SENT_70	[p3l467t1587r727b1631],
7	with	IN	O	with	_	0	SENT_70	[p3l741t1587r854b1631],
8	known	JJ	O	known	amod	10	SENT_70	[p3l870t1587r1039b1631],
9	SLCO1B1	NN	O	slco1b1	nn	10	SENT_70	[p3l1051t1590r1254b1631],
10	genotypes	NNS	O	genotype	prep_with	6	SENT_70	[p3l1274t1594r1524b1642],
11	were	VBD	O	be	auxpass	13	SENT_70	[p3l1539t1600r1661b1631],
12	randomly	RB	O	randomly	advmod	13	SENT_70	[p3l1677t1587r1914b1642],
13	allocated	VBN	O	allocate	_	0	SENT_70	[p3l1926t1587r2146b1631],
14	into	IN	O	into	_	0	SENT_70	[p3l9t1659r104b1702],
15	2	CD	NUMBER	2	num	16	SENT_70	[p3l119t1660r145b1701],
16	groups	NNS	O	group	prep_into	13	SENT_70	[p3l161t1671r328b1712],
17	(	CD	NUMBER	(	num	18	SENT_70	[p3l347t1658r402b1712],
18	A	NN	O	a	dep	16	SENT_70	[p3l347t1658r402b1712],
19	and	CC	O	and	_	0	SENT_70	[p3l415t1658r504b1702],
20	B	NN	O	b	nn	21	SENT_70	[p3l520t1658r569b1712],
21	)	NN	O	)	prep_into	13	SENT_70	[p3l520t1658r569b1712],
22	followed	VBN	O	follow	partmod	21	SENT_70	[p3l588t1658r800b1702],
23	by	IN	O	by	_	0	SENT_70	[p3l815t1658r874b1712],
24	a	DT	O	a	det	27	SENT_70	[p3l886t1671r911b1702],
25	single	JJ	O	single	amod	27	SENT_70	[p3l927t1658r1068b1712],
26	dose	NN	O	dose	nn	27	SENT_70	[p3l1084t1658r1195b1702],
27	administration	NN	O	administration	agent	22	SENT_70	[p3l1211t1658r1574b1702],
28	of	IN	O	of	_	0	SENT_70	[p3l1589t1658r1640b1702],
29	rifampicin	NN	O	rifampicin	nn	30	SENT_70	[p3l1649t1658r1901b1712],
30	phase	NN	O	phase	prep_of	27	SENT_70	[p3l1915t1658r2071b1712],
31	:	:	O	:	_	0	SENT_70	[p3l1915t1658r2071b1712],
32	A	DT	O	a	det	33	SENT_70	[p3l2088t1658r2143b1712],
33	)	NN	O	)	dep	30	SENT_70	[p3l2088t1658r2143b1712],
34	single	JJ	O	single	amod	36	SENT_70	[p3l10t1729r151b1784],
35	oral	JJ	O	oral	amod	36	SENT_70	[p3l178t1729r270b1773],
36	dose	NN	O	dose	dep	33	SENT_70	[p3l296t1729r407b1773],
37	of	IN	O	of	_	0	SENT_70	[p3l434t1729r484b1773],
38	40	CD	NUMBER	40	num	40	SENT_70	[p3l503t1731r563b1773],
39	mg	NN	O	mg	nn	40	SENT_70	[p3l589t1742r665b1784],
40	atorvastatin	NN	O	atorvastatin	prep_of	36	SENT_70	[p3l690t1730r982b1773],
41	(	CD	NUMBER	(	num	42	SENT_70	[p3l1012t1729r1121b1783],
42	one	CD	NUMBER	one	dep	67	SENT_70	[p3l1012t1729r1121b1783],
43	40	CD	NUMBER	40	num	45	SENT_70	[p3l1146t1731r1206b1773],
44	mg	NN	O	mg	nn	45	SENT_70	[p3l1233t1742r1309b1784],
45	tablet	NN	O	tablet	dep	42	SENT_70	[p3l1333t1729r1474b1773],
46	of	IN	O	of	_	0	SENT_70	[p3l1499t1729r1549b1773],
47	Lipitor	NNP	O	Lipitor	prep_of	45	SENT_70	[p3l1569t1730r1743b1784],
48	;	:	O	;	_	0	SENT_70	[p3l1569t1730r1743b1784],
49	Pﬁzer	NNP	O	Pﬁzer	dep	45	SENT_70	[p3l1773t1729r1919b1779],
50	,	,	O	,	_	0	SENT_70	[p3l1773t1729r1919b1779],
51	Da	NN	PERSON	da	appos	49	SENT_70	[p3l1945t1732r2008b1773],
52	Lian	NNP	PERSON	Lian	nn	54	SENT_70	[p3l2035t1730r2145b1779],
53	,	,	O	,	_	0	SENT_70	[p3l2035t1730r2145b1779],
54	China	NNP	LOCATION	China	dep	51	SENT_70	[p3l9t1800r167b1854],
55	)	CD	NUMBER	)	num	54	SENT_70	[p3l9t1800r167b1854],
56	plus	CC	O	plus	_	0	SENT_70	[p3l198t1800r298b1854],
57	single	JJ	O	single	amod	58	SENT_70	[p3l325t1800r467b1854],
58	dose	NN	O	dose	conj_plus	51	SENT_70	[p3l494t1800r605b1843],
59	of	IN	O	of	_	0	SENT_70	[p3l632t1800r683b1843],
60	600	CD	NUMBER	600	num	61	SENT_70	[p3l703t1802r794b1843],
61	mg	NN	O	mg	prep_of	58	SENT_70	[p3l821t1812r897b1854],
62	rifampicin	NN	O	rifampicin	dep	67	SENT_70	[p3l924t1800r1175b1854],
63	(	CD	NUMBER	(	num	62	SENT_70	[p3l1205t1800r1327b1854],
64	four	CD	NUMBER	four	number	65	SENT_70	[p3l1205t1800r1327b1854],
65	150	CD	NUMBER	150	num	67	SENT_70	[p3l1354t1802r1438b1843],
66	mg	NN	O	mg	nn	67	SENT_70	[p3l1465t1812r1541b1854],
67	capsules	NNS	O	capsule	dep	36	SENT_70	[p3l1567t1800r1772b1854],
68	of	IN	O	of	_	0	SENT_70	[p3l1799t1800r1850b1843],
69	Rifampicin	NNP	O	Rifampicin	prep_of	67	SENT_70	[p3l1871t1800r2145b1854],
70	,	,	O	,	_	0	SENT_70	[p3l1871t1800r2145b1854],
71	Zhejiang	NNP	ORGANIZATION	Zhejiang	nn	72	SENT_70	[p3l8t1871r220b1925],
72	Medicine	NNP	ORGANIZATION	Medicine	dep	85	SENT_70	[p3l240t1871r477b1921],
73	,	,	O	,	_	0	SENT_70	[p3l240t1871r477b1921],
74	Xinchang	NNP	ORGANIZATION	Xinchang	nn	76	SENT_70	[p3l497t1871r730b1925],
75	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	76	SENT_70	[p3l749t1871r1126b1915],
76	Factory	NN	ORGANIZATION	factory	appos	72	SENT_70	[p3l1147t1874r1334b1925],
77	,	,	O	,	_	0	SENT_70	[p3l1147t1874r1334b1925],
78	Xinchang	NNP	LOCATION	Xinchang	appos	72	SENT_70	[p3l1353t1871r1596b1925],
79	,	,	O	,	_	0	SENT_70	[p3l1353t1871r1596b1925],
80	China	NNP	LOCATION	China	nn	81	SENT_70	[p3l1617t1871r1775b1925],
81	)	NN	O	)	appos	72	SENT_70	[p3l1617t1871r1775b1925],
82	B	NN	O	b	dep	85	SENT_70	[p3l1800t1871r1848b1925],
83	)	CD	NUMBER	)	num	82	SENT_70	[p3l1800t1871r1848b1925],
84	single	JJ	O	single	amod	85	SENT_70	[p3l1872t1871r2014b1925],
85	dose	NN	O	dose	dep	30	SENT_70	[p3l2035t1871r2146b1915],
86	of	IN	O	of	_	0	SENT_70	[p3l9t1941r60b1985],
87	40	CD	NUMBER	40	num	89	SENT_70	[p3l76t1944r136b1985],
88	mg	NN	O	mg	nn	89	SENT_70	[p3l160t1954r236b1996],
89	atorvastatin	NN	O	atorvastatin	prep_of	85	SENT_70	[p3l259t1942r551b1985],
90	plus	CC	O	plus	prep	89	SENT_70	[p3l574t1941r673b1996],
91	placebo	NN	O	placebo	dep	90	SENT_70	[p3l698t1941r898b1996],
92	.	.	O	.	_	0	SENT_70	[p3l698t1941r898b1996],

1	The	DT	O	the	det	4	SENT_71	[p3l920t1941r1010b1985],
2	2	CD	NUMBER	2	num	4	SENT_71	[p3l1033t1944r1059b1985],
3	study	NN	O	study	nn	4	SENT_71	[p3l1085t1942r1220b1996],
4	phases	NNS	O	phase	nsubjpass	6	SENT_71	[p3l1243t1941r1407b1996],
5	were	VBD	O	be	auxpass	6	SENT_71	[p3l1430t1954r1551b1985],
6	separated	VBN	O	separate	_	0	SENT_71	[p3l1576t1942r1813b1996],
7	by	IN	O	by	_	0	SENT_71	[p3l1837t1941r1895b1996],
8	a	DT	O	a	det	11	SENT_71	[p3l1916t1954r1941b1985],
9	2-week	JJ	DURATION	2-week	amod	11	SENT_71	[p3l1964t1942r2148b1985],
10	washout	NN	O	washout	nn	11	SENT_71	[p3l8t2013r220b2056],
11	period	NN	O	period	agent	6	SENT_71	[p3l257t2013r427b2067],
12	.	.	O	.	_	0	SENT_71	[p3l257t2013r427b2067],

1	On	IN	O	on	_	0	SENT_72	[p3l466t2015r534b2056],
2	study	NN	O	study	nn	3	SENT_72	[p3l574t2013r709b2067],
3	day	NN	DURATION	day	prep_on	27	SENT_72	[p3l746t2013r833b2067],
4	1	CD	NUMBER	1	num	6	SENT_72	[p3l872t2015r891b2056],
5	(	NN	O	(	nn	6	SENT_72	[p3l938t2013r1101b2067],
6	phase	NN	O	phase	dep	3	SENT_72	[p3l938t2013r1101b2067],
7	1	CD	NUMBER	1	num	8	SENT_72	[p3l1143t2013r1188b2067],
8	)	NN	O	)	dep	3	SENT_72	[p3l1143t2013r1188b2067],
9	and	CC	O	and	_	0	SENT_72	[p3l1230t2013r1319b2056],
10	day	NN	DURATION	day	nn	13	SENT_72	[p3l1358t2013r1445b2067],
11	15	CD	NUMBER	15	num	13	SENT_72	[p3l1485t2015r1536b2056],
12	(	NN	O	(	nn	13	SENT_72	[p3l1579t2013r1742b2067],
13	phase	NN	O	phase	conj_and	3	SENT_72	[p3l1579t2013r1742b2067],
14	2	CD	NUMBER	2	num	15	SENT_72	[p3l1780t2013r1843b2067],
15	)	NN	O	)	dep	13	SENT_72	[p3l1780t2013r1843b2067],
16	,	,	O	,	_	0	SENT_72	[p3l1780t2013r1843b2067],
17	after	IN	O	after	_	0	SENT_72	[p3l1883t2013r1997b2056],
18	drug	NN	O	drug	nn	19	SENT_72	[p3l2033t2013r2147b2067],
19	administration	NN	O	administration	prep_after	27	SENT_72	[p3l9t2084r384b2134],
20	,	,	O	,	_	0	SENT_72	[p3l9t2084r384b2134],
21	a	DT	O	a	det	22	SENT_72	[p3l413t2097r438b2128],
22	series	NN	O	series	nsubj	27	SENT_72	[p3l467t2085r605b2128],
23	of	IN	O	of	_	0	SENT_72	[p3l635t2084r686b2128],
24	venous	JJ	O	venous	amod	26	SENT_72	[p3l707t2097r882b2128],
25	blood	NN	O	blood	nn	26	SENT_72	[p3l911t2084r1047b2128],
26	samples	NNS	O	sample	prep_of	22	SENT_72	[p3l1078t2084r1274b2138],
27	(	VBP	O	(	_	0	SENT_72	[p3l1308t2084r1355b2138],
28	5	CD	NUMBER	5	num	30	SENT_72	[p3l1308t2084r1355b2138],
29	ml	NN	O	ml	nn	30	SENT_72	[p3l1386t2084r1468b2138],
30	)	NN	O	)	nsubjpass	32	SENT_72	[p3l1386t2084r1468b2138],
31	was	VBD	O	be	auxpass	32	SENT_72	[p3l1499t2097r1593b2128],
32	collected	VBN	O	collect	ccomp	27	SENT_72	[p3l1623t2084r1841b2128],
33	into	IN	O	into	_	0	SENT_72	[p3l1871t2085r1966b2128],
34	EDTAcontaining	JJ	O	edtacontaining	amod	35	SENT_72	[p3l1995t2086r2146b2127, p3l9t2155r269b2209],
35	tubes	NNS	O	tube	prep_into	32	SENT_72	[p3l291t2154r423b2198],
36	before	IN	O	before	prep	32	SENT_72	[p3l446t2154r601b2198],
37	and	CC	O	and	_	0	SENT_72	[p3l623t2154r712b2198],
38	at	IN	O	at	dep	39	SENT_72	[p3l735t2161r781b2198],
39	0.5	CD	NUMBER	0.5	dep	76	SENT_72	[p3l802t2157r885b2205],
40	,	,	O	,	_	0	SENT_72	[p3l802t2157r885b2205],
41	1	CD	NUMBER	1	conj_and	39	SENT_72	[p3l907t2157r939b2205],
42	,	,	O	,	_	0	SENT_72	[p3l907t2157r939b2205],
43	2	CD	NUMBER	2	conj_and	39	SENT_72	[p3l963t2157r1002b2205],
44	,	,	O	,	_	0	SENT_72	[p3l963t2157r1002b2205],
45	3	CD	NUMBER	3	conj_and	39	SENT_72	[p3l1025t2157r1065b2205],
46	,	,	O	,	_	0	SENT_72	[p3l1025t2157r1065b2205],
47	4	CD	NUMBER	4	conj_and	39	SENT_72	[p3l1087t2157r1128b2205],
48	,	,	O	,	_	0	SENT_72	[p3l1087t2157r1128b2205],
49	6	CD	NUMBER	6	dep	76	SENT_72	[p3l1152t2157r1191b2205],
50	,	,	O	,	_	0	SENT_72	[p3l1152t2157r1191b2205],
51	8	CD	NUMBER	8	dep	76	SENT_72	[p3l1215t2157r1254b2205],
52	,	,	O	,	_	0	SENT_72	[p3l1215t2157r1254b2205],
53	10,12	CD	NUMBER	10,12	dep	76	SENT_72	[p3l1276t2157r1409b2205],
54	,	,	O	,	_	0	SENT_72	[p3l1276t2157r1409b2205],
55	16	CD	NUMBER	16	dep	76	SENT_72	[p3l1431t2157r1495b2205],
56	,	,	O	,	_	0	SENT_72	[p3l1431t2157r1495b2205],
57	24	CD	NUMBER	24	dep	76	SENT_72	[p3l1519t2157r1578b2198],
58	and	CC	O	and	_	0	SENT_72	[p3l1600t2155r1689b2198],
59	48	CD	NUMBER	48	num	60	SENT_72	[p3l1711t2157r1770b2198],
60	h.	NN	O	h.	dep	76	SENT_72	[p3l1794t2154r1835b2198],
61	In	IN	O	in	_	0	SENT_72	[p3l1859t2157r1905b2198],
62	the	DT	O	the	det	64	SENT_72	[p3l1927t2155r2005b2198],
63	third	JJ	ORDINAL	third	amod	64	SENT_72	[p3l2027t2154r2146b2198],
64	phase	NN	O	phase	prep_in	76	SENT_72	[p3l9t2226r162b2281],
65	,	,	O	,	_	0	SENT_72	[p3l9t2226r162b2281],
66	450	CD	NUMBER	450	num	68	SENT_72	[p3l187t2228r278b2270],
67	mg	NN	O	mg	nn	68	SENT_72	[p3l305t2239r381b2281],
68	rifampicin	NN	O	rifampicin	nsubjpass	76	SENT_72	[p3l406t2226r658b2281],
69	(	CD	NUMBER	(	dep	68	SENT_72	[p3l687t2226r835b2280],
70	three	CD	NUMBER	three	number	71	SENT_72	[p3l687t2226r835b2280],
71	150	CD	NUMBER	150	num	73	SENT_72	[p3l863t2229r948b2270],
72	mg	NN	O	mg	nn	73	SENT_72	[p3l974t2239r1050b2281],
73	capsules	NNS	O	capsule	dep	68	SENT_72	[p3l1075t2226r1301b2281],
74	)	NN	O	)	dep	73	SENT_72	[p3l1075t2226r1301b2281],
75	was	VBD	O	be	auxpass	76	SENT_72	[p3l1329t2239r1423b2270],
76	given	VBN	O	give	conj_and	27	SENT_72	[p3l1449t2227r1581b2281],
77	to	TO	O	to	_	0	SENT_72	[p3l1606t2233r1653b2270],
78	the	DT	O	the	det	80	SENT_72	[p3l1678t2226r1755b2270],
79	same	JJ	O	same	amod	80	SENT_72	[p3l1782t2239r1907b2270],
80	group	NN	O	group	prep_to	76	SENT_72	[p3l1932t2239r2076b2281],
81	of	IN	O	of	_	0	SENT_72	[p3l2102t2226r2152b2270],
82	volunteers	NNS	O	volunteer	prep_of	80	SENT_72	[p3l7t2297r267b2340],
83	after	IN	O	after	_	0	SENT_72	[p3l287t2297r400b2340],
84	a	DT	O	a	det	87	SENT_72	[p3l417t2309r442b2340],
85	2-week	JJ	DURATION	2-week	amod	87	SENT_72	[p3l460t2297r645b2340],
86	washout	NN	O	washout	nn	87	SENT_72	[p3l661t2297r872b2340],
87	period	NN	O	period	prep_after	76	SENT_72	[p3l890t2297r1047b2351],
88	from	IN	O	from	_	0	SENT_72	[p3l1067t2297r1183b2340],
89	the	DT	O	the	det	91	SENT_72	[p3l1201t2297r1278b2340],
90	last	JJ	O	last	amod	91	SENT_72	[p3l1298t2297r1383b2340],
91	dosing	NN	O	dosing	prep_from	87	SENT_72	[p3l1401t2297r1573b2351],
92	.	.	O	.	_	0	SENT_72	[p3l1401t2297r1573b2351],

1	Venous	JJ	O	venous	amod	3	SENT_73	[p3l1591t2299r1772b2340],
2	blood	NN	O	blood	nn	3	SENT_73	[p3l1792t2297r1928b2340],
3	samples	NNS	O	sample	nsubj	4	SENT_73	[p3l1949t2297r2145b2351],
4	(	VBP	O	(	dep	36	SENT_73	[p3l12t2368r59b2422],
5	5	CD	NUMBER	5	num	7	SENT_73	[p3l12t2368r59b2422],
6	ml	NN	O	ml	nn	7	SENT_73	[p3l81t2368r162b2422],
7	)	NN	O	)	nsubjpass	9	SENT_73	[p3l81t2368r162b2422],
8	were	VBD	O	be	auxpass	9	SENT_73	[p3l184t2381r306b2412],
9	collected	VBN	O	collect	conj_and	9	SENT_73	[p3l325t2368r543b2412],
10	into	IN	O	into	_	0	SENT_73	[p3l563t2369r657b2412],
11	EDTA-containing	JJ	O	edta-containing	amod	12	SENT_73	[p3l677t2369r1092b2422],
12	tubes	NNS	O	tube	prep_into	9	SENT_73	[p3l1110t2368r1242b2412],
13	before	IN	O	before	_	0	SENT_73	[p3l1261t2368r1416b2412],
14	and	CC	O	and	_	0	SENT_73	[p3l1435t2368r1524b2412],
15	at	IN	O	at	_	0	SENT_73	[p3l1543t2374r1589b2412],
16	0.5	CD	NUMBER	0.5	prep_before	9	SENT_73	[p3l1607t2370r1690b2418],
17	,	,	O	,	_	0	SENT_73	[p3l1607t2370r1690b2418],
18	1	CD	NUMBER	1	conj_and	16	SENT_73	[p3l1709t2370r1741b2418],
19	,	,	O	,	_	0	SENT_73	[p3l1709t2370r1741b2418],
20	2	CD	NUMBER	2	conj_and	16	SENT_73	[p3l1761t2370r1800b2418],
21	,	,	O	,	_	0	SENT_73	[p3l1761t2370r1800b2418],
22	3	CD	NUMBER	3	prep_before	9	SENT_73	[p3l1819t2370r1859b2418],
23	,	,	O	,	_	0	SENT_73	[p3l1819t2370r1859b2418],
24	4	CD	NUMBER	4	prep_before	9	SENT_73	[p3l1878t2370r1919b2418],
25	,	,	O	,	_	0	SENT_73	[p3l1878t2370r1919b2418],
26	6	CD	NUMBER	6	prep_before	9	SENT_73	[p3l1939t2370r1978b2418],
27	,	,	O	,	_	0	SENT_73	[p3l1939t2370r1978b2418],
28	8	CD	NUMBER	8	prep_before	9	SENT_73	[p3l1998t2370r2037b2418],
29	,	,	O	,	_	0	SENT_73	[p3l1998t2370r2037b2418],
30	and	CC	NUMBER	and	_	0	SENT_73	[p3l2057t2368r2146b2412],
31	12	CD	NUMBER	12	num	32	SENT_73	[p3l11t2441r64b2482],
32	h.	NN	O	h.	prep_before	9	SENT_73	[p3l94t2438r135b2482],
33	The	DT	O	the	det	34	SENT_73	[p3l161t2439r251b2482],
34	plasma	NN	O	plasma	nsubjpass	44	SENT_73	[p3l279t2438r453b2493],
35	was	VBD	O	be	auxpass	36	SENT_73	[p3l478t2451r572b2482],
36	separated	VBN	O	separate	_	0	SENT_73	[p3l601t2438r838b2493],
37	by	IN	O	by	_	0	SENT_73	[p3l866t2438r924b2493],
38	centrifugation	NN	O	centrifugation	agent	36	SENT_73	[p3l949t2438r1296b2493],
39	within	IN	O	within	_	0	SENT_73	[p3l1321t2438r1483b2482],
40	30	CD	DURATION	30	num	41	SENT_73	[p3l1510t2441r1569b2482],
41	min	NN	DURATION	min	prep_within	36	SENT_73	[p3l1598t2439r1693b2482],
42	and	CC	O	and	_	0	SENT_73	[p3l1720t2438r1809b2482],
43	immediately	RB	O	immediately	advmod	44	SENT_73	[p3l1838t2438r2148b2493],
44	frozen	VBN	O	freeze	conj_and	36	SENT_73	[p3l9t2510r163b2553],
45	in	IN	O	in	_	0	SENT_73	[p3l179t2510r224b2553],
46	polypropylene	NN	O	polypropylene	nn	47	SENT_73	[p3l238t2510r592b2564],
47	tubes	NNS	O	tube	prep_in	44	SENT_73	[p3l608t2510r739b2553],
48	at	IN	O	at	_	0	SENT_73	[p3l755t2516r801b2553],
49	—	CD	NUMBER	—	number	50	SENT_73	[p3l820t2534r860b2538],
50	20	CD	NUMBER	20	prep_at	36	SENT_73	[p3l873t2512r931b2553],
51	°	CD	NUMBER	°	num	54	SENT_73	[p3l948t2510r1009b2554],
52	C.	NNP	O	C.	nn	54	SENT_73	[p3l948t2510r1009b2554],
53	Standardized	JJ	O	standardized	amod	54	SENT_73	[p3l1026t2510r1347b2553],
54	breakfast	NN	O	breakfast	nsubjpass	56	SENT_73	[p3l1362t2510r1588b2553],
55	was	VBD	O	be	auxpass	56	SENT_73	[p3l1601t2522r1695b2553],
56	provided	VBN	O	provide	rcmod	50	SENT_73	[p3l1712t2510r1929b2564],
57	1	CD	NUMBER	1	num	58	SENT_73	[p3l1948t2512r1967b2553],
58	h	NN	O	h	dobj	56	SENT_73	[p3l1989t2510r2019b2553],
59	after	IN	O	after	_	0	SENT_73	[p3l2034t2510r2148b2553],
60	drug	NN	O	drug	nn	61	SENT_73	[p3l9t2581r122b2635],
61	dosing	NN	O	dosing	prep_after	56	SENT_73	[p3l142t2581r304b2635],
62	and	CC	O	and	_	0	SENT_73	[p3l322t2581r411b2625],
63	4	CD	NUMBER	4	num	64	SENT_73	[p3l431t2583r460b2624],
64	h	NN	O	h	npadvmod	65	SENT_73	[p3l480t2581r509b2624],
65	later	RB	O	later	advmod	70	SENT_73	[p3l529t2581r647b2631],
66	,	,	O	,	_	0	SENT_73	[p3l529t2581r647b2631],
67	warm	JJ	O	warm	amod	68	SENT_73	[p3l667t2594r810b2625],
68	meals	NNS	O	meal	nsubjpass	70	SENT_73	[p3l830t2581r971b2625],
69	were	VBD	O	be	auxpass	70	SENT_73	[p3l990t2594r1111b2625],
70	allowed	VBN	O	allow	rcmod	50	SENT_73	[p3l1131t2581r1336b2625],
71	.	.	O	.	_	0	SENT_73	[p3l1131t2581r1336b2625],

1	2.3	CD	NUMBER	2.3	_	0	SENT_74	[p3l6t2736r87b2778],
2	.	.	O	.	_	0	SENT_74	[p3l6t2736r87b2778],

1	Analytic	NNP	MISC	Analytic	_	0	SENT_75	[p3l106t2734r304b2788],
2	atorvastatin	NN	O	atorvastatin	nn	3	SENT_75	[p3l323t2735r607b2777],
3	assays	NNS	O	assay	dep	1	SENT_75	[p3l629t2746r778b2788],

1	The	DT	O	the	det	2	SENT_76	[p3l109t2879r198b2922],
2	LC	NN	O	lc	_	0	SENT_76	[p3l217t2881r382b2922],
3	.	.	O	.	_	0	SENT_76	[p3l217t2881r382b2922],

1	—	NN	O	—	_	0	SENT_77	[p3l217t2881r382b2922],
2	.	.	O	.	_	0	SENT_77	[p3l217t2881r382b2922],

1	MS	NN	O	m	nn	2	SENT_78	[p3l217t2881r382b2922],
2	equipment	NN	O	equipment	nsubj	3	SENT_78	[p3l400t2879r667b2933],
3	consisted	VBD	O	consist	ccomp	28	SENT_78	[p3l684t2879r913b2922],
4	of	IN	O	of	_	0	SENT_78	[p3l931t2878r982b2922],
5	Thermo	NNP	PERSON	Thermo	nn	12	SENT_78	[p3l991t2879r1184b2922],
6	Finnigan	NNP	PERSON	Finnigan	nn	12	SENT_78	[p3l1202t2879r1413b2933],
7	LCQ	NNP	O	LCQ	nn	12	SENT_78	[p3l1431t2881r1532b2931],
8	Deca	NNP	O	Deca	nn	12	SENT_78	[p3l1543t2881r1660b2922],
9	XP	NN	O	xp	nn	12	SENT_78	[p3l1676t2881r1742b2922],
10	Plus	NN	O	plus	nn	12	SENT_78	[p3l1759t2869r1833b2905],
11	MS	NN	O	m	nn	12	SENT_78	[p3l1851t2881r1926b2922],
12	detector	NN	O	detector	prep_of	3	SENT_78	[p3l1944t2878r2148b2922],
13	with	IN	O	with	_	0	SENT_78	[p3l8t2950r121b2993],
14	an	DT	O	a	det	17	SENT_78	[p3l137t2962r194b2993],
15	ESI	NNP	ORGANIZATION	ESI	nn	17	SENT_78	[p3l211t2952r282b2993],
16	source	NN	O	source	nn	17	SENT_78	[p3l300t2962r458b2993],
17	interface	NN	O	interface	prep_with	3	SENT_78	[p3l475t2950r701b3000],
18	,	,	O	,	_	0	SENT_78	[p3l475t2950r701b3000],
19	a	DT	O	a	det	22	SENT_78	[p3l718t2962r743b2993],
20	Surveyor	NNP	MISC	Surveyor	nn	22	SENT_78	[p3l759t2952r978b3004],
21	quarternary	JJ	O	quarternary	amod	22	SENT_78	[p3l992t2956r1285b3004],
22	pump	NN	O	pump	nsubjpass	28	SENT_78	[p3l1300t2962r1443b3004],
23	and	CC	O	and	_	0	SENT_78	[p3l1459t2950r1548b2993],
24	a	DT	O	a	det	26	SENT_78	[p3l1565t2962r1590b2993],
25	Surveyor	NNP	MISC	Surveyor	nn	26	SENT_78	[p3l1607t2952r1826b3004],
26	autosampler	NN	O	autosampler	conj_and	22	SENT_78	[p3l1840t2950r2148b3004],
27	was	VBD	O	be	auxpass	28	SENT_78	[p3l8t3033r102b3064],
28	used	VBN	O	use	_	0	SENT_78	[p3l121t3021r234b3064],
29	to	TO	O	to	aux	30	SENT_78	[p3l253t3027r300b3064],
30	determine	VB	O	determine	xcomp	28	SENT_78	[p3l319t3021r572b3064],
31	the	DT	O	the	det	33	SENT_78	[p3l591t3021r668b3064],
32	plasma	NN	O	plasma	nn	33	SENT_78	[p3l687t3021r862b3075],
33	concentration	NN	O	concentration	dobj	30	SENT_78	[p3l881t3022r1221b3064],
34	of	IN	O	of	_	0	SENT_78	[p3l1240t3021r1290b3064],
35	atorvastatin	NN	O	atorvastatin	prep_of	33	SENT_78	[p3l1303t3022r1607b3065],
36	.	.	O	.	_	0	SENT_78	[p3l1303t3022r1607b3065],

1	Xcalibur	NNP	O	Xcalibur	nsubjpass	5	SENT_79	[p3l1625t3021r1832b3064],
2	1.3	CD	NUMBER	1.3	num	3	SENT_79	[p3l1852t3023r1914b3065],
3	software	NN	O	software	dep	1	SENT_79	[p3l1936t3021r2147b3064],
4	was	VBD	O	be	auxpass	5	SENT_79	[p3l8t3105r102b3136],
5	used	VBN	O	use	_	0	SENT_79	[p3l119t3092r231b3136],
6	to	TO	O	to	aux	7	SENT_79	[p3l248t3099r295b3136],
7	operate	VB	O	operate	xcomp	5	SENT_79	[p3l312t3099r496b3147],
8	the	DT	O	the	det	9	SENT_79	[p3l512t3092r589b3136],
9	system	NN	O	system	dobj	7	SENT_79	[p3l607t3099r788b3147],
10	.	.	O	.	_	0	SENT_79	[p3l607t3099r788b3147],

1	A	DT	O	a	det	4	SENT_80	[p3l804t3094r840b3135],
2	Hypurity	NN	O	hypurity	nn	4	SENT_80	[p3l855t3093r1074b3147],
3	C18	NN	O	c18	nn	4	SENT_80	[p3l1089t3095r1160b3145],
4	column	NN	O	column	dep	5	SENT_80	[p3l1178t3092r1361b3136],
5	(	NN	O	(	dep	25	SENT_80	[p3l1381t3092r1488b3146],
6	150	CD	NUMBER	150	num	5	SENT_80	[p3l1381t3092r1488b3146],
7	x	CC	O	x	_	0	SENT_80	[p3l1501t3107r1530b3133],
8	2.1	CD	NUMBER	2.1	num	9	SENT_80	[p3l1544t3095r1605b3136],
9	mm	NN	O	mm	dep	25	SENT_80	[p3l1628t3105r1736b3142],
10	,	,	O	,	_	0	SENT_80	[p3l1628t3105r1736b3142],
11	5	CD	NUMBER	5	num	13	SENT_80	[p3l1753t3095r1778b3136],
12	u	NN	O	u	nn	13	SENT_80	[p3l1796t3092r1841b3148],
13	)	NN	O	)	nsubjpass	15	SENT_80	[p3l1796t3092r1841b3148],
14	was	VBD	O	be	auxpass	15	SENT_80	[p3l1859t3105r1954b3136],
15	used	VBN	O	use	parataxis	25	SENT_80	[p3l1971t3092r2083b3136],
16	to	TO	O	to	aux	17	SENT_80	[p3l2100t3099r2147b3136],
17	separate	VB	O	separate	xcomp	15	SENT_80	[p3l10t3169r215b3217],
18	the	DT	O	the	det	19	SENT_80	[p3l234t3163r312b3206],
19	analytes	NNS	O	analyte	dobj	17	SENT_80	[p3l332t3163r544b3217],
20	,	,	O	,	_	0	SENT_80	[p3l332t3163r544b3217],
21	temperature	NN	O	temperature	nsubjpass	25	SENT_80	[p3l565t3169r872b3217],
22	for	IN	O	for	_	0	SENT_80	[p3l892t3163r960b3206],
23	column	NN	O	column	prep_for	25	SENT_80	[p3l978t3163r1161b3206],
24	was	VBD	O	be	auxpass	25	SENT_80	[p3l1178t3175r1272b3206],
25	set	VBN	O	set	_	0	SENT_80	[p3l1293t3169r1362b3206],
26	at	IN	O	at	_	0	SENT_80	[p3l1381t3169r1427b3206],
27	40	CD	NUMBER	40	number	28	SENT_80	[p3l1444t3165r1503b3206],
28	°	CD	NUMBER	°	prep_at	25	SENT_80	[p3l1525t3163r1586b3213],
29	C.	NNP	O	C.	dobj	25	SENT_80	[p3l1525t3163r1586b3213],
30	the	DT	O	the	det	32	SENT_80	[p3l1606t3163r1684b3206],
31	mobile	JJ	O	mobile	amod	32	SENT_80	[p3l1705t3163r1872b3206],
32	phase	NN	O	phase	nsubj	35	SENT_80	[p3l1893t3163r2033b3217],
33	was	VBD	O	be	cop	35	SENT_80	[p3l2052t3175r2146b3206],
34	10	CD	NUMBER	10	num	35	SENT_80	[p3l12t3236r64b3278],
35	mmol	NN	O	mmol	rcmod	29	SENT_80	[p3l79t3234r246b3285],
36	/	:	O	/	punct	39	SENT_80	[p3l79t3234r246b3285],
37	l	NN	O	l	nn	39	SENT_80	[p3l254t3234r266b3277],
38	ammonium	NN	O	ammonium	nn	39	SENT_80	[p3l281t3235r567b3278],
39	formate	NN	O	formate	dep	29	SENT_80	[p3l582t3234r1087b3278],
40	—	CD	NUMBER	—	num	41	SENT_80	[p3l582t3234r1087b3278],
41	acetonitrile	NN	O	acetonitrile	nsubj	51	SENT_80	[p3l582t3234r1087b3278],
42	(	CD	NUMBER	(	number	43	SENT_80	[p3l1105t3234r1311b3288],
43	40/60	CD	NUMBER	40/60	num	44	SENT_80	[p3l1105t3234r1311b3288],
44	)	NN	O	)	dep	41	SENT_80	[p3l1105t3234r1311b3288],
45	,	,	O	,	_	0	SENT_80	[p3l1105t3234r1311b3288],
46	the	DT	O	the	det	48	SENT_80	[p3l1326t3234r1404b3278],
47	ﬂow	NN	O	ﬂow	nn	48	SENT_80	[p3l1419t3234r1527b3278],
48	rate	NN	O	rate	appos	41	SENT_80	[p3l1541t3240r1633b3278],
49	was	VBD	O	be	cop	51	SENT_80	[p3l1647t3247r1740b3278],
50	0.2	CD	NUMBER	0.2	num	51	SENT_80	[p3l1756t3236r1826b3278],
51	ml	NN	O	ml	rcmod	39	SENT_80	[p3l1843t3234r1904b3277],
52	/	:	O	/	punct	39	SENT_80	[p3l1910t3236r1929b3285],
53	min	NN	DURATION	min	dep	29	SENT_80	[p3l1937t3235r2043b3278],
54	.	.	O	.	_	0	SENT_80	[p3l1937t3235r2043b3278],

1	The	DT	O	the	det	3	SENT_81	[p3l2057t3234r2146b3278],
2	capillary	JJ	O	capillary	amod	3	SENT_81	[p3l9t3305r219b3359],
3	temperature	NN	O	temperature	nsubj	7	SENT_81	[p3l246t3311r552b3359],
4	was	VBD	O	be	cop	7	SENT_81	[p3l579t3317r673b3348],
5	300	CD	NUMBER	300	num	7	SENT_81	[p3l701t3307r793b3348],
6	°	NN	O	°	nn	7	SENT_81	[p3l823t3305r873b3348],
7	C	NN	O	c	_	0	SENT_81	[p3l823t3305r873b3348],
8	and	CC	O	and	_	0	SENT_81	[p3l900t3305r989b3348],
9	ion	NN	O	ion	nn	11	SENT_81	[p3l1019t3305r1094b3348],
10	spray	NN	O	spray	nn	11	SENT_81	[p3l1123t3317r1254b3359],
11	voltage	NN	O	voltage	nsubjpass	13	SENT_81	[p3l1280t3305r1458b3359],
12	was	VBD	O	be	auxpass	13	SENT_81	[p3l1485t3317r1578b3348],
13	set	VBN	O	set	conj_and	7	SENT_81	[p3l1608t3311r1677b3348],
14	at	IN	O	at	_	0	SENT_81	[p3l1704t3311r1750b3348],
15	5	CD	NUMBER	5	num	16	SENT_81	[p3l1777t3307r1802b3348],
16	kV	NN	O	kv	prep_at	13	SENT_81	[p3l1833t3305r1907b3355],
17	,	,	O	,	_	0	SENT_81	[p3l1833t3305r1907b3355],
18	selective	JJ	O	selective	amod	20	SENT_81	[p3l1936t3305r2146b3348],
19	reaction	NN	O	reaction	nn	20	SENT_81	[p3l9t3377r208b3420],
20	mode	NN	O	mode	appos	16	SENT_81	[p3l225t3376r361b3420],
21	(	CD	NUMBER	(	num	22	SENT_81	[p3l381t3376r531b3430],
22	SRM	NNP	ORGANIZATION	SRM	nsubjpass	29	SENT_81	[p3l381t3376r531b3430],
23	)	CD	NUMBER	)	num	22	SENT_81	[p3l381t3376r531b3430],
24	with	IN	O	with	_	0	SENT_81	[p3l550t3376r663b3420],
25	positive	JJ	O	positive	amod	27	SENT_81	[p3l679t3377r871b3430],
26	ion	NN	O	ion	nn	27	SENT_81	[p3l887t3377r963b3420],
27	mode	NN	O	mode	prep_with	22	SENT_81	[p3l979t3376r1115b3420],
28	was	VBD	O	be	auxpass	29	SENT_81	[p3l1131t3389r1224b3420],
29	used	VBN	O	use	rcmod	20	SENT_81	[p3l1241t3376r1354b3420],
30	to	TO	O	to	aux	31	SENT_81	[p3l1370t3383r1417b3420],
31	detect	VB	O	detect	xcomp	29	SENT_81	[p3l1434t3376r1585b3420],
32	the	DT	O	the	det	33	SENT_81	[p3l1600t3376r1677b3420],
33	analytes	NNS	O	analyte	dobj	31	SENT_81	[p3l1694t3376r1894b3430],
34	and	CC	O	and	_	0	SENT_81	[p3l1911t3376r2000b3420],
35	other	JJ	O	other	amod	37	SENT_81	[p3l2017t3376r2149b3420],
36	MS	NN	O	m	nn	37	SENT_81	[p3l9t3449r84b3490],
37	parameters	NNS	O	parameter	nsubj	40	SENT_81	[p3l100t3453r376b3501],
38	were	VBD	O	be	cop	40	SENT_81	[p3l391t3459r513b3490],
39	automatic	JJ	O	automatic	amod	40	SENT_81	[p3l528t3447r775b3490],
40	optimization	NN	O	optimization	rcmod	20	SENT_81	[p3l789t3447r1114b3501],
41	.	.	O	.	_	0	SENT_81	[p3l789t3447r1114b3501],

1	The	DT	O	the	det	3	SENT_82	[p3l1128t3447r1218b3490],
2	ion	NN	O	ion	nn	3	SENT_82	[p3l1234t3447r1309b3490],
3	transition	NN	O	transition	nsubj	7	SENT_82	[p3l1324t3447r1562b3490],
4	of	IN	O	of	_	0	SENT_82	[p3l1577t3446r1627b3490],
5	atorvastatin	NN	O	atorvastatin	prep_of	3	SENT_82	[p3l1636t3447r1929b3490],
6	was	VBD	O	be	cop	7	SENT_82	[p3l1941t3459r2035b3490],
7	m	NN	O	m	ccomp	29	SENT_82	[p3l2051t3459r2093b3490],
8	/	:	O	/	punct	10	SENT_82	[p3l2099t3449r2118b3497],
9	2	CD	NUMBER	2	number	10	SENT_82	[p3l2122t3459r2148b3490],
10	559.3	CD	NUMBER	559.3	dep	7	SENT_82	[p3l10t3520r140b3562],
11	to	TO	O	to	_	0	SENT_82	[p3l166t3524r212b3561],
12	440.2	CD	NUMBER	440.2	prep_to	10	SENT_82	[p3l234t3520r368b3562],
13	with	IN	O	with	_	0	SENT_82	[p3l393t3518r505b3561],
14	a	DT	O	a	det	16	SENT_82	[p3l528t3530r553b3561],
15	collision	NN	O	collision	nn	16	SENT_82	[p3l576t3518r779b3561],
16	energy	NN	O	energy	prep_with	7	SENT_82	[p3l803t3530r971b3572],
17	of	IN	O	of	_	0	SENT_82	[p3l992t3518r1044b3561],
18	20	CD	PERCENT	20	num	19	SENT_82	[p3l1061t3520r1165b3568],
19	%	NN	PERCENT	%	prep_of	16	SENT_82	[p3l1061t3520r1165b3568],
20	,	,	O	,	_	0	SENT_82	[p3l1061t3520r1165b3568],
21	the	DT	O	the	det	23	SENT_82	[p3l1188t3518r1266b3561],
22	ion	NN	O	ion	nn	23	SENT_82	[p3l1290t3519r1365b3561],
23	transition	NN	O	transition	nsubj	29	SENT_82	[p3l1388t3519r1626b3561],
24	of	IN	O	of	_	0	SENT_82	[p3l1649t3518r1700b3561],
25	internal	JJ	O	internal	amod	27	SENT_82	[p3l1718t3518r1908b3561],
26	standard	JJ	O	standard	amod	27	SENT_82	[p3l1933t3518r2146b3561],
27	tramadol	NN	O	tramadol	prep_of	23	SENT_82	[p3l9t3589r231b3633],
28	was	VBD	O	be	cop	29	SENT_82	[p3l244t3602r339b3633],
29	m/z	JJ	O	m/z	_	0	SENT_82	[p3l355t3591r451b3640],
30	264.0	CD	NUMBER	264.0	number	32	SENT_82	[p3l464t3591r598b3633],
31	to	TO	O	to	dep	32	SENT_82	[p3l614t3596r659b3633],
32	246.0	CD	NUMBER	246.0	dep	29	SENT_82	[p3l675t3591r808b3633],
33	with	IN	O	with	_	0	SENT_82	[p3l821t3589r934b3633],
34	a	DT	O	a	det	36	SENT_82	[p3l949t3602r973b3633],
35	collision	NN	O	collision	nn	36	SENT_82	[p3l988t3589r1191b3633],
36	energy	NN	O	energy	prep_with	29	SENT_82	[p3l1207t3602r1375b3644],
37	of	IN	O	of	_	0	SENT_82	[p3l1388t3589r1439b3633],
38	36	CD	PERCENT	36	num	39	SENT_82	[p3l1447t3589r1643b3633],
39	%	NN	PERCENT	%	prep_of	36	SENT_82	[p3l1447t3589r1643b3633],
40	.	.	O	.	_	0	SENT_82	[p3l1447t3589r1643b3633],

1	The	DT	O	the	det	2	SENT_83	[p3l1447t3589r1643b3633],
2	LOD	NNP	O	LOD	nsubj	7	SENT_83	[p3l1659t3592r1758b3633],
3	for	IN	O	for	_	0	SENT_83	[p3l1774t3589r1842b3633],
4	atorvastatin	NN	O	atorvastatin	prep_for	2	SENT_83	[p3l1854t3590r2146b3633],
5	was	VBD	O	be	cop	7	SENT_83	[p3l8t3672r102b3703],
6	0.1	CD	NUMBER	0.1	num	7	SENT_83	[p3l124t3662r185b3703],
7	ng/mL	NN	O	ng/ml	_	0	SENT_83	[p3l214t3662r380b3714],
8	and	CC	O	and	_	0	SENT_83	[p3l399t3659r488b3703],
9	the	DT	O	the	det	12	SENT_83	[p3l509t3660r587b3703],
10	calibration	NN	O	calibration	nn	12	SENT_83	[p3l610t3659r871b3703],
11	curve	NN	O	curve	nn	12	SENT_83	[p3l892t3672r1026b3703],
12	linear	NN	O	linear	conj_and	7	SENT_83	[p3l1048t3659r1189b3703],
13	from	IN	O	from	_	0	SENT_83	[p3l1209t3659r1326b3703],
14	0.47	CD	NUMBER	0.47	prep_from	12	SENT_83	[p3l1347t3662r1446b3703],
15	to	TO	NUMBER	to	_	0	SENT_83	[p3l1468t3666r1515b3703],
16	120	CD	NUMBER	120	num	17	SENT_83	[p3l1540t3662r1624b3703],
17	ng/ml	NN	O	ng/ml	prep_to	7	SENT_83	[p3l1647t3659r1811b3714],
18	.	.	O	.	_	0	SENT_83	[p3l1647t3659r1811b3714],

1	(	NN	O	(	nn	2	SENT_84	[p3l1837t3660r1932b3714],
2	r	NN	O	r	nsubj	3	SENT_84	[p3l1837t3660r1932b3714],
3	=	JJ	O	=	_	0	SENT_84	[p3l1837t3660r1932b3714],
4	0.9901	CD	NUMBER	0.9901	num	5	SENT_84	[p3l1947t3660r2146b3713],
5	)	NN	O	)	dobj	3	SENT_84	[p3l1947t3660r2146b3713],
6	.	.	O	.	_	0	SENT_84	[p3l1947t3660r2146b3713],

1	The	DT	O	the	det	3	SENT_85	[p3l7t3731r96b3774],
2	intra	JJ	O	intra	amod	3	SENT_85	[p3l131t3732r266b3774],
3	—	NN	O	—	nsubj	14	SENT_85	[p3l131t3732r266b3774],
4	and	CC	O	and	_	0	SENT_85	[p3l300t3731r389b3774],
5	inter	NN	O	inter	nsubj	14	SENT_85	[p3l423t3731r648b3785],
6	—	CD	NUMBER	—	num	8	SENT_85	[p3l423t3731r648b3785],
7	day	NN	NUMBER	day	nn	8	SENT_85	[p3l423t3731r648b3785],
8	SDs	NNS	O	sd	dep	5	SENT_85	[p3l679t3733r765b3774],
9	for	IN	O	for	_	0	SENT_85	[p3l800t3731r868b3774],
10	quality	NN	O	quality	nn	12	SENT_85	[p3l899t3731r1069b3785],
11	control	NN	O	control	nn	12	SENT_85	[p3l1100t3731r1273b3774],
12	samples	NNS	O	sample	prep_for	8	SENT_85	[p3l1307t3731r1504b3785],
13	were	VBD	O	be	cop	14	SENT_85	[p3l1537t3743r1659b3774],
14	<	JJR	O	<	_	0	SENT_85	[p3l1691t3733r1829b3775],
15	15	CD	PERCENT	15	number	16	SENT_85	[p3l1691t3733r1829b3775],
16	%	NN	PERCENT	%	amod	14	SENT_85	[p3l1691t3733r1829b3775],
17	.	.	O	.	_	0	SENT_85	[p3l1691t3733r1829b3775],

1	For	IN	O	for	_	0	SENT_86	[p3l1863t3734r1941b3774],
2	sample	NN	O	sample	nn	3	SENT_86	[p3l1973t3731r2146b3785],
3	preparation	NN	O	preparation	prep_for	9	SENT_86	[p4l9t16r308b70],
4	,	,	O	,	_	0	SENT_86	[p4l9t16r308b70],
5	200	CD	NUMBER	200	num	7	SENT_86	[p4l331t18r423b59],
6	pl	NN	O	pl	nn	7	SENT_86	[p4l445t15r485b71],
7	plasma	NN	O	plasma	nsubjpass	9	SENT_86	[p4l508t15r682b70],
8	was	VBD	O	be	auxpass	9	SENT_86	[p4l702t28r796b59],
9	added	VBN	O	add	_	0	SENT_86	[p4l819t15r968b59],
10	with	IN	O	with	_	0	SENT_86	[p4l990t15r1103b59],
11	400	CD	NUMBER	400	prep_with	9	SENT_86	[p4l1124t17r1217b59],
12	pl	NN	O	pl	nn	15	SENT_86	[p4l1239t15r1280b71],
13	256	CD	NUMBER	256	num	15	SENT_86	[p4l1302t18r1392b59],
14	ng/mL	NN	O	ng/ml	nn	15	SENT_86	[p4l1415t17r1581b70],
15	tramadol	NN	O	tramadol	dobj	9	SENT_86	[p4l1601t15r1824b59],
16	prepared	VBN	O	prepare	partmod	15	SENT_86	[p4l1847t15r2066b70],
17	by	IN	O	by	_	0	SENT_86	[p4l2089t15r2148b70],
18	acetonitrile	NN	O	acetonitrile	agent	16	SENT_86	[p4l9t86r300b136],
19	,	,	O	,	_	0	SENT_86	[p4l9t86r300b136],
20	then	RB	O	then	advmod	15	SENT_86	[p4l321t86r432b130],
21	vortex	NN	O	vortex	dep	15	SENT_86	[p4l452t92r611b130],
22	shaken	VBN	O	shake	partmod	21	SENT_86	[p4l631t86r802b130],
23	for	IN	O	for	_	0	SENT_86	[p4l825t86r892b130],
24	2	CD	DURATION	2	num	25	SENT_86	[p4l913t88r939b129],
25	min	NN	DURATION	min	prep_for	22	SENT_86	[p4l962t87r1057b129],
26	and	CC	O	and	_	0	SENT_86	[p4l1079t86r1168b130],
27	centrifugation	NN	O	centrifugation	conj_and	25	SENT_86	[p4l1190t86r1538b140],
28	under	IN	O	under	_	0	SENT_86	[p4l1559t86r1705b130],
29	13,000	CD	NUMBER	13,000	num	30	SENT_86	[p4l1728t88r1890b136],
30	r	NN	O	r	prep_under	22	SENT_86	[p4l1913t88r1956b137],
31	/	:	O	/	punct	32	SENT_86	[p4l1913t88r1956b137],
32	min	NN	DURATION	min	dep	30	SENT_86	[p4l1963t87r2058b129],
33	for	IN	O	for	_	0	SENT_86	[p4l2080t86r2148b130],
34	10	CD	DURATION	10	num	35	SENT_86	[p4l12t159r64b200],
35	min	NN	DURATION	min	prep_for	32	SENT_86	[p4l80t157r186b207],
36	,	,	O	,	_	0	SENT_86	[p4l80t157r186b207],
37	400	CD	NUMBER	400	num	40	SENT_86	[p4l200t159r294b200],
38	pl	NN	O	pl	nn	40	SENT_86	[p4l308t156r348b212],
39	upper	JJ	O	upper	amod	40	SENT_86	[p4l364t169r509b211],
40	phase	NN	O	phase	nsubjpass	42	SENT_86	[p4l522t157r663b211],
41	was	VBD	O	be	auxpass	42	SENT_86	[p4l677t169r771b200],
42	transferred	VBN	O	transfer	conj_and	9	SENT_86	[p4l786t156r1058b200],
43	and	CC	O	and	_	0	SENT_86	[p4l1074t157r1163b200],
44	10	CD	NUMBER	10	num	45	SENT_86	[p4l1181t159r1233b200],
45	pl	NN	O	pl	nsubjpass	51	SENT_86	[p4l1248t156r1288b212],
46	of	IN	O	of	_	0	SENT_86	[p4l1304t156r1355b200],
47	the	DT	O	the	det	49	SENT_86	[p4l1363t157r1441b200],
48	sample	NN	O	sample	nn	49	SENT_86	[p4l1457t157r1630b211],
49	volume	NN	O	volume	prep_of	45	SENT_86	[p4l1644t157r1828b200],
50	was	VBD	O	be	auxpass	51	SENT_86	[p4l1842t169r1935b200],
51	injected	VBN	O	inject	conj_and	9	SENT_86	[p4l1951t157r2146b211],
52	into	IN	O	into	_	0	SENT_86	[p4l10t228r104b271],
53	analysis	NN	O	analysis	nn	54	SENT_86	[p4l124t228r316b282],
54	column	NN	O	column	prep_into	51	SENT_86	[p4l336t228r531b272],
55	.	.	O	.	_	0	SENT_86	[p4l336t228r531b272],

1	2.4	CD	NUMBER	2.4	_	0	SENT_87	[p4l6t382r87b424],
2	.	.	O	.	_	0	SENT_87	[p4l6t382r87b424],

1	Analytic	NNP	MISC	Analytic	_	0	SENT_88	[p4l106t380r304b434],
2	rifampicin	NN	O	rifampicin	nn	3	SENT_88	[p4l323t380r563b434],
3	assays	NNS	O	assay	dep	1	SENT_88	[p4l585t393r734b434],

1	An	DT	O	a	det	5	SENT_89	[p4l109t528r176b569],
2	Agilent	NNP	O	Agilent	nn	5	SENT_89	[p4l192t526r369b580],
3	1100	CD	DATE	1100	num	5	SENT_89	[p4l388t528r499b569],
4	series	NN	O	series	nn	5	SENT_89	[p4l517t526r655b569],
5	HPLC	NN	O	hplc	_	0	SENT_89	[p4l673t528r800b569],
6	equipment	NN	O	equipment	nn	9	SENT_89	[p4l816t526r1084b580],
7	(	CD	NUMBER	(	num	9	SENT_89	[p4l1104t526r1301b580],
8	Agilent	NNP	ORGANIZATION	Agilent	nn	9	SENT_89	[p4l1104t526r1301b580],
9	Inc.	NNP	ORGANIZATION	Inc.	dep	5	SENT_89	[p4l1318t528r1400b570],
10	.	.	O	.	_	0	SENT_89	[p4l1318t528r1400b570],

1	Santa	NNP	LOCATION	Santa	nn	3	SENT_90	[p4l1419t528r1552b569],
2	Clara	NNP	LOCATION	Clara	nn	3	SENT_90	[p4l1569t526r1692b569],
3	CA	NNP	LOCATION	CA	nsubj	4	SENT_90	[p4l1708t526r1793b580],
4	)	VBD	O	)	_	0	SENT_90	[p4l1708t526r1793b580],
5	consisted	VBN	O	consist	csubjpass	38	SENT_90	[p4l1814t526r2043b569],
6	of	IN	O	of	_	0	SENT_90	[p4l2060t526r2111b569],
7	a	DT	O	a	det	12	SENT_90	[p4l2122t538r2147b569],
8	vacuum	NN	O	vacuum	nn	12	SENT_90	[p4l8t610r202b641],
9	degasser	NN	O	degasser	nn	12	SENT_90	[p4l219t597r433b651],
10	(	CD	NUMBER	(	num	12	SENT_90	[p4l452t597r683b651],
11	G1379A	NN	O	g1379a	nn	12	SENT_90	[p4l452t597r683b651],
12	)	NN	O	)	prep_of	5	SENT_90	[p4l452t597r683b651],
13	on	IN	O	on	_	0	SENT_90	[p4l704t610r764b641],
14	line	NN	O	line	prep_on	12	SENT_90	[p4l783t597r871b641],
15	with	IN	O	with	_	0	SENT_90	[p4l887t597r1000b641],
16	a	DT	O	a	det	22	SENT_90	[p4l1018t610r1042b641],
17	high	JJ	O	high	amod	22	SENT_90	[p4l1060t597r1167b651],
18	pressure	NN	O	pressure	nn	22	SENT_90	[p4l1185t610r1394b651],
19	quatpump	NN	O	quatpump	nn	22	SENT_90	[p4l1410t604r1663b651],
20	(	CD	NUMBER	(	num	22	SENT_90	[p4l1685t597r1910b651],
21	G1311A	NN	O	g1311a	nn	22	SENT_90	[p4l1685t597r1910b651],
22	)	NN	O	)	prep_with	5	SENT_90	[p4l1685t597r1910b651],
23	linked	VBN	O	link	partmod	22	SENT_90	[p4l1931t597r2082b641],
24	to	TO	O	to	_	0	SENT_90	[p4l2100t604r2147b641],
25	an	DT	O	a	det	29	SENT_90	[p4l9t681r66b712],
26	autosampler	NN	O	autosampler	nn	29	SENT_90	[p4l81t669r390b723],
27	(	CD	NUMBER	(	num	29	SENT_90	[p4l407t669r604b723],
28	G1329	NN	O	g1329	nn	29	SENT_90	[p4l407t669r604b723],
29	)	NN	O	)	prep_to	23	SENT_90	[p4l407t669r604b723],
30	and	CC	O	and	_	0	SENT_90	[p4l624t669r712b712],
31	a	DT	O	a	det	36	SENT_90	[p4l728t681r753b712],
32	UV	NN	O	uv	nn	36	SENT_90	[p4l768t672r841b712],
33	detector	NN	O	detector	nn	36	SENT_90	[p4l855t669r1291b723],
34	(	CD	NUMBER	(	num	36	SENT_90	[p4l855t669r1291b723],
35	G1314A	NN	O	g1314a	nn	36	SENT_90	[p4l855t669r1291b723],
36	)	NN	O	)	conj_and	29	SENT_90	[p4l855t669r1291b723],
37	was	VBD	O	be	auxpass	38	SENT_90	[p4l1309t681r1403b712],
38	used	VBN	O	use	ccomp	4	SENT_90	[p4l1419t669r1532b712],
39	to	TO	O	to	aux	40	SENT_90	[p4l1547t675r1594b712],
40	determine	VB	O	determine	xcomp	38	SENT_90	[p4l1610t669r1864b712],
41	the	DT	O	the	det	43	SENT_90	[p4l1879t669r1957b712],
42	plasma	NN	O	plasma	nn	43	SENT_90	[p4l1973t669r2147b723],
43	concentration	NN	O	concentration	dobj	40	SENT_90	[p4l9t741r350b784],
44	of	IN	O	of	_	0	SENT_90	[p4l365t740r416b784],
45	rifampicin	NN	O	rifampicin	prep_of	43	SENT_90	[p4l426t740r689b795],
46	.	.	O	.	_	0	SENT_90	[p4l426t740r689b795],

1	The	DT	O	the	det	4	SENT_91	[p4l704t740r793b784],
2	detection	NN	O	detection	nn	4	SENT_91	[p4l809t740r1039b784],
3	wave	NN	O	wave	nn	4	SENT_91	[p4l1052t753r1178b784],
4	length	NN	O	length	nsubj	7	SENT_91	[p4l1194t740r1350b795],
5	was	VBD	O	be	cop	7	SENT_91	[p4l1364t753r1458b784],
6	236	CD	NUMBER	236	num	7	SENT_91	[p4l1474t742r1564b784],
7	nm	NN	O	nm	_	0	SENT_91	[p4l1581t753r1671b784],
8	.	.	O	.	_	0	SENT_91	[p4l1581t753r1671b784],

1	a	DT	O	a	det	3	SENT_92	[p4l1688t753r1712b784],
2	Hypersil	NNP	O	Hypersil	nn	3	SENT_92	[p4l1728t740r1932b795],
3	BDS	NNP	O	BDS	_	0	SENT_92	[p4l1948t743r2043b784],
4	C18	NN	O	c18	dep	3	SENT_92	[p4l2060t743r2145b784],

1	Table	NNP	O	Table	_	0	SENT_93	[p4l6t949r142b992],
2	1	CD	NUMBER	1	num	4	SENT_93	[p4l163t951r185b992],
3	Baseline	NN	O	baseline	nn	4	SENT_93	[p4l9t1020r210b1064],
4	characteristics	NNS	O	characteristic	dep	1	SENT_93	[p4l231t1020r581b1064],
5	of	IN	O	of	_	0	SENT_93	[p4l602t1020r653b1064],
6	study	NN	O	study	nn	7	SENT_93	[p4l667t1020r802b1074],
7	subjects	NNS	O	subject	prep_of	4	SENT_93	[p4l821t1020r1029b1074],
8	.	.	O	.	_	0	SENT_93	[p4l821t1020r1029b1074],

1	Characteristic	JJ	O	characteristic	amod	8	SENT_94	[p4l9t1144r345b1188],
2	SLCO1B1	NN	O	slco1b1	nn	8	SENT_94	[p4l481t1147r692b1188],
3	C.	NN	O	c.	nn	8	SENT_94	[p4l701t1147r888b1189],
4	521TT	NN	O	521tt	nn	8	SENT_94	[p4l701t1147r888b1189],
5	SLCO1B1C	NN	O	slco1b1c	nn	8	SENT_94	[p4l991t1147r1400b1189],
6	.521	CD	NUMBER	.521	num	8	SENT_94	[p4l991t1147r1400b1189],
7	TC	NN	O	tc	nn	8	SENT_94	[p4l991t1147r1400b1189],
8	SLCO1B1C	NN	O	slco1b1c	_	0	SENT_94	[p4l1503t1147r1914b1189],
9	.521	CD	NUMBER	.521	num	11	SENT_94	[p4l1503t1147r1914b1189],
10	CC	NN	O	cc	nn	11	SENT_94	[p4l1503t1147r1914b1189],
11	P	NN	O	p	dep	8	SENT_94	[p4l2014t1147r2062b1188, p4l484t1216r652b1270],
12	(	CD	NUMBER	(	num	13	SENT_94	[p4l2014t1147r2062b1188, p4l484t1216r652b1270],
13	n	NN	O	n	npadvmod	14	SENT_94	[p4l2014t1147r2062b1188, p4l484t1216r652b1270],
14	=	JJ	O	=	amod	11	SENT_94	[p4l2014t1147r2062b1188, p4l484t1216r652b1270],
15	6	CD	NUMBER	6	num	16	SENT_94	[p4l2014t1147r2062b1188, p4l484t1216r652b1270],
16	)	NN	O	)	dep	8	SENT_94	[p4l2014t1147r2062b1188, p4l484t1216r652b1270],

1	(	NN	O	(	nn	2	SENT_95	[p4l994t1216r1162b1270],
2	n	NN	O	n	_	0	SENT_95	[p4l994t1216r1162b1270],
3	=	JJ	O	=	dep	2	SENT_95	[p4l994t1216r1162b1270],
4	6	CD	NUMBER	6	number	5	SENT_95	[p4l994t1216r1162b1270],
5	)	CD	NUMBER	)	num	11	SENT_95	[p4l994t1216r1162b1270],
6	(	NN	O	(	nn	11	SENT_95	[p4l1506t1216r1673b1270],
7	n	NN	O	n	nn	11	SENT_95	[p4l1506t1216r1673b1270],
8	=	JJ	O	=	amod	11	SENT_95	[p4l1506t1216r1673b1270],
9	4	CD	NUMBER	4	num	11	SENT_95	[p4l1506t1216r1673b1270],
10	)	NN	O	)	nn	11	SENT_95	[p4l1506t1216r1673b1270],
11	value	NN	O	value	dep	3	SENT_95	[p4l2015t1216r2144b1259],

1	Age	NNP	O	Age	_	0	SENT_96	[p4l7t1340r99b1393],
2	(	CD	NUMBER	(	num	3	SENT_96	[p4l121t1338r189b1393],
3	y	NN	O	y	dep	1	SENT_96	[p4l121t1338r189b1393],
4	)	CD	NUMBER	)	number	5	SENT_96	[p4l121t1338r189b1393],
5	22.7	CD	NUMBER	22.7	dep	3	SENT_96	[p4l481t1340r582b1383],
6	:	:	O	:	_	0	SENT_96	[p4l596t1344r637b1385],
7	|	CD	NUMBER	|	dep	3	SENT_96	[p4l596t1344r637b1385],
8	:	:	O	:	_	0	SENT_96	[p4l596t1344r637b1385],
9	1.21	CD	NUMBER	1.21	number	10	SENT_96	[p4l653t1340r740b1383],
10	21.7	CD	NUMBER	21.7	dep	7	SENT_96	[p4l993t1340r1088b1383],
11	:	:	O	:	_	0	SENT_96	[p4l1102t1344r1142b1385],
12	|	CD	NUMBER	|	dep	3	SENT_96	[p4l1102t1344r1142b1385],
13	:	:	O	:	_	0	SENT_96	[p4l1102t1344r1142b1385],
14	1.22	CD	NUMBER	1.22	number	15	SENT_96	[p4l1158t1340r1252b1383],
15	22	CD	NUMBER	22	dep	12	SENT_96	[p4l1546t1340r1604b1382],
16	:	:	O	:	_	0	SENT_96	[p4l1618t1344r1658b1385],
17	|	CD	NUMBER	|	dep	3	SENT_96	[p4l1618t1344r1658b1385],
18	:	:	O	:	_	0	SENT_96	[p4l1618t1344r1658b1385],
19	0.82	CD	NUMBER	0.82	num	22	SENT_96	[p4l1672t1340r1772b1383],
20	NS	NN	O	n	nn	22	SENT_96	[p4l2017t1340r2080b1382],
21	Body	NN	O	body	nn	22	SENT_96	[p4l9t1412r132b1467],
22	mass	NN	O	mass	dep	17	SENT_96	[p4l150t1425r271b1456],
23	index	NN	O	index	amod	22	SENT_96	[p4l291t1412r428b1456],
24	24.2	CD	NUMBER	24.2	number	23	SENT_96	[p4l481t1414r582b1456],
25	:	:	O	:	_	0	SENT_96	[p4l596t1418r637b1458],
26	|	CD	NUMBER	|	num	28	SENT_96	[p4l596t1418r637b1458],
27	:	:	O	:	_	0	SENT_96	[p4l596t1418r637b1458],
28	2.33	CD	NUMBER	2.33	dep	3	SENT_96	[p4l650t1414r750b1456],
29	24.1	CD	NUMBER	24.1	num	30	SENT_96	[p4l991t1414r1083b1456],
30	d	NN	O	d	dep	28	SENT_96	[p4l1102t1418r1142b1458],
31	:	:	O	:	_	0	SENT_96	[p4l1102t1418r1142b1458],
32	1.52	CD	NUMBER	1.52	number	33	SENT_96	[p4l1158t1414r1252b1456],
33	23.2	CD	NUMBER	23.2	dep	3	SENT_96	[p4l1502t1414r1603b1456],
34	:	:	O	:	_	0	SENT_96	[p4l1618t1418r1658b1458],
35	I	PRP	O	I	dep	33	SENT_96	[p4l1618t1418r1658b1458],
36	:	:	O	:	_	0	SENT_96	[p4l1618t1418r1658b1458],
37	0.78	CD	NUMBER	0.78	num	38	SENT_96	[p4l1672t1414r1773b1456],
38	NS	NN	O	n	dep	35	SENT_96	[p4l2016t1414r2080b1456],

1	(	NN	O	(	nn	2	SENT_97	[p4l63t1484r270b1538],
2	kg/m2	NN	O	kg/m2	_	0	SENT_97	[p4l63t1484r270b1538],
3	)	CD	NUMBER	)	dep	2	SENT_97	[p4l63t1484r270b1538],

1	Data	NNS	O	datum	nsubjpass	3	SENT_98	[p4l9t1596r120b1637],
2	are	VBP	O	be	auxpass	3	SENT_98	[p4l139t1606r214b1637],
3	given	VBN	O	give	_	0	SENT_98	[p4l232t1594r365b1648],
4	as	IN	O	as	_	0	SENT_98	[p4l384t1606r432b1637],
5	mean	NN	O	mean	prep_as	3	SENT_98	[p4l453t1599r641b1639],
6	;	:	O	;	_	0	SENT_98	[p4l453t1599r641b1639],
7	|	NN	O	|	dep	5	SENT_98	[p4l453t1599r641b1639],
8	;	:	O	;	_	0	SENT_98	[p4l453t1599r641b1639],
9	SD	NN	O	sd	nsubjpass	15	SENT_98	[p4l655t1596r730b1643],
10	,	,	O	,	_	0	SENT_98	[p4l655t1596r730b1643],
11	P	NN	O	p	dep	12	SENT_98	[p4l748t1596r814b1636],
12	<	JJR	O	<	appos	9	SENT_98	[p4l748t1596r814b1636],
13	0.05	CD	NUMBER	0.05	dep	12	SENT_98	[p4l823t1596r923b1637],
14	is	VBZ	O	be	auxpass	15	SENT_98	[p4l945t1594r980b1637],
15	considered	VBN	O	consider	parataxis	3	SENT_98	[p4l1001t1593r1269b1637],
16	as	IN	O	as	_	0	SENT_98	[p4l1289t1606r1336b1637],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_98	[p4l1358t1593r1658b1648],
18	different	JJ	O	different	prep_as	15	SENT_98	[p4l1675t1593r1898b1637],
19	.	.	O	.	_	0	SENT_98	[p4l1675t1593r1898b1637],

1	column	NN	O	column	nsubj	21	SENT_99	[p4l9t1664r193b1708],
2	(	CD	NUMBER	(	num	1	SENT_99	[p4l212t1664r304b1718],
3	4.6	CD	NUMBER	4.6	num	4	SENT_99	[p4l212t1664r304b1718],
4	x	NN	O	x	dep	1	SENT_99	[p4l317t1678r346b1705],
5	200	CD	NUMBER	200	num	6	SENT_99	[p4l359t1666r450b1708],
6	mm	NN	O	mm	dep	1	SENT_99	[p4l467t1677r574b1714],
7	,	,	O	,	_	0	SENT_99	[p4l467t1677r574b1714],
8	5	CD	NUMBER	5	num	9	SENT_99	[p4l592t1667r617b1708],
9	pun	NN	O	pun	appos	6	SENT_99	[p4l634t1677r720b1720],
10	,	,	O	,	_	0	SENT_99	[p4l634t1677r720b1720],
11	Dalian	NNP	ORGANIZATION	Dalian	nn	15	SENT_99	[p4l737t1664r892b1708],
12	Elite	NNP	ORGANIZATION	Elite	nn	15	SENT_99	[p4l908t1664r1014b1708],
13	Analytic	NNP	ORGANIZATION	Analytic	nn	15	SENT_99	[p4l1028t1664r1230b1718],
14	Instruments	NNP	ORGANIZATION	Instruments	nn	15	SENT_99	[p4l1245t1667r1542b1708],
15	Co.	NNP	ORGANIZATION	Co.	appos	6	SENT_99	[p4l1559t1666r1642b1714],
16	,	,	O	,	_	0	SENT_99	[p4l1559t1666r1642b1714],
17	Ltd.	NNP	ORGANIZATION	Ltd.	appos	6	SENT_99	[p4l1659t1664r1758b1714],
18	,	,	O	,	_	0	SENT_99	[p4l1659t1664r1758b1714],
19	China	NNP	LOCATION	China	appos	6	SENT_99	[p4l1775t1664r1933b1718],
20	)	CD	NUMBER	)	num	19	SENT_99	[p4l1775t1664r1933b1718],
21	coupled	VBN	O	couple	partmod	40	SENT_99	[p4l1953t1664r2146b1718],
22	with	IN	O	with	_	0	SENT_99	[p4l8t1734r121b1778],
23	a	DT	O	a	det	27	SENT_99	[p4l137t1747r162b1778],
24	phenomenex	NN	O	phenomenex	nn	27	SENT_99	[p4l179t1734r502b1789],
25	ODS-C18	NN	O	ods-c18	nn	27	SENT_99	[p4l518t1737r731b1778],
26	guard	NN	O	guard	nn	27	SENT_99	[p4l748t1734r889b1789],
27	column	NN	O	column	prep_with	21	SENT_99	[p4l906t1735r1089b1778],
28	(	CD	NUMBER	(	number	29	SENT_99	[p4l1109t1735r1201b1788],
29	4.0	CD	NUMBER	4.0	dep	30	SENT_99	[p4l1109t1735r1201b1788],
30	x	NN	O	x	dep	27	SENT_99	[p4l1214t1749r1243b1776],
31	3.0	CD	NUMBER	3.0	num	32	SENT_99	[p4l1256t1737r1327b1778],
32	mm	NN	O	mm	tmod	27	SENT_99	[p4l1345t1747r1452b1785],
33	,	,	O	,	_	0	SENT_99	[p4l1345t1747r1452b1785],
34	5	CD	TIME	5	num	35	SENT_99	[p4l1471t1737r1496b1778],
35	pm	NN	TIME	pm	appos	32	SENT_99	[p4l1513t1747r1600b1790],
36	,	,	O	,	_	0	SENT_99	[p4l1513t1747r1600b1790],
37	America	NNP	LOCATION	America	nn	38	SENT_99	[p4l1616t1735r1839b1788],
38	)	NN	O	)	nsubjpass	40	SENT_99	[p4l1616t1735r1839b1788],
39	was	VBD	O	be	auxpass	40	SENT_99	[p4l1859t1747r1953b1778],
40	used	VBN	O	use	_	0	SENT_99	[p4l1971t1735r2083b1778],
41	to	TO	O	to	aux	42	SENT_99	[p4l2100t1741r2147b1778],
42	separate	VB	O	separate	xcomp	40	SENT_99	[p4l10t1812r215b1860],
43	analytes	NNS	O	analyte	dobj	42	SENT_99	[p4l241t1806r453b1860],
44	.	.	O	.	_	0	SENT_99	[p4l241t1806r453b1860],

1	Temperature	NN	O	temperature	nsubjpass	6	SENT_100	[p4l478t1809r794b1860],
2	of	IN	O	of	_	0	SENT_100	[p4l820t1806r871b1849],
3	the	DT	O	the	det	4	SENT_100	[p4l891t1806r968b1849],
4	column	NN	O	column	prep_of	1	SENT_100	[p4l995t1806r1178b1849],
5	was	VBD	O	be	auxpass	6	SENT_100	[p4l1201t1818r1295b1849],
6	kept	VBN	O	keep	_	0	SENT_100	[p4l1322t1806r1430b1860],
7	at	IN	O	at	_	0	SENT_100	[p4l1454t1812r1499b1849],
8	40	CD	NUMBER	40	number	9	SENT_100	[p4l1522t1808r1582b1849],
9	°	CD	NUMBER	°	prep_at	6	SENT_100	[p4l1610t1806r1671b1850],
10	C.	NNP	O	C.	nn	13	SENT_100	[p4l1610t1806r1671b1850],
11	The	NNP	O	The	nn	13	SENT_100	[p4l1695t1806r1785b1849],
12	mobile	JJ	O	mobile	amod	13	SENT_100	[p4l1811t1806r1978b1849],
13	phase	NN	O	phase	tmod	9	SENT_100	[p4l2005t1806r2146b1860],
14	composed	VBN	O	compose	partmod	13	SENT_100	[p4l9t1877r258b1931],
15	of	IN	O	of	_	0	SENT_100	[p4l277t1877r328b1921],
16	10	CD	NUMBER	10	num	17	SENT_100	[p4l342t1879r394b1921],
17	mM	NN	O	mm	prep_of	14	SENT_100	[p4l413t1880r509b1920],
18	ammonium	NN	O	ammonium	nn	19	SENT_100	[p4l527t1878r813b1921],
19	formate	NN	O	formate	dobj	14	SENT_100	[p4l831t1877r1022b1921],
20	and	CC	O	and	_	0	SENT_100	[p4l1040t1877r1129b1921],
21	methanol	NN	O	methanol	conj_and	19	SENT_100	[p4l1148t1877r1381b1921],
22	(	CD	NUMBER	(	number	23	SENT_100	[p4l1403t1877r1506b1931],
23	30	CD	NUMBER	30	dep	19	SENT_100	[p4l1403t1877r1506b1931],
24	/	:	O	/	punct	25	SENT_100	[p4l1403t1877r1506b1931],
25	70	CD	NUMBER	70	dep	19	SENT_100	[p4l1515t1877r1704b1931],
26	,	,	O	,	_	0	SENT_100	[p4l1515t1877r1704b1931],
27	v/v	NN	O	v/v	nn	28	SENT_100	[p4l1515t1877r1704b1931],
28	)	NN	O	)	appos	25	SENT_100	[p4l1515t1877r1704b1931],
29	,	,	O	,	_	0	SENT_100	[p4l1515t1877r1704b1931],
30	the	DT	O	the	det	32	SENT_100	[p4l1723t1877r1800b1921],
31	ﬂow	NN	O	ﬂow	nn	32	SENT_100	[p4l1819t1877r1927b1921],
32	rate	NN	O	rate	nsubj	34	SENT_100	[p4l1943t1884r2036b1921],
33	was	VBD	O	be	cop	34	SENT_100	[p4l2052t1890r2146b1921],
34	1	CD	NUMBER	1	rcmod	25	SENT_100	[p4l12t1950r31b1991],
35	ml	NN	O	ml	dep	34	SENT_100	[p4l60t1948r146b1998],
36	/	:	O	/	punct	43	SENT_100	[p4l60t1948r146b1998],
37	min	NN	DURATION	min	dep	43	SENT_100	[p4l154t1948r261b1998],
38	,	,	O	,	_	0	SENT_100	[p4l154t1948r261b1998],
39	The	DT	O	the	det	40	SENT_100	[p4l283t1947r373b1991],
40	LOD	NNP	O	LOD	appos	37	SENT_100	[p4l397t1950r496b1991],
41	for	IN	O	for	mark	43	SENT_100	[p4l520t1947r588b1991],
42	rifampicin	NN	O	rifampicin	nsubj	43	SENT_100	[p4l610t1947r862b2002],
43	was	VBD	O	be	dep	34	SENT_100	[p4l882t1960r976b1991],
44	about	IN	O	about	_	0	SENT_100	[p4l1000t1948r1140b1991],
45	50	CD	NUMBER	50	num	46	SENT_100	[p4l1163t1950r1221b1991],
46	ng	NN	O	ng	prep_about	43	SENT_100	[p4l1245t1949r1327b2002],
47	/	:	O	/	punct	43	SENT_100	[p4l1245t1949r1327b2002],
48	ml	NN	O	ml	nn	51	SENT_100	[p4l1335t1948r1397b1991],
49	(	CD	NUMBER	(	num	51	SENT_100	[p4l1423t1948r1645b2002],
50	S/N23	NN	O	s/n23	nn	51	SENT_100	[p4l1423t1948r1645b2002],
51	)	NN	O	)	dep	34	SENT_100	[p4l1423t1948r1645b2002],
52	and	CC	O	and	_	0	SENT_100	[p4l1672t1947r1760b1991],
53	the	DT	O	the	det	56	SENT_100	[p4l1784t1947r1862b1991],
54	calibration	NN	O	calibration	nn	56	SENT_100	[p4l1886t1947r2147b1991],
55	curve	NN	O	curve	nn	56	SENT_100	[p4l9t2031r143b2062],
56	linear	NN	O	linear	dep	34	SENT_100	[p4l182t2019r322b2062],
57	from	IN	O	from	_	0	SENT_100	[p4l359t2019r476b2062],
58	137.5	CD	NUMBER	137.5	number	60	SENT_100	[p4l516t2021r635b2063],
59	to	TO	NUMBER	to	dep	60	SENT_100	[p4l675t2025r722b2062],
60	35,200	CD	NUMBER	35,200	num	61	SENT_100	[p4l759t2021r926b2069],
61	ng	NN	O	ng	prep_from	25	SENT_100	[p4l965t2021r1048b2073],
62	/	:	O	/	punct	25	SENT_100	[p4l965t2021r1048b2073],
63	ml	NN	O	ml	nn	65	SENT_100	[p4l1056t2019r1117b2062],
64	(	NN	O	(	nn	65	SENT_100	[p4l1159t2019r1255b2073],
65	r	NN	O	r	dep	19	SENT_100	[p4l1159t2019r1255b2073],
66	=	JJ	O	=	amod	68	SENT_100	[p4l1159t2019r1255b2073],
67	0.99958	CD	NUMBER	0.99958	tmod	66	SENT_100	[p4l1270t2019r1501b2073],
68	)	NN	O	)	dep	65	SENT_100	[p4l1270t2019r1501b2073],
69	.	.	O	.	_	0	SENT_100	[p4l1270t2019r1501b2073],

1	The	DT	O	the	det	3	SENT_101	[p4l1538t2019r1628b2062],
2	retention	NN	O	retention	nn	3	SENT_101	[p4l1667t2020r1893b2062],
3	time	NN	O	time	nsubj	6	SENT_101	[p4l1931t2020r2041b2062],
4	for	IN	O	for	_	0	SENT_101	[p4l2080t2019r2148b2062],
5	rifampicin	NN	O	rifampicin	prep_for	3	SENT_101	[p4l10t2090r261b2145],
6	was	VBD	O	be	_	0	SENT_101	[p4l277t2103r371b2134],
7	about	IN	DURATION	about	_	0	SENT_101	[p4l391t2090r531b2134],
8	5.5	CD	DURATION	5.5	num	9	SENT_101	[p4l549t2093r618b2134],
9	min	NN	DURATION	min	prep_about	6	SENT_101	[p4l639t2091r746b2134],
10	.	.	O	.	_	0	SENT_101	[p4l639t2091r746b2134],

1	The	DT	O	the	det	2	SENT_102	[p4l763t2090r853b2134],
2	intra	NN	O	intra	_	0	SENT_102	[p4l873t2091r1009b2134],
3	-	:	O	-	_	0	SENT_102	[p4l873t2091r1009b2134],
4	and	CC	O	and	_	0	SENT_102	[p4l1027t2090r1116b2134],
5	inter-day	JJ	O	inter-day	amod	6	SENT_102	[p4l1137t2090r1361b2145],
6	SDs	NNS	O	sd	conj_and	2	SENT_102	[p4l1379t2093r1465b2134],
7	for	IN	O	for	_	0	SENT_102	[p4l1485t2090r1553b2134],
8	quality	NN	O	quality	nn	10	SENT_102	[p4l1570t2090r1739b2145],
9	control	NN	O	control	nn	10	SENT_102	[p4l1756t2090r1930b2134],
10	samples	NNS	O	sample	prep_for	6	SENT_102	[p4l1949t2090r2146b2145],
11	were	VBD	O	be	cop	12	SENT_102	[p4l8t2173r130b2204],
12	<	JJR	O	<	rcmod	10	SENT_102	[p4l148t2163r286b2205],
13	15	CD	PERCENT	15	number	14	SENT_102	[p4l148t2163r286b2205],
14	%	NN	PERCENT	%	amod	10	SENT_102	[p4l148t2163r286b2205],
15	.	.	O	.	_	0	SENT_102	[p4l148t2163r286b2205],

1	For	IN	O	for	_	0	SENT_103	[p4l306t2163r384b2204],
2	sample	NN	O	sample	nn	3	SENT_103	[p4l401t2161r574b2215],
3	preparation	NN	O	preparation	prep_for	9	SENT_103	[p4l594t2161r892b2215],
4	,	,	O	,	_	0	SENT_103	[p4l594t2161r892b2215],
5	200	CD	NUMBER	200	num	7	SENT_103	[p4l913t2163r1004b2204],
6	pl	NN	O	pl	nn	7	SENT_103	[p4l1022t2161r1063b2216],
7	plasma	NN	O	plasma	nsubjpass	9	SENT_103	[p4l1082t2161r1256b2215],
8	was	VBD	O	be	auxpass	9	SENT_103	[p4l1273t2173r1367b2204],
9	added	VBN	O	add	_	0	SENT_103	[p4l1386t2161r1535b2204],
10	with	IN	O	with	_	0	SENT_103	[p4l1554t2161r1667b2204],
11	400	CD	NUMBER	400	num	13	SENT_103	[p4l1685t2163r1777b2204],
12	pl	NN	O	pl	nn	13	SENT_103	[p4l1796t2161r1836b2216],
13	acetonitrile	NN	O	acetonitrile	prep_with	9	SENT_103	[p4l1855t2161r2146b2211],
14	,	,	O	,	_	0	SENT_103	[p4l1855t2161r2146b2211],
15	then	RB	O	then	advmod	13	SENT_103	[p4l9t2232r120b2276],
16	vortex	NN	O	vortex	dep	13	SENT_103	[p4l140t2239r297b2276],
17	shaken	VBN	O	shake	partmod	16	SENT_103	[p4l319t2232r491b2276],
18	for	IN	O	for	_	0	SENT_103	[p4l513t2232r581b2276],
19	2	CD	DURATION	2	num	20	SENT_103	[p4l602t2235r628b2275],
20	min	NN	DURATION	min	prep_for	17	SENT_103	[p4l653t2233r748b2275],
21	to	TO	O	to	aux	22	SENT_103	[p4l770t2239r817b2276],
22	precipitate	VB	O	precipitate	xcomp	17	SENT_103	[p4l839t2233r1103b2287],
23	plasma	NN	O	plasma	nn	24	SENT_103	[p4l1125t2232r1299b2287],
24	protein	NN	O	protein	dep	22	SENT_103	[p4l1322t2233r1498b2287],
25	and	CC	O	and	_	0	SENT_103	[p4l1521t2232r1610b2276],
26	centrifugation	NN	O	centrifugation	dep	22	SENT_103	[p4l1632t2232r1980b2287],
27	under	IN	O	under	_	0	SENT_103	[p4l2002t2232r2148b2276],
28	13,000	CD	NUMBER	13,000	num	29	SENT_103	[p4l12t2305r174b2353],
29	r	NN	O	r	prep_under	24	SENT_103	[p4l195t2305r237b2353],
30	/	:	O	/	punct	24	SENT_103	[p4l195t2305r237b2353],
31	min	NN	DURATION	min	dep	24	SENT_103	[p4l245t2303r340b2346],
32	for	IN	O	for	_	0	SENT_103	[p4l361t2303r429b2346],
33	10	CD	DURATION	10	num	34	SENT_103	[p4l451t2305r503b2346],
34	min	NN	DURATION	min	prep_for	31	SENT_103	[p4l525t2303r631b2353],
35	,	,	O	,	_	0	SENT_103	[p4l525t2303r631b2353],
36	400	CD	NUMBER	400	num	39	SENT_103	[p4l651t2305r744b2346],
37	pl	NN	O	pl	nn	39	SENT_103	[p4l764t2303r804b2358],
38	upper	JJ	O	upper	amod	39	SENT_103	[p4l825t2315r970b2357],
39	phase	NN	O	phase	nsubjpass	41	SENT_103	[p4l990t2303r1131b2357],
40	was	VBD	O	be	auxpass	41	SENT_103	[p4l1150t2315r1244b2346],
41	transferred	VBN	O	transfer	conj_and	9	SENT_103	[p4l1265t2303r1537b2346],
42	and	CC	O	and	_	0	SENT_103	[p4l1558t2303r1647b2346],
43	20	CD	NUMBER	20	num	44	SENT_103	[p4l1669t2305r1727b2346],
44	pl	NN	O	pl	nsubjpass	50	SENT_103	[p4l1747t2303r1787b2358],
45	of	IN	O	of	_	0	SENT_103	[p4l1808t2303r1859b2346],
46	the	DT	O	the	det	48	SENT_103	[p4l1874t2303r1951b2346],
47	sample	NN	O	sample	nn	48	SENT_103	[p4l1973t2303r2146b2357],
48	volume	NN	O	volume	prep_of	44	SENT_103	[p4l8t2374r192b2418],
49	was	VBD	O	be	auxpass	50	SENT_103	[p4l210t2387r304b2418],
50	injected	VBN	O	inject	conj_and	9	SENT_103	[p4l325t2374r519b2428],
51	into	IN	O	into	_	0	SENT_103	[p4l540t2375r634b2418],
52	analysis	NN	O	analysis	nn	53	SENT_103	[p4l654t2374r846b2428],
53	column	NN	O	column	prep_into	50	SENT_103	[p4l867t2374r1061b2418],
54	.	.	O	.	_	0	SENT_103	[p4l867t2374r1061b2418],

1	2.5	CD	NUMBER	2.5	_	0	SENT_104	[p4l6t2536r88b2577],
2	.	.	O	.	_	0	SENT_104	[p4l6t2536r88b2577],

1	Pharmacokinetic	JJ	MISC	pharmacokinetic	amod	2	SENT_105	[p4l110t2533r507b2577],
2	analysis	NN	O	analysis	_	0	SENT_105	[p4l527t2533r715b2588],

1	Concentration	NN	O	concentration	nn	2	SENT_106	[p4l111t2680r467b2723],
2	data	NNS	O	datum	nsubjpass	4	SENT_106	[p4l507t2680r614b2723],
3	were	VBD	O	be	auxpass	4	SENT_106	[p4l651t2692r775b2723],
4	analyzed	VBN	O	analyze	_	0	SENT_106	[p4l814t2680r1037b2734],
5	by	IN	O	by	_	0	SENT_106	[p4l1076t2680r1135b2734],
6	non-compartmental	JJ	O	non-compartmental	amod	8	SENT_106	[p4l1174t2680r1682b2734],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_106	[p4l1723t2680r2147b2734],
8	methods	NNS	O	method	agent	4	SENT_106	[p4l10t2751r222b2794],
9	using	VBG	O	use	partmod	8	SENT_106	[p4l260t2752r392b2805],
10	WinNonlin	NNP	O	WinNonlin	nn	13	SENT_106	[p4l425t2751r697b2794],
11	Professional	NNP	O	Professional	nn	13	SENT_106	[p4l733t2751r1029b2794],
12	software	NN	O	software	nn	13	SENT_106	[p4l1066t2751r1277b2794],
13	(	NN	O	(	dobj	9	SENT_106	[p4l1317t2751r1416b2805],
14	ver	NN	O	ver	dep	13	SENT_106	[p4l1317t2751r1416b2805],
15	2.1	CD	NUMBER	2.1	num	14	SENT_106	[p4l1451t2753r1533b2801],
16	;	:	O	;	_	0	SENT_106	[p4l1451t2753r1533b2801],
17	Pharsight	NNP	ORGANIZATION	Pharsight	nn	18	SENT_106	[p4l1573t2751r1806b2805],
18	Corporation	NNP	ORGANIZATION	Corporation	dep	13	SENT_106	[p4l1842t2752r2146b2805],
19	,	,	O	,	_	0	SENT_106	[p4l1842t2752r2146b2805],
20	Mountain	NNP	ORGANIZATION	Mountain	nn	21	SENT_106	[p4l10t2823r249b2866],
21	View	NNP	ORGANIZATION	View	appos	18	SENT_106	[p4l282t2823r416b2872],
22	,	,	O	,	_	0	SENT_106	[p4l282t2823r416b2872],
23	CA	NNP	LOCATION	CA	nn	24	SENT_106	[p4l453t2822r553b2876],
24	)	NNP	O	)	appos	18	SENT_106	[p4l453t2822r553b2876],
25	.	.	O	.	_	0	SENT_106	[p4l453t2822r553b2876],

1	AUC	NN	O	auc	nsubjpass	3	SENT_107	[p4l587t2824r692b2866],
2	was	VBD	O	be	auxpass	3	SENT_107	[p4l725t2835r819b2866],
3	calculated	VBN	O	calculate	_	0	SENT_107	[p4l856t2822r1102b2866],
4	using	VBG	O	use	xcomp	3	SENT_107	[p4l1139t2823r1270b2877],
5	the	DT	O	the	det	8	SENT_107	[p4l1305t2822r1382b2866],
6	linear	JJ	O	linear	amod	8	SENT_107	[p4l1419t2822r1559b2866],
7	trapezoidal	JJ	O	trapezoidal	amod	8	SENT_107	[p4l1593t2822r1869b2877],
8	rule	NN	O	rule	dobj	4	SENT_107	[p4l1905t2822r2000b2866],
9	with	IN	O	with	_	0	SENT_107	[p4l2034t2822r2147b2866],
10	extrapolation	NN	O	extrapolation	prep_with	8	SENT_107	[p4l10t2893r338b2947],
11	from	IN	O	from	_	0	SENT_107	[p4l357t2893r473b2936],
12	o	NN	O	o	prep_from	4	SENT_107	[p4l490t2895r518b2936],
13	to	TO	O	to	_	0	SENT_107	[p4l536t2899r582b2936],
14	24	CD	NUMBER	24	num	15	SENT_107	[p4l601t2895r660b2936],
15	h	NN	O	h	prep_to	4	SENT_107	[p4l677t2893r706b2936],
16	up	IN	O	up	advmod	20	SENT_107	[p4l724t2905r785b2947],
17	to	TO	O	to	_	0	SENT_107	[p4l802t2899r849b2936],
18	the	DT	O	the	det	19	SENT_107	[p4l867t2893r944b2936],
19	last	JJ	O	last	prep_to	16	SENT_107	[p4l963t2893r1048b2936],
20	measured	VBN	O	measure	partmod	15	SENT_107	[p4l1065t2893r1305b2936],
21	concentration	NN	O	concentration	dobj	20	SENT_107	[p4l1324t2893r1664b2936],
22	that	WDT	O	that	nsubj	23	SENT_107	[p4l1681t2893r1780b2936],
23	was	VBD	O	be	rcmod	21	SENT_107	[p4l1796t2905r1890b2936],
24	above	IN	O	above	_	0	SENT_107	[p4l1908t2893r2051b2936],
25	the	DT	O	the	det	28	SENT_107	[p4l2069t2893r2146b2936],
26	lower	JJR	O	lower	amod	28	SENT_107	[p4l10t2964r150b3008],
27	detection	NN	O	detection	nn	28	SENT_107	[p4l165t2964r394b3008],
28	limit	NN	O	limit	prep_above	23	SENT_107	[p4l412t2964r536b3008],
29	.	.	O	.	_	0	SENT_107	[p4l412t2964r536b3008],

1	This	DT	O	this	det	2	SENT_108	[p4l552t2964r653b3008],
2	area	NN	O	area	nsubjpass	4	SENT_108	[p4l671t2977r774b3008],
3	was	VBD	O	be	auxpass	4	SENT_108	[p4l787t2977r881b3008],
4	extrapolated	VBN	O	extrapolate	_	0	SENT_108	[p4l899t2964r1207b3018],
5	to	TO	O	to	_	0	SENT_108	[p4l1225t2970r1272b3008],
6	inﬁnity	NN	O	inﬁnity	nn	7	SENT_108	[p4l1289t2964r1467b3018],
7	AUC	NN	O	auc	prep_to	4	SENT_108	[p4l1480t2966r1693b3023],
8	(	CD	NUMBER	(	num	9	SENT_108	[p4l1480t2966r1693b3023],
9	o	NN	O	o	dobj	4	SENT_108	[p4l1480t2966r1693b3023],
10	_	CD	NUMBER	_	number	11	SENT_108	[p4l1480t2966r1693b3023],
11	....	CD	NUMBER	....	num	12	SENT_108	[p4l1480t2966r1693b3023],
12	)	NN	O	)	nsubj	37	SENT_108	[p4l1480t2966r1693b3023],
13	by	IN	O	by	_	0	SENT_108	[p4l1712t2964r1771b3018],
14	the	DT	O	the	det	15	SENT_108	[p4l1786t2964r1864b3007],
15	addition	NN	O	addition	prep_by	12	SENT_108	[p4l1881t2964r2084b3007],
16	of	IN	O	of	_	0	SENT_108	[p4l2102t2964r2153b3007],
17	the	DT	O	the	det	18	SENT_108	[p4l9t3035r86b3079],
18	last	JJ	O	last	prep_of	15	SENT_108	[p4l116t3035r201b3079],
19	measured	VBN	O	measure	partmod	18	SENT_108	[p4l228t3035r468b3079],
20	concentration	NN	O	concentration	dobj	19	SENT_108	[p4l498t3036r838b3079],
21	divided	VBN	O	divide	partmod	20	SENT_108	[p4l867t3035r1048b3079],
22	by	IN	O	by	_	0	SENT_108	[p4l1077t3035r1136b3089],
23	the	DT	O	the	det	27	SENT_108	[p4l1162t3035r1240b3079],
24	apparent	JJ	O	apparent	amod	25	SENT_108	[p4l1269t3042r1490b3089],
25	terminal	JJ	O	terminal	amod	27	SENT_108	[p4l1517t3035r1726b3079],
26	disposition	NN	O	disposition	nn	27	SENT_108	[p4l1754t3035r2024b3089],
27	rate	NN	O	rate	agent	21	SENT_108	[p4l2054t3041r2146b3079],
28	constant	JJ	O	constant	amod	27	SENT_108	[p4l9t3112r220b3149],
29	)	CD	NUMBER	)	tmod	28	SENT_108	[p4l243t3108r313b3149],
30	\	CD	NUMBER	\	num	31	SENT_108	[p4l243t3108r313b3149],
31	z.	NN	O	z.	dobj	21	SENT_108	[p4l243t3108r313b3149],
32	)	CD	NUMBER	)	number	33	SENT_108	[p4l338t3108r454b3149],
33	\	CD	NUMBER	\	dep	31	SENT_108	[p4l338t3108r454b3149],
34	z	SYM	O	z	dep	31	SENT_108	[p4l338t3108r454b3149],
35	=	SYM	O	=	dep	37	SENT_108	[p4l338t3108r454b3149],
36	—	FW	O	—	nn	37	SENT_108	[p4l473t3105r673b3149],
37	1xthe	FW	O	1xthe	rcmod	9	SENT_108	[p4l473t3105r673b3149],
38	estimated	VBN	O	estimate	amod	39	SENT_108	[p4l698t3105r940b3149],
39	slope	NN	O	slope	xcomp	4	SENT_108	[p4l966t3106r1104b3160],
40	.	.	O	.	_	0	SENT_108	[p4l966t3106r1104b3160],

1	The	DT	O	the	det	2	SENT_109	[p4l1127t3106r1217b3149],
2	t1/2	NN	O	t1/2	nsubjpass	4	SENT_109	[p4l1243t3112r1324b3162],
3	was	VBD	O	be	auxpass	4	SENT_109	[p4l1349t3118r1443b3149],
4	calculated	VBN	O	calculate	ccomp	25	SENT_109	[p4l1469t3105r1715b3149],
5	as	IN	O	as	_	0	SENT_109	[p4l1740t3118r1788b3149],
6	t1/2	NN	O	t1/2	npadvmod	7	SENT_109	[p4l1815t3112r1895b3162],
7	=	JJ	O	=	amod	20	SENT_109	[p4l1910t3105r2146b3156],
8	ln2	NN	O	ln2	nn	20	SENT_109	[p4l1910t3105r2146b3156],
9	/	:	O	/	punct	12	SENT_109	[p4l1910t3105r2146b3156],
10	)	CD	NUMBER	)	number	11	SENT_109	[p4l1910t3105r2146b3156],
11	\	CD	NUMBER	\	num	12	SENT_109	[p4l1910t3105r2146b3156],
12	z.	NN	O	z.	dep	20	SENT_109	[p4l1910t3105r2146b3156],
13	The	DT	O	the	det	16	SENT_109	[p4l7t3177r96b3221],
14	total	JJ	O	total	amod	16	SENT_109	[p4l113t3177r223b3221],
15	oral	JJ	O	oral	amod	16	SENT_109	[p4l239t3177r332b3221],
16	clearance	NN	O	clearance	dep	12	SENT_109	[p4l349t3177r578b3221],
17	(	CD	NUMBER	(	num	18	SENT_109	[p4l598t3177r699b3231],
18	CL	NN	O	cl	dep	12	SENT_109	[p4l598t3177r699b3231],
19	/	:	O	/	punct	12	SENT_109	[p4l598t3177r699b3231],
20	F	NN	O	f	prep_as	4	SENT_109	[p4l707t3180r739b3227],
21	,	,	O	,	_	0	SENT_109	[p4l707t3180r739b3227],
22	F	NN	O	f	nsubj	25	SENT_109	[p4l757t3180r782b3220],
23	is	VBZ	O	be	cop	25	SENT_109	[p4l797t3178r832b3221],
24	bioavailability	NN	O	bioavailability	nn	25	SENT_109	[p4l849t3177r1214b3231],
25	)	NN	O	)	_	0	SENT_109	[p4l849t3177r1214b3231],
26	was	VBD	O	be	auxpass	27	SENT_109	[p4l1234t3190r1328b3221],
27	calculated	VBN	O	calculate	rcmod	25	SENT_109	[p4l1345t3177r1591b3221],
28	as	IN	O	as	_	0	SENT_109	[p4l1609t3190r1656b3221],
29	dose/AUC	NN	O	dose/auc	nn	32	SENT_109	[p4l1674t3177r2041b3236],
30	(	CD	NUMBER	(	num	32	SENT_109	[p4l1674t3177r2041b3236],
31	o	NN	O	o	nn	32	SENT_109	[p4l1674t3177r2041b3236],
32	_	NN	O	_	prep_as	27	SENT_109	[p4l1674t3177r2041b3236],
33	.	.	O	.	_	0	SENT_109	[p4l1674t3177r2041b3236],

1	.	.	O	.	_	0	SENT_110	[p4l1674t3177r2041b3236],

1	,	,	O	,	_	0	SENT_111	[p4l1674t3177r2041b3236],
2	)	NN	O	)	_	0	SENT_111	[p4l1674t3177r2041b3236],
3	.	.	O	.	_	0	SENT_111	[p4l1674t3177r2041b3236],

1	The	DT	O	the	det	2	SENT_112	[p4l2057t3177r2146b3221],
2	Vd	NN	O	vd	nsubjpass	6	SENT_112	[p4l7t3248r98b3298],
3	/	:	O	/	punct	4	SENT_112	[p4l7t3248r98b3298],
4	F	NN	O	f	dep	2	SENT_112	[p4l106t3250r131b3290],
5	was	VBD	O	be	auxpass	6	SENT_112	[p4l148t3260r242b3291],
6	estimated	VBN	O	estimate	_	0	SENT_112	[p4l262t3247r504b3291],
7	as	IN	O	as	_	0	SENT_112	[p4l524t3260r571b3291],
8	Vd	NN	O	vd	prep_as	15	SENT_112	[p4l590t3247r681b3298],
9	/	:	O	/	punct	10	SENT_112	[p4l590t3247r681b3298],
10	F	NN	O	f	dep	8	SENT_112	[p4l688t3250r713b3290],
11	=	JJ	O	=	amod	12	SENT_112	[p4l725t3266r768b3282],
12	Dose	NN	O	dose	dep	10	SENT_112	[p4l783t3249r991b3298],
13	/	:	O	/	punct	10	SENT_112	[p4l783t3249r991b3298],
14	)	CD	NUMBER	)	number	15	SENT_112	[p4l783t3249r991b3298],
15	\	CD	NUMBER	\	dobj	6	SENT_112	[p4l783t3249r991b3298],
16	z	SYM	O	z	dep	18	SENT_112	[p4l783t3249r991b3298],
17	x	CC	O	x	cc	18	SENT_112	[p4l1003t3262r1032b3289],
18	AUC	NN	O	auc	dep	15	SENT_112	[p4l1044t3249r1271b3306],
19	(	CD	NUMBER	(	num	21	SENT_112	[p4l1044t3249r1271b3306],
20	o	NN	O	o	nn	21	SENT_112	[p4l1044t3249r1271b3306],
21	_	NN	O	_	dep	18	SENT_112	[p4l1044t3249r1271b3306],
22	...	:	O	...	_	0	SENT_112	[p4l1044t3249r1271b3306],
23	,	,	O	,	_	0	SENT_112	[p4l1044t3249r1271b3306],
24	)	NN	O	)	dep	6	SENT_112	[p4l1044t3249r1271b3306],
25	.	.	O	.	_	0	SENT_112	[p4l1044t3249r1271b3306],

1	2.6	CD	NUMBER	2.6	_	0	SENT_113	[p4l6t3409r87b3451],
2	.	.	O	.	_	0	SENT_113	[p4l6t3409r87b3451],

1	Statistical	JJ	O	statistical	amod	2	SENT_114	[p4l109t3407r341b3450],
2	analysis	NN	O	analysis	_	0	SENT_114	[p4l361t3407r549b3461],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_115	[p5l111t53r346b96],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_115	[p5l362t53r555b107],
3	was	VBD	O	be	auxpass	4	SENT_115	[p5l568t65r662b96],
4	performed	VBN	O	perform	_	0	SENT_115	[p5l678t52r937b107],
5	by	IN	O	by	_	0	SENT_115	[p5l953t52r1012b107],
6	the	DT	O	the	det	8	SENT_115	[p5l1024t52r1102b96],
7	SPSS	NNP	ORGANIZATION	SPSS	nn	8	SENT_115	[p5l1117t55r1228b96],
8	software	NN	O	software	agent	4	SENT_115	[p5l1245t52r1456b96],
9	for	IN	O	for	_	0	SENT_115	[p5l1471t52r1539b96],
10	windows	NNS	O	window	prep_for	4	SENT_115	[p5l1552t52r1776b96],
11	(	CD	NUMBER	(	num	10	SENT_115	[p5l1795t53r1893b107],
12	ver	NN	O	ver	dep	10	SENT_115	[p5l1795t53r1893b107],
13	12.0	CD	NUMBER	12.0	num	12	SENT_115	[p5l1909t55r2019b103],
14	,	,	O	,	_	0	SENT_115	[p5l1909t55r2019b103],
15	SPSS	NNP	ORGANIZATION	SPSS	nn	16	SENT_115	[p5l2035t55r2146b96],
16	Inc.	NNP	ORGANIZATION	Inc.	appos	12	SENT_115	[p5l10t128r104b175],
17	,	,	O	,	_	0	SENT_115	[p5l10t128r104b175],
18	Chicago	NNP	LOCATION	Chicago	appos	12	SENT_115	[p5l121t125r323b180],
19	,	,	O	,	_	0	SENT_115	[p5l121t125r323b180],
20	IL	NN	LOCATION	il	nn	21	SENT_115	[p5l339t125r414b179],
21	)	NN	O	)	appos	12	SENT_115	[p5l339t125r414b179],
22	.	.	O	.	_	0	SENT_115	[p5l339t125r414b179],

1	Data	NNS	O	datum	nsubjpass	3	SENT_116	[p5l430t128r541b169],
2	are	VBP	O	be	auxpass	3	SENT_116	[p5l555t138r630b169],
3	expressed	VBN	O	express	_	0	SENT_116	[p5l645t125r889b180],
4	as	IN	O	as	_	0	SENT_116	[p5l904t138r952b169],
5	mean	NN	O	mean	prep_as	3	SENT_116	[p5l969t138r1103b169],
6	;	:	O	;	_	0	SENT_116	[p5l1116t131r1156b171],
7	|	NN	O	|	dep	5	SENT_116	[p5l1116t131r1156b171],
8	;	:	O	;	_	0	SENT_116	[p5l1116t131r1156b171],
9	SD	NN	O	sd	dep	5	SENT_116	[p5l1170t128r1245b169],
10	.	.	O	.	_	0	SENT_116	[p5l1170t128r1245b169],

1	The	DT	O	the	det	3	SENT_117	[p5l1259t125r1349b169],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_117	[p5l1365t125r1778b180],
3	variables	NNS	O	variable	nsubjpass	5	SENT_117	[p5l1792t125r2010b169],
4	were	VBD	O	be	auxpass	5	SENT_117	[p5l2025t138r2146b169],
5	compared	VBN	O	compare	_	0	SENT_117	[p5l9t197r254b251],
6	by	IN	O	by	_	0	SENT_117	[p5l273t197r332b251],
7	use	NN	O	use	agent	5	SENT_117	[p5l349t209r430b240],
8	of	IN	O	of	_	0	SENT_117	[p5l450t197r501b240],
9	the	DT	O	the	det	13	SENT_117	[p5l514t197r592b240],
10	paired	JJ	O	paired	amod	13	SENT_117	[p5l612t197r765b251],
11	t	NN	O	t	nn	13	SENT_117	[p5l787t203r916b240],
12	—	CD	NUMBER	—	num	13	SENT_117	[p5l787t203r916b240],
13	test	NN	O	test	prep_of	7	SENT_117	[p5l787t203r916b240],
14	between	IN	O	between	_	0	SENT_117	[p5l933t197r1145b240],
15	the	DT	O	the	det	19	SENT_117	[p5l1163t197r1241b240],
16	rifampicin	NN	O	rifampicin	nn	19	SENT_117	[p5l1261t197r1513b251],
17	and	CC	O	and	_	0	SENT_117	[p5l1532t197r1621b240],
18	placebo	NN	O	placebo	nn	19	SENT_117	[p5l1641t197r1828b251],
19	groups	NNS	O	group	prep_between	7	SENT_117	[p5l1848t209r2015b251],
20	after	IN	O	after	_	0	SENT_117	[p5l2034t197r2149b240],
21	normality	NN	O	normality	nn	22	SENT_117	[p5l10t269r251b323],
22	test	NN	O	test	prep_after	5	SENT_117	[p5l269t275r369b319],
23	,	,	O	,	_	0	SENT_117	[p5l269t275r369b319],
24	except	IN	O	except	_	0	SENT_117	[p5l388t276r548b323],
25	for	IN	O	for	_	0	SENT_117	[p5l565t269r633b313],
26	Tmax	NN	O	tmax	prep_except_for	5	SENT_117	[p5l651t272r757b321],
27	in	IN	O	in	_	0	SENT_117	[p5l775t270r820b312],
28	which	WDT	O	which	rel	36	SENT_117	[p5l836t269r987b313],
29	the	DT	O	the	det	30	SENT_117	[p5l1006t269r1083b313],
30	Wilcoxon	NNP	PERSON	Wilcoxon	poss	34	SENT_117	[p5l1101t269r1370b313],
31	's	POS	O	's	_	0	SENT_117	[p5l1101t269r1370b313],
32	signed	VBN	O	sign	amod	34	SENT_117	[p5l1390t269r1548b323],
33	rank	NN	O	rank	nn	34	SENT_117	[p5l1568t269r1678b313],
34	test	NN	O	test	nsubjpass	36	SENT_117	[p5l1695t275r1785b313],
35	was	VBD	O	be	auxpass	36	SENT_117	[p5l1801t282r1895b313],
36	used	VBN	O	use	rcmod	26	SENT_117	[p5l1914t269r2039b313],
37	.	.	O	.	_	0	SENT_117	[p5l1914t269r2039b313],

1	The	DT	O	the	det	3	SENT_118	[p5l2057t269r2146b313],
2	mean	JJ	O	mean	amod	3	SENT_118	[p5l10t353r144b384],
3	changes	NNS	O	change	nsubjpass	13	SENT_118	[p5l172t341r368b395],
4	in	IN	O	in	_	0	SENT_118	[p5l396t341r440b384],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_118	[p5l467t341r880b395],
6	parameters	NNS	O	parameter	prep_in	3	SENT_118	[p5l907t347r1184b395],
7	across	IN	O	across	_	0	SENT_118	[p5l1211t353r1361b384],
8	the	DT	O	the	det	11	SENT_118	[p5l1388t340r1466b384],
9	SLCOIBI	NNP	O	SLCOIBI	nn	11	SENT_118	[p5l1491t343r1694b384],
10	genotype	NN	O	genotype	nn	11	SENT_118	[p5l1726t347r1952b395],
11	groups	NNS	O	group	prep_across	6	SENT_118	[p5l1979t353r2146b395],
12	were	VBD	O	be	auxpass	13	SENT_118	[p5l8t425r130b456],
13	compared	VBN	O	compare	_	0	SENT_118	[p5l149t413r394b467],
14	by	IN	O	by	_	0	SENT_118	[p5l413t413r473b467],
15	using	VBG	O	use	agent	13	SENT_118	[p5l490t413r622b467],
16	one-way	JJ	O	one-way	amod	17	SENT_118	[p5l641t425r855b467],
17	ANOVA	NNP	O	ANOVA	dobj	15	SENT_118	[p5l871t415r1065b457],
18	.	.	O	.	_	0	SENT_118	[p5l871t415r1065b457],

1	A	DT	O	a	det	3	SENT_119	[p5l1084t415r1120b456],
2	P	NN	O	p	dep	3	SENT_119	[p5l1136t415r1201b456],
3	<	JJR	O	<	nsubjpass	6	SENT_119	[p5l1136t415r1201b456],
4	0.05	CD	NUMBER	0.05	dep	3	SENT_119	[p5l1210t415r1311b457],
5	was	VBD	O	be	auxpass	6	SENT_119	[p5l1331t425r1425b456],
6	considered	VBN	O	consider	_	0	SENT_119	[p5l1446t413r1713b456],
7	signiﬁcant	NN	O	signiﬁcant	dobj	6	SENT_119	[p5l1734t413r1999b467],
8	.	.	O	.	_	0	SENT_119	[p5l1734t413r1999b467],

1	3	LS	NUMBER	3	_	0	SENT_120	[p5l8t596r61b648],
2	.	.	O	.	_	0	SENT_120	[p5l8t596r61b648],

1	Results	NNS	O	result	_	0	SENT_121	[p5l87t593r316b647],

1	3.1	CD	NUMBER	3.1	_	0	SENT_122	[p5l7t773r98b826],
2	.	.	O	.	_	0	SENT_122	[p5l7t773r98b826],

1	Effect	NN	O	effect	nn	3	SENT_123	[p5l126t770r294b839],
2	ofSLCO1B1	NN	O	ofslco1b1	nn	3	SENT_123	[p5l318t770r654b839],
3	521T	NN	O	521t	_	0	SENT_123	[p5l684t773r910b826],
4	>	JJR	O	>	amod	6	SENT_123	[p5l684t773r910b826],
5	C	NN	O	c	nn	6	SENT_123	[p5l684t773r910b826],
6	polymorphism	NN	O	polymorphism	dep	3	SENT_123	[p5l929t771r1365b839],
7	on	IN	O	on	_	0	SENT_123	[p5l1395t787r1465b826],
8	the	DT	O	the	det	9	SENT_123	[p5l1497t771r1586b826],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_123	[p5l1610t770r2147b839],
10	of	IN	O	of	_	0	SENT_123	[p5l10t860r74b929],
11	rifampicin	NN	O	rifampicin	prep_of	9	SENT_123	[p5l91t860r396b929],

1	As	IN	O	as	mark	2	SENT_124	[p5l109t1041r181b1093],
2	shown	VBN	O	show	_	0	SENT_124	[p5l211t1039r413b1093],
3	in	IN	O	in	_	0	SENT_124	[p5l441t1039r497b1093],
4	Table	NNP	O	Table	prep_in	2	SENT_124	[p5l521t1038r681b1093],
5	2	CD	NUMBER	2	num	4	SENT_124	[p5l710t1041r743b1093],
6	and	CC	O	and	_	0	SENT_124	[p5l773t1038r884b1093],
7	Fig	NN	O	fig	prep_in	2	SENT_124	[p5l913t1039r1013b1107],
8	.	.	O	.	_	0	SENT_124	[p5l913t1039r1013b1107],

1	1	CD	NUMBER	1	_	0	SENT_125	[p5l1041t1041r1081b1102],
2	,	,	O	,	_	0	SENT_125	[p5l1041t1041r1081b1102],
3	the	DT	O	the	det	7	SENT_125	[p5l1110t1038r1207b1093],
4	AUC	NN	O	auc	nn	7	SENT_125	[p5l1233t1041r1498b1113],
5	(	NN	O	(	nn	7	SENT_125	[p5l1233t1041r1498b1113],
6	o	NN	O	o	nn	7	SENT_125	[p5l1233t1041r1498b1113],
7	_	NN	O	_	appos	1	SENT_125	[p5l1233t1041r1498b1113],
8	.	.	O	.	_	0	SENT_125	[p5l1233t1041r1498b1113],

1	,	,	O	,	_	0	SENT_126	[p5l1233t1041r1498b1113],
2	.	.	O	.	_	0	SENT_126	[p5l1233t1041r1498b1113],

1	.	.	O	.	_	0	SENT_127	[p5l1233t1041r1498b1113],
2	)	SYM	O	)	_	0	SENT_127	[p5l1233t1041r1498b1113],

1	values	NNS	O	value	nsubj	6	SENT_128	[p5l1528t1038r1719b1093],
2	of	IN	O	of	_	0	SENT_128	[p5l1749t1038r1812b1093],
3	rifampicin	NN	O	rifampicin	prep_of	1	SENT_128	[p5l1833t1038r2147b1107],
4	were	VBD	O	be	cop	6	SENT_128	[p5l8t1142r161b1181],
5	6l	JJ	O	6l	amod	6	SENT_128	[p5l189t1129r374b1185],
6	.6	CD	NUMBER	.6	_	0	SENT_128	[p5l189t1129r374b1185],
7	:	:	O	:	_	0	SENT_128	[p5l189t1129r374b1185],
8	I	CD	NUMBER	i	dep	6	SENT_128	[p5l189t1129r374b1185],
9	:	:	O	:	_	0	SENT_128	[p5l189t1129r374b1185],
10	15.5	CD	NUMBER	15.5	dep	6	SENT_128	[p5l395t1129r513b1182],
11	vs	CC	O	vs	_	0	SENT_128	[p5l543t1142r602b1181],
12	57.0	CD	NUMBER	57.0	conj_vs	10	SENT_128	[p5l631t1129r816b1185],
13	:	:	O	:	_	0	SENT_128	[p5l631t1129r816b1185],
14	I	PRP	O	I	dep	6	SENT_128	[p5l631t1129r816b1185],
15	:	:	O	:	_	0	SENT_128	[p5l631t1129r816b1185],
16	6.9	CD	NUMBER	6.9	dep	6	SENT_128	[p5l834t1129r921b1182],
17	vs	CC	O	vs	_	0	SENT_128	[p5l950t1142r1009b1181],
18	58.91	CD	NUMBER	58.91	number	19	SENT_128	[p5l1037t1129r1230b1185],
19	17.5	CD	NUMBER	17.5	num	21	SENT_128	[p5l1251t1129r1362b1182],
20	(	NN	O	(	nn	21	SENT_128	[p5l1396t1126r1666b1195],
21	P	NN	O	p	npadvmod	22	SENT_128	[p5l1396t1126r1666b1195],
22	>	JJR	O	>	amod	24	SENT_128	[p5l1396t1126r1666b1195],
23	0.05	CD	NUMBER	0.05	num	24	SENT_128	[p5l1396t1126r1666b1195],
24	)	NN	O	)	dep	6	SENT_128	[p5l1396t1126r1666b1195],
25	in	IN	O	in	_	0	SENT_128	[p5l1699t1127r1755b1181],
26	participants	NNS	O	participant	prep_in	24	SENT_128	[p5l1782t1127r2146b1195],
27	with	IN	O	with	_	0	SENT_128	[p5l8t1216r149b1271],
28	SLCOIBI	NN	PERSON	slcoibus	nn	33	SENT_128	[p5l175t1218r427b1271],
29	c.	NN	O	c.	nn	33	SENT_128	[p5l462t1218r704b1279],
30	521TT	NN	O	521tt	nn	33	SENT_128	[p5l462t1218r704b1279],
31	,	,	O	,	_	0	SENT_128	[p5l462t1218r704b1279],
32	c.	NN	O	c.	dep	33	SENT_128	[p5l734t1218r969b1271],
33	521TC	NN	O	521tc	prep_with	26	SENT_128	[p5l734t1218r969b1271],
34	and	CC	O	and	_	0	SENT_128	[p5l996t1216r1107b1271],
35	c.	NN	O	c.	nn	37	SENT_128	[p5l1137t1218r1375b1271],
36	521CC	NN	O	521cc	nn	37	SENT_128	[p5l1137t1218r1375b1271],
37	genotypes	NNS	O	genotype	conj_and	33	SENT_128	[p5l1401t1224r1728b1284],
38	.	.	O	.	_	0	SENT_128	[p5l1401t1224r1728b1284],

1	This	DT	O	this	nsubj	2	SENT_129	[p5l1755t1216r1881b1271],
2	showed	VBD	O	show	_	0	SENT_129	[p5l1911t1216r2146b1271],
3	that	IN	O	that	complm	6	SENT_129	[p5l9t1305r136b1360],
4	SLCOIBI	NNP	O	SLCOIBI	nn	5	SENT_129	[p5l184t1307r444b1360],
5	genotypes	NNS	O	genotype	nsubj	6	SENT_129	[p5l501t1313r825b1373],
6	conferred	VBD	O	confer	ccomp	2	SENT_129	[p5l876t1304r1180b1360],
7	no	DT	O	no	det	9	SENT_129	[p5l1232t1321r1307b1360],
8	statistic	NN	O	statistic	nn	9	SENT_129	[p5l1358t1306r1605b1360],
9	impact	NN	O	impact	dobj	6	SENT_129	[p5l1655t1305r1872b1373],
10	on	IN	O	on	_	0	SENT_129	[p5l1920t1321r1996b1360],
11	the	DT	O	the	det	12	SENT_129	[p5l2046t1305r2146b1360],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_129	[p5l10t1393r554b1462],
13	of	IN	O	of	_	0	SENT_129	[p5l579t1393r643b1448],
14	rifampicin	NN	O	rifampicin	prep_of	12	SENT_129	[p5l660t1393r989b1462],
15	.	.	O	.	_	0	SENT_129	[p5l660t1393r989b1462],

1	3.2	CD	NUMBER	3.2	_	0	SENT_130	[p5l7t1588r107b1640],
2	.	.	O	.	_	0	SENT_130	[p5l7t1588r107b1640],

1	Effect	NN	O	effect	_	0	SENT_131	[p5l151t1585r315b1654],
2	of	IN	O	of	_	0	SENT_131	[p5l354t1585r417b1654],
3	rifampicin	NN	O	rifampicin	prep_of	1	SENT_131	[p5l449t1585r746b1654],
4	on	IN	O	on	_	0	SENT_131	[p5l791t1601r860b1640],
5	atorvastatin	NN	O	atorvastatin	nn	6	SENT_131	[p5l904t1586r1258b1640],
6	kinetics	NNS	O	kinetics	prep_on	1	SENT_131	[p5l1302t1585r1523b1640],
7	based	VBN	O	base	_	0	SENT_131	[p5l1566t1585r1733b1640],
8	on	IN	O	on	prepc_based_on	1	SENT_131	[p5l1775t1601r1845b1640],
9	SLCOIBI	NNP	O	SLCOIBI	nn	10	SENT_131	[p5l1887t1588r2139b1640],
10	521T	NN	O	521t	pobj	1	SENT_131	[p5l8t1676r231b1727],
11	>	JJR	O	>	amod	13	SENT_131	[p5l8t1676r231b1727],
12	C	NN	O	c	nn	13	SENT_131	[p5l8t1676r231b1727],
13	genotype	NN	O	genotype	dep	10	SENT_131	[p5l248t1682r520b1741],

1	Interestingly	RB	O	interestingly	advmod	8	SENT_132	[p5l112t1851r519b1919],
2	,	,	O	,	_	0	SENT_132	[p5l112t1851r519b1919],
3	SLCOIBI	NN	O	slcoibus	nn	4	SENT_132	[p5l553t1854r810b1906],
4	521T	NN	O	521t	nsubj	8	SENT_132	[p5l848t1854r1077b1906],
5	>	JJR	O	>	dep	6	SENT_132	[p5l848t1854r1077b1906],
6	C	NN	O	c	amod	4	SENT_132	[p5l848t1854r1077b1906],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_132	[p5l1111t1851r1493b1919],
8	inﬂuenced	VBD	O	inﬂuenced	_	0	SENT_132	[p5l1527t1851r1853b1906],
9	the	DT	O	the	det	10	SENT_132	[p5l1888t1851r1986b1906],
10	percentage	NN	O	percentage	dobj	8	SENT_132	[p5l2021t1867r2146b1919, p5l10t1948r258b2008],
11	of	IN	O	of	_	0	SENT_132	[p5l308t1940r373b1995],
12	changes	NNS	O	change	prep_of	10	SENT_132	[p5l415t1940r673b2008],
13	of	IN	O	of	_	0	SENT_132	[p5l723t1940r790b1995],
14	atorvastatin	NN	O	atorvastatin	nn	15	SENT_132	[p5l831t1941r1222b1995],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	12	SENT_132	[p5l1270t1940r1868b2008],
16	.	.	O	.	_	0	SENT_132	[p5l1270t1940r1868b2008],

1	Among	IN	O	among	_	0	SENT_133	[p5l1916t1942r2147b2008],
2	SLCOIBI	NNP	O	SLCOIBI	prep_among	3	SENT_133	[p5l8t2031r265b2083],
3	c.	VBD	O	c.	_	0	SENT_133	[p5l301t2031r548b2092],
4	521TT	NN	O	521tt	nn	7	SENT_133	[p5l301t2031r548b2092],
5	,	,	O	,	_	0	SENT_133	[p5l301t2031r548b2092],
6	c.	NN	O	c.	dep	7	SENT_133	[p5l577t2031r817b2084],
7	52lTC	NN	O	52ltc	dobj	3	SENT_133	[p5l577t2031r817b2084],
8	and	CC	O	and	_	0	SENT_133	[p5l845t2028r957b2083],
9	c.	NN	O	c.	nn	11	SENT_133	[p5l986t2031r1229b2084],
10	52lCC	NN	O	52lcc	nn	11	SENT_133	[p5l986t2031r1229b2084],
11	groups	NNS	O	group	dobj	3	SENT_133	[p5l1255t2044r1467b2097],
12	the	DT	O	the	det	14	SENT_133	[p5l1496t2028r1595b2083],
13	increase	NN	O	increase	nn	14	SENT_133	[p5l1624t2029r1879b2083],
14	percentage	NN	O	percentage	nsubj	3	SENT_133	[p5l1908t2044r2146b2097, p5l9t2125r138b2186],
15	of	IN	O	of	_	0	SENT_133	[p5l179t2117r243b2172],
16	AUC	NN	O	auc	prep_of	14	SENT_133	[p5l273t2120r567b2192],
17	(	CD	NUMBER	(	num	16	SENT_133	[p5l273t2120r567b2192],
18	0_43	CD	NUMBER	0_43	num	19	SENT_133	[p5l273t2120r567b2192],
19	)	NN	O	)	nsubj	37	SENT_133	[p5l273t2120r567b2192],
20	were	VBD	O	be	cop	37	SENT_133	[p5l609t2133r762b2172],
21	833i245	CD	PERCENT	833i245	num	22	SENT_133	[p5l804t2120r1157b2175],
22	%	NN	PERCENT	%	nn	37	SENT_133	[p5l804t2120r1157b2175],
23	vs	CC	O	vs	_	0	SENT_133	[p5l1197t2133r1257b2172],
24	468i233	CD	PERCENT	468i233	num	25	SENT_133	[p5l1295t2120r1652b2175],
25	%	NN	PERCENT	%	nn	37	SENT_133	[p5l1295t2120r1652b2175],
26	vs	CC	O	vs	_	0	SENT_133	[p5l1692t2133r1752b2172],
27	330	CD	NUMBER	330	conj_vs	22	SENT_133	[p5l1791t2120r2147b2175],
28	:	:	O	:	_	0	SENT_133	[p5l1791t2120r2147b2175],
29	I	PRP	O	I	dep	25	SENT_133	[p5l1791t2120r2147b2175],
30	:223	CD	PERCENT	:223	num	31	SENT_133	[p5l1791t2120r2147b2175],
31	%	NN	PERCENT	%	dep	29	SENT_133	[p5l1791t2120r2147b2175],
32	respectively	RB	O	respectively	advmod	34	SENT_133	[p5l10t2205r524b2274],
33	(	CD	NUMBER	(	num	34	SENT_133	[p5l10t2205r524b2274],
34	P	NN	O	p	rcmod	31	SENT_133	[p5l10t2205r524b2274],
35	=	JJ	O	=	amod	37	SENT_133	[p5l10t2205r524b2274],
36	0.007	CD	NUMBER	0.007	tmod	35	SENT_133	[p5l542t2206r759b2274],
37	)	NN	O	)	rcmod	16	SENT_133	[p5l542t2206r759b2274],
38	.	.	O	.	_	0	SENT_133	[p5l542t2206r759b2274],

1	The	DT	O	the	det	3	SENT_134	[p5l781t2205r894b2260],
2	percentage	NN	O	percentage	nn	3	SENT_134	[p5l918t2214r1261b2274],
3	decrease	NN	O	decrease	nsubjpass	11	SENT_134	[p5l1284t2205r1554b2260],
4	of	IN	O	of	_	0	SENT_134	[p5l1577t2205r1642b2260],
5	elimination	NN	O	elimination	nn	6	SENT_134	[p5l1657t2205r2016b2260],
6	t1/2	NN	O	t1/2	prep_of	3	SENT_134	[p5l2042t2214r2145b2277],
7	and	CC	O	and	_	0	SENT_134	[p5l10t2293r122b2348],
8	CL/F	NN	O	cl/f	prep_of	3	SENT_134	[p5l165t2296r307b2358],
9	were	VBD	O	be	auxpass	11	SENT_134	[p5l345t2309r498b2348],
10	also	RB	O	also	advmod	11	SENT_134	[p5l541t2293r661b2348],
11	inﬂuenced	VBN	O	inﬂuenced	dep	15	SENT_134	[p5l703t2293r1030b2348],
12	by	IN	O	by	_	0	SENT_134	[p5l1071t2293r1145b2362],
13	SLCOIBI	NN	O	slcoibus	nn	14	SENT_134	[p5l1183t2296r1440b2348],
14	genotypes	NNS	O	genotype	agent	11	SENT_134	[p5l1488t2302r1806b2362],
15	(	VBP	O	(	_	0	SENT_134	[p5l1853t2293r2145b2362],
16	P	NN	O	p	dep	17	SENT_134	[p5l1853t2293r2145b2362],
17	<	JJR	O	<	dobj	15	SENT_134	[p5l1853t2293r2145b2362],
18	0.01	CD	NUMBER	0.01	num	19	SENT_134	[p5l1853t2293r2145b2362],
19	)	NN	O	)	nsubj	15	SENT_134	[p5l1853t2293r2145b2362],
20	.	.	O	.	_	0	SENT_134	[p5l1853t2293r2145b2362],

1	Although	IN	O	although	mark	4	SENT_135	[p5l7t2383r297b2451],
2	not	RB	O	not	neg	4	SENT_135	[p5l318t2391r419b2438],
3	statistically	RB	O	statistically	advmod	4	SENT_135	[p5l439t2383r794b2451],
4	signiﬁcant	JJ	O	signiﬁcant	advcl	17	SENT_135	[p5l813t2383r1151b2451],
5	,	,	O	,	_	0	SENT_135	[p5l813t2383r1151b2451],
6	the	DT	O	the	det	8	SENT_135	[p5l1172t2383r1270b2438],
7	increase	NN	O	increase	nn	8	SENT_135	[p5l1292t2384r1546b2438],
8	percentage	NN	O	percentage	nsubj	17	SENT_135	[p5l1567t2391r1910b2451],
9	of	IN	O	of	_	0	SENT_135	[p5l1931t2383r1995b2438],
10	Cmax	NN	O	cmax	prep_of	8	SENT_135	[p5l2010t2386r2148b2449],
11	from	IN	O	from	_	0	SENT_135	[p5l10t2471r157b2527],
12	SLCO1B1c	NN	O	slco1b1c	nn	15	SENT_135	[p5l191t2474r703b2527],
13	.521	CD	NUMBER	.521	num	15	SENT_135	[p5l191t2474r703b2527],
14	CC	NN	O	cc	nn	15	SENT_135	[p5l191t2474r703b2527],
15	group	NN	O	group	prep_from	10	SENT_135	[p5l738t2488r919b2540],
16	was	VBD	O	be	cop	17	SENT_135	[p5l955t2488r1074b2527],
17	higher	JJR	O	higher	_	0	SENT_135	[p5l1112t2472r1313b2540],
18	than	IN	O	than	_	0	SENT_135	[p5l1348t2472r1488b2527],
19	those	DT	O	those	prep_than	17	SENT_135	[p5l1524t2472r1692b2527],
20	derived	VBN	O	derive	partmod	19	SENT_135	[p5l1729t2472r1962b2527],
21	from	IN	O	from	_	0	SENT_135	[p5l2000t2471r2146b2527],
22	carriers	NNS	O	carrier	prep_from	20	SENT_135	[p5l10t2561r244b2615],
23	of	IN	O	of	_	0	SENT_135	[p5l268t2560r332b2615],
24	the	DT	O	the	det	30	SENT_135	[p5l348t2560r446b2615],
25	SLCOIBI	NNP	O	SLCOIBI	nn	30	SENT_135	[p5l468t2563r725b2615],
26	wild	JJ	O	wild	amod	30	SENT_135	[p5l754t2560r1059b2629],
27	—	NN	O	—	nn	30	SENT_135	[p5l754t2560r1059b2629],
28	type	NN	O	type	nn	30	SENT_135	[p5l754t2560r1059b2629],
29	(	CD	NUMBER	(	num	30	SENT_135	[p5l1087t2560r1218b2628],
30	P	NN	O	p	prep_of	22	SENT_135	[p5l1087t2560r1218b2628],
31	:	:	O	:	_	0	SENT_135	[p5l1087t2560r1218b2628],
32	0.054	CD	NUMBER	0.054	num	33	SENT_135	[p5l1236t2560r1452b2628],
33	)	NN	O	)	dep	30	SENT_135	[p5l1236t2560r1452b2628],
34	.	.	O	.	_	0	SENT_135	[p5l1236t2560r1452b2628],

1	4	LS	NUMBER	4	_	0	SENT_136	[p5l7t2756r61b2807],
2	.	.	O	.	_	0	SENT_136	[p5l7t2756r61b2807],

1	Discussion	NN	O	discussion	_	0	SENT_137	[p5l87t2752r430b2806],

1	In	IN	O	in	_	0	SENT_138	[p5l112t2933r169b2984],
2	this	DT	O	this	det	3	SENT_138	[p5l198t2929r309b2984],
3	study	NN	O	study	prep_in	6	SENT_138	[p5l340t2929r518b2998],
4	,	,	O	,	_	0	SENT_138	[p5l340t2929r518b2998],
5	we	PRP	O	we	nsubj	6	SENT_138	[p5l548t2945r637b2984],
6	found	VBD	O	find	_	0	SENT_138	[p5l668t2929r844b2984],
7	that	IN	O	that	complm	17	SENT_138	[p5l874t2930r997b2984],
8	co	NN	O	co	nn	10	SENT_138	[p5l1025t2929r1575b2984],
9	—	CD	NUMBER	—	num	10	SENT_138	[p5l1025t2929r1575b2984],
10	administration	NN	O	administration	nsubj	17	SENT_138	[p5l1025t2929r1575b2984],
11	of	IN	O	of	_	0	SENT_138	[p5l1605t2929r1669b2984],
12	rifampicin	NN	O	rifampicin	prep_of	10	SENT_138	[p5l1691t2929r2005b2998],
13	and	CC	O	and	_	0	SENT_138	[p5l2034t2929r2145b2984],
14	atorvastatin	NN	O	atorvastatin	prep_of	10	SENT_138	[p5l10t3020r374b3074],
15	may	MD	O	may	aux	17	SENT_138	[p5l405t3035r534b3087],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_138	[p5l563t3019r937b3087],
17	change	VB	O	change	ccomp	6	SENT_138	[p5l963t3019r1178b3087],
18	atorvastatin	NN	O	atorvastatin	nn	19	SENT_138	[p5l1208t3020r1573b3074],
19	pharmacokinetics	NNS	O	pharmacokinetic	dobj	17	SENT_138	[p5l1601t3019r2145b3087],
20	in	FW	O	in	nn	21	SENT_138	[p5l10t3109r62b3163],
21	vivo	FW	O	vivo	dep	27	SENT_138	[p5l99t3109r233b3171],
22	,	,	O	,	_	0	SENT_138	[p5l99t3109r233b3171],
23	while	IN	O	while	mark	27	SENT_138	[p5l270t3108r441b3163],
24	this	DT	O	this	det	25	SENT_138	[p5l479t3108r589b3163],
25	effect	NN	O	effect	nsubj	27	SENT_138	[p5l628t3108r796b3163],
26	could	MD	O	could	aux	27	SENT_138	[p5l832t3108r997b3163],
27	vary	VB	O	vary	parataxis	17	SENT_138	[p5l1033t3124r1167b3176],
28	according	VBG	O	accord	_	0	SENT_138	[p5l1201t3108r1499b3176],
29	to	TO	O	to	prepc_according_to	27	SENT_138	[p5l1535t3116r1593b3163],
30	SLCOIBI	NNP	O	SLCOIBI	nn	31	SENT_138	[p5l1628t3111r1880b3163],
31	52lT	NN	O	52lt	pobj	27	SENT_138	[p5l1922t3111r2148b3163],
32	>	JJR	O	>	amod	34	SENT_138	[p5l1922t3111r2148b3163],
33	C	NN	O	c	nn	34	SENT_138	[p5l1922t3111r2148b3163],
34	genotypes	NNS	O	genotype	dobj	17	SENT_138	[p5l9t3204r336b3265],
35	.	.	O	.	_	0	SENT_138	[p5l9t3204r336b3265],

1	Single	JJ	O	single	amod	3	SENT_139	[p5l371t3196r554b3265],
2	oral	JJ	O	oral	amod	3	SENT_139	[p5l587t3196r702b3251],
3	dose	NN	O	dose	nsubj	7	SENT_139	[p5l736t3196r874b3251],
4	of	IN	O	of	_	0	SENT_139	[p5l908t3196r971b3251],
5	rifampicin	NN	O	rifampicin	nn	6	SENT_139	[p5l997t3196r1312b3265],
6	signiﬁcantly	NN	O	signiﬁcantly	prep_of	3	SENT_139	[p5l1345t3196r1719b3265],
7	led	VBD	O	lead	_	0	SENT_139	[p5l1749t3196r1839b3251],
8	to	TO	O	to	_	0	SENT_139	[p5l1872t3204r1931b3251],
9	5-fold	JJ	O	5-fold	amod	10	SENT_139	[p5l1965t3196r2146b3251],
10	increase	NN	O	increase	prep_to	7	SENT_139	[p5l10t3286r260b3340],
11	of	IN	O	of	_	0	SENT_139	[p5l305t3285r368b3340],
12	peripheral	JJ	O	peripheral	amod	13	SENT_139	[p5l406t3285r721b3354],
13	exposure	NN	O	exposure	prep_of	10	SENT_139	[p5l766t3301r1043b3354],
14	of	IN	O	of	_	0	SENT_139	[p5l1089t3285r1152b3340],
15	atorvastatin	NN	O	atorvastatin	prep_of	13	SENT_139	[p5l1189t3286r1554b3340],
16	and	CC	O	and	_	0	SENT_139	[p5l1598t3285r1709b3340],
17	the	DT	O	the	det	19	SENT_139	[p5l1754t3285r1851b3340],
18	increase	NN	O	increase	nn	19	SENT_139	[p5l1897t3286r2146b3340],
19	percentage	NN	O	percentage	nsubj	31	SENT_139	[p5l10t3383r346b3443],
20	of	IN	O	of	_	0	SENT_139	[p5l366t3374r430b3429],
21	AUC	NN	O	auc	prep_of	19	SENT_139	[p5l439t3377r727b3449],
22	(	CD	NUMBER	(	number	23	SENT_139	[p5l439t3377r727b3449],
23	0_43	CD	NUMBER	0_43	num	25	SENT_139	[p5l439t3377r727b3449],
24	)	NN	O	)	nn	25	SENT_139	[p5l439t3377r727b3449],
25	values	NNS	O	value	nsubjpass	28	SENT_139	[p5l748t3375r940b3429],
26	were	VBD	O	be	auxpass	28	SENT_139	[p5l959t3390r1110b3429],
27	nearly	RB	O	nearly	advmod	28	SENT_139	[p5l1130t3375r1322b3443],
28	tripled	VBN	O	triple	rcmod	21	SENT_139	[p5l1338t3375r1541b3443],
29	in	IN	O	in	_	0	SENT_139	[p5l1563t3375r1619b3429],
30	SLCOIBI	NNP	O	SLCOIBI	prep_in	28	SENT_139	[p5l1635t3377r1888b3429],
31	c.	VBD	O	c.	conj_and	7	SENT_139	[p5l1915t3377r2149b3430],
32	52lTT	NN	O	52ltt	nn	33	SENT_139	[p5l1915t3377r2149b3430],
33	participants	NNS	O	participant	dobj	31	SENT_139	[p5l10t3463r374b3531],
34	compared	VBN	O	compare	_	0	SENT_139	[p5l399t3462r703b3531],
35	with	IN	O	with	prepc_compared_with	31	SENT_139	[p5l726t3462r868b3517],
36	c.	NN	O	c.	nn	39	SENT_139	[p5l892t3465r1041b3518],
37	521	CD	NUMBER	521	num	39	SENT_139	[p5l892t3465r1041b3518],
38	CC	NN	O	cc	nn	39	SENT_139	[p5l1053t3465r1130b3517],
39	carriers	NNS	O	carrier	pobj	31	SENT_139	[p5l1154t3463r1398b3518],
40	.	.	O	.	_	0	SENT_139	[p5l1154t3463r1398b3518],

1	OATP1B1	NN	O	oatp1b1	nsubjpass	4	SENT_140	[p5l112t3554r381b3607],
2	is	VBZ	O	be	auxpass	4	SENT_140	[p5l415t3553r459b3607],
3	speciﬁcally	RB	O	speciﬁcally	advmod	4	SENT_140	[p5l486t3552r822b3620],
4	expressed	VBN	O	express	_	0	SENT_140	[p5l845t3552r1148b3620],
5	at	IN	O	at	_	0	SENT_140	[p5l1174t3560r1231b3607],
6	the	DT	O	the	det	8	SENT_140	[p5l1254t3552r1351b3607],
7	basolateral	JJ	O	basolateral	amod	8	SENT_140	[p5l1376t3552r1708b3607],
8	membrane	NN	O	membrane	prep_at	4	SENT_140	[p5l1734t3552r2065b3607],
9	of	IN	O	of	_	0	SENT_140	[p5l2091t3552r2154b3607],
10	hepatocytes	NNS	O	hepatocyte	prep_of	8	SENT_140	[p6l10t17r375b85],
11	which	WDT	O	which	nsubj	12	SENT_140	[p6l397t17r586b72],
12	hints	VBZ	O	hint	rcmod	10	SENT_140	[p6l609t17r760b72],
13	that	IN	O	that	complm	20	SENT_140	[p6l783t17r906b72],
14	genetic	JJ	O	genetic	amod	15	SENT_140	[p6l926t18r1147b85],
15	variations	NNS	O	variation	nsubj	20	SENT_140	[p6l1167t18r1469b72],
16	in	IN	O	in	_	0	SENT_140	[p6l1493t18r1549b71],
17	SLCO1B1	NN	O	slco1b1	nn	18	SENT_140	[p6l1569t20r1822b72],
18	gene	NN	O	gene	prep_in	15	SENT_140	[p6l1851t33r1995b85],
19	may	MD	O	may	aux	20	SENT_140	[p6l2019t33r2148b85],
20	inﬂuence	VB	O	inﬂuence	ccomp	12	SENT_140	[p6l10t105r292b160],
21	the	DT	O	the	det	23	SENT_140	[p6l326t105r424b160],
22	cellular	JJ	O	cellular	amod	23	SENT_140	[p6l459t105r686b160],
23	uptake	NN	O	uptake	dobj	20	SENT_140	[p6l718t105r926b174],
24	of	IN	O	of	_	0	SENT_140	[p6l962t105r1025b160],
25	its	PRP$	O	its	poss	26	SENT_140	[p6l1053t106r1122b160],
26	substrates	NNS	O	substrate	prep_of	23	SENT_140	[p6l1159t105r1466b160],
27	including	VBG	O	include	_	0	SENT_140	[p6l1503t105r1790b174],
28	exogenous	JJ	O	exogenous	amod	29	SENT_140	[p6l1823t121r2146b174],
29	drugs	NNS	O	drug	prep_including	26	SENT_140	[p6l10t194r179b263],
30	and	CC	O	and	_	0	SENT_140	[p6l207t194r318b249],
31	endogenous	JJ	O	endogenous	amod	32	SENT_140	[p6l347t194r717b263],
32	compounds	NNS	O	compound	nsubj	33	SENT_140	[p6l745t194r1101b263],
33	[	VBP	O	[	conj_and	20	SENT_140	[p6l1133t194r1261b263],
34	18	CD	NUMBER	18	num	35	SENT_140	[p6l1133t194r1261b263],
35	]	CD	NUMBER	]	dobj	33	SENT_140	[p6l1133t194r1261b263],
36	.	.	O	.	_	0	SENT_140	[p6l1133t194r1261b263],

1	Naturally	RB	O	naturally	advmod	2	SENT_141	[p6l1290t194r1572b263],
2	occurring	VBG	O	occur	_	0	SENT_141	[p6l1597t195r1889b263],
3	SNPs	NNS	O	snp	dobj	2	SENT_141	[p6l1915t197r2062b249],
4	of	IN	O	of	prep	3	SENT_141	[p6l2091t194r2154b249],
5	SLCO1B1	NN	O	slco1b1	dep	13	SENT_141	[p6l8t286r261b339],
6	such	JJ	O	such	_	0	SENT_141	[p6l318t284r456b339],
7	as	IN	O	as	_	0	SENT_141	[p6l504t300r563b339],
8	388A	NN	O	388a	prep_such_as	5	SENT_141	[p6l611t286r854b339],
9	>	JJR	O	>	amod	10	SENT_141	[p6l611t286r854b339],
10	G	NN	O	g	dep	13	SENT_141	[p6l611t286r854b339],
11	(	CD	NUMBER	(	num	13	SENT_141	[p6l906t284r1298b352],
12	Asn130Asp	NN	O	asn130asp	nn	13	SENT_141	[p6l906t284r1298b352],
13	)	NN	O	)	dep	17	SENT_141	[p6l906t284r1298b352],
14	and	CC	O	and	_	0	SENT_141	[p6l1351t284r1461b339],
15	521T	NN	O	521t	dep	17	SENT_141	[p6l1511t286r1738b339],
16	>	JJR	O	>	amod	17	SENT_141	[p6l1511t286r1738b339],
17	C	NN	O	c	dep	4	SENT_141	[p6l1511t286r1738b339],
18	(	CD	NUMBER	(	num	20	SENT_141	[p6l1789t284r2142b352],
19	Val174Ala	NN	O	val174alum	nn	20	SENT_141	[p6l1789t284r2142b352],
20	)	NN	O	)	dep	17	SENT_141	[p6l1789t284r2142b352],

1	Y.	NNP	O	Y.	_	0	SENT_142	[p6l753t428r793b454],
2	.	.	O	.	_	0	SENT_142	[p6l753t428r793b454],

1	—	NN	O	—	_	0	SENT_143	[p6l753t428r793b454],
2	.	.	O	.	_	0	SENT_143	[p6l753t428r793b454],
3	]	SYM	O	]	dep	1	SENT_143	[p6l753t428r793b454],

1	.	.	O	.	_	0	SENT_144	[p6l753t428r793b454],

1	He	PRP	O	he	_	0	SENT_145	[p6l803t428r834b449],
2	et	FW	O	et	nn	3	SENT_145	[p6l845t430r866b449],
3	al.	FW	O	al.	dep	1	SENT_145	[p6l875t427r900b449],
4	/	:	O	/	punct	1	SENT_145	[p6l912t428r922b452],
5	Clinica	NNP	PERSON	Clinica	nn	7	SENT_145	[p6l934t427r1011b449],
6	Chimica	NNP	PERSON	Chimica	nn	7	SENT_145	[p6l1022t427r1113b449],
7	Acta	NNP	PERSON	Acta	dep	1	SENT_145	[p6l1122t428r1174b449],
8	405	CD	NUMBER	405	number	9	SENT_145	[p6l1183t428r1227b449],
9	(	CD	NUMBER	(	num	11	SENT_145	[p6l1238t427r1317b454],
10	2009	CD	DATE	2009	number	11	SENT_145	[p6l1238t427r1317b454],
11	)	CD	NUMBER	)	dep	7	SENT_145	[p6l1238t427r1317b454],
12	49-52	CD	NUMBER	49-52	number	13	SENT_145	[p6l1328t428r1401b449],
13	51	CD	NUMBER	51	num	11	SENT_145	[p6l2130t428r2154b449],

1	Table	NNP	O	Table	nn	3	SENT_146	[p6l6t510r73b531],
2	2	CD	NUMBER	2	num	3	SENT_146	[p6l82t511r96b531],
3	Effects	NNS	O	effect	nsubj	5	SENT_146	[p6l6t545r83b567],
4	ofSLCO1B1	NN	O	ofslco1b1	nn	5	SENT_146	[p6l91t545r218b567],
5	521T	NN	O	521t	_	0	SENT_146	[p6l227t546r315b567],
6	>	JJR	O	>	amod	8	SENT_146	[p6l227t546r315b567],
7	C	NN	O	c	nn	8	SENT_146	[p6l227t546r315b567],
8	polymorphism	NN	O	polymorphism	dobj	5	SENT_146	[p6l322t545r499b572],
9	on	IN	O	on	_	0	SENT_146	[p6l506t551r535b566],
10	the	DT	O	the	det	12	SENT_146	[p6l543t545r581b567],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_146	[p6l588t545r790b572],
12	parameters	NNS	O	parameter	prep_on	8	SENT_146	[p6l798t548r933b572],
13	of	IN	O	of	_	0	SENT_146	[p6l940t545r966b566],
14	atorvastatin	NN	O	atorvastatin	prep_of	12	SENT_146	[p6l969t545r1112b567],
15	after	IN	O	after	_	0	SENT_146	[p6l1120t545r1176b567],
16	single	JJ	O	single	amod	18	SENT_146	[p6l1182t545r1252b572],
17	oral	JJ	O	oral	amod	18	SENT_146	[p6l1259t545r1304b567],
18	dose	NN	O	dose	prep_after	5	SENT_146	[p6l1311t545r1366b567],
19	of	IN	O	of	_	0	SENT_146	[p6l1373t545r1398b567],
20	40	CD	NUMBER	40	num	22	SENT_146	[p6l1402t546r1431b566],
21	mg	NN	O	mg	nn	22	SENT_146	[p6l1439t551r1476b572],
22	atorvastatin	NN	O	atorvastatin	prep_of	18	SENT_146	[p6l1483t545r1626b567],
23	plus	CC	O	plus	prep	22	SENT_146	[p6l1633t545r1682b572],
24	placebo	NN	O	placebo	dep	23	SENT_146	[p6l1689t545r1781b572],
25	or	CC	O	or	_	0	SENT_146	[p6l1788t551r1813b566],
26	600	CD	NUMBER	600	num	28	SENT_146	[p6l1820t546r1865b567],
27	mg	NN	O	mg	nn	28	SENT_146	[p6l1872t551r1910b572],
28	rifampicin	NN	O	rifampicin	prep_of	18	SENT_146	[p6l1917t545r2039b572],
29	as	IN	O	as	_	0	SENT_146	[p6l2047t551r2070b566],
30	a	DT	O	a	det	33	SENT_146	[p6l2078t551r2090b567],
31	single	JJ	O	single	amod	33	SENT_146	[p6l6t580r75b607],
32	oral	JJ	O	oral	amod	33	SENT_146	[p6l83t580r128b601],
33	dose	NN	O	dose	prep_as	28	SENT_146	[p6l138t580r192b601],
34	30-min	JJ	DURATION	30-min	amod	33	SENT_146	[p6l202t580r290b601],
35	before	IN	O	before	_	0	SENT_146	[p6l300t580r375b601],
36	atorvastatin	NN	O	atorvastatin	nn	37	SENT_146	[p6l385t580r528b601],
37	dosing	NN	O	dosing	prep_before	34	SENT_146	[p6l537t580r622b607],
38	.	.	O	.	_	0	SENT_146	[p6l537t580r622b607],

1	Phase	NN	O	phase	nn	3	SENT_147	[p6l6t637r74b658],
2	Genotype	NN	O	genotype	nn	3	SENT_147	[p6l378t638r493b664],
3	AUC	NN	O	auc	_	0	SENT_147	[p6l556t638r669b666],
4	(	CD	NUMBER	(	num	5	SENT_147	[p6l556t638r669b666],
5	o_43	NN	O	o_43	dep	3	SENT_147	[p6l556t638r669b666],
6	)	CD	NUMBER	)	number	7	SENT_147	[p6l556t638r669b666],
7	(	CD	NUMBER	(	dep	3	SENT_147	[p6l682t637r806b664],
8	ng-h/ml	JJ	O	ng-h/ml	amod	13	SENT_147	[p6l682t637r806b664],
9	)	NN	O	)	nn	13	SENT_147	[p6l682t637r806b664],
10	AUC	NN	O	auc	nn	13	SENT_147	[p6l871t638r975b666],
11	(	CD	NUMBER	(	num	13	SENT_147	[p6l871t638r975b666],
12	o	NN	O	o	nn	13	SENT_147	[p6l871t638r975b666],
13	_	NN	O	_	dep	7	SENT_147	[p6l871t638r975b666],
14	.	.	O	.	_	0	SENT_147	[p6l871t638r975b666],

1	.	.	O	.	_	0	SENT_148	[p6l871t638r975b666],
2	)	SYM	O	)	_	0	SENT_148	[p6l871t638r975b666],

1	(	NN	O	(	dep	163	SENT_149	[p6l988t637r1112b664],
2	ng-h/ml	JJ	O	ng-h/ml	dep	163	SENT_149	[p6l988t637r1112b664],
3	)	NN	O	)	dep	163	SENT_149	[p6l988t637r1112b664],
4	Cmax	NN	O	cmax	dep	163	SENT_149	[p6l1178t638r1231b663],
5	(	CD	NUMBER	(	dep	163	SENT_149	[p6l1243t637r1338b664],
6	ng/ml	NN	O	ng/ml	dep	163	SENT_149	[p6l1243t637r1338b664],
7	)	CD	NUMBER	)	dep	163	SENT_149	[p6l1243t637r1338b664],
8	T1	NN	O	t1	dep	163	SENT_149	[p6l1404t638r1448b665],
9	,	,	O	,	_	0	SENT_149	[p6l1404t638r1448b665],
10	;	:	O	;	_	0	SENT_149	[p6l1404t638r1448b665],
11	h	NN	O	h	dep	163	SENT_149	[p6l1471t637r1496b663],
12	)	CD	NUMBER	)	dep	163	SENT_149	[p6l1471t637r1496b663],
13	Tmax	NN	O	tmax	dep	163	SENT_149	[p6l1584t638r1636b663],
14	(	CD	NUMBER	(	dep	163	SENT_149	[p6l1648t637r1682b664],
15	h	NN	O	h	dep	163	SENT_149	[p6l1648t637r1682b664],
16	)	CD	NUMBER	)	dep	163	SENT_149	[p6l1648t637r1682b664],
17	CL/F	NN	O	cl/f	dep	163	SENT_149	[p6l1781t638r1836b662],
18	(	CD	NUMBER	(	dep	163	SENT_149	[p6l1847t637r1909b664],
19	L/h	NN	O	l/h	dep	163	SENT_149	[p6l1847t637r1909b664],
20	)	CD	NUMBER	)	dep	163	SENT_149	[p6l1847t637r1909b664],
21	Vd/F	NN	O	vd/f	dep	163	SENT_149	[p6l2038t637r2098b662],
22	(	NN	O	(	dep	163	SENT_149	[p6l2110t637r2136b664],
23	1	CD	NUMBER	1	dep	163	SENT_149	[p6l2110t637r2136b664],
24	)	CD	NUMBER	)	dep	163	SENT_149	[p6l2110t637r2136b664],
25	Atorvastatin	NNP	O	Atorvastatin	dep	163	SENT_149	[p6l6t698r152b719],
26	(	CD	NUMBER	(	dep	163	SENT_149	[p6l164t697r274b724],
27	Placebo	NNP	O	Placebo	dep	163	SENT_149	[p6l164t697r274b724],
28	)	CD	NUMBER	)	dep	163	SENT_149	[p6l164t697r274b724],
29	c.	NN	O	c.	dep	163	SENT_149	[p6l377t699r468b719],
30	521T1	NN	O	521t1	dep	163	SENT_149	[p6l377t699r468b719],
31	‘	CD	NUMBER	‘	dep	163	SENT_149	[p6l377t699r468b719],
32	26	CD	NUMBER	26	dep	163	SENT_149	[p6l554t699r583b719],
33	:	:	O	:	_	0	SENT_149	[p6l589t709r609b720],
34	:	:	O	:	_	0	SENT_149	[p6l589t709r609b720],
35	6.7	CD	NUMBER	6.7	dep	163	SENT_149	[p6l616t699r650b719],
36	27.4	CD	NUMBER	27.4	dep	163	SENT_149	[p6l867t699r915b719],
37	:	:	O	:	_	0	SENT_149	[p6l920t709r940b720],
38	:	:	O	:	_	0	SENT_149	[p6l920t709r940b720],
39	7.2	CD	NUMBER	7.2	dep	163	SENT_149	[p6l947t699r978b719],
40	3.4	CD	NUMBER	3.4	dep	163	SENT_149	[p6l1171t699r1206b719],
41	:	:	O	:	_	0	SENT_149	[p6l1212t709r1231b720],
42	:	:	O	:	_	0	SENT_149	[p6l1212t709r1231b720],
43	0.9	CD	NUMBER	0.9	dep	163	SENT_149	[p6l1238t699r1273b719],
44	12.0	CD	NUMBER	12.0	dep	163	SENT_149	[p6l1396t699r1444b719],
45	:2	CD	NUMBER	:2	dep	163	SENT_149	[p6l1450t709r1470b720],
46	2.5	CD	NUMBER	2.5	dep	163	SENT_149	[p6l1476t699r1510b719],
47	1.42	CD	NUMBER	1.42	dep	163	SENT_149	[p6l1576t698r1621b719],
48	:2	CD	NUMBER	:2	dep	163	SENT_149	[p6l1628t709r1648b720],
49	1.4	CD	NUMBER	1.4	dep	163	SENT_149	[p6l1656t698r1687b719],
50	1580.8	CD	NUMBER	1580.8	dep	163	SENT_149	[p6l1771t699r1847b719],
51	:	:	O	:	_	0	SENT_149	[p6l1854t709r1874b720],
52	:	:	O	:	_	0	SENT_149	[p6l1854t709r1874b720],
53	563.6	CD	NUMBER	563.6	dep	163	SENT_149	[p6l1881t699r1945b719],
54	27.3	CD	NUMBER	27.3	dep	163	SENT_149	[p6l2026t699r2072b719],
55	:	:	O	:	_	0	SENT_149	[p6l2079t709r2099b720],
56	:	:	O	:	_	0	SENT_149	[p6l2079t709r2099b720],
57	9.6	CD	NUMBER	9.6	dep	163	SENT_149	[p6l2105t699r2139b719],
58	c.	NN	O	c.	dep	163	SENT_149	[p6l80t734r172b755],
59	521TC	NN	O	521tc	dep	163	SENT_149	[p6l80t734r172b755],
60	30.8	CD	NUMBER	30.8	dep	163	SENT_149	[p6l259t734r308b755],
61	:	:	O	:	_	0	SENT_149	[p6l315t745r335b756],
62	:	:	O	:	_	0	SENT_149	[p6l315t745r335b756],
63	4.3	CD	NUMBER	4.3	dep	163	SENT_149	[p6l341t734r375b755],
64	31.6	CD	NUMBER	31.6	dep	163	SENT_149	[p6l573t734r620b755],
65	:	:	O	:	_	0	SENT_149	[p6l627t745r647b756],
66	:	:	O	:	_	0	SENT_149	[p6l627t745r647b756],
67	4.4	CD	NUMBER	4.4	dep	163	SENT_149	[p6l652t734r688b755],
68	5.7	CD	NUMBER	5.7	dep	163	SENT_149	[p6l880t734r914b755],
69	:	:	O	:	_	0	SENT_149	[p6l921t745r941b756],
70	:	:	O	:	_	0	SENT_149	[p6l921t745r941b756],
71	1.6	CD	NUMBER	1.6	dep	163	SENT_149	[p6l949t734r980b755],
72	10.7	CD	NUMBER	10.7	dep	163	SENT_149	[p6l1107t734r1153b755],
73	:	:	O	:	_	0	SENT_149	[p6l1160t745r1180b756],
74	:	:	O	:	_	0	SENT_149	[p6l1160t745r1180b756],
75	2,0	CD	NUMBER	2,0	dep	163	SENT_149	[p6l1186t734r1221b755],
76	1.25	CD	NUMBER	1.25	dep	163	SENT_149	[p6l1287t734r1333b755],
77	:	:	O	:	_	0	SENT_149	[p6l1340t745r1360b756],
78	:	:	O	:	_	0	SENT_149	[p6l1340t745r1360b756],
79	0.8	CD	NUMBER	0.8	dep	163	SENT_149	[p6l1367t734r1401b755],
80	1282.4	CD	NUMBER	1282.4	dep	163	SENT_149	[p6l1484t734r1562b755],
81	:	:	O	:	_	0	SENT_149	[p6l1569t745r1588b756],
82	:	:	O	:	_	0	SENT_149	[p6l1569t745r1588b756],
83	157.7	CD	NUMBER	157.7	dep	163	SENT_149	[p6l1596t734r1655b755],
84	20	CD	NUMBER	20	dep	163	SENT_149	[p6l1741t734r1769b755],
85	:	:	O	:	_	0	SENT_149	[p6l1776t745r1795b756],
86	:	:	O	:	_	0	SENT_149	[p6l1776t745r1795b756],
87	5.6	CD	NUMBER	5.6	dep	163	SENT_149	[p6l1802t734r1837b755],
88	c.	NN	O	c.	dep	163	SENT_149	[p6l1845t734r1938b755],
89	521CC	NN	O	521cc	dep	163	SENT_149	[p6l1845t734r1938b755],
90	56.1	CD	NUMBER	56.1	dep	163	SENT_149	[p6l2024t734r2069b755],
91	:	:	O	:	_	0	SENT_149	[p6l2078t745r2098b756],
92	:	:	O	:	_	0	SENT_149	[p6l2078t745r2098b756],
93	32.5	CD	NUMBER	32.5	dep	163	SENT_149	[p6l2104t734r2154b755],
94	56.9	CD	NUMBER	56.9	dep	163	SENT_149	[p6l43t770r93b791],
95	:	:	O	:	_	0	SENT_149	[p6l99t781r119b792],
96	:	:	O	:	_	0	SENT_149	[p6l99t781r119b792],
97	37.2	CD	NUMBER	37.2	dep	163	SENT_149	[p6l125t770r172b791],
98	12.1	CD	NUMBER	12.1	dep	163	SENT_149	[p6l350t770r392b791],
99	:	:	O	:	_	0	SENT_149	[p6l402t781r421b792],
100	:	:	O	:	_	0	SENT_149	[p6l402t781r421b792],
101	8.5	CD	NUMBER	8.5	dep	163	SENT_149	[p6l428t770r462b791],
102	8.8	CD	NUMBER	8.8	dep	163	SENT_149	[p6l574t770r608b791],
103	:	:	O	:	_	0	SENT_149	[p6l615t781r635b792],
104	:	:	O	:	_	0	SENT_149	[p6l615t781r635b792],
105	2.1	CD	NUMBER	2.1	dep	163	SENT_149	[p6l642t770r671b791],
106	0.5	CD	NUMBER	0.5	dep	163	SENT_149	[p6l755t770r789b791],
107	882.9	CD	NUMBER	882.9	dep	163	SENT_149	[p6l952t770r1016b791],
108	:	:	O	:	_	0	SENT_149	[p6l1023t781r1043b792],
109	:	:	O	:	_	0	SENT_149	[p6l1023t781r1043b792],
110	376.2	CD	NUMBER	376.2	dep	163	SENT_149	[p6l1049t770r1112b791],
111	12	CD	NUMBER	12	dep	163	SENT_149	[p6l1210t770r1236b791],
112	:	:	O	:	_	0	SENT_149	[p6l1243t781r1263b792],
113	:	:	O	:	_	0	SENT_149	[p6l1243t781r1263b792],
114	7	CD	NUMBER	7	dep	163	SENT_149	[p6l1270t770r1282b791],
115	P	NN	O	p	dep	163	SENT_149	[p6l1291t769r1379b791],
116	—	NN	O	—	dep	163	SENT_149	[p6l1291t769r1379b791],
117	value	NN	O	value	dep	163	SENT_149	[p6l1291t769r1379b791],
118	0.02	CD	NUMBER	0.02	dep	163	SENT_149	[p6l1471t770r1520b791],
119	0.02	CD	NUMBER	0.02	dep	163	SENT_149	[p6l1786t770r1835b791],
120	0.001	CD	NUMBER	0.001	dep	163	SENT_149	[p6l2092t770r2154b791],
121	0.03	CD	NUMBER	0.03	dep	163	SENT_149	[p6l1454t806r1503b827],
122	NS	NN	O	n	dep	163	SENT_149	[p6l1634t806r1666b827],
123	0.02	CD	NUMBER	0.02	dep	163	SENT_149	[p6l1831t806r1880b827],
124	0.007	CD	NUMBER	0.007	dep	163	SENT_149	[p6l2089t806r2154b827],
125	AtOl	NN	O	atol	dep	163	SENT_149	[p6l6t841r153b862],
126	'	''	O	'	_	0	SENT_149	[p6l6t841r153b862],
127	V3St3tlI1	NN	O	v3st3tli1	dep	163	SENT_149	[p6l6t841r153b862],
128	_	NN	O	_	dep	163	SENT_149	[p6l165t840r314b867],
129	D	NN	O	d	dep	163	SENT_149	[p6l165t840r314b867],
130	[	NN	O	[	dep	163	SENT_149	[p6l165t840r314b867],
131	+	CC	O	+	dep	163	SENT_149	[p6l165t840r314b867],
132	`	``	O	`	_	0	SENT_149	[p6l379t841r471b862],
133	D	NN	O	d	dep	163	SENT_149	[p6l379t841r471b862],
134	[	NN	O	[	dep	163	SENT_149	[p6l379t841r471b862],
135	+	CC	O	+	dep	163	SENT_149	[p6l379t841r471b862],
136	i	FW	O	i	dep	163	SENT_149	[p6l558t841r618b862],
137	D	NN	O	d	dep	163	SENT_149	[p6l558t841r618b862],
138	[	NN	O	[	dep	163	SENT_149	[p6l558t841r618b862],
139	+	CC	O	+	dep	163	SENT_149	[p6l558t841r618b862],
140	:2	CD	NUMBER	:2	dep	163	SENT_149	[p6l624t852r644b863],
141	9	CD	NUMBER	9	dep	163	SENT_149	[p6l650t841r700b862],
142	C	NN	O	c	dep	163	SENT_149	[p6l650t841r700b862],
143	[	NN	O	[	dep	163	SENT_149	[p6l650t841r700b862],
144	+	CC	O	+	dep	163	SENT_149	[p6l650t841r700b862],
145	Q	NNP	O	Q	dep	163	SENT_149	[p6l873t841r937b862],
146	D	NNP	O	D	dep	163	SENT_149	[p6l873t841r937b862],
147	[	NN	O	[	dep	163	SENT_149	[p6l873t841r937b862],
148	+	CC	O	+	dep	163	SENT_149	[p6l873t841r937b862],
149	:	:	O	:	_	0	SENT_149	[p6l945t852r964b863],
150	:	:	O	:	_	0	SENT_149	[p6l945t852r964b863],
151	;	:	O	;	_	0	SENT_149	[p6l971t841r996b862],
152	C	NN	O	c	dep	163	SENT_149	[p6l971t841r996b862],
153	[	NN	O	[	dep	163	SENT_149	[p6l971t841r996b862],
154	+	CC	O	+	dep	163	SENT_149	[p6l971t841r996b862],
155	>	JJR	O	>	dep	163	SENT_149	[p6l1179t841r1228b862],
156	D	NN	O	d	dep	163	SENT_149	[p6l1179t841r1228b862],
157	[	NN	O	[	dep	163	SENT_149	[p6l1179t841r1228b862],
158	+	CC	O	+	dep	163	SENT_149	[p6l1179t841r1228b862],
159	:	:	O	:	_	0	SENT_149	[p6l1235t852r1255b863],
160	:	:	O	:	_	0	SENT_149	[p6l1235t852r1255b863],
161	15	CD	NUMBER	15	dep	163	SENT_149	[p6l1263t842r1305b862],
162	.	.	O	.	_	0	SENT_149	[p6l1263t842r1305b862],
163	]	SYM	O	]	_	0	SENT_149	[p6l1263t842r1305b862],

1	5.5	CD	NUMBER	5.5	dep	222	SENT_150	[p6l1405t842r1439b862],
2	:2	CD	NUMBER	:2	dep	222	SENT_150	[p6l1446t852r1466b863],
3	`	``	O	`	_	0	SENT_150	[p6l1474t841r1504b862],
4	1	CD	NUMBER	1	dep	222	SENT_150	[p6l1474t841r1504b862],
5	D	NN	O	d	dep	222	SENT_150	[p6l1474t841r1504b862],
6	[	NN	O	[	dep	222	SENT_150	[p6l1474t841r1504b862],
7	+	CC	O	+	dep	222	SENT_150	[p6l1474t841r1504b862],
8	T	NN	O	t	dep	222	SENT_150	[p6l1585t841r1634b862],
9	D	NN	O	d	dep	222	SENT_150	[p6l1585t841r1634b862],
10	[	NN	O	[	dep	222	SENT_150	[p6l1585t841r1634b862],
11	+	CC	O	+	dep	222	SENT_150	[p6l1585t841r1634b862],
12	:	:	O	:	_	0	SENT_150	[p6l1641t852r1661b863],
13	:	:	O	:	_	0	SENT_150	[p6l1641t852r1661b863],
14	D	NN	O	d	dep	222	SENT_150	[p6l1668t841r1718b862],
15	[	NN	O	[	dep	222	SENT_150	[p6l1668t841r1718b862],
16	+	CC	O	+	dep	222	SENT_150	[p6l1668t841r1718b862],
17	ycD	NN	O	ycd	dep	222	SENT_150	[p6l1782t841r1844b862],
18	[	NN	O	[	dep	222	SENT_150	[p6l1782t841r1844b862],
19	+	CC	O	+	dep	222	SENT_150	[p6l1782t841r1844b862],
20	:	:	O	:	_	0	SENT_150	[p6l1851t852r1871b863],
21	:	:	O	:	_	0	SENT_150	[p6l1851t852r1871b863],
22	ĆD	NN	O	ćd	dep	222	SENT_150	[p6l1878t841r1927b862],
23	[	NN	O	[	dep	222	SENT_150	[p6l1878t841r1927b862],
24	+	CC	O	+	dep	222	SENT_150	[p6l1878t841r1927b862],
25	:	:	O	:	_	0	SENT_150	[p6l2078t852r2098b863],
26	:	:	O	:	_	0	SENT_150	[p6l2078t852r2098b863],
27	ÆD	NN	O	æd	dep	222	SENT_150	[p6l2105t841r2140b862],
28	[	NN	O	[	dep	222	SENT_150	[p6l2105t841r2140b862],
29	+	CC	O	+	dep	222	SENT_150	[p6l2105t841r2140b862],
30	c.	NN	O	c.	dep	222	SENT_150	[p6l43t877r135b898],
31	521TC	NN	O	521tc	dep	222	SENT_150	[p6l43t877r135b898],
32	141.3	CD	NUMBER	141.3	dep	222	SENT_150	[p6l223t877r281b898],
33	:	:	O	:	_	0	SENT_150	[p6l288t888r308b899],
34	:	:	O	:	_	0	SENT_150	[p6l288t888r308b899],
35	71.7	CD	NUMBER	71.7	dep	222	SENT_150	[p6l315t877r361b898],
36	161.4	CD	NUMBER	161.4	dep	222	SENT_150	[p6l538t877r598b898],
37	:	:	O	:	_	0	SENT_150	[p6l604t888r624b899],
38	:	:	O	:	_	0	SENT_150	[p6l604t888r624b899],
39	62.6	CD	NUMBER	62.6	dep	222	SENT_150	[p6l630t877r680b898],
40	42.9	CD	NUMBER	42.9	dep	222	SENT_150	[p6l842t877r893b898],
41	:	:	O	:	_	0	SENT_150	[p6l899t888r919b899],
42	:	:	O	:	_	0	SENT_150	[p6l899t888r919b899],
43	27.4	CD	NUMBER	27.4	dep	222	SENT_150	[p6l925t877r973b898],
44	6	CD	NUMBER	6	dep	222	SENT_150	[p6l1069t877r1082b898],
45	:	:	O	:	_	0	SENT_150	[p6l1088t888r1108b899],
46	:	:	O	:	_	0	SENT_150	[p6l1088t888r1108b899],
47	2.8	CD	NUMBER	2.8	dep	222	SENT_150	[p6l1115t877r1149b898],
48	1	CD	NUMBER	1	dep	222	SENT_150	[p6l1250t877r1259b898],
49	:	:	O	:	_	0	SENT_150	[p6l1269t888r1289b899],
50	:	:	O	:	_	0	SENT_150	[p6l1269t888r1289b899],
51	0.55	CD	NUMBER	0.55	dep	222	SENT_150	[p6l1295t877r1345b898],
52	367.5	CD	NUMBER	367.5	dep	222	SENT_150	[p6l1445t877r1508b898],
53	:	:	O	:	_	0	SENT_150	[p6l1515t888r1535b899],
54	:	:	O	:	_	0	SENT_150	[p6l1515t888r1535b899],
55	221	CD	NUMBER	221	dep	222	SENT_150	[p6l1541t877r1581b898],
56	3.9	CD	NUMBER	3.9	dep	222	SENT_150	[p6l1703t877r1738b898],
57	:	:	O	:	_	0	SENT_150	[p6l1745t888r1764b899],
58	:	:	O	:	_	0	SENT_150	[p6l1745t888r1764b899],
59	4.4	CD	NUMBER	4.4	dep	222	SENT_150	[p6l1770t877r1806b898],
60	c.	NN	O	c.	dep	222	SENT_150	[p6l1814t877r1873b898],
61	521	CD	NUMBER	521	dep	222	SENT_150	[p6l1814t877r1873b898],
62	CC	NN	O	cc	dep	222	SENT_150	[p6l1877t877r1908b898],
63	234.4	CD	NUMBER	234.4	dep	222	SENT_150	[p6l1993t877r2059b898],
64	:	:	O	:	_	0	SENT_150	[p6l2065t888r2085b899],
65	:	:	O	:	_	0	SENT_150	[p6l2065t888r2085b899],
66	135.3	CD	NUMBER	135.3	dep	222	SENT_150	[p6l2093t877r2154b898],
67	262.6	CD	NUMBER	262.6	dep	222	SENT_150	[p6l51t913r116b934],
68	:	:	O	:	_	0	SENT_150	[p6l122t924r142b935],
69	:	:	O	:	_	0	SENT_150	[p6l122t924r142b935],
70	62.5	CD	NUMBER	62.5	dep	222	SENT_150	[p6l149t913r198b934],
71	90.8	CD	NUMBER	90.8	dep	222	SENT_150	[p6l357t913r406b934],
72	:	:	O	:	_	0	SENT_150	[p6l413t924r433b935],
73	:	:	O	:	_	0	SENT_150	[p6l413t924r433b935],
74	31.4	CD	NUMBER	31.4	dep	222	SENT_150	[p6l439t913r487b934],
75	5.3	CD	NUMBER	5.3	dep	222	SENT_150	[p6l583t913r616b934],
76	:	:	O	:	_	0	SENT_150	[p6l623t924r643b935],
77	:	:	O	:	_	0	SENT_150	[p6l623t924r643b935],
78	0.5	CD	NUMBER	0.5	dep	222	SENT_150	[p6l650t913r684b934],
79	0.5	CD	NUMBER	0.5	dep	222	SENT_150	[p6l763t913r797b934],
80	218.8	CD	NUMBER	218.8	dep	222	SENT_150	[p6l959t913r1021b934],
81	:	:	O	:	_	0	SENT_150	[p6l1028t924r1048b935],
82	:	:	O	:	_	0	SENT_150	[p6l1028t924r1048b935],
83	124.3	CD	NUMBER	124.3	dep	222	SENT_150	[p6l1056t913r1118b934],
84	1.8	CD	NUMBER	1.8	dep	222	SENT_150	[p6l1218t913r1249b934],
85	:	:	O	:	_	0	SENT_150	[p6l1256t924r1276b935],
86	:	:	O	:	_	0	SENT_150	[p6l1256t924r1276b935],
87	1.3	CD	NUMBER	1.3	dep	222	SENT_150	[p6l1284t913r1314b934],
88	P	NN	O	p	dep	222	SENT_150	[p6l1322t912r1410b934],
89	—	NN	O	—	dep	222	SENT_150	[p6l1322t912r1410b934],
90	value	NN	O	value	dep	222	SENT_150	[p6l1322t912r1410b934],
91	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1502t913r1533b934],
92	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1817t913r1848b934],
93	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l2123t913r2154b934],
94	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1488t949r1519b970],
95	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1669t949r1700b970],
96	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1865t949r1896b970],
97	NS	VBZ	ORGANIZATION	n	dep	222	SENT_150	[p6l2123t949r2154b970],
98	Rifampicin	NNP	ORGANIZATION	Rifampicin	dep	222	SENT_150	[p6l6t984r134b1011],
99	kinetics	NNS	O	kinetics	dep	222	SENT_150	[p6l144t984r236b1006],
100	c.	VBP	O	c.	dep	222	SENT_150	[p6l378t985r470b1006],
101	521Tl	NN	O	521tl	dep	222	SENT_150	[p6l378t985r470b1006],
102	'	''	O	'	_	0	SENT_150	[p6l378t985r470b1006],
103	"	``	O	"	dep	222	SENT_150	[p6l557t979r615b1006],
104	476	CD	NUMBER	476	dep	222	SENT_150	[p6l557t979r615b1006],
105	:	:	O	:	_	0	SENT_150	[p6l621t996r641b1007],
106	:	:	O	:	_	0	SENT_150	[p6l621t996r641b1007],
107	10.7	CD	NUMBER	10.7	dep	222	SENT_150	[p6l649t985r696b1006],
108	561.6	CD	NUMBER	561.6	dep	222	SENT_150	[p6l871t983r928b1006],
109	;	:	O	;	_	0	SENT_150	[p6l934t996r954b1007],
110	:	:	O	:	_	0	SENT_150	[p6l934t996r954b1007],
111	15.5	CD	NUMBER	15.5	dep	222	SENT_150	[p6l962t985r1008b1006],
112	d7	NN	O	d7	dep	222	SENT_150	[p6l1177t979r1221b1006],
113	.8	CD	NUMBER	.8	dep	222	SENT_150	[p6l1177t979r1221b1006],
114	:	:	O	:	_	0	SENT_150	[p6l1228t996r1248b1007],
115	:	:	O	:	_	0	SENT_150	[p6l1228t996r1248b1007],
116	1.8	CD	NUMBER	1.8	dep	222	SENT_150	[p6l1256t985r1287b1006],
117	5.3	CD	NUMBER	5.3	dep	222	SENT_150	[p6l1404t985r1437b1006],
118	:	:	O	:	_	0	SENT_150	[p6l1444t996r1464b1007],
119	:	:	O	:	_	0	SENT_150	[p6l1444t996r1464b1007],
120	2.5	CD	NUMBER	2.5	dep	222	SENT_150	[p6l1471t985r1505b1006],
121	1.4	CD	NUMBER	1.4	dep	222	SENT_150	[p6l1585t985r1617b1006],
122	:	:	O	:	_	0	SENT_150	[p6l1623t996r1642b1007],
123	:	:	O	:	_	0	SENT_150	[p6l1623t996r1642b1007],
124	0.8	CD	NUMBER	0.8	dep	222	SENT_150	[p6l1649t985r1683b1006],
125	7805.1	CD	NUMBER	7805.1	dep	222	SENT_150	[p6l1781t985r1856b1006],
126	:	:	O	:	_	0	SENT_150	[p6l1865t996r1885b1007],
127	:	:	O	:	_	0	SENT_150	[p6l1865t996r1885b1007],
128	2447	CD	DATE	2447	dep	222	SENT_150	[p6l1892t985r1950b1005],
129	58.1	CD	NUMBER	58.1	dep	222	SENT_150	[p6l2039t985r2083b1006],
130	:	:	O	:	_	0	SENT_150	[p6l2093t996r2112b1007],
131	:	:	O	:	_	0	SENT_150	[p6l2093t996r2112b1007],
132	31.6	CD	NUMBER	31.6	dep	222	SENT_150	[p6l6t1021r53b1042],
133	c.	NN	O	c.	dep	222	SENT_150	[p6l52t1057r144b1078],
134	521TC	NN	O	521tc	dep	222	SENT_150	[p6l52t1057r144b1078],
135	46.2	CD	NUMBER	46.2	dep	222	SENT_150	[p6l230t1057r280b1078],
136	:	:	O	:	_	0	SENT_150	[p6l287t1068r307b1079],
137	:	:	O	:	_	0	SENT_150	[p6l287t1068r307b1079],
138	12.6	CD	NUMBER	12.6	dep	222	SENT_150	[p6l315t1057r363b1078],
139	57.0	CD	NUMBER	57.0	dep	222	SENT_150	[p6l546t1057r593b1078],
140	:	:	O	:	_	0	SENT_150	[p6l599t1068r619b1079],
141	:	:	O	:	_	0	SENT_150	[p6l599t1068r619b1079],
142	6.9	CD	NUMBER	6.9	dep	222	SENT_150	[p6l626t1057r660b1078],
143	7.7	CD	NUMBER	7.7	dep	222	SENT_150	[p6l852t1058r884b1078],
144	:	:	O	:	_	0	SENT_150	[p6l890t1068r910b1079],
145	:	:	O	:	_	0	SENT_150	[p6l890t1068r910b1079],
146	3.4	CD	NUMBER	3.4	dep	222	SENT_150	[p6l917t1057r952b1078],
147	5.2	CD	NUMBER	5.2	dep	222	SENT_150	[p6l1078t1057r1112b1078],
148	:	:	O	:	_	0	SENT_150	[p6l1119t1068r1138b1079],
149	:	:	O	:	_	0	SENT_150	[p6l1119t1068r1138b1079],
150	3.1	CD	NUMBER	3.1	dep	222	SENT_150	[p6l1144t1057r1175b1078],
151	1.7	CD	NUMBER	1.7	dep	222	SENT_150	[p6l1259t1058r1290b1078],
152	:	:	O	:	_	0	SENT_150	[p6l1297t1068r1317b1079],
153	:	:	O	:	_	0	SENT_150	[p6l1297t1068r1317b1079],
154	0.6	CD	NUMBER	0.6	dep	222	SENT_150	[p6l1323t1057r1358b1078],
155	7983.7	CD	NUMBER	7983.7	dep	222	SENT_150	[p6l1455t1057r1535b1078],
156	2	CD	NUMBER	2	dep	222	SENT_150	[p6l1541t1068r1561b1079],
157	:	:	O	:	_	0	SENT_150	[p6l1541t1068r1561b1079],
158	966.6	CD	NUMBER	966.6	dep	222	SENT_150	[p6l1568t1057r1634b1078],
159	61.6	CD	NUMBER	61.6	dep	222	SENT_150	[p6l1713t1057r1760b1078],
160	:	:	O	:	_	0	SENT_150	[p6l1766t1068r1786b1079],
161	:	:	O	:	_	0	SENT_150	[p6l1766t1068r1786b1079],
162	42.1	CD	NUMBER	42.1	dep	222	SENT_150	[p6l1791t1057r1837b1078],
163	c.	NN	O	c.	dep	222	SENT_150	[p6l1846t1057r1904b1078],
164	521	CD	NUMBER	521	dep	222	SENT_150	[p6l1846t1057r1904b1078],
165	CC	NN	O	cc	dep	222	SENT_150	[p6l1909t1057r1939b1077],
166	50.1	CD	NUMBER	50.1	dep	222	SENT_150	[p6l2025t1057r2070b1078],
167	:	:	O	:	_	0	SENT_150	[p6l2079t1068r2099b1079],
168	:	:	O	:	_	0	SENT_150	[p6l2079t1068r2099b1079],
169	13.6	CD	NUMBER	13.6	dep	222	SENT_150	[p6l2107t1057r2154b1078],
170	58.9	CD	NUMBER	58.9	dep	222	SENT_150	[p6l20t1093r70b1114],
171	:	:	O	:	_	0	SENT_150	[p6l76t1104r96b1115],
172	:	:	O	:	_	0	SENT_150	[p6l76t1104r96b1115],
173	17.5	CD	NUMBER	17.5	dep	222	SENT_150	[p6l104t1093r147b1114],
174	10.3	CD	NUMBER	10.3	dep	222	SENT_150	[p6l327t1093r373b1114],
175	2	CD	NUMBER	2	dep	222	SENT_150	[p6l380t1104r400b1115],
176	:	:	O	:	_	0	SENT_150	[p6l380t1104r400b1115],
177	2.2	CD	NUMBER	2.2	dep	222	SENT_150	[p6l407t1093r441b1114],
178	4.2	CD	NUMBER	4.2	dep	222	SENT_150	[p6l551t1093r585b1114],
179	:	:	O	:	_	0	SENT_150	[p6l592t1104r612b1115],
180	:	:	O	:	_	0	SENT_150	[p6l592t1104r612b1115],
181	0.8	CD	NUMBER	0.8	dep	222	SENT_150	[p6l619t1093r653b1114],
182	0.9	CD	NUMBER	0.9	dep	222	SENT_150	[p6l732t1093r767b1114],
183	:	:	O	:	_	0	SENT_150	[p6l773t1104r793b1115],
184	:	:	O	:	_	0	SENT_150	[p6l773t1104r793b1115],
185	0.3	CD	NUMBER	0.3	dep	222	SENT_150	[p6l799t1093r833b1114],
186	8343.6	CD	NUMBER	8343.6	dep	222	SENT_150	[p6l929t1093r1009b1114],
187	2	CD	NUMBER	2	dep	222	SENT_150	[p6l1015t1104r1035b1115],
188	:	:	O	:	_	0	SENT_150	[p6l1015t1104r1035b1115],
189	3238.3	CD	NUMBER	3238.3	dep	222	SENT_150	[p6l1041t1093r1121b1114],
190	49.4	CD	NUMBER	49.4	dep	222	SENT_150	[p6l1186t1093r1237b1114],
191	:	:	O	:	_	0	SENT_150	[p6l1243t1104r1263b1115],
192	:	:	O	:	_	0	SENT_150	[p6l1243t1104r1263b1115],
193	17.3	CD	NUMBER	17.3	dep	222	SENT_150	[p6l1271t1093r1314b1114],
194	P	NN	O	p	dep	222	SENT_150	[p6l1322t1092r1410b1114],
195	—	NN	O	—	dep	222	SENT_150	[p6l1322t1092r1410b1114],
196	value	NN	O	value	dep	222	SENT_150	[p6l1322t1092r1410b1114],
197	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1502t1093r1533b1114],
198	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1817t1093r1848b1114],
199	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l2123t1093r2154b1114],
200	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1488t1129r1519b1149],
201	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1668t1129r1700b1149],
202	NS	NN	ORGANIZATION	n	dep	222	SENT_150	[p6l1865t1129r1896b1149],
203	NS	NNP	ORGANIZATION	NS	dep	222	SENT_150	[p6l2123t1129r2154b1149],
204	Data	NNP	ORGANIZATION	Data	dep	222	SENT_150	[p6l6t1179r60b1199],
205	are	VBP	O	be	dep	222	SENT_150	[p6l67t1184r103b1199],
206	given	VBN	O	give	dep	222	SENT_150	[p6l110t1178r175b1205],
207	as	IN	O	as	dep	222	SENT_150	[p6l182t1184r205b1199],
208	mean	NN	O	mean	dep	222	SENT_150	[p6l213t1184r279b1199],
209	:	:	O	:	_	0	SENT_150	[p6l285t1190r305b1201],
210	:	:	O	:	_	0	SENT_150	[p6l285t1190r305b1201],
211	SD	NN	O	sd	dep	222	SENT_150	[p6l312t1179r348b1203],
212	,	,	O	,	_	0	SENT_150	[p6l312t1179r348b1203],
213	AL	NN	O	al	dep	222	SENT_150	[p6l355t1179r386b1199],
214	C	NN	O	c	dep	222	SENT_150	[p6l391t1179r594b1207],
215	(	CD	NUMBER	(	dep	222	SENT_150	[p6l391t1179r594b1207],
216	0_4g	NN	O	0_4g	dep	222	SENT_150	[p6l391t1179r594b1207],
217	)	CD	NUMBER	)	dep	222	SENT_150	[p6l391t1179r594b1207],
218	/	:	O	/	dep	222	SENT_150	[p6l391t1179r594b1207],
219	AUC	NN	O	auc	dep	222	SENT_150	[p6l391t1179r594b1207],
220	(	CD	NUMBER	(	dep	222	SENT_150	[p6l391t1179r594b1207],
221	0	CD	NUMBER	0	dep	222	SENT_150	[p6l391t1179r594b1207],
222	_	NN	O	_	_	0	SENT_150	[p6l391t1179r594b1207],
223	.	.	O	.	_	0	SENT_150	[p6l391t1179r594b1207],

1	.	.	O	.	_	0	SENT_151	[p6l391t1179r594b1207],
2	)	SYM	O	)	_	0	SENT_151	[p6l391t1179r594b1207],

1	,	,	O	,	_	0	SENT_152	[p6l391t1179r594b1207],
2	Area	NNP	O	Area	nsubj	47	SENT_152	[p6l601t1179r656b1199],
3	under	IN	O	under	_	0	SENT_152	[p6l663t1178r734b1199],
4	plasma	NN	O	plasma	nn	5	SENT_152	[p6l741t1178r826b1205],
5	concentration	NN	O	concentration	prep_under	2	SENT_152	[p6l833t1178r1066b1199],
6	—	CD	NUMBER	—	num	8	SENT_152	[p6l833t1178r1066b1199],
7	time	NN	O	time	nn	8	SENT_152	[p6l833t1178r1066b1199],
8	curve	NN	O	curve	dep	5	SENT_152	[p6l1073t1184r1139b1199],
9	from	IN	O	from	_	0	SENT_152	[p6l1146t1178r1203b1199],
10	time	NN	O	time	nn	11	SENT_152	[p6l1210t1178r1264b1199],
11	o	NN	O	o	prep_from	8	SENT_152	[p6l1271t1179r1285b1199],
12	to	TO	O	to	_	0	SENT_152	[p6l1292t1181r1315b1199],
13	48	CD	NUMBER	48	num	14	SENT_152	[p6l1321t1179r1350b1199],
14	h	NN	O	h	prep_to	11	SENT_152	[p6l1358t1178r1373b1199],
15	or	CC	O	or	_	0	SENT_152	[p6l1380t1184r1405b1199],
16	inﬁnity	NN	O	inﬁnity	conj_or	14	SENT_152	[p6l1412t1178r1505b1205],
17	;	:	O	;	_	0	SENT_152	[p6l1412t1178r1505b1205],
18	Cmax	NNP	O	Cmax	dep	11	SENT_152	[p6l1514t1179r1572b1204],
19	,	,	O	,	_	0	SENT_152	[p6l1514t1179r1572b1204],
20	peak	JJ	O	peak	amod	22	SENT_152	[p6l1580t1178r1637b1205],
21	plasma	NN	O	plasma	nn	22	SENT_152	[p6l1644t1178r1729b1205],
22	concentration	NN	O	concentration	appos	18	SENT_152	[p6l1736t1178r1910b1203],
23	;	:	O	;	_	0	SENT_152	[p6l1736t1178r1910b1203],
24	T1/2	NN	O	t1/2	dep	11	SENT_152	[p6l1919t1179r1970b1206],
25	,	,	O	,	_	0	SENT_152	[p6l1919t1179r1970b1206],
26	elimination	NN	O	elimination	nn	28	SENT_152	[p6l1977t1178r2115b1199],
27	half	NN	O	half	nn	28	SENT_152	[p6l6t1213r53b1235],
28	life	NN	O	life	appos	24	SENT_152	[p6l61t1213r104b1238],
29	:	:	O	:	_	0	SENT_152	[p6l61t1213r104b1238],
30	Tmx	NN	O	tmx	dep	11	SENT_152	[p6l116t1214r173b1239],
31	,	,	O	,	_	0	SENT_152	[p6l116t1214r173b1239],
32	time	NN	O	time	appos	30	SENT_152	[p6l182t1213r237b1235],
33	to	TO	O	to	aux	34	SENT_152	[p6l246t1216r269b1235],
34	reach	VB	O	reach	infmod	11	SENT_152	[p6l279t1213r344b1235],
35	Cmax	NNP	O	Cmax	dobj	34	SENT_152	[p6l353t1214r414b1239],
36	;	:	O	;	_	0	SENT_152	[p6l353t1214r414b1239],
37	CL/F	NN	O	cl/f	dep	8	SENT_152	[p6l425t1214r484b1238],
38	,	,	O	,	_	0	SENT_152	[p6l425t1214r484b1238],
39	oral	JJ	O	oral	amod	40	SENT_152	[p6l494t1213r539b1235],
40	clearance	NN	O	clearance	appos	37	SENT_152	[p6l548t1213r668b1238],
41	;	:	O	;	_	0	SENT_152	[p6l548t1213r668b1238],
42	Vd/F	NN	O	vd/f	dep	8	SENT_152	[p6l679t1213r842b1238],
43	,	,	O	,	_	0	SENT_152	[p6l679t1213r842b1238],
44	vo1ume	NN	O	vo1ume	appos	42	SENT_152	[p6l679t1213r842b1238],
45	of	IN	O	of	_	0	SENT_152	[p6l852t1213r877b1235],
46	distribution	NN	O	distribution	prep_of	44	SENT_152	[p6l883t1213r1024b1235],
47	based	VBN	O	base	_	0	SENT_152	[p6l1034t1213r1102b1235],
48	on	IN	O	on	_	0	SENT_152	[p6l1112t1219r1141b1235],
49	the	DT	O	the	det	51	SENT_152	[p6l1151t1213r1189b1235],
50	terminal	JJ	O	terminal	amod	51	SENT_152	[p6l1198t1213r1300b1235],
51	phase	NN	O	phase	prep_on	47	SENT_152	[p6l1310t1213r1385b1240],
52	.	.	O	.	_	0	SENT_152	[p6l1310t1213r1385b1240],

1	“	NN	O	“	nn	3	SENT_153	[p6l6t1248r147b1275],
2	Percentage	NN	O	percentage	nn	3	SENT_153	[p6l6t1248r147b1275],
3	change	NN	O	change	nsubjpass	5	SENT_153	[p6l157t1248r242b1275],
4	was	VBD	O	be	auxpass	5	SENT_153	[p6l250t1255r296b1270],
5	calculated	VBN	O	calculate	_	0	SENT_153	[p6l306t1248r427b1270],
6	as	IN	O	as	_	0	SENT_153	[p6l437t1255r460b1270],
7	(	NN	O	(	nn	8	SENT_153	[p6l471t1249r617b1275],
8	parameters	NNS	O	parameter	prep_as	5	SENT_153	[p6l471t1249r617b1275],
9	during	IN	O	during	prep	5	SENT_153	[p6l627t1249r706b1275],
10	rifampicin	NN	O	rifampicin	nn	11	SENT_153	[p6l716t1248r838b1275],
11	phase	NN	O	phase	dep	9	SENT_153	[p6l848t1248r927b1275],
12	)	CD	NUMBER	)	dep	11	SENT_153	[p6l848t1248r927b1275],
13	/	:	O	/	punct	11	SENT_153	[p6l931t1249r941b1273],
14	(	CD	NUMBER	(	num	15	SENT_153	[p6l946t1249r1092b1275],
15	parameters	NNS	O	parameter	dep	11	SENT_153	[p6l946t1249r1092b1275],
16	during	IN	O	during	_	0	SENT_153	[p6l1101t1248r1181b1275],
17	placebo	NN	O	placebo	nn	18	SENT_153	[p6l1190t1248r1282b1275],
18	phase	NN	O	phase	prep_during	15	SENT_153	[p6l1292t1248r1371b1275],
19	)	CD	NUMBER	)	dobj	5	SENT_153	[p6l1292t1248r1371b1275],
20	x	CC	O	x	_	0	SENT_153	[p6l1378t1256r1392b1269],
21	100	CD	NUMBER	100	dobj	5	SENT_153	[p6l1401t1250r1448b1270],
22	.	.	O	.	_	0	SENT_153	[p6l1401t1250r1448b1270],

1	“	NN	O	“	nn	2	SENT_154	[p6l7t1284r191b1338],
2	Values	NNS	O	value	nsubjpass	4	SENT_154	[p6l7t1284r191b1338],
3	are	VBP	O	be	auxpass	4	SENT_154	[p6l212t1306r286b1338],
4	expressed	VBN	O	express	_	0	SENT_154	[p6l306t1294r549b1349],
5	as	IN	O	as	_	0	SENT_154	[p6l570t1306r617b1338],
6	AUC	NN	O	auc	prep_as	4	SENT_154	[p6l636t1296r878b1354],
7	(	CD	NUMBER	(	number	8	SENT_154	[p6l636t1296r878b1354],
8	0_12	CD	NUMBER	0_12	num	9	SENT_154	[p6l636t1296r878b1354],
9	)	NN	O	)	dep	4	SENT_154	[p6l636t1296r878b1354],
10	.	.	O	.	_	0	SENT_154	[p6l636t1296r878b1354],

1	“	NN	O	“	nsubj	4	SENT_155	[p6l8t1366r115b1410],
2	The	DT	O	the	det	3	SENT_155	[p6l8t1366r115b1410],
3	unit	NN	O	unit	dep	1	SENT_155	[p6l135t1368r233b1410],
4	is	VBZ	O	be	_	0	SENT_155	[p6l252t1368r288b1410],
5	;	:	O	;	_	0	SENT_155	[p6l307t1367r445b1423],
6	.	.	O	.	_	0	SENT_155	[p6l307t1367r445b1423],

1	Lg-h	JJ	O	lg-h	_	0	SENT_156	[p6l307t1367r445b1423],
2	/	:	O	/	punct	3	SENT_156	[p6l307t1367r445b1423],
3	ml	NN	O	ml	dep	1	SENT_156	[p6l453t1367r526b1411],
4	.	.	O	.	_	0	SENT_156	[p6l453t1367r526b1411],

1	dThe	NNP	O	dThe	nn	2	SENT_157	[p6l8t1432r120b1485],
2	unit	NN	O	unit	nsubj	4	SENT_157	[p6l140t1442r239b1485],
3	is	VBZ	O	be	cop	4	SENT_157	[p6l258t1442r293b1485],
4	H8/rnl	NN	O	h8/rnl	_	0	SENT_157	[p6l312t1441r472b1498],
5	.	.	O	.	_	0	SENT_157	[p6l312t1441r472b1498],

1	P	NN	O	p	nsubj	2	SENT_158	[p6l491t1444r556b1485],
2	<	JJR	O	<	_	0	SENT_158	[p6l491t1444r556b1485],
3	0.05	CD	NUMBER	0.05	dobj	2	SENT_158	[p6l566t1444r666b1486],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_158	[p6l688t1441r988b1496],
5	different	JJ	O	different	amod	3	SENT_158	[p6l1006t1441r1218b1485],
6	between	IN	O	between	_	0	SENT_158	[p6l1236t1441r1448b1485],
7	groups	NNS	O	group	prep_between	2	SENT_158	[p6l1466t1454r1646b1496],
8	.	.	O	.	_	0	SENT_158	[p6l1466t1454r1646b1496],

1	which	WDT	O	which	dep	35	SENT_159	[p6l7t1652r201b1707],
2	deﬁne	JJ	O	deﬁne	amod	3	SENT_159	[p6l251t1652r444b1707],
3	SLCO1B1	NN	O	slco1b1	dep	10	SENT_159	[p6l494t1652r872b1707],
4	*	CD	NUMBER	*	num	5	SENT_159	[p6l494t1652r872b1707],
5	1b	NN	O	1b	dep	3	SENT_159	[p6l494t1652r872b1707],
6	(	CD	NUMBER	(	num	7	SENT_159	[p6l927t1652r1247b1720],
7	388A	NN	O	388a	dep	10	SENT_159	[p6l927t1652r1247b1720],
8	>	JJR	O	>	amod	10	SENT_159	[p6l927t1652r1247b1720],
9	G	NN	O	g	nn	10	SENT_159	[p6l927t1652r1247b1720],
10	)	NNS	O	)	dep	27	SENT_159	[p6l927t1652r1247b1720],
11	,	,	O	,	_	0	SENT_159	[p6l927t1652r1247b1720],
12	SLCO1B1	NN	O	slco1b1	appos	10	SENT_159	[p6l1297t1652r1639b1707],
13	*	CD	NUMBER	*	number	14	SENT_159	[p6l1297t1652r1639b1707],
14	5	CD	NUMBER	5	num	19	SENT_159	[p6l1297t1652r1639b1707],
15	(	NN	O	(	nn	19	SENT_159	[p6l1692t1652r1977b1720],
16	521T	NN	O	521t	nn	19	SENT_159	[p6l1692t1652r1977b1720],
17	>	JJR	O	>	dep	18	SENT_159	[p6l1692t1652r1977b1720],
18	C	NN	O	c	amod	19	SENT_159	[p6l1692t1652r1977b1720],
19	)	NN	O	)	dep	12	SENT_159	[p6l1692t1652r1977b1720],
20	and	CC	O	and	_	0	SENT_159	[p6l2031t1652r2144b1707],
21	SLCO1B1	NN	O	slco1b1	conj_and	10	SENT_159	[p6l6t1741r371b1796],
22	*	CD	NUMBER	*	number	23	SENT_159	[p6l6t1741r371b1796],
23	15	CD	NUMBER	15	num	25	SENT_159	[p6l6t1741r371b1796],
24	(	NN	O	(	nn	25	SENT_159	[p6l418t1741r685b1809],
25	388A	NN	O	388a	dep	21	SENT_159	[p6l418t1741r685b1809],
26	>	JJR	O	>	amod	27	SENT_159	[p6l418t1741r685b1809],
27	G	NN	O	g	dep	35	SENT_159	[p6l418t1741r685b1809],
28	and	CC	O	and	_	0	SENT_159	[p6l728t1741r839b1796],
29	521T	NN	O	521t	dep	35	SENT_159	[p6l884t1741r1134b1809],
30	>	JJR	O	>	amod	31	SENT_159	[p6l884t1741r1134b1809],
31	C	NN	O	c	dep	27	SENT_159	[p6l884t1741r1134b1809],
32	)	CD	NUMBER	)	num	33	SENT_159	[p6l884t1741r1134b1809],
33	haplotypes	NNS	O	haplotype	nsubjpass	35	SENT_159	[p6l1182t1741r1516b1809],
34	were	VBD	O	be	auxpass	35	SENT_159	[p6l1558t1757r1711b1796],
35	found	VBN	O	find	_	0	SENT_159	[p6l1754t1741r1930b1796],
36	to	TO	O	to	aux	38	SENT_159	[p6l1974t1749r2031b1796],
37	be	VB	O	be	auxpass	38	SENT_159	[p6l2075t1741r2145b1796],
38	associated	VBN	O	associate	xcomp	35	SENT_159	[p6l9t1829r321b1884],
39	with	IN	O	with	_	0	SENT_159	[p6l350t1829r490b1884],
40	marked	JJ	O	marked	amod	41	SENT_159	[p6l520t1829r750b1884],
41	alterations	NNS	O	alteration	prep_with	38	SENT_159	[p6l780t1829r1103b1884],
42	of	IN	O	of	_	0	SENT_159	[p6l1133t1829r1196b1884],
43	transporter	NN	O	transporter	nn	44	SENT_159	[p6l1217t1837r1565b1898],
44	activity	NN	O	activity	prep_of	41	SENT_159	[p6l1591t1830r1816b1898],
45	in	FW	O	in	prep	44	SENT_159	[p6l1844t1830r1896b1884],
46	vivo	FW	O	vivo	pobj	45	SENT_159	[p6l1924t1830r2058b1885],
47	.	.	O	.	_	0	SENT_159	[p6l1924t1830r2058b1885],

1	In	IN	O	in	_	0	SENT_160	[p6l2089t1833r2145b1884],
2	our	PRP$	O	we	poss	4	SENT_160	[p6l9t1934r113b1973],
3	previous	JJ	O	previous	amod	4	SENT_160	[p6l159t1919r424b1987],
4	studies	NNS	O	study	prep_in	8	SENT_160	[p6l474t1918r705b1981],
5	,	,	O	,	_	0	SENT_160	[p6l474t1918r705b1981],
6	we	PRP	O	we	nsubj	8	SENT_160	[p6l753t1934r843b1973],
7	have	VBP	O	have	aux	8	SENT_160	[p6l892t1918r1034b1973],
8	proved	VBN	O	prove	_	0	SENT_160	[p6l1082t1918r1295b1987],
9	that	IN	O	that	complm	14	SENT_160	[p6l1343t1918r1467b1973],
10	SLCO1B1	NN	O	slco1b1	nn	12	SENT_160	[p6l1511t1921r1766b1973],
11	c.	NN	O	c.	nn	12	SENT_160	[p6l1821t1921r2056b1973],
12	521CC	NN	O	521cc	nsubj	14	SENT_160	[p6l1821t1921r2056b1973],
13	is	VBZ	O	be	cop	14	SENT_160	[p6l2100t1919r2144b1973],
14	responsible	JJ	O	responsible	ccomp	8	SENT_160	[p6l9t2007r358b2076],
15	for	IN	O	for	_	0	SENT_160	[p6l398t2007r483b2062],
16	108	CD	PERCENT	108	num	17	SENT_160	[p6l524t2010r671b2062],
17	%	NN	PERCENT	%	prep_for	14	SENT_160	[p6l524t2010r671b2062],
18	increase	NN	O	increase	nsubj	29	SENT_160	[p6l709t2008r959b2062],
19	of	IN	O	of	_	0	SENT_160	[p6l998t2007r1061b2062],
20	nateglinide	NN	O	nateglinide	nn	22	SENT_160	[p6l1093t2007r1436b2076],
21	AUC	NN	ORGANIZATION	auc	nn	22	SENT_160	[p6l1472t2010r1602b2062],
22	value	NN	O	value	prep_of	18	SENT_160	[p6l1639t2007r1801b2062],
23	compared	VBN	O	compare	_	0	SENT_160	[p6l1841t2007r2145b2076],
24	with	IN	O	with	prepc_compared_with	22	SENT_160	[p6l7t2097r148b2151],
25	SLCO1B1	NN	O	slco1b1	nn	28	SENT_160	[p6l173t2099r425b2151],
26	c.	NN	O	c.	nn	28	SENT_160	[p6l460t2099r687b2152],
27	521TT	NN	O	521tt	nn	28	SENT_160	[p6l460t2099r687b2152],
28	individuals	NNS	O	individual	pobj	22	SENT_160	[p6l708t2096r1043b2151],
29	[	VBP	O	[	rcmod	17	SENT_160	[p6l1075t2096r1203b2165],
30	19	CD	NUMBER	19	num	31	SENT_160	[p6l1075t2096r1203b2165],
31	]	CD	NUMBER	]	dobj	29	SENT_160	[p6l1075t2096r1203b2165],
32	.	.	O	.	_	0	SENT_160	[p6l1075t2096r1203b2165],

1	The	DT	O	the	det	3	SENT_161	[p6l1229t2096r1341b2151],
2	lipid	NN	O	lipid	nn	3	SENT_161	[p6l1369t2096r1807b2165],
3	—	NN	O	—	nsubjpass	18	SENT_161	[p6l1369t2096r1807b2165],
4	lowering	VBG	O	lower	partmod	3	SENT_161	[p6l1369t2096r1807b2165],
5	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_161	[p6l1833t2096r2064b2165],
6	of	IN	O	of	_	0	SENT_161	[p6l2089t2096r2153b2151],
7	multiple	JJ	O	multiple	amod	10	SENT_161	[p6l9t2186r437b2254],
8	—	NN	O	—	nn	10	SENT_161	[p6l9t2186r437b2254],
9	dose	NN	O	dose	nn	10	SENT_161	[p6l9t2186r437b2254],
10	pravastatin	NN	O	pravastatin	prep_of	5	SENT_161	[p6l469t2187r809b2254],
11	in	IN	O	in	_	0	SENT_161	[p6l841t2187r897b2240],
12	coronary	JJ	O	coronary	amod	15	SENT_161	[p6l929t2202r1201b2254],
13	heart	NN	O	heart	nn	15	SENT_161	[p6l1231t2186r1392b2241],
14	disease	NN	O	disease	nn	15	SENT_161	[p6l1421t2186r1642b2241],
15	patients	NNS	O	patient	prep_in	10	SENT_161	[p6l1674t2187r1918b2254],
16	is	VBZ	O	be	auxpass	18	SENT_161	[p6l1951t2187r1995b2241],
17	also	RB	O	also	advmod	18	SENT_161	[p6l2027t2186r2145b2241],
18	correlated	VBN	O	correlate	_	0	SENT_161	[p6l9t2275r317b2330],
19	with	IN	O	with	_	0	SENT_161	[p6l341t2275r481b2330],
20	SLCOIB1	NN	O	slcoib1	nn	21	SENT_161	[p6l503t2278r756b2330],
21	521T	NN	O	521t	prep_with	18	SENT_161	[p6l784t2278r1009b2330],
22	>	JJR	O	>	amod	24	SENT_161	[p6l784t2278r1009b2330],
23	C	NN	O	c	nn	24	SENT_161	[p6l784t2278r1009b2330],
24	allele	NN	O	allele	dep	21	SENT_161	[p6l1032t2275r1192b2330],
25	[	CD	NUMBER	[	number	26	SENT_161	[p6l1220t2275r1353b2343],
26	20	CD	NUMBER	20	num	27	SENT_161	[p6l1220t2275r1353b2343],
27	]	NN	O	]	dep	24	SENT_161	[p6l1220t2275r1353b2343],
28	.	.	O	.	_	0	SENT_161	[p6l1220t2275r1353b2343],

1	In	IN	O	in	_	0	SENT_162	[p6l1379t2278r1436b2329],
2	addition	NN	O	addition	prep_in	5	SENT_162	[p6l1460t2275r1714b2330],
3	many	JJ	O	many	amod	4	SENT_162	[p6l1739t2291r1908b2343],
4	studies	NNS	O	study	nsubj	5	SENT_162	[p6l1931t2275r2145b2330],
5	revealed	VBD	O	reveal	_	0	SENT_162	[p6l9t2363r266b2418],
6	that	IN	O	that	complm	10	SENT_162	[p6l300t2363r423b2418],
7	SLCO1B1	NN	O	slco1b1	nsubj	10	SENT_162	[p6l450t2364r816b2418],
8	*	CD	NUMBER	*	num	9	SENT_162	[p6l450t2364r816b2418],
9	15	CD	NUMBER	15	dep	7	SENT_162	[p6l450t2364r816b2418],
10	led	VBD	O	lead	ccomp	5	SENT_162	[p6l848t2363r938b2418],
11	to	TO	O	to	_	0	SENT_162	[p6l971t2371r1028b2418],
12	increased	VBN	O	increase	amod	14	SENT_162	[p6l1062t2363r1351b2418],
13	plasma	NN	O	plasma	nn	14	SENT_162	[p6l1384t2363r1601b2432],
14	concentration	NN	O	concentration	prep_to	10	SENT_162	[p6l1633t2364r2057b2418],
15	of	IN	O	of	_	0	SENT_162	[p6l2089t2363r2153b2418],
16	pravastatin	NN	O	pravastatin	prep_of	14	SENT_162	[p6l9t2453r363b2521],
17	,	,	O	,	_	0	SENT_162	[p6l9t2453r363b2521],
18	pitavastatin	NN	O	pitavastatin	conj_and	16	SENT_162	[p6l386t2453r744b2521],
19	and	CC	O	and	_	0	SENT_162	[p6l764t2452r875b2507],
20	rosuvastatin	NN	O	rosuvastatin	conj_and	16	SENT_162	[p6l898t2453r1273b2507],
21	compared	VBN	O	compare	_	0	SENT_162	[p6l1293t2452r1597b2521],
22	with	IN	O	with	prepc_compared_with	10	SENT_162	[p6l1618t2452r1759b2507],
23	SLCO1	NN	O	slco1	nn	25	SENT_162	[p6l1777t2455r1955b2507],
24	B1	NN	O	b1	nn	25	SENT_162	[p6l1963t2455r2030b2506],
25	*	NN	O	*	pobj	10	SENT_162	[p6l2047t2453r2102b2506],
26	1	CD	NUMBER	1	num	27	SENT_162	[p6l2047t2453r2102b2506],
27	a	DT	O	a	dep	25	SENT_162	[p6l2113t2468r2145b2507],
28	and	CC	O	and	_	0	SENT_162	[p6l9t2542r121b2597],
29	SLCO1B1	NN	O	slco1b1	nn	31	SENT_162	[p6l168t2542r541b2597],
30	*	CD	NUMBER	*	num	31	SENT_162	[p6l168t2542r541b2597],
31	1b	NN	O	1b	pobj	10	SENT_162	[p6l168t2542r541b2597],
32	[	CD	NUMBER	[	number	33	SENT_162	[p6l594t2542r872b2610],
33	4,21,22	CD	NUMBER	4,21,22	num	34	SENT_162	[p6l594t2542r872b2610],
34	]	NN	O	]	dep	31	SENT_162	[p6l594t2542r872b2610],
35	.	.	O	.	_	0	SENT_162	[p6l594t2542r872b2610],

1	Moreover	RB	O	moreover	advmod	16	SENT_163	[p6l923t2545r1233b2605],
2	,	,	O	,	_	0	SENT_163	[p6l923t2545r1233b2605],
3	Deng	NNP	PERSON	Deng	nsubjpass	16	SENT_163	[p6l1283t2545r1443b2610],
4	et	FW	O	et	nn	5	SENT_163	[p6l1490t2550r1547b2597],
5	al.	FW	O	al.	dep	3	SENT_163	[p6l1594t2542r1660b2597],
6	demonstrated	VBN	O	demonstrate	partmod	3	SENT_163	[p6l1710t2542r2144b2597],
7	recently	RB	DATE	recently	advmod	6	SENT_163	[p6l9t2631r266b2699],
8	,	,	O	,	_	0	SENT_163	[p6l9t2631r266b2699],
9	high	JJ	O	high	amod	11	SENT_163	[p6l303t2630r436b2699],
10	efﬁcient	JJ	O	efﬁcient	amod	11	SENT_163	[p6l471t2630r719b2685],
11	substrates	NNS	O	substrate	dobj	6	SENT_163	[p6l753t2630r1060b2685],
12	such	JJ	O	such	_	0	SENT_163	[p6l1097t2631r1234b2685],
13	as	IN	O	as	_	0	SENT_163	[p6l1269t2646r1328b2685],
14	pitavastatin	NN	O	pitavastatin	prep_such_as	11	SENT_163	[p6l1364t2631r1721b2699],
15	was	VBD	O	be	auxpass	16	SENT_163	[p6l1752t2646r1869b2685],
16	affected	VBN	O	affect	_	0	SENT_163	[p6l1904t2630r2144b2685],
17	by	IN	O	by	_	0	SENT_163	[p6l8t2720r81b2788],
18	SLCO1B1	NN	O	slco1b1	nn	20	SENT_163	[p6l97t2723r350b2775],
19	genetic	JJ	O	genetic	amod	20	SENT_163	[p6l377t2721r599b2788],
20	variants	NNS	O	variant	agent	16	SENT_163	[p6l617t2721r861b2775],
21	greater	JJR	O	greater	dep	23	SENT_163	[p6l882t2728r1100b2788],
22	than	IN	O	than	dep	23	SENT_163	[p6l1119t2720r1257b2775],
23	low	JJ	O	low	amod	25	SENT_163	[p6l1278t2720r1390b2775],
24	efﬁcient	JJ	O	efﬁcient	amod	25	SENT_163	[p6l1409t2720r1657b2775],
25	substrates	NNS	O	substrate	tmod	16	SENT_163	[p6l1677t2720r1985b2775],
26	such	JJ	O	such	_	0	SENT_163	[p6l2007t2720r2145b2775],
27	as	IN	O	as	_	0	SENT_163	[p6l8t2825r68b2864],
28	pravastatin	NN	O	pravastatin	prep_such_as	25	SENT_163	[p6l87t2810r428b2877],
29	in	IN	O	in	_	0	SENT_163	[p6l446t2810r502b2863],
30	a	DT	O	a	det	31	SENT_163	[p6l520t2825r551b2864],
31	model	NN	O	model	prep_in	28	SENT_163	[p6l570t2809r760b2864],
32	using	VBG	O	use	partmod	31	SENT_163	[p6l779t2810r943b2877],
33	oocytes	NNS	O	oocyte	dobj	32	SENT_163	[p6l960t2817r1188b2877],
34	over	IN	O	over	_	0	SENT_163	[p6l1207t2810r1695b2877],
35	—	CD	NUMBER	—	prep_over	32	SENT_163	[p6l1207t2810r1695b2877],
36	expressing	VBG	O	express	xcomp	32	SENT_163	[p6l1207t2810r1695b2877],
37	OATP1B1	NN	O	oatp1b1	dobj	36	SENT_163	[p6l1712t2811r1982b2864],
38	[	CD	NUMBER	[	num	40	SENT_163	[p6l2012t2809r2144b2877],
39	23	CD	NUMBER	23	num	40	SENT_163	[p6l2012t2809r2144b2877],
40	]	NN	O	]	dep	25	SENT_163	[p6l2012t2809r2144b2877],
41	.	.	O	.	_	0	SENT_163	[p6l2012t2809r2144b2877],

1	These	DT	O	these	det	2	SENT_164	[p6l6t2897r182b2952],
2	studies	NNS	O	study	nsubj	3	SENT_164	[p6l211t2897r425b2952],
3	indicate	VBP	O	indicate	dep	21	SENT_164	[p6l453t2897r694b2952],
4	that	IN	O	that	complm	15	SENT_164	[p6l721t2897r844b2952],
5	the	DT	O	the	det	7	SENT_164	[p6l869t2897r966b2952],
6	system	NN	O	system	nn	7	SENT_164	[p6l994t2905r1207b2966],
7	exposure	NN	O	exposure	nsubj	15	SENT_164	[p6l1233t2913r1510b2966],
8	of	IN	O	of	_	0	SENT_164	[p6l1538t2897r1601b2952],
9	statins	NNS	O	statin	prep_of	7	SENT_164	[p6l1621t2898r1819b2952],
10	in	IN	O	in	_	0	SENT_164	[p6l1848t2898r1903b2952],
11	human	JJ	O	human	amod	12	SENT_164	[p6l1931t2897r2145b2952],
12	body	NN	O	body	prep_in	9	SENT_164	[p6l8t2986r160b3055],
13	may	MD	O	may	aux	15	SENT_164	[p6l192t3002r321b3055],
14	probably	RB	O	probably	advmod	15	SENT_164	[p6l354t2986r625b3055],
15	rely	VB	O	rely	ccomp	3	SENT_164	[p6l656t2986r771b3055],
16	on	IN	O	on	_	0	SENT_164	[p6l802t3002r877b3041],
17	both	CC	O	both	dep	20	SENT_164	[p6l910t2986r1049b3041],
18	the	DT	O	the	det	20	SENT_164	[p6l1081t2986r1178b3041],
19	transporter	NN	O	transporter	nn	20	SENT_164	[p6l1211t2994r1559b3055],
20	activities	NNS	O	activity	prep_on	15	SENT_164	[p6l1590t2987r1861b3041],
21	(	VBP	O	(	_	0	SENT_164	[p6l1899t2986r2146b3055],
22	genetic	JJ	O	genetic	amod	24	SENT_164	[p6l1899t2986r2146b3055],
23	background	NN	O	background	nn	24	SENT_164	[p6l8t3076r394b3144],
24	)	NN	O	)	dobj	21	SENT_164	[p6l8t3076r394b3144],
25	and	CC	O	and	_	0	SENT_164	[p6l423t3076r534b3131],
26	transportation	NN	O	transportation	nn	27	SENT_164	[p6l559t3077r1001b3144],
27	efﬁciency	NN	O	efﬁciency	dobj	21	SENT_164	[p6l1026t3076r1318b3144],
28	(	CD	NUMBER	(	num	31	SENT_164	[p6l1345t3076r1513b3144],
29	drug	NN	O	drug	nn	31	SENT_164	[p6l1345t3076r1513b3144],
30	property	NN	O	property	nn	31	SENT_164	[p6l1537t3076r1846b3144],
31	)	NN	O	)	nsubj	21	SENT_164	[p6l1537t3076r1846b3144],
32	.	.	O	.	_	0	SENT_164	[p6l1537t3076r1846b3144],

1	In	IN	O	in	mark	4	SENT_165	[p6l111t3168r168b3219],
2	order	NN	O	order	dep	4	SENT_165	[p6l215t3164r380b3219],
3	to	TO	O	to	aux	4	SENT_165	[p6l424t3173r482b3219],
4	access	VB	O	access	_	0	SENT_165	[p6l529t3180r717b3219],
5	the	DT	O	the	det	6	SENT_165	[p6l763t3164r861b3219],
6	impact	NN	O	impact	dobj	4	SENT_165	[p6l908t3165r1118b3233],
7	of	IN	O	of	_	0	SENT_165	[p6l1163t3164r1226b3219],
8	SLCO1B1	NN	O	slco1b1	nn	9	SENT_165	[p6l1262t3167r1514b3219],
9	genotypes	NNS	O	genotype	prep_of	6	SENT_165	[p6l1567t3173r1880b3233],
10	on	IN	O	on	_	0	SENT_165	[p6l1927t3180r2002b3219],
11	the	DT	O	the	prep_on	4	SENT_165	[p6l2048t3165r2145b3219],

1	OATP1B1	NN	O	oatp1b1	nsubj	2	SENT_166	[p7l9t19r278b72],
2	mediated	VBD	O	mediate	_	0	SENT_166	[p7l309t17r595b72],
3	drug	NN	O	drug	nn	6	SENT_166	[p7l618t17r944b85],
4	—	CD	NUMBER	—	num	6	SENT_166	[p7l618t17r944b85],
5	drug	NN	O	drug	nn	6	SENT_166	[p7l618t17r944b85],
6	interaction	NN	O	interaction	nsubjpass	16	SENT_166	[p7l966t18r1312b80],
7	,	,	O	,	_	0	SENT_166	[p7l966t18r1312b80],
8	single	JJ	O	single	amod	10	SENT_166	[p7l1336t17r1513b85],
9	oral	JJ	O	oral	amod	10	SENT_166	[p7l1537t17r1651b72],
10	dose	NN	O	dose	appos	6	SENT_166	[p7l1674t17r1812b72],
11	of	IN	O	of	_	0	SENT_166	[p7l1835t17r1898b72],
12	600	CD	NUMBER	600	num	14	SENT_166	[p7l1914t20r2028b72],
13	mg	NN	O	mg	nn	14	SENT_166	[p7l2051t33r2146b85],
14	rifampicin	NN	O	rifampicin	prep_of	10	SENT_166	[p7l9t105r323b174],
15	was	VBD	O	be	auxpass	16	SENT_166	[p7l338t121r455b160],
16	co-administered	VBN	O	co-administer	ccomp	2	SENT_166	[p7l476t106r976b160],
17	as	IN	O	as	_	0	SENT_166	[p7l997t121r1056b160],
18	a	DT	O	a	det	20	SENT_166	[p7l1076t121r1107b160],
19	competitive	JJ	O	competitive	amod	20	SENT_166	[p7l1126t106r1488b174],
20	inhibitor	NN	O	inhibitor	prep_as	16	SENT_166	[p7l1508t105r1776b160],
21	of	IN	O	of	_	0	SENT_166	[p7l1793t105r1856b160],
22	OATP1	NN	O	oatp1	nn	23	SENT_166	[p7l1868t108r2058b160],
23	B1	NN	O	b1	prep_of	20	SENT_166	[p7l2071t108r2137b160],
24	[	CD	NUMBER	[	number	25	SENT_166	[p7l12t194r206b263],
25	14,15	CD	NUMBER	14,15	num	26	SENT_166	[p7l12t194r206b263],
26	]	NN	O	]	dep	23	SENT_166	[p7l12t194r206b263],
27	to	TO	O	to	aux	28	SENT_166	[p7l243t202r301b249],
28	inhibit	VB	O	inhibit	xcomp	16	SENT_166	[p7l336t194r538b249],
29	hepatic	JJ	O	hepatic	amod	30	SENT_166	[p7l571t194r794b263],
30	uptake	NN	O	uptake	dobj	28	SENT_166	[p7l828t194r1035b263],
31	of	IN	O	of	_	0	SENT_166	[p7l1069t194r1132b249],
32	atorvastatin	NN	O	atorvastatin	prep_of	30	SENT_166	[p7l1158t195r1538b250],
33	.	.	O	.	_	0	SENT_166	[p7l1158t195r1538b250],

1	Interestingly	RB	O	interestingly	advmod	12	SENT_167	[p7l1573t194r1970b263],
2	,	,	O	,	_	0	SENT_167	[p7l1573t194r1970b263],
3	after	IN	O	after	mark	6	SENT_167	[p7l2005t194r2147b249],
4	rifampicin	NN	O	rifampicin	nsubjpass	6	SENT_167	[p7l9t284r323b352],
5	was	VBD	O	be	auxpass	6	SENT_167	[p7l342t300r460b339],
6	co-administered	VBN	O	co-administer	dep	12	SENT_167	[p7l484t284r985b339],
7	the	DT	O	the	det	9	SENT_167	[p7l1009t284r1106b339],
8	plasma	NN	O	plasma	nn	9	SENT_167	[p7l1130t284r1347b352],
9	concentration	NN	O	concentration	nsubj	12	SENT_167	[p7l1371t285r1795b339],
10	of	IN	O	of	_	0	SENT_167	[p7l1818t284r1882b339],
11	atorvastatin	NN	O	atorvastatin	prep_of	9	SENT_167	[p7l1898t292r2144b339, p7l8t374r149b428],
12	deviate	VBP	O	deviate	_	0	SENT_167	[p7l185t373r407b428],
13	the	DT	O	the	det	14	SENT_167	[p7l443t373r539b428],
14	discipline	NN	O	discipline	dobj	12	SENT_167	[p7l576t373r869b441],
15	of	IN	O	of	_	0	SENT_167	[p7l905t373r968b428],
16	gene	NN	O	gene	nn	19	SENT_167	[p7l995t373r1381b441],
17	—	NN	O	—	nn	19	SENT_167	[p7l995t373r1381b441],
18	dosage	NN	O	dosage	nn	19	SENT_167	[p7l995t373r1381b441],
19	effect	NN	O	effect	prep_of	14	SENT_167	[p7l1418t372r1599b428],
20	.	.	O	.	_	0	SENT_167	[p7l1418t372r1599b428],

1	As	IN	O	as	mark	2	SENT_168	[p7l1633t375r1705b428],
2	illustrated	VBN	O	illustrate	_	0	SENT_168	[p7l1742t373r2051b428],
3	in	IN	O	in	_	0	SENT_168	[p7l2089t374r2145b427],
4	Fig	NN	O	fig	prep_in	2	SENT_168	[p7l9t462r109b529],
5	.	.	O	.	_	0	SENT_168	[p7l9t462r109b529],

1	2	CD	NUMBER	2	nsubj	17	SENT_169	[p7l156t464r205b524],
2	,	,	O	,	_	0	SENT_169	[p7l156t464r205b524],
3	the	DT	O	the	det	5	SENT_169	[p7l251t461r348b516],
4	increase	NN	O	increase	nn	5	SENT_169	[p7l395t462r644b516],
5	percentage	NN	O	percentage	dep	10	SENT_169	[p7l690t469r1028b530],
6	of	IN	O	of	_	0	SENT_169	[p7l1073t461r1137b516],
7	AUC	NN	O	auc	prep_of	5	SENT_169	[p7l1172t464r1460b535],
8	(	CD	NUMBER	(	dep	10	SENT_169	[p7l1172t464r1460b535],
9	0_48	CD	NUMBER	0_48	num	10	SENT_169	[p7l1172t464r1460b535],
10	)	NN	O	)	dep	1	SENT_169	[p7l1172t464r1460b535],
11	of	IN	O	of	_	0	SENT_169	[p7l1509t461r1573b516],
12	SLCO1B1	NN	O	slco1b1	nn	15	SENT_169	[p7l1608t464r1862b516],
13	c.	NN	O	c.	nn	15	SENT_169	[p7l1914t464r2148b516],
14	521TT	NN	O	521tt	nn	15	SENT_169	[p7l1914t464r2148b516],
15	participants	NNS	O	participant	prep_of	10	SENT_169	[p7l9t551r373b618],
16	nearly	RB	O	nearly	advmod	17	SENT_169	[p7l406t550r597b618],
17	tripled	VBD	O	triple	dep	26	SENT_169	[p7l627t550r830b618],
18	the	DT	O	the	det	19	SENT_169	[p7l863t550r960b605],
19	increase	NN	O	increase	dobj	17	SENT_169	[p7l994t551r1243b605],
20	of	IN	O	of	_	0	SENT_169	[p7l1276t550r1339b605],
21	SLCO1B1	NN	O	slco1b1	nn	25	SENT_169	[p7l1361t553r1614b605],
22	c.	NN	O	c.	nn	25	SENT_169	[p7l1654t553r1802b605],
23	521	CD	NUMBER	521	num	25	SENT_169	[p7l1654t553r1802b605],
24	CC	NN	O	cc	nn	25	SENT_169	[p7l1815t553r1892b605],
25	participants	NNS	O	participant	prep_of	19	SENT_169	[p7l1924t551r2145b618, p7l9t646r174b707],
26	(	VBP	O	(	_	0	SENT_169	[p7l205t638r334b707],
27	P	NN	O	p	nsubj	28	SENT_169	[p7l205t638r334b707],
28	=	JJ	O	=	xcomp	26	SENT_169	[p7l205t638r334b707],
29	0.007	CD	NUMBER	0.007	num	30	SENT_169	[p7l352t638r564b706],
30	)	NN	O	)	nsubj	26	SENT_169	[p7l352t638r564b706],
31	.	.	O	.	_	0	SENT_169	[p7l352t638r564b706],

1	As	IN	O	as	mark	2	SENT_170	[p7l589t641r661b693],
2	calculated	VBN	O	calculate	advcl	15	SENT_170	[p7l689t638r996b693],
3	in	IN	O	in	_	0	SENT_170	[p7l1023t639r1079b693],
4	this	DT	O	this	det	5	SENT_170	[p7l1106t638r1217b693],
5	study	NN	O	study	prep_in	2	SENT_170	[p7l1244t638r1423b707],
6	,	,	O	,	_	0	SENT_170	[p7l1244t638r1423b707],
7	the	DT	O	the	det	9	SENT_170	[p7l1450t638r1547b693],
8	plasma	NN	O	plasma	nn	9	SENT_170	[p7l1574t638r1791b707],
9	concentration	NN	O	concentration	nsubjpass	15	SENT_170	[p7l1817t646r2145b693, p7l8t728r128b782],
10	of	IN	O	of	_	0	SENT_170	[p7l152t727r216b782],
11	rifampicin	NN	O	rifampicin	prep_of	9	SENT_170	[p7l232t727r546b796],
12	was	VBD	O	be	auxpass	15	SENT_170	[p7l565t743r682b782],
13	not	RB	O	not	neg	15	SENT_170	[p7l707t735r807b782],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_170	[p7l830t727r1203b796],
15	altered	VBN	O	alter	_	0	SENT_170	[p7l1223t727r1435b782],
16	by	IN	O	by	_	0	SENT_170	[p7l1458t727r1532b796],
17	SLCOIBI	NN	O	slcoibus	nn	18	SENT_170	[p7l1550t730r1802b782],
18	genotypes	NNS	O	genotype	agent	15	SENT_170	[p7l1832t735r2145b796],
19	which	WDT	O	which	nsubj	20	SENT_170	[p7l7t816r196b871],
20	indicated	VBD	O	indicate	rcmod	18	SENT_170	[p7l227t816r509b871],
21	that	IN	O	that	complm	30	SENT_170	[p7l540t816r663b871],
22	ﬁrst	NN	O	ﬁrst	nn	23	SENT_170	[p7l692t816r813b871],
23	OATP1B1	NN	O	oatp1b1	nsubj	30	SENT_170	[p7l842t819r1112b871],
24	may	MD	O	may	aux	30	SENT_170	[p7l1151t832r1282b885],
25	probably	RB	O	probably	advmod	30	SENT_170	[p7l1311t816r1581b885],
26	not	RB	O	not	neg	30	SENT_170	[p7l1611t825r1711b871],
27	be	VB	O	be	cop	30	SENT_170	[p7l1739t816r1809b871],
28	the	DT	O	the	det	30	SENT_170	[p7l1841t817r1937b871],
29	major	JJ	O	major	amod	30	SENT_170	[p7l1969t817r2147b885],
30	transporter	NN	O	transporter	ccomp	20	SENT_170	[p7l8t914r356b974],
31	for	IN	O	for	_	0	SENT_170	[p7l384t905r469b960],
32	the	DT	O	the	det	34	SENT_170	[p7l497t905r594b960],
33	hepatic	JJ	O	hepatic	amod	34	SENT_170	[p7l625t906r849b974],
34	uptake	NN	O	uptake	prep_for	30	SENT_170	[p7l878t906r1085b974],
35	of	IN	O	of	_	0	SENT_170	[p7l1115t905r1179b960],
36	rifampicin	NN	O	rifampicin	prep_of	34	SENT_170	[p7l1202t905r1516b974],
37	in	IN	O	in	_	0	SENT_170	[p7l1546t906r1602b960],
38	humans	NNS	O	human	prep_in	36	SENT_170	[p7l1633t906r1876b960],
39	and	CC	O	and	_	0	SENT_170	[p7l1906t905r2017b960],
40	the	DT	O	the	det	44	SENT_170	[p7l2048t906r2145b960],
41	second	JJ	ORDINAL	second	amod	44	SENT_170	[p7l10t995r220b1050],
42	different	JJ	O	different	amod	44	SENT_170	[p7l245t995r509b1050],
43	change	NN	O	change	nn	44	SENT_170	[p7l532t995r747b1063],
44	percentage	NN	O	percentage	nsubjpass	53	SENT_170	[p7l772t1003r1108b1063],
45	of	IN	O	of	_	0	SENT_170	[p7l1133t995r1196b1050],
46	atorvastatin	NN	O	atorvastatin	nn	47	SENT_170	[p7l1213t996r1578b1050],
47	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	44	SENT_170	[p7l1600t995r2144b1063],
48	between	IN	O	between	_	0	SENT_170	[p7l8t1084r272b1139],
49	individuals	NNS	O	individual	prep_between	47	SENT_170	[p7l300t1084r635b1139],
50	can	MD	O	can	aux	53	SENT_170	[p7l663t1092r871b1139],
51	not	RB	O	not	neg	53	SENT_170	[p7l663t1092r871b1139],
52	be	VB	O	be	auxpass	53	SENT_170	[p7l896t1084r966b1139],
53	explained	VBN	O	explain	conj_and	30	SENT_170	[p7l993t1084r1290b1152],
54	by	IN	O	by	_	0	SENT_170	[p7l1318t1084r1392b1152],
55	difference	NN	O	difference	agent	53	SENT_170	[p7l1416t1084r1721b1139],
56	of	IN	O	of	_	0	SENT_170	[p7l1749t1084r1812b1139],
57	rifampicin	NN	O	rifampicin	nn	58	SENT_170	[p7l1832t1084r2145b1152],
58	concentrations	NNS	O	concentration	prep_of	55	SENT_170	[p7l9t1173r477b1228],
59	.	.	O	.	_	0	SENT_170	[p7l9t1173r477b1228],

1	Apparently	RB	O	apparently	advmod	9	SENT_171	[p7l501t1172r843b1241],
2	rifampicin	NN	O	rifampicin	nn	4	SENT_171	[p7l867t1172r1181b1241],
3	mediated	JJ	O	mediated	amod	4	SENT_171	[p7l1206t1172r1492b1227],
4	change	NN	O	change	nsubjpass	9	SENT_171	[p7l1518t1172r1733b1241],
5	of	IN	O	of	_	0	SENT_171	[p7l1759t1172r1822b1227],
6	atorvastatin	NN	O	atorvastatin	nn	7	SENT_171	[p7l1839t1180r2145b1227, p7l8t1262r90b1316],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	4	SENT_171	[p7l113t1261r657b1330],
8	is	VBZ	O	be	auxpass	9	SENT_171	[p7l684t1262r728b1316],
9	correlated	VBN	O	correlate	_	0	SENT_171	[p7l753t1261r1061b1316],
10	with	IN	O	with	_	0	SENT_171	[p7l1085t1261r1226b1316],
11	SLCO1B1	NN	O	slco1b1	nn	12	SENT_171	[p7l1248t1264r1501b1316],
12	genotypes	NNS	O	genotype	prep_with	9	SENT_171	[p7l1532t1269r1859b1330],
13	.	.	O	.	_	0	SENT_171	[p7l1532t1269r1859b1330],

1	Previous	JJ	O	previous	amod	2	SENT_172	[p7l1886t1262r2145b1316],
2	studies	NNS	O	study	nsubj	4	SENT_172	[p7l10t1351r223b1406],
3	have	VBP	O	have	aux	4	SENT_172	[p7l261t1351r400b1406],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_172	[p7l437t1351r864b1406],
5	that	IN	O	that	complm	10	SENT_172	[p7l900t1351r1023b1406],
6	rifampicin	NN	O	rifampicin	nsubj	10	SENT_172	[p7l1058t1351r1372b1419],
7	is	VBZ	O	be	cop	10	SENT_172	[p7l1408t1352r1452b1406],
8	a	DT	O	a	det	10	SENT_172	[p7l1489t1367r1519b1406],
9	potent	JJ	O	potent	amod	10	SENT_172	[p7l1555t1359r1755b1419],
10	inhibitor	NN	O	inhibitor	ccomp	4	SENT_172	[p7l1789t1351r2056b1406],
11	of	IN	O	of	_	0	SENT_172	[p7l2090t1351r2153b1406],
12	SLCO1B1	NN	O	slco1b1	nn	14	SENT_172	[p7l9t1442r270b1494],
13	(	CD	NUMBER	(	num	14	SENT_172	[p7l305t1440r465b1508],
14	IC50	NN	O	ic50	prep_of	10	SENT_172	[p7l305t1440r465b1508],
15	1.5	CD	NUMBER	1.5	num	16	SENT_172	[p7l489t1443r567b1495],
16	uM	NN	O	um	dep	14	SENT_172	[p7l591t1439r715b1508],
17	)	CD	NUMBER	)	number	18	SENT_172	[p7l591t1439r715b1508],
18	[	CD	NUMBER	[	dep	16	SENT_172	[p7l746t1439r877b1508],
19	24	CD	NUMBER	24	num	20	SENT_172	[p7l746t1439r877b1508],
20	]	NN	O	]	dep	18	SENT_172	[p7l746t1439r877b1508],
21	.	.	O	.	_	0	SENT_172	[p7l746t1439r877b1508],

1	The	DT	O	the	det	3	SENT_173	[p7l899t1440r1010b1494],
2	fold	JJ	O	fold	amod	3	SENT_173	[p7l1033t1439r1147b1494],
3	changes	NNS	O	change	nsubjpass	8	SENT_173	[p7l1171t1440r1415b1508],
4	in	IN	O	in	_	0	SENT_173	[p7l1439t1440r1495b1494],
5	atorvastatin	NN	O	atorvastatin	nn	6	SENT_173	[p7l1517t1440r1882b1494],
6	AUC	NN	O	auc	prep_in	3	SENT_173	[p7l1901t1442r2031b1494],
7	are	VBP	O	be	auxpass	8	SENT_173	[p7l2053t1455r2146b1494],
8	expected	VBN	O	expect	_	0	SENT_173	[p7l9t1529r282b1597],
9	to	TO	O	to	aux	10	SENT_173	[p7l302t1537r360b1584],
10	differ	VB	O	differ	xcomp	8	SENT_173	[p7l380t1529r544b1584],
11	between	IN	O	between	_	0	SENT_173	[p7l562t1529r825b1584],
12	genotypes	NNS	O	genotype	prep_between	10	SENT_173	[p7l844t1537r1156b1597],
13	since	IN	O	since	mark	18	SENT_173	[p7l1178t1530r1329b1584],
14	the	DT	O	the	det	16	SENT_173	[p7l1349t1529r1446b1584],
15	uninhibited	JJ	O	uninhibited	amod	16	SENT_173	[p7l1466t1529r1822b1584],
16	values	NNS	O	value	nsubj	18	SENT_173	[p7l1841t1529r2032b1584],
17	are	VBP	O	be	cop	18	SENT_173	[p7l2053t1545r2145b1584],
18	lower	JJR	O	lower	advcl	10	SENT_173	[p7l9t1618r185b1673],
19	in	IN	O	in	_	0	SENT_173	[p7l232t1619r288b1672],
20	"	``	O	"	punct	21	SENT_173	[p7l331t1621r407b1672],
21	IT	NNP	O	IT	prep_in	18	SENT_173	[p7l331t1621r407b1672],
22	and	CC	O	and	_	0	SENT_173	[p7l450t1618r561b1673],
23	TC	NNP	O	TC	nn	24	SENT_173	[p7l607t1621r685b1673],
24	individuals	NNS	O	individual	conj_and	21	SENT_173	[p7l732t1618r1071b1673],
25	compared	VBN	O	compare	_	0	SENT_173	[p7l1120t1618r1427b1686],
26	with	IN	O	with	prepc_compared_with	24	SENT_173	[p7l1474t1618r1616b1673],
27	CC	NN	O	cc	nn	28	SENT_173	[p7l1665t1621r1742b1673],
28	individuals	NNS	O	individual	pobj	24	SENT_173	[p7l1790t1618r2144b1673],
29	.	.	O	.	_	0	SENT_173	[p7l1790t1618r2144b1673],

1	However	RB	O	however	advmod	7	SENT_174	[p7l9t1710r294b1770],
2	,	,	O	,	_	0	SENT_174	[p7l9t1710r294b1770],
3	rifampicin	NN	O	rifampicin	nsubj	7	SENT_174	[p7l327t1706r641b1775],
4	is	VBZ	O	be	cop	7	SENT_174	[p7l672t1707r716b1761],
5	a	DT	O	a	det	7	SENT_174	[p7l748t1722r779b1761],
6	potent	JJ	O	potent	amod	7	SENT_174	[p7l809t1714r1009b1775],
7	inducer	NN	O	inducer	_	0	SENT_174	[p7l1039t1706r1273b1761],
8	of	IN	O	of	_	0	SENT_174	[p7l1301t1706r1364b1761],
9	OATP1B1	NN	O	oatp1b1	prep_of	7	SENT_174	[p7l1388t1709r1658b1761],
10	as	RB	O	as	advmod	11	SENT_174	[p7l1696t1722r1755b1761],
11	well	RB	O	well	advmod	7	SENT_174	[p7l1786t1706r1929b1762],
12	.	.	O	.	_	0	SENT_174	[p7l1786t1706r1929b1762],

1	When	WRB	O	when	advmod	4	SENT_175	[p7l1959t1706r2146b1761],
2	it	PRP	O	it	nsubjpass	4	SENT_175	[p7l9t1796r50b1850],
3	is	VBZ	O	be	auxpass	4	SENT_175	[p7l79t1796r123b1850],
4	administered	VBN	O	administer	advcl	14	SENT_175	[p7l153t1795r558b1850],
5	in	IN	O	in	_	0	SENT_175	[p7l587t1796r644b1850],
6	a	DT	O	a	det	9	SENT_175	[p7l672t1811r703b1850],
7	comparatively	RB	O	comparatively	advmod	8	SENT_175	[p7l732t1795r1169b1864],
8	long	JJ	O	long	amod	9	SENT_175	[p7l1197t1795r1328b1864],
9	term	NN	O	term	prep_in	4	SENT_175	[p7l1356t1803r1502b1850],
10	the	DT	O	the	det	12	SENT_175	[p7l1531t1795r1627b1850],
11	induction	NN	O	induction	nn	12	SENT_175	[p7l1657t1795r1949b1850],
12	effect	NN	O	effect	nsubj	14	SENT_175	[p7l1979t1795r2147b1850],
13	will	MD	O	will	aux	14	SENT_175	[p7l7t1885r121b1939],
14	be	VB	O	be	_	0	SENT_175	[p7l158t1885r228b1940],
15	overwhelmingly	RB	O	overwhelmingly	advmod	14	SENT_175	[p7l267t1885r769b1953],
16	via	IN	O	via	_	0	SENT_175	[p7l803t1886r892b1940],
17	a	DT	O	a	det	19	SENT_175	[p7l929t1901r960b1940],
18	PXR	NN	O	pxr	nn	19	SENT_175	[p7l997t1888r1120b1939],
19	pathway	NN	O	pathway	prep_via	14	SENT_175	[p7l1155t1885r1420b1953],
20	[	CD	NUMBER	[	number	21	SENT_175	[p7l1458t1885r1684b1953],
21	25,26	CD	NUMBER	25,26	num	22	SENT_175	[p7l1458t1885r1684b1953],
22	]	NN	O	]	dep	14	SENT_175	[p7l1458t1885r1684b1953],
23	.	.	O	.	_	0	SENT_175	[p7l1458t1885r1684b1953],

1	In	IN	O	in	_	0	SENT_176	[p7l1723t1888r1780b1939],
2	this	DT	O	this	det	3	SENT_176	[p7l1817t1885r1927b1940],
3	study	NN	O	study	prep_in	6	SENT_176	[p7l1966t1885r2144b1953],
4	,	,	O	,	_	0	SENT_176	[p7l1966t1885r2144b1953],
5	rifampicin	NN	O	rifampicin	nsubj	6	SENT_176	[p7l9t1974r323b2042],
6	displayed	VBD	O	display	_	0	SENT_176	[p7l347t1974r637b2042],
7	an	DT	O	a	det	10	SENT_176	[p7l662t1990r733b2029],
8	acute	JJ	O	acute	amod	10	SENT_176	[p7l757t1982r918b2029],
9	inhibition	NN	O	inhibition	nn	10	SENT_176	[p7l944t1974r1243b2029],
10	effect	NN	O	effect	nsubj	13	SENT_176	[p7l1267t1973r1435b2029],
11	on	IN	O	on	_	0	SENT_176	[p7l1457t1990r1532b2029],
12	OATP1B1	NN	O	oatp1b1	prep_on	10	SENT_176	[p7l1556t1976r1826b2029],
13	mediated	VBD	O	mediate	ccomp	6	SENT_176	[p7l1858t1974r2144b2029],
14	uptaking	VBG	O	uptake	xcomp	13	SENT_176	[p7l9t2062r280b2131],
15	on	IN	O	on	_	0	SENT_176	[p7l307t2078r381b2117],
16	atorvastatin	NN	O	atorvastatin	prep_on	14	SENT_176	[p7l410t2063r775b2117],
17	while	IN	O	while	mark	22	SENT_176	[p7l800t2062r971b2117],
18	a	DT	O	a	det	20	SENT_176	[p7l1000t2078r1031b2117],
19	single	JJ	O	single	amod	20	SENT_176	[p7l1061t2062r1237b2131],
20	dose	NN	O	dose	nsubjpass	22	SENT_176	[p7l1267t2062r1405b2117],
21	was	VBD	O	be	auxpass	22	SENT_176	[p7l1432t2078r1549b2117],
22	administered	VBN	O	administer	advcl	13	SENT_176	[p7l1579t2062r1999b2117],
23	.	.	O	.	_	0	SENT_176	[p7l1579t2062r1999b2117],

1	In	IN	O	in	_	0	SENT_177	[p7l2029t2065r2086b2116],
2	a	DT	O	a	det	5	SENT_177	[p7l2115t2078r2146b2117],
3	similar	JJ	O	similar	amod	5	SENT_177	[p7l10t2152r220b2207],
4	panel	NN	O	panel	nn	5	SENT_177	[p7l252t2152r419b2220],
5	study	NN	O	study	prep_in	25	SENT_177	[p7l455t2152r633b2220],
6	,	,	O	,	_	0	SENT_177	[p7l455t2152r633b2220],
7	baicalin	NN	O	baicalin	nsubjpass	25	SENT_177	[p7l668t2152r919b2215],
8	,	,	O	,	_	0	SENT_177	[p7l668t2152r919b2215],
9	a	DT	O	a	det	12	SENT_177	[p7l955t2168r986b2207],
10	Chinese	JJ	MISC	chinese	amod	12	SENT_177	[p7l1020t2152r1257b2207],
11	traditional	JJ	O	traditional	amod	12	SENT_177	[p7l1292t2152r1612b2207],
12	drug	NN	O	drug	appos	7	SENT_177	[p7l1647t2152r1789b2220],
13	which	WDT	O	which	nsubjpass	16	SENT_177	[p7l1821t2152r2010b2207],
14	has	VBZ	O	have	aux	16	SENT_177	[p7l2045t2152r2145b2207],
15	been	VBN	O	be	auxpass	16	SENT_177	[p7l8t2240r155b2295],
16	shown	VBN	O	show	rcmod	12	SENT_177	[p7l178t2240r380b2295],
17	to	TO	O	to	aux	20	SENT_177	[p7l402t2248r461b2295],
18	be	VB	O	be	cop	20	SENT_177	[p7l483t2240r552b2295],
19	an	DT	O	a	det	20	SENT_177	[p7l576t2256r647b2295],
20	inducer	NN	O	inducer	xcomp	16	SENT_177	[p7l670t2240r904b2295],
21	of	IN	O	of	_	0	SENT_177	[p7l923t2240r987b2295],
22	OATP1B1	NN	O	oatp1b1	prep_of	20	SENT_177	[p7l1002t2243r1287b2304],
23	,	,	O	,	_	0	SENT_177	[p7l1002t2243r1287b2304],
24	was	VBD	O	be	auxpass	25	SENT_177	[p7l1310t2256r1427b2295],
25	given	VBN	O	give	_	0	SENT_177	[p7l1449t2241r1614b2309],
26	to	TO	O	to	_	0	SENT_177	[p7l1636t2248r1695b2295],
27	volunteers	NNS	O	volunteer	prep_to	25	SENT_177	[p7l1715t2240r2039b2295],
28	for	IN	O	for	_	0	SENT_177	[p7l2062t2240r2147b2295],
29	continuously	RB	O	continuously	amod	34	SENT_177	[p7l9t2329r407b2398],
30	14	CD	DURATION	14	num	31	SENT_177	[p7l433t2332r499b2384],
31	days	NNS	NUMBER	day	tmod	29	SENT_177	[p7l523t2329r658b2398],
32	before	IN	O	before	_	0	SENT_177	[p7l683t2329r875b2384],
33	rosuvastatin	NN	O	rosuvastatin	prep_before	29	SENT_177	[p7l901t2330r1275b2384],
34	administration	NN	O	administration	prep_for	27	SENT_177	[p7l1299t2329r1767b2385],
35	.	.	O	.	_	0	SENT_177	[p7l1299t2329r1767b2385],

1	Baicalin	NN	O	baicalin	nsubj	17	SENT_178	[p7l1793t2329r2029b2384],
2	led	VBD	O	lead	rcmod	1	SENT_178	[p7l2055t2329r2144b2384],
3	to	TO	O	to	_	0	SENT_178	[p7l9t2426r67b2473],
4	differences	NNS	O	difference	prep_to	2	SENT_178	[p7l97t2418r430b2473],
5	in	IN	O	in	_	0	SENT_178	[p7l461t2419r517b2472],
6	reduction	NN	O	reduction	prep_in	4	SENT_178	[p7l547t2418r840b2473],
7	of	IN	O	of	_	0	SENT_178	[p7l870t2418r933b2473],
8	plasma	NN	O	plasma	nn	9	SENT_178	[p7l956t2418r1173b2487],
9	concentrations	NNS	O	concentration	prep_of	6	SENT_178	[p7l1202t2419r1655b2473],
10	of	IN	O	of	_	0	SENT_178	[p7l1685t2418r1749b2473],
11	rosuvastatin	NN	O	rosuvastatin	prep_of	9	SENT_178	[p7l1771t2419r2146b2473],
12	based	VBN	O	base	_	0	SENT_178	[p7l8t2507r183b2562],
13	on	IN	O	on	prepc_based_on	2	SENT_178	[p7l225t2523r300b2562],
14	different	JJ	O	different	amod	16	SENT_178	[p7l340t2507r604b2562],
15	SLCO1B1	NN	O	slco1b1	nn	16	SENT_178	[p7l641t2510r893b2562],
16	haplotypes	NNS	O	haplotype	pobj	2	SENT_178	[p7l942t2507r1276b2576],
17	[	VBP	O	[	_	0	SENT_178	[p7l1322t2507r1453b2576],
18	27	CD	NUMBER	27	num	19	SENT_178	[p7l1322t2507r1453b2576],
19	]	CD	NUMBER	]	dobj	17	SENT_178	[p7l1322t2507r1453b2576],
20	.	.	O	.	_	0	SENT_178	[p7l1322t2507r1453b2576],

1	Meanwhile	RB	O	meanwhile	advmod	13	SENT_179	[p7l1496t2507r1851b2570],
2	,	,	O	,	_	0	SENT_179	[p7l1496t2507r1851b2570],
3	the	DT	O	the	det	5	SENT_179	[p7l1892t2507r1989b2562],
4	oral	JJ	O	oral	amod	5	SENT_179	[p7l2030t2507r2146b2562],
5	volume	NN	O	volume	nsubj	13	SENT_179	[p7l7t2596r236b2651],
6	of	IN	O	of	_	0	SENT_179	[p7l276t2596r339b2650],
7	distribution	NN	O	distribution	prep_of	5	SENT_179	[p7l371t2596r732b2651],
8	of	IN	O	of	_	0	SENT_179	[p7l771t2596r834b2650],
9	atorvastatin	NN	O	atorvastatin	prep_of	7	SENT_179	[p7l866t2597r1231b2650],
10	was	VBD	O	be	cop	13	SENT_179	[p7l1266t2612r1384b2651],
11	44	CD	PERCENT	44	num	12	SENT_179	[p7l1422t2599r1541b2650],
12	%	NN	PERCENT	%	npadvmod	13	SENT_179	[p7l1422t2599r1541b2650],
13	lower	JJR	O	lower	_	0	SENT_179	[p7l1580t2597r1755b2650],
14	in	IN	O	in	_	0	SENT_179	[p7l1793t2597r1849b2650],
15	SLCOIBI	NNP	O	SLCOIBI	prep_in	13	SENT_179	[p7l1886t2599r2138b2650],

1	c.	NN	O	c.	nn	4	SENT_180	[p7l9t2687r157b2740],
2	521	CD	NUMBER	521	num	1	SENT_180	[p7l9t2687r157b2740],
3	CC	NN	O	cc	nn	4	SENT_180	[p7l170t2687r247b2739],
4	carriers	NNS	O	carrier	nsubj	8	SENT_180	[p7l268t2685r497b2739],
5	compared	VBN	O	compare	_	0	SENT_180	[p7l519t2684r824b2753],
6	with	IN	O	with	prepc_compared_with	4	SENT_180	[p7l844t2684r985b2739],
7	SLCOIBI	NNP	PERSON	SLCOIBI	pobj	4	SENT_180	[p7l1005t2687r1256b2739],
8	c.	VBP	O	c.	_	0	SENT_180	[p7l1286t2687r1520b2740],
9	521TT	JJ	O	521tt	amod	10	SENT_180	[p7l1286t2687r1520b2740],
10	subjects	NNS	O	subject	dobj	8	SENT_180	[p7l1537t2684r1798b2753],
11	.	.	O	.	_	0	SENT_180	[p7l1537t2684r1798b2753],

1	This	DT	O	this	nsubjpass	4	SENT_181	[p7l1817t2684r1943b2739],
2	might	MD	O	might	aux	4	SENT_181	[p7l1966t2684r2147b2753],
3	be	VB	O	be	auxpass	4	SENT_181	[p7l8t2774r79b2829],
4	caused	VBN	O	cause	_	0	SENT_181	[p7l103t2774r310b2829],
5	by	IN	O	by	_	0	SENT_181	[p7l333t2774r407b2842],
6	differences	NNS	O	difference	agent	4	SENT_181	[p7l428t2774r762b2829],
7	in	IN	O	in	_	0	SENT_181	[p7l787t2775r843b2828],
8	the	DT	O	the	det	9	SENT_181	[p7l866t2774r963b2829],
9	volume	NN	O	volume	prep_in	6	SENT_181	[p7l986t2774r1214b2829],
10	of	IN	O	of	_	0	SENT_181	[p7l1239t2774r1302b2829],
11	distribution	NN	O	distribution	prep_of	9	SENT_181	[p7l1318t2774r1678b2829],
12	of	IN	O	of	_	0	SENT_181	[p7l1702t2773r1765b2829],
13	atorvastatin	NN	O	atorvastatin	nn	18	SENT_181	[p7l1781t2775r2146b2829],
14	due	JJ	O	due	amod	16	SENT_181	[p7l9t2863r120b2918],
15	to	TO	O	to	dep	16	SENT_181	[p7l138t2871r197b2918],
16	impaired	JJ	O	impaired	amod	18	SENT_181	[p7l216t2863r488b2931],
17	drug	NN	O	drug	nn	18	SENT_181	[p7l507t2863r649b2931],
18	transport	NN	O	transport	prep_of	11	SENT_181	[p7l666t2871r951b2931],
19	in	IN	O	in	_	0	SENT_181	[p7l968t2864r1024b2917],
20	the	DT	O	the	det	21	SENT_181	[p7l1041t2863r1138b2918],
21	liver	NN	O	liver	prep_in	4	SENT_181	[p7l1157t2863r1293b2918],
22	which	WDT	O	which	nsubj	32	SENT_181	[p7l1307t2863r1496b2918],
23	in	IN	O	in	_	0	SENT_181	[p7l1514t2864r1570b2917],
24	turn	NN	O	turn	prep_in	25	SENT_181	[p7l1588t2871r1718b2918],
25	decreases	VBZ	O	decrease	rcmod	21	SENT_181	[p7l1736t2863r2029b2918],
26	the	DT	O	the	det	27	SENT_181	[p7l2048t2863r2145b2918],
27	bioavailability	NN	O	bioavailability	dobj	25	SENT_181	[p7l8t2951r440b3020],
28	of	IN	O	of	_	0	SENT_181	[p7l456t2951r520b3006],
29	atorvastatin	NN	O	atorvastatin	prep_of	27	SENT_181	[p7l530t2952r895b3006],
30	and	CC	O	and	_	0	SENT_181	[p7l914t2951r1025b3006],
31	thereby	RB	O	thereby	advmod	32	SENT_181	[p7l1043t2951r1279b3019],
32	increases	VBZ	O	increase	conj_and	25	SENT_181	[p7l1297t2952r1575b3006],
33	the	DT	O	the	det	35	SENT_181	[p7l1595t2951r1692b3006],
34	oral	JJ	O	oral	amod	35	SENT_181	[p7l1711t2951r1826b3006],
35	volume	NN	O	volume	dobj	32	SENT_181	[p7l1842t2951r2070b3006],
36	of	IN	O	of	_	0	SENT_181	[p7l2090t2951r2153b3006],
37	distribution	NN	O	distribution	prep_of	35	SENT_181	[p7l9t3040r383b3095],
38	.	.	O	.	_	0	SENT_181	[p7l9t3040r383b3095],

1	We	PRP	O	we	nsubj	2	SENT_182	[p7l424t3043r525b3095],
2	assume	VBP	O	assume	dep	9	SENT_182	[p7l567t3056r794b3095],
3	SLCO1B1521T	NN	O	slco1b1521t	dobj	2	SENT_182	[p7l834t3043r1320b3095],
4	>	JJR	O	>	amod	6	SENT_182	[p7l834t3043r1320b3095],
5	C	NN	O	c	nn	6	SENT_182	[p7l834t3043r1320b3095],
6	polymorphism	NN	O	polymorphism	dep	3	SENT_182	[p7l1362t3040r1812b3109],
7	might	MD	O	might	aux	9	SENT_182	[p7l1854t3040r2035b3109],
8	be	VB	O	be	auxpass	9	SENT_182	[p7l2075t3040r2145b3095],
9	correlated	VBN	O	correlate	_	0	SENT_182	[p7l9t3129r317b3183],
10	with	IN	O	with	_	0	SENT_182	[p7l335t3129r476b3183],
11	the	DT	O	the	det	12	SENT_182	[p7l493t3129r590b3183],
12	distribution	NN	O	distribution	prep_with	9	SENT_182	[p7l609t3130r969b3183],
13	of	IN	O	of	_	0	SENT_182	[p7l987t3129r1051b3183],
14	atorvastatin	NN	O	atorvastatin	prep_of	12	SENT_182	[p7l1061t3130r1426b3183],
15	in	IN	O	in	_	0	SENT_182	[p7l1444t3130r1500b3183],
16	other	JJ	O	other	amod	17	SENT_182	[p7l1518t3129r1682b3183],
17	tissues	NNS	O	tissue	prep_in	9	SENT_182	[p7l1698t3130r1902b3183],
18	besides	IN	O	besides	_	0	SENT_182	[p7l1920t3129r2145b3184],
19	liver	NN	O	liver	prep_besides	17	SENT_182	[p7l9t3217r145b3272],
20	[	CD	NUMBER	[	num	19	SENT_182	[p7l169t3217r301b3286],
21	28	CD	NUMBER	28	num	22	SENT_182	[p7l169t3217r301b3286],
22	]	NN	O	]	nsubjpass	9	SENT_182	[p7l169t3217r301b3286],
23	.	.	O	.	_	0	SENT_182	[p7l169t3217r301b3286],

1	However	RB	O	however	advmod	10	SENT_183	[p7l326t3221r610b3281],
2	,	,	O	,	_	0	SENT_183	[p7l326t3221r610b3281],
3	to	TO	O	to	_	0	SENT_183	[p7l634t3225r693b3272],
4	date	NN	O	date	prep_to	10	SENT_183	[p7l715t3217r859b3280],
5	,	,	O	,	_	0	SENT_183	[p7l715t3217r859b3280],
6	no	DT	O	no	det	7	SENT_183	[p7l884t3233r958b3272],
7	evidence	NN	O	evidence	nsubjpass	10	SENT_183	[p7l981t3217r1252b3272],
8	has	VBZ	O	have	aux	10	SENT_183	[p7l1276t3217r1375b3272],
9	been	VBN	O	be	auxpass	10	SENT_183	[p7l1398t3217r1545b3272],
10	presented	VBN	O	present	_	0	SENT_183	[p7l1567t3217r1870b3286],
11	to	TO	O	to	aux	12	SENT_183	[p7l1893t3225r1951b3272],
12	prove	VB	O	prove	xcomp	10	SENT_183	[p7l1974t3233r2145b3286],
13	this	DT	O	this	det	14	SENT_183	[p8l9t17r119b72],
14	hypothesis	NN	O	hypothesis	dobj	12	SENT_183	[p8l145t17r488b85],
15	.	.	O	.	_	0	SENT_183	[p8l145t17r488b85],

1	Rifampicin	NNP	O	Rifampicin	nsubj	2	SENT_184	[p8l111t106r440b174],
2	led	VBD	O	lead	_	0	SENT_184	[p8l461t106r551b161],
3	to	TO	O	to	_	0	SENT_184	[p8l573t114r632b161],
4	a	DT	O	a	det	6	SENT_184	[p8l654t122r684b161],
5	large	JJ	O	large	amod	6	SENT_184	[p8l706t106r854b174],
6	increase	NN	O	increase	prep_to	2	SENT_184	[p8l877t107r1126b161],
7	in	IN	O	in	_	0	SENT_184	[p8l1149t107r1204b160],
8	AUC	NN	O	auc	prep_in	6	SENT_184	[p8l1224t108r1353b161],
9	of	IN	O	of	_	0	SENT_184	[p8l1374t106r1438b161],
10	atorvastatin	NN	O	atorvastatin	prep_of	8	SENT_184	[p8l1452t107r1816b161],
11	in	IN	O	in	_	0	SENT_184	[p8l1839t107r1894b160],
12	carriers	NNS	O	carrier	nn	14	SENT_184	[p8l1916t107r2145b161],
13	ofSLCO1B1	NN	O	ofslco1b1	nn	14	SENT_184	[p8l9t194r333b249],
14	c.	NN	O	c.	prep_in	2	SENT_184	[p8l359t197r507b250],
15	521	CD	NUMBER	521	num	17	SENT_184	[p8l359t197r507b250],
16	CC	NN	O	cc	nn	17	SENT_184	[p8l520t197r597b249],
17	individuals	NNS	O	individual	dep	14	SENT_184	[p8l615t194r950b249],
18	as	RB	O	as	_	0	SENT_184	[p8l969t210r1029b249],
19	well	RB	O	well	_	0	SENT_184	[p8l1046t194r1175b249],
20	as	IN	O	as	_	0	SENT_184	[p8l1194t210r1253b249],
21	in	IN	O	in	_	0	SENT_184	[p8l1273t195r1329b248],
22	non	JJ	O	non	amod	24	SENT_184	[p8l1348t195r1739b249],
23	—	NN	O	—	nn	24	SENT_184	[p8l1348t195r1739b249],
24	carriers	NNS	O	carrier	conj_and	14	SENT_184	[p8l1348t195r1739b249],
25	.	.	O	.	_	0	SENT_184	[p8l1348t195r1739b249],

1	In	IN	O	in	_	0	SENT_185	[p8l1759t197r1816b248],
2	a	DT	O	a	det	4	SENT_185	[p8l1834t210r1865b249],
3	previous	JJ	O	previous	amod	4	SENT_185	[p8l1883t195r2144b263],
4	study	NN	O	study	prep_in	17	SENT_185	[p8l10t283r188b352],
5	,	,	O	,	_	0	SENT_185	[p8l10t283r188b352],
6	the	DT	O	the	det	7	SENT_185	[p8l219t283r315b338],
7	inﬂuence	NN	O	inﬂuence	nsubjpass	17	SENT_185	[p8l347t283r627b338],
8	of	IN	O	of	_	0	SENT_185	[p8l658t283r721b338],
9	an	DT	O	a	det	12	SENT_185	[p8l744t299r815b338],
10	intravenous	JJ	O	intravenous	amod	12	SENT_185	[p8l846t284r1206b338],
11	single	JJ	O	single	amod	12	SENT_185	[p8l1238t283r1414b352],
12	dose	NN	O	dose	prep_of	7	SENT_185	[p8l1445t283r1583b338],
13	of	IN	O	of	_	0	SENT_185	[p8l1614t283r1677b338],
14	rifampicin	NN	O	rifampicin	prep_of	12	SENT_185	[p8l1701t283r2014b352],
15	has	VBZ	O	have	aux	17	SENT_185	[p8l2045t283r2144b338],
16	been	VBN	O	be	auxpass	17	SENT_185	[p8l8t373r155b427],
17	reported	VBN	O	report	_	0	SENT_185	[p8l175t373r437b441],
18	which	WDT	O	which	nsubj	19	SENT_185	[p8l456t372r645b427],
19	increased	VBD	O	increase	ccomp	17	SENT_185	[p8l665t373r954b427],
20	AUC	NN	O	auc	dobj	19	SENT_185	[p8l972t375r1101b427],
21	of	IN	O	of	_	0	SENT_185	[p8l1120t372r1184b427],
22	atorvastatin	NN	O	atorvastatin	prep_of	20	SENT_185	[p8l1196t373r1560b427],
23	to	TO	O	to	_	0	SENT_185	[p8l1579t381r1636b427],
24	more	JJR	O	more	mwe	25	SENT_185	[p8l1658t388r1815b427],
25	than	IN	O	than	quantmod	26	SENT_185	[p8l1835t373r1972b427],
26	865	CD	PERCENT	865	num	27	SENT_185	[p8l1992t375r2146b427],
27	%	NN	PERCENT	%	prep_to	19	SENT_185	[p8l1992t375r2146b427],
28	[	CD	NUMBER	[	number	29	SENT_185	[p8l12t461r137b530],
29	11	CD	NUMBER	11	num	30	SENT_185	[p8l12t461r137b530],
30	]	NN	O	]	dep	27	SENT_185	[p8l12t461r137b530],
31	.	.	O	.	_	0	SENT_185	[p8l12t461r137b530],

1	In	IN	O	in	_	0	SENT_186	[p8l171t465r228b516],
2	our	PRP$	O	we	poss	3	SENT_186	[p8l260t477r363b516],
3	study	NN	O	study	prep_in	23	SENT_186	[p8l393t462r571b530],
4	,	,	O	,	_	0	SENT_186	[p8l393t462r571b530],
5	such	PDT	O	such	predet	9	SENT_186	[p8l605t462r743b516],
6	a	DT	O	a	det	9	SENT_186	[p8l774t477r805b516],
7	similar	JJ	O	similar	amod	9	SENT_186	[p8l837t462r1047b516],
8	large	JJ	O	large	amod	9	SENT_186	[p8l1076t462r1224b530],
9	increase	NN	O	increase	nsubj	23	SENT_186	[p8l1257t462r1506b516],
10	in	IN	O	in	_	0	SENT_186	[p8l1539t462r1594b516],
11	AUC	NN	O	auc	nn	12	SENT_186	[p8l1624t464r1754b516],
12	(	NN	O	(	prep_in	9	SENT_186	[p8l1788t461r1993b530],
13	833	CD	PERCENT	833	number	14	SENT_186	[p8l1788t461r1993b530],
14	%	NN	PERCENT	%	amod	12	SENT_186	[p8l1788t461r1993b530],
15	)	CD	NUMBER	)	nsubjpass	17	SENT_186	[p8l1788t461r1993b530],
16	was	VBD	O	be	auxpass	17	SENT_186	[p8l2027t477r2144b516],
17	observed	VBN	O	observe	rcmod	12	SENT_186	[p8l9t551r287b606],
18	in	IN	O	in	_	0	SENT_186	[p8l336t552r392b605],
19	the	DT	O	the	det	20	SENT_186	[p8l440t551r536b606],
20	group	NN	O	group	prep_in	17	SENT_186	[p8l584t567r763b619],
21	of	IN	O	of	_	0	SENT_186	[p8l812t551r875b606],
22	SLCOIBI	NNP	ORGANIZATION	SLCOIBI	prep_of	20	SENT_186	[p8l914t554r1168b606],
23	c.	VBD	O	c.	_	0	SENT_186	[p8l1223t554r1458b606],
24	521TT	NN	O	521tt	dobj	23	SENT_186	[p8l1223t554r1458b606],
25	whereas	IN	O	whereas	mark	32	SENT_186	[p8l1502t551r1761b606],
26	carriers	NNS	O	carrier	nsubj	32	SENT_186	[p8l1810t552r2040b606],
27	of	IN	O	of	_	0	SENT_186	[p8l2089t551r2153b606],
28	SLCOIBI	NNP	ORGANIZATION	SLCOIBI	nn	29	SENT_186	[p8l6t642r258b694],
29	c.	NN	O	c.	prep_of	26	SENT_186	[p8l311t642r460b694],
30	521	CD	NUMBER	521	num	31	SENT_186	[p8l311t642r460b694],
31	CC	NN	O	cc	dep	26	SENT_186	[p8l472t642r549b694],
32	showed	VBD	O	show	advcl	23	SENT_186	[p8l594t640r829b694],
33	less	JJR	O	less	amod	34	SENT_186	[p8l875t640r984b694],
34	increase	NN	O	increase	dobj	32	SENT_186	[p8l1031t641r1295b694],
35	.	.	O	.	_	0	SENT_186	[p8l1031t641r1295b694],

1	Since	IN	O	since	mark	5	SENT_187	[p8l1341t641r1499b694],
2	Lau	NNP	PERSON	Lau	nsubj	5	SENT_187	[p8l1545t643r1649b694],
3	et	FW	O	et	nn	4	SENT_187	[p8l1694t648r1751b694],
4	al.	FW	O	al.	dep	2	SENT_187	[p8l1795t640r1859b694],
5	did	VBD	O	do	advcl	15	SENT_187	[p8l1905t640r2001b694],
6	not	RB	O	not	neg	7	SENT_187	[p8l2047t648r2147b694],
7	genotype	NN	O	genotype	nsubj	10	SENT_187	[p8l8t735r291b796],
8	the	DT	O	the	det	10	SENT_187	[p8l313t727r409b782],
9	study	NN	O	study	nn	10	SENT_187	[p8l432t727r601b796],
10	participants	NNS	O	participant	xcomp	5	SENT_187	[p8l621t728r984b796],
11	it	PRP	O	it	nsubjpass	15	SENT_187	[p8l1007t728r1048b782],
12	can	MD	O	can	aux	15	SENT_187	[p8l1069t735r1276b782],
13	not	RB	O	not	neg	15	SENT_187	[p8l1069t735r1276b782],
14	be	VB	O	be	auxpass	15	SENT_187	[p8l1296t727r1366b782],
15	stated	VBN	O	state	_	0	SENT_187	[p8l1389t727r1572b782],
16	if	IN	O	if	mark	23	SENT_187	[p8l1594t727r1639b781],
17	all	DT	O	all	det	18	SENT_187	[p8l1653t727r1723b782],
18	volunteers	NNS	O	volunteer	nsubj	23	SENT_187	[p8l1743t727r2066b782],
19	in	IN	O	in	_	0	SENT_187	[p8l2089t728r2145b781],
20	their	PRP$	O	they	poss	21	SENT_187	[p8l8t817r155b872],
21	study	NN	O	study	prep_in	18	SENT_187	[p8l202t817r370b885],
22	were	VBD	O	be	cop	23	SENT_187	[p8l415t833r567b872],
23	carriers	NNS	O	carrier	advcl	15	SENT_187	[p8l615t818r844b872],
24	of	IN	O	of	_	0	SENT_187	[p8l893t817r957b872],
25	high-transport	JJ	O	high-transport	amod	27	SENT_187	[p8l997t817r1449b885],
26	activity	NN	O	activity	nn	27	SENT_187	[p8l1496t818r1722b885],
27	variants	NNS	O	variant	prep_of	23	SENT_187	[p8l1766t818r2026b872],
28	.	.	O	.	_	0	SENT_187	[p8l1766t818r2026b872],

1	As	IN	O	as	_	0	SENT_188	[p8l2073t819r2144b872],
2	another	DT	O	another	det	3	SENT_188	[p8l9t906r248b960],
3	difference	NN	O	difference	prep_as	17	SENT_188	[p8l272t905r591b969],
4	,	,	O	,	_	0	SENT_188	[p8l272t905r591b969],
5	in	IN	O	in	_	0	SENT_188	[p8l618t906r674b960],
6	the	DT	O	the	det	7	SENT_188	[p8l699t906r796b960],
7	study	NN	O	study	prep_in	17	SENT_188	[p8l823t905r992b974],
8	by	IN	O	by	_	0	SENT_188	[p8l1015t905r1088b974],
9	Lau	NNP	PERSON	Lau	prep_by	7	SENT_188	[p8l1113t909r1216b960],
10	et	FW	O	et	nn	11	SENT_188	[p8l1242t914r1299b960],
11	al.	FW	O	al.	dep	9	SENT_188	[p8l1323t905r1403b969],
12	,	,	O	,	_	0	SENT_188	[p8l1323t905r1403b969],
13	600	CD	NUMBER	600	num	15	SENT_188	[p8l1431t908r1544b960],
14	mg	NN	O	mg	nn	15	SENT_188	[p8l1571t921r1666b974],
15	rifampicin	NN	O	rifampicin	nsubjpass	17	SENT_188	[p8l1691t905r2006b974],
16	was	VBD	O	be	auxpass	17	SENT_188	[p8l2027t921r2144b960],
17	given	VBN	O	give	_	0	SENT_188	[p8l8t996r173b1063],
18	intravenously	RB	O	intravenously	advmod	17	SENT_188	[p8l195t995r623b1063],
19	,	,	O	,	_	0	SENT_188	[p8l195t995r623b1063],
20	thus	RB	O	thus	advmod	17	SENT_188	[p8l645t995r777b1050],
21	resulting	VBG	O	result	xcomp	17	SENT_188	[p8l799t995r1070b1063],
22	in	IN	O	in	_	0	SENT_188	[p8l1091t996r1147b1049],
23	a	DT	O	a	det	25	SENT_188	[p8l1168t1011r1199b1050],
24	higher	JJR	O	higher	amod	25	SENT_188	[p8l1221t995r1419b1063],
25	bioavailability	NN	O	bioavailability	prep_in	21	SENT_188	[p8l1438t995r1870b1063],
26	than	IN	O	than	_	0	SENT_188	[p8l1889t995r2027b1050],
27	the	DT	O	the	det	29	SENT_188	[p8l2048t995r2145b1050],
28	oral	JJ	O	oral	amod	29	SENT_188	[p8l9t1084r123b1139],
29	formulation	NN	O	formulation	prep_than	25	SENT_188	[p8l147t1084r510b1139],
30	of	IN	O	of	_	0	SENT_188	[p8l532t1084r596b1139],
31	600	CD	NUMBER	600	num	32	SENT_188	[p8l610t1087r724b1139],
32	mg	NN	O	mg	prep_of	29	SENT_188	[p8l747t1100r842b1152],
33	given	VBN	O	give	prep	21	SENT_188	[p8l862t1085r1027b1152],
34	in	IN	O	in	pcomp	33	SENT_188	[p8l1049t1085r1105b1138],
35	our	PRP$	O	we	poss	36	SENT_188	[p8l1128t1100r1231b1139],
36	study	NN	O	study	pobj	34	SENT_188	[p8l1252t1084r1430b1152],
37	.	.	O	.	_	0	SENT_188	[p8l1252t1084r1430b1152],

1	Thus	RB	O	thus	dep	5	SENT_189	[p8l1451t1084r1613b1147],
2	,	,	O	,	_	0	SENT_189	[p8l1451t1084r1613b1147],
3	the	DT	O	the	det	5	SENT_189	[p8l1635t1084r1732b1139],
4	bio	NN	O	bio	nn	5	SENT_189	[p8l1754t1084r2145b1139],
5	—	NN	O	—	_	0	SENT_189	[p8l1754t1084r2145b1139],
6	available	JJ	O	available	amod	5	SENT_189	[p8l1754t1084r2145b1139],

1	.1	NN	NUMBER	.1	_	0	SENT_190	[p8l117t1282r138b1328],
2	«	CD	NUMBER	«	num	3	SENT_190	[p8l144t1282r178b1328],
3	I3	NN	O	i3	dep	1	SENT_190	[p8l144t1282r178b1328],

1	—	NN	O	—	_	0	SENT_191	[p8l1345t1291r1438b1328],
2	=	JJ	O	=	amod	1	SENT_191	[p8l1345t1291r1438b1328],
3	e	SYM	O	e	dep	6	SENT_191	[p8l1345t1291r1438b1328],
4	—	CD	NUMBER	—	num	6	SENT_191	[p8l1345t1291r1438b1328],
5	SLCOIB1	NN	O	slcoib1	nn	6	SENT_191	[p8l1487t1282r1766b1334],
6	c.	NN	O	c.	dep	13	SENT_191	[p8l1800t1282r2055b1334],
7	52	CD	NUMBER	52	number	8	SENT_191	[p8l1800t1282r2055b1334],
8	‘	CD	NUMBER	‘	num	10	SENT_191	[p8l1800t1282r2055b1334],
9	lCC	NN	O	lcc	nn	10	SENT_191	[p8l1800t1282r2055b1334],
10	c	NN	O	c	dep	6	SENT_191	[p8l1345t1389r1438b1417],
11	+	CC	O	+	_	0	SENT_191	[p8l1345t1389r1438b1417],
12	SLCOIB1	NN	O	slcoib1	conj_+	10	SENT_191	[p8l1487t1374r1766b1426],
13	C.	FW	O	c.	dep	1	SENT_191	[p8l1800t1374r2045b1426],
14	52	CD	NUMBER	52	number	15	SENT_191	[p8l1800t1374r2045b1426],
15	‘	CD	NUMBER	‘	num	16	SENT_191	[p8l1800t1374r2045b1426],
16	lTC	NN	O	ltc	dep	13	SENT_191	[p8l1800t1374r2045b1426],
17	+	CC	O	+	_	0	SENT_191	[p8l1345t1484r1438b1509],
18	SLCO1B1	NN	O	slco1b1	nn	19	SENT_191	[p8l1487t1466r1766b1519],
19	C	NN	O	c	dep	13	SENT_191	[p8l1800t1466r2042b1519],
20	:	:	O	:	_	0	SENT_191	[p8l1800t1466r2042b1519],
21	.521	CD	NUMBER	.521	dep	1	SENT_191	[p8l1800t1466r2042b1519],
22	TT	NN	O	tt	dep	21	SENT_191	[p8l1800t1466r2042b1519],

1	Rifampin	NNP	MISC	Rifampin	nn	3	SENT_192	[p8l24t2253r86b2505],
2	plasma	NN	O	plasma	nn	3	SENT_192	[p8l24t2026r86b2226],
3	concentration	NN	O	concentration	_	0	SENT_192	[p8l24t1604r74b2001],
4	(	CD	NUMBER	(	num	5	SENT_192	[p8l24t1356r89b1580],
5	u.	NN	O	u.	dep	3	SENT_192	[p8l24t1356r89b1580],
6	gl	NN	O	gl	dep	5	SENT_192	[p8l24t1356r89b1580],
7	'	''	O	'	_	0	SENT_192	[p8l24t1356r89b1580],
8	.	.	O	.	_	0	SENT_192	[p8l24t1356r89b1580],

1	mL	NN	O	ml	_	0	SENT_193	[p8l24t1356r89b1580],
2	)	SYM	O	)	dep	1	SENT_193	[p8l24t1356r89b1580],

1	ﬁs	NNS	O	ﬁs	_	0	SENT_194	[p8l117t1460r190b1506, p8l1029t2683r1171b2732],
2	'	POS	O	'	_	0	SENT_194	[p8l117t1460r190b1506, p8l1029t2683r1171b2732],
3	I	PRP	O	I	advmod	4	SENT_194	[p8l117t1460r190b1506, p8l1029t2683r1171b2732],
4	|	VBP	O	|	rcmod	1	SENT_194	[p8l117t1460r190b1506, p8l1029t2683r1171b2732],
5	'	''	O	'	_	0	SENT_194	[p8l117t1460r190b1506, p8l1029t2683r1171b2732],
6	lme	NN	O	lme	dep	1	SENT_194	[p8l117t1460r190b1506, p8l1029t2683r1171b2732],

1	(	NN	O	(	nn	2	SENT_195	[p8l1195t2683r1272b2747],
2	h	NN	O	h	_	0	SENT_195	[p8l1195t2683r1272b2747],
3	)	CD	NUMBER	)	dep	2	SENT_195	[p8l1195t2683r1272b2747],

1	Fig	NN	O	fig	_	0	SENT_196	[p8l8t2837r96b2891],
2	.	.	O	.	_	0	SENT_196	[p8l8t2837r96b2891],

1	1	LS	NUMBER	1	_	0	SENT_197	[p8l116t2839r154b2881],
2	.	.	O	.	_	0	SENT_197	[p8l116t2839r154b2881],

1	Mean	NN	O	mean	nn	3	SENT_198	[p8l177t2840r312b2880],
2	plasma	NN	O	plasma	nn	3	SENT_198	[p8l335t2837r509b2891],
3	concentration	NN	O	concentration	_	0	SENT_198	[p8l532t2838r872b2880],
4	of	IN	O	of	_	0	SENT_198	[p8l895t2837r946b2880],
5	rifampicin	NN	O	rifampicin	prep_of	3	SENT_198	[p8l964t2837r1215b2891],
6	in	IN	O	in	_	0	SENT_198	[p8l1239t2838r1284b2880],
7	16	CD	NUMBER	16	num	9	SENT_198	[p8l1309t2839r1362b2880],
8	healthy	JJ	O	healthy	amod	9	SENT_198	[p8l1386t2837r1569b2891],
9	volunteers	NNS	O	volunteer	prep_in	3	SENT_198	[p8l1588t2837r1849b2880],
10	after	IN	O	after	_	0	SENT_198	[p8l1872t2837r1986b2880],
11	single	JJ	O	single	amod	13	SENT_198	[p8l2008t2837r2149b2891],
12	oral	JJ	O	oral	amod	13	SENT_198	[p8l9t2908r101b2952],
13	dose	NN	O	dose	prep_after	9	SENT_198	[p8l125t2908r236b2952],
14	of	IN	O	of	_	0	SENT_198	[p8l261t2908r311b2952],
15	450	CD	NUMBER	450	num	17	SENT_198	[p8l328t2911r419b2952],
16	mg	NN	O	mg	nn	17	SENT_198	[p8l444t2921r520b2963],
17	rifampicin	NN	O	rifampicin	prep_of	3	SENT_198	[p8l544t2908r807b2963],
18	.	.	O	.	_	0	SENT_198	[p8l544t2908r807b2963],

1	Solid	JJ	O	solid	amod	2	SENT_199	[p8l833t2908r951b2952],
2	circles	NNS	O	circle	nsubj	3	SENT_199	[p8l976t2908r1128b2952],
3	(	VBP	O	(	dep	37	SENT_199	[p8l1156t2908r1238b2962],
4	o	NN	O	o	nsubj	6	SENT_199	[p8l1156t2908r1238b2962],
5	)	CD	NUMBER	)	num	4	SENT_199	[p8l1156t2908r1238b2962],
6	represent	VBP	O	represent	ccomp	3	SENT_199	[p8l1266t2915r1500b2963],
7	SLCOIBI	NNP	PERSON	SLCOIBI	nsubj	8	SENT_199	[p8l1521t2911r1723b2952],
8	c.	VBD	O	c.	ccomp	6	SENT_199	[p8l1754t2911r1940b2952],
9	521TT	CD	NUMBER	521tt	number	10	SENT_199	[p8l1754t2911r1940b2952],
10	(	CD	NUMBER	(	num	11	SENT_199	[p8l1966t2908r2149b2962],
11	n	NN	O	n	nsubj	18	SENT_199	[p8l1966t2908r2149b2962],
12	=	JJ	O	=	amod	11	SENT_199	[p8l1966t2908r2149b2962],
13	6	CD	NUMBER	6	num	14	SENT_199	[p8l1966t2908r2149b2962],
14	)	NN	O	)	tmod	12	SENT_199	[p8l1966t2908r2149b2962],
15	,	,	O	,	_	0	SENT_199	[p8l1966t2908r2149b2962],
16	solid	JJ	O	solid	amod	17	SENT_199	[p8l9t2980r123b3023],
17	squares	NNS	O	square	appos	14	SENT_199	[p8l147t2992r331b3034],
18	(	VBP	O	(	ccomp	8	SENT_199	[p8l357t2980r439b3034],
19	I	PRP	O	I	nsubj	21	SENT_199	[p8l357t2980r439b3034],
20	)	RB	O	)	advmod	21	SENT_199	[p8l357t2980r439b3034],
21	represent	VBP	O	represent	ccomp	18	SENT_199	[p8l466t2986r700b3034],
22	SLCOIBI	NNP	O	SLCOIBI	nsubj	23	SENT_199	[p8l720t2982r922b3023],
23	c.	VBD	O	c.	ccomp	21	SENT_199	[p8l951t2982r1140b3024],
24	521TC	NN	O	521tc	nn	26	SENT_199	[p8l951t2982r1140b3024],
25	(	NN	O	(	nn	26	SENT_199	[p8l1165t2980r1270b3034],
26	n	NN	O	n	nsubj	34	SENT_199	[p8l1165t2980r1270b3034],
27	=	JJ	O	=	amod	26	SENT_199	[p8l1165t2980r1270b3034],
28	6	CD	NUMBER	6	num	29	SENT_199	[p8l1285t2980r1348b3034],
29	)	NN	O	)	tmod	27	SENT_199	[p8l1285t2980r1348b3034],
30	,	,	O	,	_	0	SENT_199	[p8l1285t2980r1348b3034],
31	and	CC	O	and	_	0	SENT_199	[p8l1372t2980r1461b3023],
32	open	JJ	O	open	amod	33	SENT_199	[p8l1485t2992r1605b3034],
33	circles	NNS	O	circle	tmod	27	SENT_199	[p8l1628t2980r1781b3023],
34	(	VBP	O	(	ccomp	23	SENT_199	[p8l1808t2980r1890b3034],
35	o	NN	O	o	dobj	34	SENT_199	[p8l1808t2980r1890b3034],
36	)	CD	NUMBER	)	num	35	SENT_199	[p8l1808t2980r1890b3034],
37	represent	VBP	O	represent	_	0	SENT_199	[p8l1917t2986r2151b3034],
38	SLCOIBI	NNP	PERSON	SLCOIBI	nn	39	SENT_199	[p8l7t3053r209b3095],
39	c.	NN	O	c.	nsubj	42	SENT_199	[p8l234t3053r354b3095],
40	521	CD	NUMBER	521	num	42	SENT_199	[p8l234t3053r354b3095],
41	CC	NN	O	cc	nn	42	SENT_199	[p8l364t3053r426b3095],
42	(	NN	O	(	xcomp	37	SENT_199	[p8l448t3051r496b3105],
43	11	CD	NUMBER	11	num	46	SENT_199	[p8l448t3051r496b3105],
44	=	JJ	O	=	amod	46	SENT_199	[p8l510t3069r553b3086],
45	4	CD	NUMBER	4	tmod	44	SENT_199	[p8l566t3051r630b3105],
46	)	NN	O	)	nsubj	37	SENT_199	[p8l566t3051r630b3105],
47	.	.	O	.	_	0	SENT_199	[p8l566t3051r630b3105],

1	Data	NNS	O	datum	nsubjpass	3	SENT_200	[p8l652t3054r762b3095],
2	are	VBP	O	be	auxpass	3	SENT_200	[p8l782t3064r856b3095],
3	expressed	VBN	O	express	_	0	SENT_200	[p8l876t3051r1119b3105],
4	as	IN	O	as	_	0	SENT_200	[p8l1139t3064r1187b3095],
5	mean	NN	O	mean	prep_as	3	SENT_200	[p8l1208t3064r1343b3095],
6	:	:	O	:	_	0	SENT_200	[p8l1356t3057r1396b3097],
7	I	PRP	O	I	dep	5	SENT_200	[p8l1356t3057r1396b3097],
8	:	:	O	:	_	0	SENT_200	[p8l1356t3057r1396b3097],
9	SD	NN	O	sd	dep	5	SENT_200	[p8l1410t3053r1485b3095],
10	.	.	O	.	_	0	SENT_200	[p8l1410t3053r1485b3095],

1	52	CD	NUMBER	52	num	2	SENT_201	[p8l377t3181r404b3202],
2	}	CD	NUMBER	}	_	0	SENT_201	[p8l1133t3181r1173b3207],
3	’	NN	O	’	dep	2	SENT_201	[p8l1133t3181r1173b3207],
4	.	.	O	.	_	0	SENT_201	[p8l1133t3181r1173b3207],

1	.	.	O	.	_	0	SENT_202	[p8l1133t3181r1173b3207],

1	—	NN	O	—	_	0	SENT_203	[p8l1133t3181r1173b3207],
2	.	.	O	.	_	0	SENT_203	[p8l1133t3181r1173b3207],

1	j.	NN	O	j.	_	0	SENT_204	[p8l1133t3181r1173b3207],
2	He	PRP	O	he	dep	1	SENT_204	[p8l1184t3181r1215b3202],
3	et	FW	O	et	nn	4	SENT_204	[p8l1225t3183r1247b3202],
4	al.	FW	O	al.	dep	2	SENT_204	[p8l1256t3180r1280b3202],
5	/	:	O	/	punct	8	SENT_204	[p8l1293t3181r1302b3206],
6	Clinica	NNP	PERSON	Clinica	nn	8	SENT_204	[p8l1315t3180r1392b3202],
7	Chimica	NNP	PERSON	Chimica	nn	8	SENT_204	[p8l1402t3180r1494b3202],
8	Acta	NNP	PERSON	Acta	dep	4	SENT_204	[p8l1503t3181r1554b3202],
9	405	CD	NUMBER	405	number	10	SENT_204	[p8l1564t3181r1607b3202],
10	(	CD	NUMBER	(	dep	8	SENT_204	[p8l1619t3180r1698b3207],
11	2009	CD	DATE	2009	dep	10	SENT_204	[p8l1619t3180r1698b3207],
12	)	CD	NUMBER	)	num	13	SENT_204	[p8l1619t3180r1698b3207],
13	49-52	CD	NUMBER	49-52	dep	1	SENT_204	[p8l1709t3181r1782b3202],

1	dose	NN	O	dose	nsubj	8	SENT_205	[p8l10t3319r148b3374],
2	of	IN	O	of	_	0	SENT_205	[p8l167t3319r230b3374],
3	rifampicin	NN	O	rifampicin	prep_of	1	SENT_205	[p8l241t3319r556b3388],
4	in	IN	O	in	_	0	SENT_205	[p8l574t3320r630b3373],
5	our	PRP$	O	we	poss	6	SENT_205	[p8l648t3335r751b3374],
6	study	NN	O	study	prep_in	3	SENT_205	[p8l768t3319r937b3388],
7	might	MD	O	might	aux	8	SENT_205	[p8l954t3319r1135b3388],
8	be	VB	O	be	_	0	SENT_205	[p8l1151t3319r1221b3374],
9	less	RBR	O	less	advmod	8	SENT_205	[p8l1240t3319r1349b3374],
10	which	WDT	O	which	nsubj	13	SENT_205	[p8l1366t3319r1555b3374],
11	might	MD	O	might	aux	13	SENT_205	[p8l1574t3319r1755b3388],
12	have	VB	O	have	aux	13	SENT_205	[p8l1772t3319r1912b3374],
13	led	VBN	O	lead	dep	9	SENT_205	[p8l1931t3319r2021b3374],
14	to	TO	O	to	_	0	SENT_205	[p8l2039t3327r2098b3374],
15	a	DT	O	a	det	19	SENT_205	[p8l2116t3335r2147b3374],
16	slightly	RB	O	slightly	advmod	17	SENT_205	[p8l11t3408r234b3477],
17	lower	JJR	O	lower	amod	19	SENT_205	[p8l265t3408r439b3463],
18	inhibition	NN	O	inhibition	nn	19	SENT_205	[p8l470t3408r769b3463],
19	effect	NN	O	effect	prep_to	13	SENT_205	[p8l802t3408r982b3464],
20	.	.	O	.	_	0	SENT_205	[p8l802t3408r982b3464],

1	In	IN	O	in	_	0	SENT_206	[p8l1016t3411r1073b3462],
2	a	DT	O	a	det	5	SENT_206	[p8l1105t3424r1136b3463],
3	recent	JJ	O	recent	amod	5	SENT_206	[p8l1168t3416r1360b3463],
4	cohort	NN	O	cohort	nn	5	SENT_206	[p8l1391t3408r1590b3463],
5	study	NN	O	study	prep_in	27	SENT_206	[p8l1621t3408r1799b3477],
6	,	,	O	,	_	0	SENT_206	[p8l1621t3408r1799b3477],
7	Link	NNP	O	Link	nsubj	27	SENT_206	[p8l1833t3408r1961b3462],
8	et	FW	O	et	nn	9	SENT_206	[p8l1992t3416r2050b3463],
9	al.	FW	O	al.	dep	7	SENT_206	[p8l2080t3408r2145b3464],
10	found	VBN	O	find	partmod	7	SENT_206	[p8l10t3497r186b3552],
11	out	IN	O	out	_	0	SENT_206	[p8l216t3506r316b3552],
12	that	IN	O	that	complm	19	SENT_206	[p8l343t3497r466b3552],
13	common	JJ	O	common	amod	14	SENT_206	[p8l494t3513r763b3552],
14	variants	NNS	O	variant	nsubjpass	19	SENT_206	[p8l790t3498r1034b3552],
15	in	IN	O	in	_	0	SENT_206	[p8l1064t3498r1120b3552],
16	SLCOIBI	NNP	O	SLCOIBI	prep_in	14	SENT_206	[p8l1146t3500r1398b3552],
17	are	VBP	O	be	auxpass	19	SENT_206	[p8l1435t3513r1528b3552],
18	strongly	RB	O	strongly	advmod	19	SENT_206	[p8l1557t3497r1806b3566],
19	associated	VBN	O	associate	prepc_out	10	SENT_206	[p8l1833t3497r2145b3552],
20	with	IN	O	with	_	0	SENT_206	[p8l8t3587r149b3641],
21	an	DT	O	a	det	23	SENT_206	[p8l173t3602r245b3641],
22	increased	VBN	O	increase	amod	23	SENT_206	[p8l269t3586r558b3641],
23	risk	NN	O	risk	prep_with	19	SENT_206	[p8l584t3586r695b3641],
24	of	IN	O	of	_	0	SENT_206	[p8l717t3586r781b3641],
25	statin	NN	O	statin	nn	26	SENT_206	[p8l798t3586r1243b3641],
26	—	NN	O	—	prep_of	23	SENT_206	[p8l798t3586r1243b3641],
27	induced	VBD	O	induce	_	0	SENT_206	[p8l798t3586r1243b3641],
28	myopathy	JJ	O	myopathy	amod	29	SENT_206	[p8l1269t3587r1575b3655],
29	[	NN	O	[	dobj	27	SENT_206	[p8l1601t3586r1733b3655],
30	29	CD	NUMBER	29	num	31	SENT_206	[p8l1601t3586r1733b3655],
31	]	NN	O	]	dep	29	SENT_206	[p8l1601t3586r1733b3655],
32	.	.	O	.	_	0	SENT_206	[p8l1601t3586r1733b3655],

1	In	IN	O	in	_	0	SENT_207	[p8l1759t3590r1816b3641],
2	our	PRP$	O	we	poss	3	SENT_207	[p8l1840t3602r1944b3641],
3	study	NN	O	study	pobj	1	SENT_207	[p8l1967t3586r2145b3655],
4	,	,	O	,	_	0	SENT_207	[p8l1967t3586r2145b3655],

1	rifampicin	NN	O	rifampicin	poss	3	SENT_208	[p9l10t17r368b85],
2	's	POS	O	's	_	0	SENT_208	[p9l10t17r368b85],
3	interaction	NN	O	interaction	nsubj	6	SENT_208	[p9l408t18r740b72],
4	with	IN	O	with	_	0	SENT_208	[p9l774t17r915b72],
5	atorvastatin	NN	O	atorvastatin	prep_with	3	SENT_208	[p9l953t18r1318b72],
6	mimics	VBZ	O	mimic	ccomp	16	SENT_208	[p9l1357t18r1576b72],
7	the	DT	O	the	det	8	SENT_208	[p9l1615t17r1711b72],
8	effect	NN	O	effect	dobj	6	SENT_208	[p9l1751t17r1919b72],
9	of	IN	O	of	_	0	SENT_208	[p9l1955t17r2018b72],
10	the	DT	O	the	det	12	SENT_208	[p9l2049t17r2146b72],
11	SLCOIBI	NNP	O	SLCOIBI	nn	12	SENT_208	[p9l7t108r260b161],
12	genotype	NN	O	genotype	prep_of	8	SENT_208	[p9l300t114r598b174],
13	,	,	O	,	_	0	SENT_208	[p9l300t114r598b174],
14	It	PRP	O	it	nsubj	16	SENT_208	[p9l634t109r676b161],
15	is	VBZ	O	be	cop	16	SENT_208	[p9l709t106r752b161],
16	possible	JJ	O	possible	_	0	SENT_208	[p9l788t106r1035b174],
17	that	IN	O	that	complm	26	SENT_208	[p9l1069t106r1192b161],
18	co	NN	O	co	nn	20	SENT_208	[p9l1225t106r1774b161],
19	—	CD	NUMBER	—	num	20	SENT_208	[p9l1225t106r1774b161],
20	administration	NN	O	administration	nsubjpass	26	SENT_208	[p9l1225t106r1774b161],
21	of	IN	O	of	_	0	SENT_208	[p9l1809t105r1872b161],
22	the	DT	O	the	det	24	SENT_208	[p9l1899t106r1996b161],
23	two	CD	NUMBER	two	num	24	SENT_208	[p9l2030t114r2145b161],
24	drugs	NNS	O	drug	prep_of	20	SENT_208	[p9l10t194r179b263],
25	is	VBZ	O	be	auxpass	26	SENT_208	[p9l201t195r244b249],
26	associated	VBN	O	associate	ccomp	16	SENT_208	[p9l265t194r578b249],
27	with	IN	O	with	_	0	SENT_208	[p9l597t194r738b249],
28	an	DT	O	a	det	30	SENT_208	[p9l758t210r829b249],
29	increased	VBN	O	increase	amod	30	SENT_208	[p9l850t194r1139b249],
30	risk	NN	O	risk	prep_with	26	SENT_208	[p9l1160t194r1271b249],
31	of	IN	O	of	_	0	SENT_208	[p9l1290t194r1354b249],
32	myopathy	NN	O	myopathy	prep_of	30	SENT_208	[p9l1367t194r1672b263],
33	which	WDT	O	which	nsubj	34	SENT_208	[p9l1689t194r1878b249],
34	requires	VBZ	O	require	rcmod	30	SENT_208	[p9l1899t195r2146b263],
35	further	JJ	O	further	amod	36	SENT_208	[p9l10t283r226b339],
36	investigations	NNS	O	investigation	dobj	34	SENT_208	[p9l248t284r688b352],
37	.	.	O	.	_	0	SENT_208	[p9l248t284r688b352],

1	In	IN	O	in	_	0	SENT_209	[p9l112t376r169b427],
2	summary	NN	O	summary	prep_in	9	SENT_209	[p9l193t388r492b441],
3	,	,	O	,	_	0	SENT_209	[p9l193t388r492b441],
4	SLCOIBI	NNP	O	SLCOIBI	nn	5	SENT_209	[p9l513t375r766b427],
5	52lT	NN	O	52lt	nsubj	9	SENT_209	[p9l793t375r1018b427],
6	>	JJR	O	>	dep	7	SENT_209	[p9l793t375r1018b427],
7	C	NN	O	c	amod	5	SENT_209	[p9l793t375r1018b427],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_209	[p9l1041t372r1413b441],
9	inﬂuenced	VBD	O	inﬂuenced	_	0	SENT_209	[p9l1435t372r1756b427],
10	the	DT	O	the	det	14	SENT_209	[p9l1779t372r1876b427],
11	atorvastatin	NN	O	atorvastatin	nn	14	SENT_209	[p9l1899t381r2146b427, p9l9t462r508b530],
12	—	NN	O	—	nn	14	SENT_209	[p9l1899t381r2146b427, p9l9t462r508b530],
13	rifampicin	NN	O	rifampicin	nn	14	SENT_209	[p9l1899t381r2146b427, p9l9t462r508b530],
14	interaction	NN	O	interaction	dobj	9	SENT_209	[p9l531t463r863b517],
15	but	CC	O	but	_	0	SENT_209	[p9l886t462r988b517],
16	not	RB	O	not	_	0	SENT_209	[p9l1009t470r1109b517],
17	the	DT	O	the	det	18	SENT_209	[p9l1130t462r1227b517],
18	pharmacokinetics	NNS	O	pharmacokinetic	dobj	9	SENT_209	[p9l1250t462r1794b530],
19	of	IN	O	of	_	0	SENT_209	[p9l1818t462r1882b517],
20	rifampi	NN	O	rifampus	nn	22	SENT_209	[p9l1898t462r2146b530],
21	—	CD	NUMBER	—	num	22	SENT_209	[p9l1898t462r2146b530],
22	cin	NN	O	cin	prep_of	18	SENT_209	[p9l10t552r98b606],
23	in	FW	O	in	nn	24	SENT_209	[p9l123t552r176b606],
24	vivo	FW	O	vivo	advmod	27	SENT_209	[p9l199t552r318b606],
25	while	IN	O	while	dep	27	SENT_209	[p9l342t551r513b606],
26	SLCOIBI	NNP	PERSON	SLCOIBI	nsubj	27	SENT_209	[p9l536t554r788b606],
27	c.	VBP	O	c.	dep	9	SENT_209	[p9l820t554r1054b606],
28	52lTT	JJ	O	52ltt	amod	29	SENT_209	[p9l820t554r1054b606],
29	individuals	NNS	O	individual	nsubjpass	32	SENT_209	[p9l1077t551r1412b606],
30	may	MD	O	may	aux	32	SENT_209	[p9l1438t567r1569b619],
31	be	VB	O	be	auxpass	32	SENT_209	[p9l1591t551r1661b606],
32	inﬂuenced	VBN	O	inﬂuenced	ccomp	27	SENT_209	[p9l1687t551r2008b606],
33	to	TO	O	to	_	0	SENT_209	[p9l2033t559r2091b606],
34	a	DT	O	a	det	36	SENT_209	[p9l2116t567r2147b606],
35	greater	JJR	O	greater	amod	36	SENT_209	[p9l9t647r228b708],
36	degree	NN	O	degree	prep_to	32	SENT_209	[p9l250t639r455b708],
37	than	IN	O	than	mark	39	SENT_209	[p9l479t639r617b694],
38	SLCOIBI	NNP	O	SLCOIBI	nsubj	39	SENT_209	[p9l638t642r891b694],
39	c.	VBD	O	c.	advcl	32	SENT_209	[p9l923t642r1071b695],
40	52l	CD	NUMBER	52l	num	42	SENT_209	[p9l923t642r1071b695],
41	CC	NN	O	cc	nn	42	SENT_209	[p9l1084t642r1161b694],
42	carriers	NNS	O	carrier	dobj	39	SENT_209	[p9l1185t640r1429b695],
43	.	.	O	.	_	0	SENT_209	[p9l1185t640r1429b695],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_210	[p9l6t818r643b886],

1	This	DT	O	this	det	2	SENT_211	[p9l109t996r235b1051],
2	work	NN	O	work	nsubjpass	4	SENT_211	[p9l283t996r443b1051],
3	was	VBD	O	be	auxpass	4	SENT_211	[p9l488t1012r606b1051],
4	supported	VBN	O	support	_	0	SENT_211	[p9l656t996r968b1064],
5	by	IN	O	by	_	0	SENT_211	[p9l1017t996r1091b1064],
6	the	DT	O	the	det	10	SENT_211	[p9l1136t996r1234b1051],
7	National	NNP	ORGANIZATION	National	nn	10	SENT_211	[p9l1283t996r1542b1051],
8	Natural	NNP	ORGANIZATION	Natural	nn	10	SENT_211	[p9l1591t996r1818b1051],
9	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	10	SENT_211	[p9l1866t996r2147b1051],
10	Foundation	NNP	ORGANIZATION	Foundation	agent	4	SENT_211	[p9l10t1085r357b1140],
11	of	IN	ORGANIZATION	of	_	0	SENT_211	[p9l389t1085r452b1140],
12	China	NNP	ORGANIZATION	China	nn	13	SENT_211	[p9l477t1085r650b1140],
13	grants	NNS	O	grant	prep_of	10	SENT_211	[p9l681t1093r870b1153],
14	F30130210	NN	O	f30130210	dep	13	SENT_211	[p9l904t1088r1245b1148],
15	,	,	O	,	_	0	SENT_211	[p9l904t1088r1245b1148],
16	C30000211	NN	O	c30000211	dep	13	SENT_211	[p9l1279t1088r1614b1140],
17	and	CC	O	and	_	0	SENT_211	[p9l1654t1085r1764b1140],
18	C30200346	NN	O	c30200346	dep	13	SENT_211	[p9l1798t1088r2147b1140],
19	and	CC	O	and	_	0	SENT_211	[p9l10t1174r121b1229],
20	by	IN	O	by	_	0	SENT_211	[p9l146t1174r218b1243],
21	China	NNP	ORGANIZATION	China	nn	23	SENT_211	[p9l242t1174r414b1229],
22	Medical	NNP	ORGANIZATION	Medical	nn	23	SENT_211	[p9l439t1174r678b1229],
23	Board	NNP	ORGANIZATION	Board	conj_and	10	SENT_211	[p9l703t1174r878b1229],
24	of	IN	ORGANIZATION	of	_	0	SENT_211	[p9l903t1174r967b1229],
25	New	NNP	ORGANIZATION	New	nn	27	SENT_211	[p9l984t1178r1122b1229],
26	York	NNP	ORGANIZATION	York	nn	27	SENT_211	[p9l1143t1174r1282b1229],
27	grants	NNS	O	grant	prep_of	23	SENT_211	[p9l1304t1182r1494b1243],
28	99-697	CD	NUMBER	99-697	dep	4	SENT_211	[p9l1519t1177r1734b1229],
29	and	CC	O	and	_	0	SENT_211	[p9l1760t1174r1871b1229],
30	01-755	CD	NUMBER	01-755	dep	4	SENT_211	[p9l1896t1177r2126b1230],
31	.	.	O	.	_	0	SENT_211	[p9l1896t1177r2126b1230],

1	References	NNS	O	reference	_	0	SENT_212	[p9l9t1352r356b1407],

1	[	NN	O	[	nn	5	SENT_213	[p9l39t1498r99b1553],
2	1	CD	NUMBER	1	num	5	SENT_213	[p9l39t1498r99b1553],
3	]	CD	NUMBER	]	num	5	SENT_213	[p9l39t1498r99b1553],
4	Konig	NNP	PERSON	Konig	nn	5	SENT_213	[p9l134t1499r273b1553],
5	J	NNP	PERSON	J	_	0	SENT_213	[p9l294t1501r325b1553],
6	,	,	O	,	_	0	SENT_213	[p9l294t1501r325b1553],
7	Cui	NNP	PERSON	Cui	nn	8	SENT_213	[p9l354t1499r430b1542],
8	Y	NN	PERSON	y	appos	5	SENT_213	[p9l457t1501r496b1549],
9	,	,	O	,	_	0	SENT_213	[p9l457t1501r496b1549],
10	Nies	NNPS	PERSON	Nies	appos	5	SENT_213	[p9l525t1499r628b1542],
11	AT	IN	O	at	amod	10	SENT_213	[p9l655t1501r726b1549],
12	,	,	O	,	_	0	SENT_213	[p9l655t1501r726b1549],
13	Keppler	NNP	PERSON	Keppler	nn	19	SENT_213	[p9l755t1499r945b1553],
14	D.	NNP	O	D.	nn	19	SENT_213	[p9l972t1501r1019b1543],
15	A	NNP	O	A	nn	19	SENT_213	[p9l1045t1501r1082b1542],
16	novel	JJ	O	novel	amod	19	SENT_213	[p9l1108t1499r1239b1542],
17	human	JJ	O	human	amod	19	SENT_213	[p9l1268t1499r1440b1542],
18	organic	JJ	O	organic	amod	19	SENT_213	[p9l1468t1499r1650b1553],
19	anion	NN	O	anion	appos	5	SENT_213	[p9l1676t1499r1813b1542],
20	transporting	VBG	O	transport	partmod	19	SENT_213	[p9l1841t1499r2147b1553],
21	polypeptide	NN	O	polypeptide	dobj	20	SENT_213	[p9l134t1565r426b1619],
22	localized	JJ	O	localized	amod	21	SENT_213	[p9l459t1565r673b1608],
23	to	TO	O	to	_	0	SENT_213	[p9l707t1571r754b1608],
24	the	DT	O	the	det	27	SENT_213	[p9l786t1565r864b1608],
25	basolateral	JJ	O	basolateral	amod	27	SENT_213	[p9l896t1565r1163b1608],
26	hepatocyte	NN	O	hepatocyte	nn	27	SENT_213	[p9l1197t1565r1467b1619],
27	membrane	NN	O	membrane	prep_to	22	SENT_213	[p9l1500t1565r1778b1609],
28	.	.	O	.	_	0	SENT_213	[p9l1500t1565r1778b1609],

1	Am	NNP	O	Am	nn	6	SENT_214	[p9l1810t1567r1894b1608],
2	J	NNP	O	J	nn	6	SENT_214	[p9l1921t1568r1940b1619],
3	Physiol	NNP	O	Physiol	nn	6	SENT_214	[p9l1973t1565r2146b1619],
4	Gastrointest	NNP	O	Gastrointest	nn	6	SENT_214	[p9l134t1631r432b1674],
5	Liver	NN	O	liver	nn	6	SENT_214	[p9l451t1631r570b1674],
6	Physiol	NNP	O	Physiol	_	0	SENT_214	[p9l589t1630r762b1685],
7	2000	CD	DATE	2000	num	9	SENT_214	[p9l782t1633r1298b1681],
8	;	:	O	;	_	0	SENT_214	[p9l782t1633r1298b1681],
9	278	CD	NUMBER	278	dep	6	SENT_214	[p9l782t1633r1298b1681],
10	:	:	O	:	_	0	SENT_214	[p9l782t1633r1298b1681],
11	G156	NN	O	g156	nn	12	SENT_214	[p9l782t1633r1298b1681],
12	—	NN	O	—	dep	6	SENT_214	[p9l782t1633r1298b1681],
13	164	CD	NUMBER	164	dep	12	SENT_214	[p9l782t1633r1298b1681],
14	.	.	O	.	_	0	SENT_214	[p9l782t1633r1298b1681],

1	[	NN	O	[	nn	5	SENT_215	[p9l39t1697r99b1751],
2	2	CD	NUMBER	2	num	5	SENT_215	[p9l39t1697r99b1751],
3	]	CD	NUMBER	]	num	5	SENT_215	[p9l39t1697r99b1751],
4	Tirona	NNP	O	Tirona	nn	5	SENT_215	[p9l131t1698r289b1741],
5	RG	NNP	O	RG	_	0	SENT_215	[p9l304t1699r382b1747],
6	,	,	O	,	_	0	SENT_215	[p9l304t1699r382b1747],
7	Leake	NNP	PERSON	Leake	nn	8	SENT_215	[p9l398t1697r534b1741],
8	BF	NNP	O	BF	appos	5	SENT_215	[p9l550t1700r615b1747],
9	,	,	O	,	_	0	SENT_215	[p9l550t1700r615b1747],
10	Merino	NNP	O	Merino	nn	11	SENT_215	[p9l631t1698r806b1741],
11	G	NNP	O	G	appos	5	SENT_215	[p9l822t1699r868b1747],
12	,	,	O	,	_	0	SENT_215	[p9l822t1699r868b1747],
13	Kim	NNP	PERSON	Kim	nn	14	SENT_215	[p9l885t1698r982b1740],
14	RB	NN	O	rb	appos	5	SENT_215	[p9l997t1700r1070b1741],
15	.	.	O	.	_	0	SENT_215	[p9l997t1700r1070b1741],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_216	[p9l1086t1697r1469b1751],
2	in	IN	O	in	_	0	SENT_216	[p9l1485t1698r1530b1740],
3	OATP-C	NN	O	oatp-c	prep_in	1	SENT_216	[p9l1545t1699r1741b1741],
4	:	:	O	:	_	0	SENT_216	[p9l1545t1699r1741b1741],
5	identiﬁcation	NN	O	identiﬁcation	dep	1	SENT_216	[p9l1760t1697r2087b1741],
6	of	IN	O	of	_	0	SENT_216	[p9l2102t1697r2153b1741],
7	multiple	JJ	O	multiple	amod	9	SENT_216	[p9l134t1763r345b1818],
8	allelic	JJ	O	allelic	amod	9	SENT_216	[p9l385t1763r532b1807],
9	variants	NNS	O	variant	prep_of	5	SENT_216	[p9l570t1764r772b1807],
10	associated	VBN	O	associate	dep	5	SENT_216	[p9l811t1763r1070b1807],
11	with	IN	O	with	_	0	SENT_216	[p9l1109t1763r1224b1807],
12	altered	JJ	O	altered	amod	14	SENT_216	[p9l1264t1763r1438b1807],
13	transport	NN	O	transport	nn	14	SENT_216	[p9l1478t1770r1713b1818],
14	activity	NN	O	activity	prep_with	10	SENT_216	[p9l1752t1764r1938b1818],
15	among	IN	O	among	_	0	SENT_216	[p9l1975t1776r2147b1818],
16	European	JJ	MISC	european	amod	17	SENT_216	[p9l134t1832r388b1883],
17	—	NN	O	—	prep_among	14	SENT_216	[p9l134t1832r388b1883],
18	and	CC	O	and	_	0	SENT_216	[p9l408t1829r497b1872],
19	African	JJ	MISC	african	conj_and	10	SENT_216	[p9l515t1829r1020b1883],
20	.	.	O	.	_	0	SENT_216	[p9l515t1829r1020b1883],

1	—	NN	O	—	_	0	SENT_217	[p9l515t1829r1020b1883],
2	.	.	O	.	_	0	SENT_217	[p9l515t1829r1020b1883],

1	Americans	NNPS	MISC	Americans	_	0	SENT_218	[p9l515t1829r1020b1883],
2	.	.	O	.	_	0	SENT_218	[p9l515t1829r1020b1883],

1	J	NNP	O	J	nn	3	SENT_219	[p9l515t1829r1020b1883],
2	Biol	NNP	O	Biol	nn	3	SENT_219	[p9l1040t1829r1130b1872],
3	Chem	NNP	O	Chem	_	0	SENT_219	[p9l1151t1829r1291b1872],
4	2001	CD	DATE	2001	num	3	SENT_219	[p9l1311t1831r1426b1872],
5	;	:	O	;	_	0	SENT_219	[p9l1439t1831r1820b1879],
6	276:35669	CD	NUMBER	276:35669	number	7	SENT_219	[p9l1439t1831r1820b1879],
7	—	CD	NUMBER	—	dep	3	SENT_219	[p9l1439t1831r1820b1879],
8	75	CD	NUMBER	75	dep	7	SENT_219	[p9l1439t1831r1820b1879],
9	.	.	O	.	_	0	SENT_219	[p9l1439t1831r1820b1879],

1	[	NN	O	[	_	0	SENT_220	[p9l39t1895r99b1949],
2	3	CD	NUMBER	3	num	1	SENT_220	[p9l39t1895r99b1949],
3	]	CD	NUMBER	]	num	5	SENT_220	[p9l39t1895r99b1949],
4	Kameyama	NNP	PERSON	Kameyama	nn	5	SENT_220	[p9l134t1898r404b1949],
5	Y	NN	PERSON	y	dep	1	SENT_220	[p9l439t1898r478b1945],
6	,	,	O	,	_	0	SENT_220	[p9l439t1898r478b1945],
7	Yamashita	NNP	PERSON	Yamashita	nn	8	SENT_220	[p9l514t1895r768b1939],
8	K	NNP	PERSON	K	appos	5	SENT_220	[p9l804t1898r847b1945],
9	,	,	O	,	_	0	SENT_220	[p9l804t1898r847b1945],
10	Kobayashi	NNP	LOCATION	Kobayashi	nn	11	SENT_220	[p9l885t1895r1133b1949],
11	K	NNP	LOCATION	K	appos	5	SENT_220	[p9l1171t1898r1214b1945],
12	,	,	O	,	_	0	SENT_220	[p9l1171t1898r1214b1945],
13	Hosokawa	NNP	PERSON	Hosokawa	nn	14	SENT_220	[p9l1251t1895r1503b1939],
14	M	NNP	O	M	appos	5	SENT_220	[p9l1540t1898r1598b1945],
15	,	,	O	,	_	0	SENT_220	[p9l1540t1898r1598b1945],
16	Chiba	NNP	O	Chiba	nn	19	SENT_220	[p9l1635t1895r1772b1939],
17	K.	NNP	O	K.	nn	19	SENT_220	[p9l1809t1898r1852b1939],
18	Functional	JJ	O	functional	amod	19	SENT_220	[p9l1890t1895r2146b1939],
19	characterization	NN	O	characterization	appos	5	SENT_220	[p9l133t1961r529b2004],
20	of	IN	O	of	_	0	SENT_220	[p9l564t1961r615b2004],
21	SLCO1B1	NN	O	slco1b1	nn	23	SENT_220	[p9l642t1963r852b2004],
22	(	CD	NUMBER	(	num	23	SENT_220	[p9l896t1961r1119b2015],
23	OATP-C	NN	O	oatp-c	prep_of	19	SENT_220	[p9l896t1961r1119b2015],
24	)	CD	NUMBER	)	num	25	SENT_220	[p9l896t1961r1119b2015],
25	variants	NNS	O	variant	dep	19	SENT_220	[p9l1155t1961r1363b2011],
26	,	,	O	,	_	0	SENT_220	[p9l1155t1961r1363b2011],
27	SLCO1B1	NN	O	slco1b1	appos	5	SENT_220	[p9l1398t1961r1685b2011],
28	*	CD	NUMBER	*	number	29	SENT_220	[p9l1398t1961r1685b2011],
29	5	CD	NUMBER	5	dep	27	SENT_220	[p9l1398t1961r1685b2011],
30	,	,	O	,	_	0	SENT_220	[p9l1398t1961r1685b2011],
31	SLCO1B1	NN	O	slco1b1	appos	1	SENT_220	[p9l1720t1961r2021b2004],
32	*	CD	NUMBER	*	number	33	SENT_220	[p9l1720t1961r2021b2004],
33	15	CD	NUMBER	15	dep	31	SENT_220	[p9l1720t1961r2021b2004],
34	and	CC	O	and	_	0	SENT_220	[p9l2057t1961r2146b2004],
35	SLCO1B1	NN	O	slco1b1	appos	1	SENT_220	[p9l134t2028r693b2077],
36	*	CD	NUMBER	*	number	37	SENT_220	[p9l134t2028r693b2077],
37	15	CD	NUMBER	15	dep	35	SENT_220	[p9l134t2028r693b2077],
38	+	CC	O	+	_	0	SENT_220	[p9l134t2028r693b2077],
39	C1007G	NN	O	c1007g	appos	1	SENT_220	[p9l134t2028r693b2077],
40	,	,	O	,	_	0	SENT_220	[p9l134t2028r693b2077],
41	by	IN	O	by	_	0	SENT_220	[p9l709t2027r768b2082],
42	using	VBG	O	use	prepc_by	39	SENT_220	[p9l781t2028r913b2082],
43	transient	JJ	O	transient	amod	45	SENT_220	[p9l927t2028r1148b2071],
44	expression	NN	O	expression	nn	45	SENT_220	[p9l1162t2028r1425b2082],
45	systems	NNS	O	system	dobj	42	SENT_220	[p9l1441t2034r1634b2082],
46	of	IN	O	of	_	0	SENT_220	[p9l1650t2027r1701b2071],
47	HeLa	NN	O	helum	nn	50	SENT_220	[p9l1711t2030r1830b2071],
48	and	CC	O	and	_	0	SENT_220	[p9l1845t2027r1934b2071],
49	HEK293	NN	O	hek293	nn	50	SENT_220	[p9l1951t2029r2144b2071],
50	cells	NNS	O	cell	prep_of	45	SENT_220	[p9l133t2092r251b2136],
51	.	.	O	.	_	0	SENT_220	[p9l133t2092r251b2136],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_221	[p9l271t2092r655b2147],
2	Genomics	NNP	O	Genomics	_	0	SENT_221	[p9l673t2093r913b2136],
3	2005	CD	DATE	2005	num	2	SENT_221	[p9l934t2095r1345b2143],
4	;	:	O	;	_	0	SENT_221	[p9l934t2095r1345b2143],
5	15:513	CD	NUMBER	15:513	number	6	SENT_221	[p9l934t2095r1345b2143],
6	—	CD	NUMBER	—	dep	2	SENT_221	[p9l934t2095r1345b2143],
7	22	CD	NUMBER	22	dep	6	SENT_221	[p9l934t2095r1345b2143],
8	.	.	O	.	_	0	SENT_221	[p9l934t2095r1345b2143],

1	[	NN	O	[	nn	5	SENT_222	[p9l39t2159r99b2213],
2	4	CD	NUMBER	4	num	5	SENT_222	[p9l39t2159r99b2213],
3	]	CD	NUMBER	]	num	5	SENT_222	[p9l39t2159r99b2213],
4	Mwinyi	NNP	PERSON	Mwinyi	nn	5	SENT_222	[p9l134t2160r318b2213],
5	J	NNP	PERSON	J	_	0	SENT_222	[p9l328t2162r359b2213],
6	,	,	O	,	_	0	SENT_222	[p9l328t2162r359b2213],
7	Johne	NNP	O	Johne	nn	8	SENT_222	[p9l370t2159r513b2213],
8	A	NNP	O	A	appos	5	SENT_222	[p9l527t2161r574b2209],
9	,	,	O	,	_	0	SENT_222	[p9l527t2161r574b2209],
10	Bauer	NNP	PERSON	Bauer	appos	5	SENT_222	[p9l590t2162r731b2203],
11	5	CD	NUMBER	5	num	10	SENT_222	[p9l746t2161r782b2209],
12	,	,	O	,	_	0	SENT_222	[p9l746t2161r782b2209],
13	Roots	NNS	O	root	appos	5	SENT_222	[p9l798t2162r931b2203],
14	I	PRP	O	I	dep	13	SENT_222	[p9l947t2162r972b2209],
15	,	,	O	,	_	0	SENT_222	[p9l947t2162r972b2209],
16	Gerloff	NNP	PERSON	Gerloff	nn	18	SENT_222	[p9l988t2159r1161b2203],
17	T.	NNP	O	T.	nn	18	SENT_222	[p9l1168t2162r1205b2203],
18	Evidence	NN	O	evidence	appos	5	SENT_222	[p9l1222t2159r1441b2203],
19	for	IN	O	for	_	0	SENT_222	[p9l1457t2159r1526b2203],
20	inverse	JJ	O	inverse	amod	21	SENT_222	[p9l1540t2160r1715b2203],
21	effects	NNS	O	effect	prep_for	18	SENT_222	[p9l1731t2159r1888b2203],
22	of	IN	O	of	_	0	SENT_222	[p9l1905t2159r1956b2203],
23	OATP-C	NN	O	oatp-c	nn	25	SENT_222	[p9l1965t2161r2147b2203],
24	(	CD	NUMBER	(	num	25	SENT_222	[p9l137t2225r388b2279],
25	SLC21A6	NN	O	slc21a6	prep_of	21	SENT_222	[p9l137t2225r388b2279],
26	)	CD	NUMBER	)	num	27	SENT_222	[p9l137t2225r388b2279],
27	5	CD	NUMBER	5	dep	5	SENT_222	[p9l424t2228r449b2269],
28	and	CC	O	and	_	0	SENT_222	[p9l482t2225r571b2269],
29	1b	CD	NUMBER	1b	num	30	SENT_222	[p9l606t2225r662b2269],
30	haplotypes	NNS	O	haplotype	conj_and	27	SENT_222	[p9l694t2225r962b2280],
31	on	IN	O	on	_	0	SENT_222	[p9l994t2238r1054b2269],
32	pravastatin	NN	O	pravastatin	nn	33	SENT_222	[p9l1085t2226r1357b2280],
33	kinetics	NNS	O	kinetics	prep_on	27	SENT_222	[p9l1389t2225r1588b2269],
34	.	.	O	.	_	0	SENT_222	[p9l1389t2225r1588b2269],

1	Clin	NNP	O	Clin	nn	3	SENT_223	[p9l1621t2225r1714b2269],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_223	[p9l1746t2225r2005b2269],
3	Ther	NNP	O	Ther	_	0	SENT_223	[p9l2034t2225r2148b2269],
4	2004	CD	DATE	2004	num	3	SENT_223	[p9l133t2293r542b2341],
5	;	:	O	;	_	0	SENT_223	[p9l133t2293r542b2341],
6	75:415	CD	NUMBER	75:415	number	7	SENT_223	[p9l133t2293r542b2341],
7	—	CD	NUMBER	—	dep	3	SENT_223	[p9l133t2293r542b2341],
8	21	CD	NUMBER	21	dep	7	SENT_223	[p9l133t2293r542b2341],
9	.	.	O	.	_	0	SENT_223	[p9l133t2293r542b2341],

1	[	NN	O	[	nsubj	18	SENT_224	[p9l39t2357r99b2411],
2	5	CD	NUMBER	5	number	3	SENT_224	[p9l39t2357r99b2411],
3	]	CD	NUMBER	]	num	5	SENT_224	[p9l39t2357r99b2411],
4	Pasanen	NN	PERSON	pasanen	nn	5	SENT_224	[p9l134t2360r334b2400],
5	MK	NN	O	mk	dep	1	SENT_224	[p9l369t2360r462b2407],
6	,	,	O	,	_	0	SENT_224	[p9l369t2360r462b2407],
7	Neuvonen	NN	O	neuvonen	nn	8	SENT_224	[p9l499t2360r749b2400],
8	M	NN	O	m	appos	1	SENT_224	[p9l785t2360r843b2407],
9	,	,	O	,	_	0	SENT_224	[p9l785t2360r843b2407],
10	Neuvonen	NNP	PERSON	Neuvonen	nn	11	SENT_224	[p9l880t2360r1130b2400],
11	PJ	NNP	PERSON	PJ	npadvmod	17	SENT_224	[p9l1166t2360r1220b2411],
12	,	,	O	,	_	0	SENT_224	[p9l1166t2360r1220b2411],
13	Niemi	NNP	PERSON	Niemi	nn	15	SENT_224	[p9l1256t2358r1401b2400],
14	M.	NNP	O	M.	nn	15	SENT_224	[p9l1438t2360r1496b2401],
15	SLCO1B1	NNP	O	SLCO1B1	appos	11	SENT_224	[p9l1533t2359r1743b2400],
16	polymorphism	NN	O	polymorphism	dep	15	SENT_224	[p9l1785t2357r2147b2411],
17	markedly	RB	O	markedly	advmod	18	SENT_224	[p9l134t2423r368b2477],
18	affects	VBZ	O	affect	_	0	SENT_224	[p9l404t2423r563b2466],
19	the	DT	O	the	det	20	SENT_224	[p9l602t2423r681b2466],
20	pharmacokinetics	NNS	O	pharmacokinetic	dobj	18	SENT_224	[p9l720t2423r1162b2477],
21	of	IN	O	of	_	0	SENT_224	[p9l1202t2423r1253b2466],
22	simvastatin	NN	O	simvastatin	nn	23	SENT_224	[p9l1286t2423r1570b2466],
23	acid	NN	O	acid	prep_of	20	SENT_224	[p9l1609t2423r1720b2467],
24	.	.	O	.	_	0	SENT_224	[p9l1609t2423r1720b2467],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_225	[p9l1760t2423r2147b2477],
2	Genomics	NNP	O	Genomics	_	0	SENT_225	[p9l134t2490r374b2533],
3	2006	CD	DATE	2006	num	2	SENT_225	[p9l394t2491r780b2539],
4	;	:	O	;	_	0	SENT_225	[p9l394t2491r780b2539],
5	16:873	CD	NUMBER	16:873	number	6	SENT_225	[p9l394t2491r780b2539],
6	—	CD	NUMBER	—	dep	2	SENT_225	[p9l394t2491r780b2539],
7	9	CD	NUMBER	9	dep	6	SENT_225	[p9l394t2491r780b2539],
8	.	.	O	.	_	0	SENT_225	[p9l394t2491r780b2539],

1	[	NN	O	[	nn	4	SENT_226	[p9l39t2554r99b2609],
2	6	CD	NUMBER	6	num	4	SENT_226	[p9l39t2554r99b2609],
3	]	NN	O	]	nn	4	SENT_226	[p9l39t2554r99b2609],
4	Kantola	NN	O	kantolum	_	0	SENT_226	[p9l134t2555r320b2598],
5	T	NN	O	t	dep	4	SENT_226	[p9l334t2557r371b2605],
6	,	,	O	,	_	0	SENT_226	[p9l334t2557r371b2605],
7	Kivisto	NNP	ORGANIZATION	Kivisto	nn	8	SENT_226	[p9l390t2555r556b2598],
8	KT	NNP	ORGANIZATION	KT	appos	5	SENT_226	[p9l574t2557r644b2605],
9	,	,	O	,	_	0	SENT_226	[p9l574t2557r644b2605],
10	Neuvonen	NNP	O	Neuvonen	nn	11	SENT_226	[p9l663t2557r913b2598],
11	PJ	NNP	O	PJ	appos	5	SENT_226	[p9l931t2557r984b2609],
12	.	.	O	.	_	0	SENT_226	[p9l931t2557r984b2609],

1	Effect	NN	O	effect	_	0	SENT_227	[p9l1003t2554r1140b2598],
2	of	IN	O	of	_	0	SENT_227	[p9l1156t2554r1207b2598],
3	itraconazole	NN	O	itraconazole	prep_of	1	SENT_227	[p9l1219t2554r1518b2598],
4	on	IN	O	on	_	0	SENT_227	[p9l1536t2567r1596b2598],
5	the	DT	O	the	det	6	SENT_227	[p9l1613t2554r1691b2598],
6	pharmaco1	NN	O	pharmaco1	prep_on	3	SENT_227	[p9l1710t2554r2145b2609],
7	<	JJR	O	<	amod	8	SENT_227	[p9l1710t2554r2145b2609],
8	inetics	NNS	O	inetic	dep	1	SENT_227	[p9l1710t2554r2145b2609],
9	of	IN	O	of	_	0	SENT_227	[p9l133t2621r184b2665],
10	atorvastatin	NN	O	atorvastatin	prep_of	8	SENT_227	[p9l197t2622r501b2665],
11	.	.	O	.	_	0	SENT_227	[p9l197t2622r501b2665],

1	Clin	NNP	O	Clin	nn	3	SENT_228	[p9l522t2621r615b2665],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_228	[p9l636t2621r894b2665],
3	Ther	NNP	O	Ther	_	0	SENT_228	[p9l913t2621r1026b2665],
4	1998	CD	DATE	1998	num	3	SENT_228	[p9l1047t2623r1430b2671],
5	;	:	O	;	_	0	SENT_228	[p9l1047t2623r1430b2671],
6	64:58	CD	NUMBER	64:58	number	7	SENT_228	[p9l1047t2623r1430b2671],
7	—	CD	NUMBER	—	dep	3	SENT_228	[p9l1047t2623r1430b2671],
8	65	CD	NUMBER	65	dep	7	SENT_228	[p9l1047t2623r1430b2671],
9	.	.	O	.	_	0	SENT_228	[p9l1047t2623r1430b2671],

1	[	NN	O	[	nn	5	SENT_229	[p9l39t2687r99b2741],
2	7	CD	NUMBER	7	num	5	SENT_229	[p9l39t2687r99b2741],
3	]	CD	NUMBER	]	num	5	SENT_229	[p9l39t2687r99b2741],
4	Jacobsen	NNP	PERSON	Jacobsen	nn	5	SENT_229	[p9l127t2687r342b2741],
5	W	NNP	PERSON	W	_	0	SENT_229	[p9l362t2690r425b2737],
6	,	,	O	,	_	0	SENT_229	[p9l362t2690r425b2737],
7	Kuhn	NNP	PERSON	Kuhn	nn	8	SENT_229	[p9l450t2687r576b2731],
8	B	NNP	O	B	appos	5	SENT_229	[p9l599t2690r640b2737],
9	,	,	O	,	_	0	SENT_229	[p9l599t2690r640b2737],
10	Soldner	NNP	O	Soldner	nn	11	SENT_229	[p9l664t2687r848b2731],
11	A	NNP	O	A	appos	5	SENT_229	[p9l868t2689r914b2737],
12	,	,	O	,	_	0	SENT_229	[p9l868t2689r914b2737],
13	et	FW	O	et	nn	14	SENT_229	[p9l937t2693r983b2731],
14	al.	FW	O	al.	appos	5	SENT_229	[p9l1005t2687r1055b2731],
15	.	.	O	.	_	0	SENT_229	[p9l1005t2687r1055b2731],

1	Lactonization	NN	MISC	lactonization	nsubj	6	SENT_230	[p9l1080t2688r1399b2731],
2	is	VBZ	O	be	cop	6	SENT_230	[p9l1423t2688r1458b2731],
3	the	DT	O	the	det	6	SENT_230	[p9l1481t2687r1558b2731],
4	critical	JJ	O	critical	amod	6	SENT_230	[p9l1581t2687r1741b2731],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_230	[p9l1764t2687r1859b2731],
6	step	NN	O	step	_	0	SENT_230	[p9l1882t2694r1979b2741],
7	in	IN	O	in	_	0	SENT_230	[p9l2003t2688r2048b2730],
8	the	DT	O	the	det	9	SENT_230	[p9l2070t2687r2147b2731],
9	disposition	NN	O	disposition	prep_in	6	SENT_230	[p9l133t2753r396b2807],
10	of	IN	O	of	_	0	SENT_230	[p9l413t2753r464b2796],
11	the	DT	O	the	det	12	SENT_230	[p9l475t2753r552b2796],
12	3-hydroxy	NN	O	3-hydroxy	prep_of	9	SENT_230	[p9l568t2753r1363b2807],
13	.	.	O	.	_	0	SENT_230	[p9l568t2753r1363b2807],

1	—	NN	O	—	_	0	SENT_231	[p9l568t2753r1363b2807],
2	.	.	O	.	_	0	SENT_231	[p9l568t2753r1363b2807],

1	3-methylglutaryl	NN	O	3-methylglutaryl	_	0	SENT_232	[p9l568t2753r1363b2807],
2	.	.	O	.	_	0	SENT_232	[p9l568t2753r1363b2807],

1	—	NN	O	—	_	0	SENT_233	[p9l568t2753r1363b2807],
2	.	.	O	.	_	0	SENT_233	[p9l568t2753r1363b2807],

1	CoA	NN	O	coa	nn	4	SENT_234	[p9l568t2753r1363b2807],
2	reductase	NN	O	reductase	nn	4	SENT_234	[p9l1379t2753r1609b2796],
3	inhibitor	NN	O	inhibitor	nn	4	SENT_234	[p9l1627t2753r1836b2796],
4	atorvastatin	NN	O	atorvastatin	_	0	SENT_234	[p9l1850t2754r2145b2797],
5	.	.	O	.	_	0	SENT_234	[p9l1850t2754r2145b2797],

1	Drug	NN	O	drug	nn	3	SENT_235	[p9l134t2821r252b2873],
2	Metab	NNP	O	Metab	nn	3	SENT_235	[p9l268t2818r419b2862],
3	Dispos	NNP	O	Dispos	_	0	SENT_235	[p9l436t2819r593b2873],
4	2000	CD	DATE	2000	num	3	SENT_235	[p9l611t2821r1050b2869],
5	;	:	O	;	_	0	SENT_235	[p9l611t2821r1050b2869],
6	28:1369	CD	NUMBER	28:1369	num	7	SENT_235	[p9l611t2821r1050b2869],
7	—	NN	O	—	dep	3	SENT_235	[p9l611t2821r1050b2869],
8	78	CD	NUMBER	78	dep	7	SENT_235	[p9l611t2821r1050b2869],
9	.	.	O	.	_	0	SENT_235	[p9l611t2821r1050b2869],

1	[	NN	O	[	_	0	SENT_236	[p9l39t2884r100b2939],
2	8	CD	NUMBER	8	number	3	SENT_236	[p9l39t2884r100b2939],
3	]	CD	NUMBER	]	dep	1	SENT_236	[p9l39t2884r100b2939],
4	Jacobson	NNP	PERSON	Jacobson	nn	5	SENT_236	[p9l127t2885r348b2939],
5	TA	NNP	O	TA	dep	3	SENT_236	[p9l376t2886r451b2928],
6	.	.	O	.	_	0	SENT_236	[p9l376t2886r451b2928],

1	Comparative	JJ	O	comparative	amod	4	SENT_237	[p9l485t2885r795b2939],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_237	[p9l828t2885r1241b2939],
3	interaction	NN	O	interaction	nn	4	SENT_237	[p9l1273t2885r1539b2928],
4	proﬁles	NNS	O	proﬁles	nsubj	13	SENT_237	[p9l1571t2884r1752b2939],
5	of	IN	O	of	_	0	SENT_237	[p9l1784t2884r1835b2928],
6	pravastatin	NN	O	pravastatin	prep_of	4	SENT_237	[p9l1861t2885r2145b2939],
7	,	,	O	,	_	0	SENT_237	[p9l1861t2885r2145b2939],
8	simvastatin	NN	O	simvastatin	prep_of	4	SENT_237	[p9l134t2952r431b3001],
9	,	,	O	,	_	0	SENT_237	[p9l134t2952r431b3001],
10	and	CC	O	and	_	0	SENT_237	[p9l470t2951r560b2995],
11	atorvastatin	NN	O	atorvastatin	prep_of	4	SENT_237	[p9l599t2952r898b2995],
12	when	WRB	O	when	dep	6	SENT_237	[p9l934t2951r1074b2995],
13	coadministered	VBN	O	coadminister	_	0	SENT_237	[p9l1112t2951r1499b2995],
14	with	IN	O	with	_	0	SENT_237	[p9l1538t2951r1652b2995],
15	cytochrome	NN	O	cytochrome	nn	17	SENT_237	[p9l1691t2951r1984b3006],
16	P450	NN	O	p450	nn	17	SENT_237	[p9l2024t2953r2145b2995],
17	inhibitors	NNS	O	inhibitor	prep_with	13	SENT_237	[p9l134t3017r382b3061],
18	.	.	O	.	_	0	SENT_237	[p9l134t3017r382b3061],

1	Am	VBP	O	be	dep	3	SENT_238	[p9l400t3019r517b3072],
2	]	CD	NUMBER	]	num	3	SENT_238	[p9l400t3019r517b3072],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_238	[p9l537t3017r710b3061],
4	2004	CD	DATE	2004	num	3	SENT_238	[p9l729t3019r1142b3067],
5	;	:	O	;	_	0	SENT_238	[p9l729t3019r1142b3067],
6	94:1140	CD	NUMBER	94:1140	dep	3	SENT_238	[p9l729t3019r1142b3067],
7	—	CD	NUMBER	—	num	8	SENT_238	[p9l729t3019r1142b3067],
8	6	CD	NUMBER	6	dep	6	SENT_238	[p9l729t3019r1142b3067],
9	.	.	O	.	_	0	SENT_238	[p9l729t3019r1142b3067],

1	[	NN	O	[	nn	3	SENT_239	[p9l39t3083r99b3137],
2	9	CD	NUMBER	9	num	3	SENT_239	[p9l39t3083r99b3137],
3	]	NN	O	]	_	0	SENT_239	[p9l39t3083r99b3137],
4	Lau	NNP	PERSON	Lau	nn	5	SENT_239	[p9l134t3086r216b3127],
5	YY	NNP	O	YY	dep	3	SENT_239	[p9l241t3086r314b3133],
6	,	,	O	,	_	0	SENT_239	[p9l241t3086r314b3133],
7	Okochi	NNP	PERSON	Okochi	nn	8	SENT_239	[p9l341t3083r511b3127],
8	H	NNP	PERSON	H	appos	5	SENT_239	[p9l538t3086r586b3133],
9	,	,	O	,	_	0	SENT_239	[p9l538t3086r586b3133],
10	Huang	NNP	PERSON	Huang	nn	11	SENT_239	[p9l614t3086r774b3137],
11	Y	NN	PERSON	y	appos	5	SENT_239	[p9l797t3086r837b3133],
12	,	,	O	,	_	0	SENT_239	[p9l797t3086r837b3133],
13	Benet	NNP	PERSON	Benet	nn	14	SENT_239	[p9l864t3086r1004b3127],
14	LZ	NNP	O	LZ	appos	5	SENT_239	[p9l1029t3086r1094b3127],
15	.	.	O	.	_	0	SENT_239	[p9l1029t3086r1094b3127],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_240	[p9l1122t3083r1556b3127],
2	of	IN	O	of	_	0	SENT_240	[p9l1584t3083r1635b3127],
3	atorvastatin	NN	O	atorvastatin	prep_of	1	SENT_240	[p9l1655t3084r1947b3127],
4	and	CC	O	and	_	0	SENT_240	[p9l1974t3083r2063b3127],
5	its	PRP$	O	its	poss	7	SENT_240	[p9l2091t3084r2146b3127],
6	hydroxy	NN	O	hydroxy	nn	7	SENT_240	[p9l134t3149r334b3203],
7	metabolites	NNS	O	metabolite	conj_and	1	SENT_240	[p9l348t3149r634b3193],
8	in	IN	O	in	_	0	SENT_240	[p9l651t3150r696b3192],
9	rats	NNS	O	rat	prep_in	7	SENT_240	[p9l711t3156r799b3193],
10	and	CC	O	and	_	0	SENT_240	[p9l815t3149r904b3193],
11	the	DT	O	the	det	12	SENT_240	[p9l920t3149r997b3193],
12	effects	NNS	O	effect	conj_and	1	SENT_240	[p9l1013t3149r1169b3193],
13	of	IN	O	of	_	0	SENT_240	[p9l1185t3149r1236b3193],
14	concomitant	JJ	O	concomitant	amod	15	SENT_240	[p9l1245t3150r1553b3193],
15	rifampicin	NN	O	rifampicin	prep_of	12	SENT_240	[p9l1568t3149r1819b3203],
16	single	JJ	O	single	amod	17	SENT_240	[p9l1836t3149r1977b3203],
17	doses	NNS	O	dose	dep	12	SENT_240	[p9l1992t3149r2142b3193],
18	:	:	O	:	_	0	SENT_240	[p9l1992t3149r2142b3193],
19	relevance	NN	O	relevance	dep	1	SENT_240	[p9l134t3215r366b3258],
20	of	IN	O	of	_	0	SENT_240	[p9l386t3215r437b3258],
21	ﬁrst-pass	JJ	O	ﬁrst-pass	amod	22	SENT_240	[p9l450t3215r674b3269],
22	effect	NN	O	effect	prep_of	19	SENT_240	[p9l695t3215r829b3258],
23	from	IN	O	from	_	0	SENT_240	[p9l848t3215r965b3258],
24	hepatic	JJ	O	hepatic	amod	26	SENT_240	[p9l983t3215r1163b3269],
25	uptake	NN	O	uptake	nn	26	SENT_240	[p9l1182t3215r1348b3269],
26	transporters	NNS	O	transporter	prep_from	22	SENT_240	[p9l1367t3221r1680b3269],
27	,	,	O	,	_	0	SENT_240	[p9l1367t3221r1680b3269],
28	and	CC	O	and	_	0	SENT_240	[p9l1700t3215r1789b3258],
29	intestinal	JJ	O	intestinal	amod	32	SENT_240	[p9l1810t3215r2038b3258],
30	and	CC	O	and	_	0	SENT_240	[p9l2057t3215r2146b3258],
31	hepatic	JJ	O	hepatic	amod	32	SENT_240	[p9l134t3280r313b3335],
32	metabolism	NN	O	metabolism	conj_and	22	SENT_240	[p9l332t3280r633b3324],
33	.	.	O	.	_	0	SENT_240	[p9l332t3280r633b3324],

1	Drug	NN	O	drug	nn	3	SENT_241	[p9l654t3283r773b3335],
2	Metab	NNP	O	Metab	nn	3	SENT_241	[p9l793t3280r946b3324],
3	Dispos	NNP	O	Dispos	_	0	SENT_241	[p9l967t3281r1127b3335],
4	2006	CD	DATE	2006	num	3	SENT_241	[p9l1148t3283r1585b3331],
5	;	:	O	;	_	0	SENT_241	[p9l1148t3283r1585b3331],
6	34:1175	CD	NUMBER	34:1175	number	7	SENT_241	[p9l1148t3283r1585b3331],
7	—	CD	NUMBER	—	dep	3	SENT_241	[p9l1148t3283r1585b3331],
8	81	CD	NUMBER	81	dep	7	SENT_241	[p9l1148t3283r1585b3331],
9	.	.	O	.	_	0	SENT_241	[p9l1148t3283r1585b3331],

1	[	NN	O	[	nn	5	SENT_242	[p9l6t3347r94b3401],
2	10	CD	NUMBER	10	num	5	SENT_242	[p9l6t3347r94b3401],
3	]	CD	NUMBER	]	num	5	SENT_242	[p9l6t3347r94b3401],
4	Lau	NNP	PERSON	Lau	nn	5	SENT_242	[p9l128t3350r212b3391],
5	YY	NNP	O	YY	_	0	SENT_242	[p9l225t3350r299b3397],
6	,	,	O	,	_	0	SENT_242	[p9l225t3350r299b3397],
7	Okochi	NNP	PERSON	Okochi	nn	8	SENT_242	[p9l315t3347r485b3391],
8	H	NNP	PERSON	H	appos	5	SENT_242	[p9l502t3350r550b3397],
9	,	,	O	,	_	0	SENT_242	[p9l502t3350r550b3397],
10	Huang	NNP	PERSON	Huang	nn	11	SENT_242	[p9l566t3350r727b3401],
11	Y	NN	PERSON	y	appos	5	SENT_242	[p9l739t3350r779b3397],
12	,	,	O	,	_	0	SENT_242	[p9l739t3350r779b3397],
13	Benet	NNP	PERSON	Benet	nn	14	SENT_242	[p9l796t3350r935b3391],
14	LZ	NNP	O	LZ	appos	5	SENT_242	[p9l950t3350r1015b3391],
15	.	.	O	.	_	0	SENT_242	[p9l950t3350r1015b3391],

1	Multiple	JJ	O	multiple	amod	2	SENT_243	[p9l1032t3347r1239b3401],
2	transporters	NNS	O	transporter	nsubj	3	SENT_243	[p9l1255t3353r1558b3401],
3	affect	VBP	O	affect	_	0	SENT_243	[p9l1573t3347r1708b3391],
4	the	DT	O	the	det	5	SENT_243	[p9l1722t3347r1800b3391],
5	disposition	NN	O	disposition	dobj	3	SENT_243	[p9l1816t3347r2087b3401],
6	of	IN	O	of	_	0	SENT_243	[p9l2103t3347r2153b3391],
7	atorvastatin	NN	O	atorvastatin	prep_of	5	SENT_243	[p9l128t3413r421b3456],
8	and	CC	O	and	_	0	SENT_243	[p9l439t3413r528b3456],
9	its	PRP$	O	its	poss	13	SENT_243	[p9l547t3413r602b3456],
10	two	CD	NUMBER	two	num	13	SENT_243	[p9l621t3419r714b3456],
11	active	JJ	O	active	amod	13	SENT_243	[p9l732t3413r875b3456],
12	hydroxy	NN	O	hydroxy	nn	13	SENT_243	[p9l893t3413r1095b3467],
13	metabolites	NNS	O	metabolite	prep_of	5	SENT_243	[p9l1112t3413r1415b3457],
14	:	:	O	:	_	0	SENT_243	[p9l1112t3413r1415b3457],
15	application	NN	O	application	dep	5	SENT_243	[p9l1436t3413r1710b3467],
16	of	IN	O	of	prep	15	SENT_243	[p9l1728t3413r1779b3456],
17	in	FW	O	in	nn	18	SENT_243	[p9l1791t3413r1837b3456],
18	vitro	FW	O	vitro	dep	16	SENT_243	[p9l1852t3413r1968b3456],
19	and	CC	O	and	_	0	SENT_243	[p9l1986t3413r2075b3456],
20	ex	FW	O	ex	nn	21	SENT_243	[p9l2094t3425r2149b3456],
21	situ	FW	O	situ	conj_and	18	SENT_243	[p9l129t3480r217b3522],
22	systems	NNS	O	system	dep	21	SENT_243	[p9l237t3482r477b3533],
23	.	.	O	.	_	0	SENT_243	[p9l237t3482r477b3533],

1	J	NNP	O	J	nn	4	SENT_244	[p9l237t3482r477b3533],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_244	[p9l497t3479r757b3522],
3	Exp	NN	O	exp	nn	4	SENT_244	[p9l777t3482r866b3533],
4	T	NN	O	t	_	0	SENT_244	[p9l884t3482r915b3522],
5	her	PRP$	O	she	poss	8	SENT_244	[p9l917t3479r998b3522],
6	2006	CD	DATE	2006	num	8	SENT_244	[p9l1017t3481r1457b3529],
7	;	:	O	;	_	0	SENT_244	[p9l1017t3481r1457b3529],
8	316:762	CD	NUMBER	316:762	dep	4	SENT_244	[p9l1017t3481r1457b3529],
9	—	CD	NUMBER	—	number	10	SENT_244	[p9l1017t3481r1457b3529],
10	71	CD	NUMBER	71	dep	8	SENT_244	[p9l1017t3481r1457b3529],
11	.	.	O	.	_	0	SENT_244	[p9l1017t3481r1457b3529],

1	[	RB	O	[	dep	5	SENT_245	[p9l6t3544r92b3599],
2	11	CD	NUMBER	11	num	5	SENT_245	[p9l6t3544r92b3599],
3	]	CD	NUMBER	]	num	5	SENT_245	[p9l6t3544r92b3599],
4	Lau	NNP	PERSON	Lau	nn	5	SENT_245	[p9l126t3547r209b3588],
5	YY	NNP	O	YY	_	0	SENT_245	[p9l227t3547r301b3595],
6	,	,	O	,	_	0	SENT_245	[p9l227t3547r301b3595],
7	Huang	NNP	PERSON	Huang	nn	8	SENT_245	[p9l321t3547r481b3599],
8	Y	NN	PERSON	y	appos	5	SENT_245	[p9l498t3547r538b3595],
9	,	,	O	,	_	0	SENT_245	[p9l498t3547r538b3595],
10	Frassetto	NNP	PERSON	Frassetto	nn	11	SENT_245	[p9l559t3547r776b3588],
11	L	NNP	O	L	appos	5	SENT_245	[p9l797t3547r832b3595],
12	,	,	O	,	_	0	SENT_245	[p9l797t3547r832b3595],
13	Benet	NNP	PERSON	Benet	nn	14	SENT_245	[p9l853t3547r992b3588],
14	LZ	NNP	O	LZ	appos	11	SENT_245	[p9l1011t3547r1076b3588],
15	.	.	O	.	_	0	SENT_245	[p9l1011t3547r1076b3588],

1	Effect	NN	O	effect	_	0	SENT_246	[p9l1097t3544r1234b3588],
2	of	IN	O	of	_	0	SENT_246	[p9l1253t3544r1304b3588],
3	OATPIB	NNP	O	OATPIB	nn	5	SENT_246	[p9l1317t3546r1508b3588],
4	transporter	NN	O	transporter	nn	5	SENT_246	[p9l1528t3551r1809b3599],
5	inhibition	NN	O	inhibition	prep_of	1	SENT_246	[p9l1827t3544r2067b3588],
6	on	IN	O	on	_	0	SENT_246	[p9l2088t3557r2148b3588],
7	the	DT	O	the	det	8	SENT_246	[p9l125t3611r203b3654],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_246	[p9l227t3611r664b3665],
9	of	IN	O	of	_	0	SENT_246	[p9l688t3611r739b3654],
10	atorvastatin	NN	O	atorvastatin	prep_of	8	SENT_246	[p9l755t3611r1048b3654],
11	in	IN	O	in	_	0	SENT_246	[p9l1071t3611r1116b3654],
12	healthy	JJ	O	healthy	amod	13	SENT_246	[p9l1139t3611r1322b3665],
13	volunteers	NNS	O	volunteer	prep_in	1	SENT_246	[p9l1342t3611r1615b3655],
14	.	.	O	.	_	0	SENT_246	[p9l1342t3611r1615b3655],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_247	[p9l1638t3611r1732b3654],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_247	[p9l1754t3611r2014b3654],
3	T	NN	O	t	_	0	SENT_247	[p9l2035t3613r2066b3654],
4	her	PRP$	O	she	poss	5	SENT_247	[p9l2068t3611r2149b3654],
5	2007	CD	DATE	2007	dep	3	SENT_247	[p9l126t3679r577b3727],
6	;	:	O	;	_	0	SENT_247	[p9l126t3679r577b3727],
7	81:194	CD	NUMBER	81:194	number	8	SENT_247	[p9l126t3679r577b3727],
8	-204	CD	NUMBER	-204	dep	5	SENT_247	[p9l126t3679r577b3727],
9	.	.	O	.	_	0	SENT_247	[p9l126t3679r577b3727],

1	[	NN	O	[	nn	5	SENT_248	[p9l6t3742r96b3797],
2	12	CD	NUMBER	12	num	5	SENT_248	[p9l6t3742r96b3797],
3	]	CD	NUMBER	]	num	5	SENT_248	[p9l6t3742r96b3797],
4	Hochman	NNP	PERSON	Hochman	nn	5	SENT_248	[p9l130t3743r366b3786],
5	JH	NNP	O	JH	_	0	SENT_248	[p9l385t3745r456b3797],
6	,	,	O	,	_	0	SENT_248	[p9l385t3745r456b3797],
7	Pudvah	NNP	PERSON	Pudvah	nn	8	SENT_248	[p9l483t3743r663b3786],
8	N	NNP	PERSON	N	appos	5	SENT_248	[p9l689t3745r736b3793],
9	,	,	O	,	_	0	SENT_248	[p9l689t3745r736b3793],
10	Qiu	NNP	O	Qiu	nn	11	SENT_248	[p9l763t3743r846b3795],
11	J	NNP	O	J	appos	5	SENT_248	[p9l864t3745r895b3797],
12	,	,	O	,	_	0	SENT_248	[p9l864t3745r895b3797],
13	et	FW	O	et	nn	14	SENT_248	[p9l922t3749r967b3786],
14	al.	FW	O	al.	appos	5	SENT_248	[p9l991t3743r1043b3786],
15	.	.	O	.	_	0	SENT_248	[p9l991t3743r1043b3786],

1	Interactions	NNS	O	interaction	_	0	SENT_249	[p9l1069t3743r1360b3786],
2	of	IN	O	of	_	0	SENT_249	[p9l1386t3742r1437b3786],
3	human	JJ	O	human	amod	4	SENT_249	[p9l1456t3742r1629b3786],
4	P-glycoprotein	NN	MISC	p-glycoprotein	prep_of	1	SENT_249	[p9l1654t3743r2012b3797],
5	with	IN	O	with	_	0	SENT_249	[p9l2034t3743r2148b3786],
6	simvastatin	NN	O	simvastatin	prep_with	1	SENT_249	[p10l130t14r422b63],
7	,	,	O	,	_	0	SENT_249	[p10l130t14r422b63],
8	simvastatin	NN	O	simvastatin	nn	9	SENT_249	[p10l443t14r724b57],
9	acid	NN	O	acid	prep_with	1	SENT_249	[p10l744t13r854b63],
10	,	,	O	,	_	0	SENT_249	[p10l744t13r854b63],
11	and	CC	O	and	_	0	SENT_249	[p10l875t13r964b57],
12	atorvastatin	NN	O	atorvastatin	conj_and	6	SENT_249	[p10l984t14r1289b57],
13	.	.	O	.	_	0	SENT_249	[p10l984t14r1289b57],

1	Pharm	NNP	O	Pharm	nn	2	SENT_250	[p10l1311t13r1471b57],
2	Res	NNP	O	Res	_	0	SENT_250	[p10l1491t16r1571b57],
3	2004	CD	DATE	2004	num	2	SENT_250	[p10l1591t15r1788b63],
4	;	:	O	;	_	0	SENT_250	[p10l1591t15r1788b63],
5	21	CD	NUMBER	21	num	6	SENT_250	[p10l1591t15r1788b63],
6	21686-91	CD	NUMBER	21686-91	dep	2	SENT_250	[p10l1801t15r2035b57],
7	.	.	O	.	_	0	SENT_250	[p10l1801t15r2035b57],

1	[	RB	O	[	advmod	2	SENT_251	[p10l6t78r94b133],
2	13	CD	NUMBER	13	_	0	SENT_251	[p10l6t78r94b133],
3	]	CD	NUMBER	]	num	5	SENT_251	[p10l6t78r94b133],
4	Boyd	NNP	PERSON	Boyd	nn	5	SENT_251	[p10l129t79r249b133],
5	RA	NN	O	ra	dep	2	SENT_251	[p10l269t81r347b129],
6	,	,	O	,	_	0	SENT_251	[p10l269t81r347b129],
7	Stern	NNP	PERSON	Stern	nn	8	SENT_251	[p10l368t81r495b122],
8	RH	NNP	O	RH	appos	5	SENT_251	[p10l515t81r596b129],
9	,	,	O	,	_	0	SENT_251	[p10l515t81r596b129],
10	Stewart	NNP	PERSON	Stewart	nn	11	SENT_251	[p10l617t81r805b122],
11	BH	NNP	O	BH	appos	5	SENT_251	[p10l824t81r904b129],
12	,	,	O	,	_	0	SENT_251	[p10l824t81r904b129],
13	et	FW	O	et	nn	14	SENT_251	[p10l925t85r971b122],
14	al.	FW	O	al.	appos	5	SENT_251	[p10l989t79r1041b123],
15	.	.	O	.	_	0	SENT_251	[p10l989t79r1041b123],

1	Atorvastatin	NN	O	atorvastatin	nn	2	SENT_252	[p10l1060t79r1362b122],
2	coadministration	NN	O	coadministration	nsubj	4	SENT_252	[p10l1383t79r1803b122],
3	may	MD	O	may	aux	4	SENT_252	[p10l1823t91r1928b133],
4	increase	VB	O	increase	_	0	SENT_252	[p10l1947t79r2147b122],
5	digoxin	NN	O	digoxin	nn	6	SENT_252	[p10l128t145r315b199],
6	concentrations	NNS	O	concentration	dobj	4	SENT_252	[p10l355t146r729b188],
7	by	IN	O	by	_	0	SENT_252	[p10l769t145r828b199],
8	inhibition	NN	O	inhibition	prep_by	4	SENT_252	[p10l867t145r1114b188],
9	of	IN	O	of	_	0	SENT_252	[p10l1154t145r1205b188],
10	intestinal	JJ	O	intestinal	amod	11	SENT_252	[p10l1239t145r1475b188],
11	P	NN	O	p	prep_of	8	SENT_252	[p10l1515t145r2146b199],
12	—	CD	NUMBER	—	num	14	SENT_252	[p10l1515t145r2146b199],
13	glycoprotein	NN	O	glycoprotein	nn	14	SENT_252	[p10l1515t145r2146b199],
14	—	NN	O	—	nsubj	15	SENT_252	[p10l1515t145r2146b199],
15	mediated	VBD	O	mediate	rcmod	11	SENT_252	[p10l1515t145r2146b199],
16	secretion	NN	O	secretion	dobj	15	SENT_252	[p10l129t211r397b265],
17	.	.	O	.	_	0	SENT_252	[p10l129t211r397b265],
18	]	SYM	O	]	dep	4	SENT_252	[p10l129t211r397b265],

1	Clin	NNP	O	Clin	nn	2	SENT_253	[p10l418t210r511b254],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_253	[p10l531t211r791b254],
3	2000	CD	DATE	2000	num	2	SENT_253	[p10l811t213r1091b261],
4	;	:	O	;	_	0	SENT_253	[p10l811t213r1091b261],
5	40:91	CD	NUMBER	40:91	number	6	SENT_253	[p10l811t213r1091b261],
6	-8	CD	NUMBER	-8	dep	2	SENT_253	[p10l1101t213r1171b254],
7	.	.	O	.	_	0	SENT_253	[p10l1101t213r1171b254],

1	[	RB	O	[	dep	5	SENT_254	[p10l6t276r94b331],
2	14	CD	NUMBER	14	num	5	SENT_254	[p10l6t276r94b331],
3	]	CD	NUMBER	]	num	5	SENT_254	[p10l6t276r94b331],
4	Tirona	NNP	O	Tirona	nn	5	SENT_254	[p10l126t277r285b320],
5	RG	NNP	O	RG	_	0	SENT_254	[p10l312t279r391b327],
6	,	,	O	,	_	0	SENT_254	[p10l312t279r391b327],
7	Leake	NNP	PERSON	Leake	nn	8	SENT_254	[p10l421t277r558b320],
8	BF	NNP	O	BF	appos	5	SENT_254	[p10l587t279r652b327],
9	,	,	O	,	_	0	SENT_254	[p10l587t279r652b327],
10	Wolkoff	NNP	PERSON	Wolkoff	nn	11	SENT_254	[p10l679t277r881b320],
11	AW	NNP	O	AW	appos	5	SENT_254	[p10l901t279r998b327],
12	,	,	O	,	_	0	SENT_254	[p10l901t279r998b327],
13	Kim	NNP	PERSON	Kim	nn	14	SENT_254	[p10l1028t277r1126b320],
14	RB	NN	O	rb	appos	11	SENT_254	[p10l1154t279r1228b321],
15	.	.	O	.	_	0	SENT_254	[p10l1154t279r1228b321],

1	Human	JJ	O	human	amod	3	SENT_255	[p10l1258t279r1438b320],
2	organic	JJ	O	organic	amod	3	SENT_255	[p10l1466t277r1648b331],
3	anion	NN	O	anion	_	0	SENT_255	[p10l1675t277r1813b320],
4	transporting	VBG	O	transport	dep	3	SENT_255	[p10l1841t277r2149b331],
5	polypeptide-C	NN	O	polypeptide-c	nn	8	SENT_255	[p10l128t343r477b398],
6	(	CD	NUMBER	(	num	8	SENT_255	[p10l500t343r753b397],
7	SLC21A6	NN	O	slc21a6	nn	8	SENT_255	[p10l500t343r753b397],
8	)	NN	O	)	dobj	4	SENT_255	[p10l500t343r753b397],
9	is	VBZ	O	be	cop	12	SENT_255	[p10l776t344r811b387],
10	a	DT	O	a	det	12	SENT_255	[p10l832t356r857b387],
11	major	JJ	O	major	amod	12	SENT_255	[p10l877t344r1020b398],
12	determinant	NN	O	determinant	rcmod	8	SENT_255	[p10l1038t343r1346b387],
13	of	IN	O	of	prep	12	SENT_255	[p10l1364t343r1415b387],
14	rifampin-mediated	JJ	O	rifampin-mediated	amod	16	SENT_255	[p10l1429t343r1897b398],
15	pregnane	NN	O	pregnane	nn	16	SENT_255	[p10l1917t356r2147b398],
16	X	NN	O	x	dep	13	SENT_255	[p10l126t412r162b452],
17	receptor	NN	O	receptor	nn	18	SENT_255	[p10l181t415r388b463],
18	activation	NN	O	activation	dep	16	SENT_255	[p10l405t410r691b463],
19	.	.	O	.	_	0	SENT_255	[p10l405t410r691b463],
20	]	SYM	O	]	dep	12	SENT_255	[p10l405t410r691b463],

1	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_256	[p10l711t409r970b452],
2	Exp	NNP	O	Exp	nn	3	SENT_256	[p10l991t412r1080b463],
3	Ther	NNP	O	Ther	_	0	SENT_256	[p10l1098t409r1213b452],
4	2003	CD	DATE	2003	num	3	SENT_256	[p10l1231t411r1654b459],
5	;	:	O	;	_	0	SENT_256	[p10l1231t411r1654b459],
6	304:223	CD	NUMBER	304:223	number	7	SENT_256	[p10l1231t411r1654b459],
7	—	CD	NUMBER	—	dep	3	SENT_256	[p10l1231t411r1654b459],
8	8	CD	NUMBER	8	dep	7	SENT_256	[p10l1231t411r1654b459],
9	.	.	O	.	_	0	SENT_256	[p10l1231t411r1654b459],

1	[	RB	O	[	advmod	2	SENT_257	[p10l6t475r94b529],
2	15	CD	NUMBER	15	_	0	SENT_257	[p10l6t475r94b529],
3	]	CD	NUMBER	]	num	5	SENT_257	[p10l6t475r94b529],
4	Vavricka	NNP	O	Vavricka	nn	5	SENT_257	[p10l126t475r339b519],
5	SR	NN	O	sr	dep	2	SENT_257	[p10l353t477r423b525],
6	,	,	O	,	_	0	SENT_257	[p10l353t477r423b525],
7	Van	NNP	PERSON	Van	nn	9	SENT_257	[p10l436t478r532b519],
8	Montfoort	NNP	PERSON	Montfoort	nn	9	SENT_257	[p10l547t475r799b519],
9	]	NN	O	]	appos	5	SENT_257	[p10l807t478r838b529],
10	,	,	O	,	_	0	SENT_257	[p10l807t478r838b529],
11	Ha	NNP	O	Ha	nn	12	SENT_257	[p10l854t478r918b519],
12	HR	NNP	DURATION	HR	appos	5	SENT_257	[p10l933t478r1015b525],
13	,	,	O	,	_	0	SENT_257	[p10l933t478r1015b525],
14	Meier	NNP	PERSON	Meier	nn	16	SENT_257	[p10l1031t476r1174b519],
15	P	NN	O	p	nn	16	SENT_257	[p10l1188t478r1242b529],
16	]	NN	O	]	appos	5	SENT_257	[p10l1188t478r1242b529],
17	,	,	O	,	_	0	SENT_257	[p10l1188t478r1242b529],
18	Fattinger	NNP	O	Fattinger	nn	20	SENT_257	[p10l1258t476r1478b529],
19	K.	NNP	O	K.	nn	20	SENT_257	[p10l1491t478r1534b519],
20	Interactions	NNS	O	interaction	appos	5	SENT_257	[p10l1550t476r1841b519],
21	of	IN	O	of	_	0	SENT_257	[p10l1857t475r1908b519],
22	rifamycin	NN	O	rifamycin	nn	23	SENT_257	[p10l1917t475r2148b529],
23	SV	NN	O	sv	prep_of	20	SENT_257	[p10l128t543r191b584],
24	and	CC	O	and	_	0	SENT_257	[p10l207t541r296b584],
25	rifampicin	NN	O	rifampicin	prep_of	20	SENT_257	[p10l317t541r569b595],
26	with	IN	O	with	_	0	SENT_257	[p10l585t541r698b584],
27	organic	JJ	O	organic	amod	30	SENT_257	[p10l718t541r900b595],
28	anion	NN	O	anion	nn	30	SENT_257	[p10l918t541r1055b584],
29	uptake	NN	O	uptake	nn	30	SENT_257	[p10l1074t541r1241b595],
30	systems	NNS	O	system	prep_with	5	SENT_257	[p10l1261t547r1455b595],
31	of	IN	O	of	_	0	SENT_257	[p10l1474t541r1526b584],
32	human	JJ	O	human	amod	33	SENT_257	[p10l1539t541r1711b584],
33	liver	NN	O	liver	prep_of	30	SENT_257	[p10l1730t541r1846b585],
34	.	.	O	.	_	0	SENT_257	[p10l1730t541r1846b585],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_258	[p10l1867t541r2149b595],
2	2002	CD	DATE	2002	num	1	SENT_258	[p10l128t609r547b657],
3	;	:	O	;	_	0	SENT_258	[p10l128t609r547b657],
4	36:164	CD	NUMBER	36:164	number	5	SENT_258	[p10l128t609r547b657],
5	—	CD	NUMBER	—	dep	1	SENT_258	[p10l128t609r547b657],
6	72	CD	NUMBER	72	dep	5	SENT_258	[p10l128t609r547b657],
7	.	.	O	.	_	0	SENT_258	[p10l128t609r547b657],

1	[	RB	O	[	dep	5	SENT_259	[p10l6t672r94b727],
2	16	CD	NUMBER	16	num	5	SENT_259	[p10l6t672r94b727],
3	]	CD	NUMBER	]	num	5	SENT_259	[p10l6t672r94b727],
4	Letschert	NNP	O	Letschert	nn	5	SENT_259	[p10l129t673r354b716],
5	K	NNP	O	K	_	0	SENT_259	[p10l385t675r428b723],
6	,	,	O	,	_	0	SENT_259	[p10l385t675r428b723],
7	Faulstich	NNP	PERSON	Faulstich	nn	8	SENT_259	[p10l462t672r678b716],
8	H	NNP	O	H	appos	5	SENT_259	[p10l711t675r760b723],
9	,	,	O	,	_	0	SENT_259	[p10l711t675r760b723],
10	Keller	NNP	PERSON	Keller	nn	11	SENT_259	[p10l793t672r935b716],
11	D	NNP	O	D	appos	5	SENT_259	[p10l967t675r1013b723],
12	,	,	O	,	_	0	SENT_259	[p10l967t675r1013b723],
13	Keppler	NNP	PERSON	Keppler	nn	16	SENT_259	[p10l1047t673r1238b727],
14	D.	NNP	O	D.	nn	16	SENT_259	[p10l1270t675r1316b716],
15	Molecular	JJ	O	molecular	amod	16	SENT_259	[p10l1350t672r1597b716],
16	characterization	NN	O	characterization	conj_and	11	SENT_259	[p10l1628t672r2025b716],
17	and	CC	O	and	_	0	SENT_259	[p10l2058t672r2147b716],
18	inhibition	NN	O	inhibition	conj_and	11	SENT_259	[p10l128t739r369b783],
19	of	IN	O	of	_	0	SENT_259	[p10l385t739r436b783],
20	amanitin	NN	O	amanitin	nn	21	SENT_259	[p10l446t740r666b783],
21	uptake	NN	O	uptake	prep_of	18	SENT_259	[p10l682t739r849b793],
22	into	IN	O	into	_	0	SENT_259	[p10l866t740r961b783],
23	human	JJ	O	human	amod	24	SENT_259	[p10l977t739r1150b783],
24	hepatocytes	NNS	O	hepatocyte	prep_into	21	SENT_259	[p10l1166t739r1472b793],
25	.	.	O	.	_	0	SENT_259	[p10l1166t739r1472b793],

1	Toxicol	NNP	O	Toxicol	nn	2	SENT_260	[p10l1487t739r1661b783],
2	Sci	NNP	O	Sci	_	0	SENT_260	[p10l1677t740r1743b783],
3	2006	CD	DATE	2006	num	2	SENT_260	[p10l1760t741r2147b789],
4	;	:	O	;	_	0	SENT_260	[p10l1760t741r2147b789],
5	91:140	CD	NUMBER	91:140	number	6	SENT_260	[p10l1760t741r2147b789],
6	—	CD	NUMBER	—	dep	2	SENT_260	[p10l1760t741r2147b789],
7	9	CD	NUMBER	9	dep	6	SENT_260	[p10l1760t741r2147b789],
8	.	.	O	.	_	0	SENT_260	[p10l1760t741r2147b789],

1	[	NN	O	[	nn	5	SENT_261	[p10l6t805r93b859],
2	17	CD	NUMBER	17	num	5	SENT_261	[p10l6t805r93b859],
3	]	CD	NUMBER	]	num	5	SENT_261	[p10l6t805r93b859],
4	Xu	NNP	O	Xu	nn	5	SENT_261	[p10l124t808r192b849],
5	LY	NNP	O	LY	_	0	SENT_261	[p10l229t808r289b855],
6	,	,	O	,	_	0	SENT_261	[p10l229t808r289b855],
7	He	PRP	O	he	appos	5	SENT_261	[p10l328t808r393b849],
8	Y	NN	O	y	dep	7	SENT_261	[p10l429t808r490b859],
9	]	CD	NUMBER	]	num	8	SENT_261	[p10l429t808r490b859],
10	,	,	O	,	_	0	SENT_261	[p10l429t808r490b859],
11	Zhang	NNP	PERSON	Zhang	nn	12	SENT_261	[p10l527t805r679b859],
12	W	NNP	PERSON	W	appos	5	SENT_261	[p10l714t808r779b855],
13	,	,	O	,	_	0	SENT_261	[p10l714t808r779b855],
14	et	FW	O	et	nn	15	SENT_261	[p10l817t812r863b849],
15	al.	FW	O	al.	appos	5	SENT_261	[p10l900t805r952b849],
16	.	.	O	.	_	0	SENT_261	[p10l900t805r952b849],

1	Organic	NNP	O	Organic	nn	2	SENT_262	[p10l991t806r1181b859],
2	anion	NN	O	anion	nsubj	3	SENT_262	[p10l1218t806r1354b849],
3	transporting	VBG	O	transport	_	0	SENT_262	[p10l1392t806r1700b859],
4	polypeptide	NN	O	polypeptide	nn	6	SENT_262	[p10l1736t805r2141b859],
5	—	CD	NUMBER	—	num	6	SENT_262	[p10l1736t805r2141b859],
6	1B1	NN	O	1b1	dobj	3	SENT_262	[p10l1736t805r2141b859],

1	haplotypes	NNS	O	haplotype	_	0	SENT_263	[p10l127t871r396b925],
2	in	IN	O	in	_	0	SENT_263	[p10l417t872r462b914],
3	Chinese	JJ	MISC	chinese	amod	4	SENT_263	[p10l481t871r672b914],
4	patients	NNS	O	patient	prep_in	1	SENT_263	[p10l693t872r902b925],
5	.	.	O	.	_	0	SENT_263	[p10l693t872r902b925],

1	Acta	NNP	O	Acta	nn	3	SENT_264	[p10l921t873r1029b914],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_264	[p10l1048t871r1308b914],
3	Sin	NNP	O	Sin	_	0	SENT_264	[p10l1328t872r1402b914],
4	2007	CD	DATE	2007	num	3	SENT_264	[p10l1422t873r1836b921],
5	;	:	O	;	_	0	SENT_264	[p10l1422t873r1836b921],
6	28:1693	CD	NUMBER	28:1693	num	7	SENT_264	[p10l1422t873r1836b921],
7	—	NN	O	—	dep	3	SENT_264	[p10l1422t873r1836b921],
8	7	CD	NUMBER	7	dep	7	SENT_264	[p10l1422t873r1836b921],
9	.	.	O	.	_	0	SENT_264	[p10l1422t873r1836b921],

1	[	NN	O	[	_	0	SENT_265	[p10l6t937r94b991],
2	18	CD	NUMBER	18	num	1	SENT_265	[p10l6t937r94b991],
3	]	CD	NUMBER	]	num	5	SENT_265	[p10l6t937r94b991],
4	Hilgendorf	NN	PERSON	hilgendorf	nn	5	SENT_265	[p10l128t937r390b991],
5	C	NN	PERSON	c	dep	1	SENT_265	[p10l407t939r448b987],
6	,	,	O	,	_	0	SENT_265	[p10l407t939r448b987],
7	Ahlin	NNP	PERSON	Ahlin	nn	8	SENT_265	[p10l471t937r600b980],
8	G	NNP	PERSON	G	appos	5	SENT_265	[p10l625t939r671b987],
9	,	,	O	,	_	0	SENT_265	[p10l625t939r671b987],
10	Seithel	NNP	O	Seithel	nn	11	SENT_265	[p10l696t937r857b980],
11	A	NNP	O	A	appos	5	SENT_265	[p10l880t939r926b987],
12	,	,	O	,	_	0	SENT_265	[p10l880t939r926b987],
13	Artursson	NNP	O	Artursson	nn	14	SENT_265	[p10l949t939r1186b980],
14	P	NN	O	p	appos	5	SENT_265	[p10l1211t940r1244b987],
15	,	,	O	,	_	0	SENT_265	[p10l1211t940r1244b987],
16	Ungell	NNP	ORGANIZATION	Ungell	nn	17	SENT_265	[p10l1269t937r1421b991],
17	AL	NNP	ORGANIZATION	AL	appos	5	SENT_265	[p10l1445t939r1516b987],
18	,	,	O	,	_	0	SENT_265	[p10l1445t939r1516b987],
19	Karlsson	NNP	PERSON	Karlsson	nn	20	SENT_265	[p10l1542t937r1745b980],
20	]	NNP	O	]	appos	5	SENT_265	[p10l1763t940r1794b991],
21	.	.	O	.	_	0	SENT_265	[p10l1763t940r1794b991],

1	Expression	NN	O	expression	_	0	SENT_266	[p10l1818t938r2079b991],
2	of	IN	O	of	_	0	SENT_266	[p10l2104t937r2154b980],
3	thirty-six	CD	NUMBER	thirty-six	num	6	SENT_266	[p10l127t1003r351b1057],
4	drug	NN	O	drug	nn	6	SENT_266	[p10l368t1003r481b1057],
5	transporter	NN	O	transporter	nn	6	SENT_266	[p10l498t1009r770b1057],
6	genes	NNS	O	gene	prep_of	1	SENT_266	[p10l786t1015r923b1057],
7	in	IN	O	in	_	0	SENT_266	[p10l942t1003r987b1046],
8	human	JJ	O	human	amod	9	SENT_266	[p10l1006t1003r1175b1046],
9	intestine	NN	O	intestine	prep_in	1	SENT_266	[p10l1195t1003r1414b1053],
10	,	,	O	,	_	0	SENT_266	[p10l1195t1003r1414b1053],
11	liver	NN	O	liver	conj_and	9	SENT_266	[p10l1433t1003r1545b1053],
12	,	,	O	,	_	0	SENT_266	[p10l1433t1003r1545b1053],
13	kidney	NN	O	kidney	conj_and	9	SENT_266	[p10l1565t1003r1735b1057],
14	,	,	O	,	_	0	SENT_266	[p10l1565t1003r1735b1057],
15	and	CC	O	and	_	0	SENT_266	[p10l1755t1003r1842b1046],
16	organotypic	JJ	O	organotypic	amod	18	SENT_266	[p10l1862t1003r2149b1057],
17	cell	NN	O	cell	nn	18	SENT_266	[p10l128t1069r208b1112],
18	lines	NNS	O	line	prep_in	1	SENT_266	[p10l226t1069r346b1113],
19	.	.	O	.	_	0	SENT_266	[p10l226t1069r346b1113],

1	Drug	NN	O	drug	nn	3	SENT_267	[p10l365t1071r484b1123],
2	Metab	NNP	O	Metab	nn	3	SENT_267	[p10l500t1069r651b1112],
3	Dispos	NNP	O	Dispos	_	0	SENT_267	[p10l669t1069r826b1123],
4	2007	CD	DATE	2007	num	3	SENT_267	[p10l844t1071r1281b1119],
5	;	:	O	;	_	0	SENT_267	[p10l844t1071r1281b1119],
6	35:1333	CD	NUMBER	35:1333	number	7	SENT_267	[p10l844t1071r1281b1119],
7	—	CD	NUMBER	—	dep	3	SENT_267	[p10l844t1071r1281b1119],
8	40	CD	NUMBER	40	dep	7	SENT_267	[p10l844t1071r1281b1119],
9	.	.	O	.	_	0	SENT_267	[p10l844t1071r1281b1119],

1	[	NN	O	[	nn	5	SENT_268	[p10l6t1135r94b1190],
2	19	CD	NUMBER	19	num	5	SENT_268	[p10l6t1135r94b1190],
3	]	CD	NUMBER	]	num	5	SENT_268	[p10l6t1135r94b1190],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_268	[p10l127t1135r279b1190],
5	W	NNP	PERSON	W	_	0	SENT_268	[p10l301t1138r365b1185],
6	,	,	O	,	_	0	SENT_268	[p10l301t1138r365b1185],
7	He	PRP	O	he	appos	5	SENT_268	[p10l391t1138r456b1179],
8	Y	NN	O	y	dep	7	SENT_268	[p10l478t1138r539b1190],
9	]	CD	NUMBER	]	num	8	SENT_268	[p10l478t1138r539b1190],
10	,	,	O	,	_	0	SENT_268	[p10l478t1138r539b1190],
11	Han	NNP	O	Han	nn	12	SENT_268	[p10l564t1138r661b1179],
12	CT	NNP	O	CT	appos	5	SENT_268	[p10l686t1138r754b1185],
13	,	,	O	,	_	0	SENT_268	[p10l686t1138r754b1185],
14	et	FW	O	et	nn	15	SENT_268	[p10l779t1142r825b1179],
15	al.	FW	O	al.	appos	5	SENT_268	[p10l848t1135r900b1179],
16	.	.	O	.	_	0	SENT_268	[p10l848t1135r900b1179],

1	Effect	NN	O	effect	_	0	SENT_269	[p10l926t1135r1063b1179],
2	of	IN	O	of	_	0	SENT_269	[p10l1086t1135r1137b1179],
3	SLCO1B1	NN	O	slco1b1	nn	5	SENT_269	[p10l1155t1138r1366b1179],
4	genetic	JJ	O	genetic	amod	5	SENT_269	[p10l1396t1136r1575b1190],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_269	[p10l1598t1135r1961b1190],
6	on	IN	O	on	_	0	SENT_269	[p10l1985t1148r2045b1179],
7	the	DT	O	the	det	8	SENT_269	[p10l2069t1135r2147b1179],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	5	SENT_269	[p10l128t1201r566b1255],
9	of	IN	O	of	_	0	SENT_269	[p10l587t1201r638b1245],
10	nateglinide	NN	O	nateglinide	prep_of	1	SENT_269	[p10l652t1201r940b1255],
11	.	.	O	.	_	0	SENT_269	[p10l652t1201r940b1255],

1	Br	NN	O	br	nn	4	SENT_270	[p10l961t1204r1044b1255],
2	]	CD	NUMBER	]	num	4	SENT_270	[p10l961t1204r1044b1255],
3	Clin	NNP	O	Clin	nn	4	SENT_270	[p10l1064t1201r1158b1245],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_270	[p10l1178t1201r1437b1245],
5	2006	CD	DATE	2006	dep	4	SENT_270	[p10l1458t1203r1880b1251],
6	;	:	O	;	_	0	SENT_270	[p10l1458t1203r1880b1251],
7	62:567	CD	NUMBER	62:567	number	8	SENT_270	[p10l1458t1203r1880b1251],
8	—	CD	NUMBER	—	dep	4	SENT_270	[p10l1458t1203r1880b1251],
9	72	CD	NUMBER	72	dep	8	SENT_270	[p10l1458t1203r1880b1251],
10	.	.	O	.	_	0	SENT_270	[p10l1458t1203r1880b1251],

1	[	RB	O	[	dep	5	SENT_271	[p10l6t1267r98b1322],
2	20	CD	NUMBER	20	num	5	SENT_271	[p10l6t1267r98b1322],
3	]	CD	NUMBER	]	num	5	SENT_271	[p10l6t1267r98b1322],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_271	[p10l131t1266r283b1321],
5	W	NNP	PERSON	W	_	0	SENT_271	[p10l318t1269r382b1317],
6	,	,	O	,	_	0	SENT_271	[p10l318t1269r382b1317],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_271	[p10l422t1267r544b1310],
8	BL	NN	O	bl	appos	5	SENT_271	[p10l583t1269r650b1317],
9	,	,	O	,	_	0	SENT_271	[p10l583t1269r650b1317],
10	Ozdemir	NNP	PERSON	Ozdemir	nn	11	SENT_271	[p10l689t1266r901b1310],
11	V	NNP	O	V	appos	5	SENT_271	[p10l935t1269r981b1317],
12	,	,	O	,	_	0	SENT_271	[p10l935t1269r981b1317],
13	et	FW	O	et	nn	14	SENT_271	[p10l1020t1273r1067b1310],
14	al.	FW	O	al.	appos	11	SENT_271	[p10l1103t1267r1155b1310],
15	.	.	O	.	_	0	SENT_271	[p10l1103t1267r1155b1310],

1	SLCO1B1	NN	O	slco1b1	_	0	SENT_272	[p10l1194t1269r1405b1310],
2	521T	SYM	O	521t	dep	15	SENT_272	[p10l1446t1269r1647b1310],
3	-	:	O	-	_	0	SENT_272	[p10l1446t1269r1647b1310],
4	>	JJR	O	>	dep	5	SENT_272	[p10l1446t1269r1647b1310],
5	C	NN	O	c	amod	8	SENT_272	[p10l1446t1269r1647b1310],
6	functional	JJ	O	functional	amod	8	SENT_272	[p10l1685t1266r1932b1310],
7	genetic	JJ	O	genetic	amod	8	SENT_272	[p10l1970t1267r2149b1321],
8	polymorphism	NN	O	polymorphism	npadvmod	15	SENT_272	[p10l132t1333r495b1387],
9	and	CC	O	and	_	0	SENT_272	[p10l510t1333r599b1377],
10	lipid-lowering	JJ	O	lipid-lowering	amod	11	SENT_272	[p10l616t1333r969b1387],
11	efﬁcacy	NN	O	efﬁcacy	npadvmod	15	SENT_272	[p10l983t1333r1169b1387],
12	of	IN	O	of	_	0	SENT_272	[p10l1183t1333r1234b1377],
13	multiple-dose	JJ	O	multiple-dose	amod	14	SENT_272	[p10l1244t1333r1588b1387],
14	pravastatin	NN	O	pravastatin	prep_of	11	SENT_272	[p10l1605t1334r1879b1387],
15	in	IN	O	in	dep	1	SENT_272	[p10l1895t1334r1941b1376],
16	Chinese	JJ	MISC	chinese	amod	20	SENT_272	[p10l1956t1333r2147b1377],
17	coronary	JJ	O	coronary	amod	20	SENT_272	[p10l132t1412r351b1454],
18	heart	NN	O	heart	nn	20	SENT_272	[p10l369t1399r498b1443],
19	disease	NN	O	disease	nn	20	SENT_272	[p10l517t1399r693b1443],
20	patients	NNS	O	patient	pobj	15	SENT_272	[p10l714t1400r924b1454],
21	.	.	O	.	_	0	SENT_272	[p10l714t1400r924b1454],

1	Br	NN	O	br	nn	4	SENT_273	[p10l944t1402r1028b1454],
2	]	CD	NUMBER	]	num	4	SENT_273	[p10l944t1402r1028b1454],
3	Clin	NNP	O	Clin	nn	4	SENT_273	[p10l1048t1399r1142b1443],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_273	[p10l1162t1399r1421b1443],
5	2007	CD	DATE	2007	dep	4	SENT_273	[p10l1442t1401r1864b1449],
6	;	:	O	;	_	0	SENT_273	[p10l1442t1401r1864b1449],
7	64:346	CD	NUMBER	64:346	number	8	SENT_273	[p10l1442t1401r1864b1449],
8	—	CD	NUMBER	—	dep	4	SENT_273	[p10l1442t1401r1864b1449],
9	52	CD	NUMBER	52	dep	8	SENT_273	[p10l1442t1401r1864b1449],
10	.	.	O	.	_	0	SENT_273	[p10l1442t1401r1864b1449],

1	[	NN	O	[	_	0	SENT_274	[p10l6t1465r96b1519],
2	21	CD	NUMBER	21	number	3	SENT_274	[p10l6t1465r96b1519],
3	]	CD	NUMBER	]	num	6	SENT_274	[p10l6t1465r96b1519],
4	Chung	NNP	PERSON	Chung	nn	6	SENT_274	[p10l129t1465r287b1519],
5	]	CD	NUMBER	]	num	6	SENT_274	[p10l299t1468r360b1519],
6	Y	NN	O	y	dep	1	SENT_274	[p10l299t1468r360b1519],
7	,	,	O	,	_	0	SENT_274	[p10l299t1468r360b1519],
8	Cho	NNP	PERSON	Cho	appos	6	SENT_274	[p10l381t1465r472b1508],
9	]	CD	NUMBER	]	num	10	SENT_274	[p10l487t1468r547b1519],
10	Y	NN	O	y	dep	1	SENT_274	[p10l487t1468r547b1519],
11	,	,	O	,	_	0	SENT_274	[p10l487t1468r547b1519],
12	Yu	NNP	PERSON	Yu	nn	13	SENT_274	[p10l566t1468r628b1508],
13	KS	NN	PERSON	k	appos	10	SENT_274	[p10l648t1467r721b1515],
14	,	,	O	,	_	0	SENT_274	[p10l648t1467r721b1515],
15	et	FW	O	et	nn	16	SENT_274	[p10l741t1471r787b1508],
16	al.	FW	O	al.	appos	1	SENT_274	[p10l805t1465r857b1509],
17	.	.	O	.	_	0	SENT_274	[p10l805t1465r857b1509],

1	Effect	NN	O	effect	nsubj	5	SENT_275	[p10l878t1465r1015b1508],
2	of	IN	O	of	_	0	SENT_275	[p10l1034t1465r1084b1508],
3	OATP1B1	NN	O	oatp1b1	prep_of	1	SENT_275	[p10l1098t1467r1314b1508],
4	(	CD	NUMBER	(	num	5	SENT_275	[p10l1344t1465r1603b1519],
5	SLCO1B1	NN	O	slco1b1	_	0	SENT_275	[p10l1344t1465r1603b1519],
6	)	CD	NUMBER	)	num	8	SENT_275	[p10l1344t1465r1603b1519],
7	variant	JJ	O	variant	amod	8	SENT_275	[p10l1625t1466r1799b1508],
8	alleles	NNS	O	allele	dobj	5	SENT_275	[p10l1817t1465r1969b1508],
9	on	IN	O	on	_	0	SENT_275	[p10l1990t1477r2050b1508],
10	the	DT	O	the	det	11	SENT_275	[p10l2069t1465r2147b1508],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_275	[p10l129t1531r567b1585],
12	of	IN	O	of	_	0	SENT_275	[p10l604t1530r655b1574],
13	pitavastatin	NN	O	pitavastatin	prep_of	11	SENT_275	[p10l684t1531r971b1585],
14	in	IN	O	in	_	0	SENT_275	[p10l1007t1531r1052b1574],
15	healthy	JJ	O	healthy	amod	16	SENT_275	[p10l1088t1530r1272b1585],
16	volunteers	NNS	O	volunteer	prep_in	5	SENT_275	[p10l1304t1531r1577b1574],
17	.	.	O	.	_	0	SENT_275	[p10l1304t1531r1577b1574],

1	Clin	NNP	O	Clin	nn	3	SENT_276	[p10l1613t1530r1706b1574],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_276	[p10l1742t1530r2001b1574],
3	Ther	NNP	O	Ther	_	0	SENT_276	[p10l2036t1530r2149b1574],
4	2005	CD	DATE	2005	num	3	SENT_276	[p10l129t1599r552b1647],
5	;	:	O	;	_	0	SENT_276	[p10l129t1599r552b1647],
6	78:342	CD	NUMBER	78:342	number	7	SENT_276	[p10l129t1599r552b1647],
7	—	CD	NUMBER	—	dep	3	SENT_276	[p10l129t1599r552b1647],
8	50	CD	NUMBER	50	dep	7	SENT_276	[p10l129t1599r552b1647],
9	.	.	O	.	_	0	SENT_276	[p10l129t1599r552b1647],

1	[	NN	O	[	nn	5	SENT_277	[p10l6t1663r98b1718],
2	22	CD	NUMBER	22	num	5	SENT_277	[p10l6t1663r98b1718],
3	]	CD	NUMBER	]	num	5	SENT_277	[p10l6t1663r98b1718],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_277	[p10l132t1666r210b1707],
5	E	NNP	PERSON	E	_	0	SENT_277	[p10l232t1666r269b1713],
6	,	,	O	,	_	0	SENT_277	[p10l232t1666r269b1713],
7	Ryan	NNP	PERSON	Ryan	nn	8	SENT_277	[p10l291t1666r408b1718],
8	S	NNP	PERSON	S	appos	5	SENT_277	[p10l429t1666r465b1713],
9	,	,	O	,	_	0	SENT_277	[p10l429t1666r465b1713],
10	Birmingham	NNP	LOCATION	Birmingham	nn	11	SENT_277	[p10l486t1663r787b1718],
11	B	NNP	O	B	appos	5	SENT_277	[p10l806t1666r846b1713],
12	,	,	O	,	_	0	SENT_277	[p10l806t1666r846b1713],
13	et	FW	O	et	nn	14	SENT_277	[p10l867t1670r914b1707],
14	al.	FW	O	al.	appos	5	SENT_277	[p10l932t1663r983b1707],
15	.	.	O	.	_	0	SENT_277	[p10l932t1663r983b1707],

1	Rosuvastatin	NNP	O	Rosuvastatin	nn	2	SENT_278	[p10l1005t1664r1309b1707],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_278	[p10l1328t1663r1755b1718],
3	and	CC	O	and	_	0	SENT_278	[p10l1776t1663r1864b1707],
4	pharmacogenetics	NNS	O	pharmacogenetic	conj_and	2	SENT_278	[p10l1886t1663r2147b1718, p10l131t1729r326b1783],
5	in	IN	O	in	_	0	SENT_278	[p10l361t1729r407b1772],
6	white	JJ	O	white	amod	9	SENT_278	[p10l437t1728r575b1772],
7	and	CC	O	and	_	0	SENT_278	[p10l610t1728r697b1772],
8	Asian	JJ	MISC	asian	amod	9	SENT_278	[p10l730t1729r862b1772],
9	subjects	NNS	O	subject	prep_in	4	SENT_278	[p10l897t1728r1088b1783],
10	residing	VBG	O	reside	partmod	2	SENT_278	[p10l1124t1728r1316b1783],
11	in	IN	O	in	_	0	SENT_278	[p10l1350t1729r1395b1772],
12	the	DT	O	the	det	14	SENT_278	[p10l1429t1728r1505b1772],
13	same	JJ	O	same	amod	14	SENT_278	[p10l1540t1741r1663b1772],
14	environment	NN	O	environment	prep_in	10	SENT_278	[p10l1698t1729r2021b1772],
15	.	.	O	.	_	0	SENT_278	[p10l1698t1729r2021b1772],

1	Clin	NNP	O	Clin	nn	3	SENT_279	[p10l2056t1729r2149b1772],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_279	[p10l132t1795r385b1839],
3	Ther	NNP	O	Ther	_	0	SENT_279	[p10l401t1795r513b1839],
4	2005	CD	DATE	2005	num	3	SENT_279	[p10l528t1797r932b1845],
5	;	:	O	;	_	0	SENT_279	[p10l528t1797r932b1845],
6	78:330	CD	NUMBER	78:330	number	7	SENT_279	[p10l528t1797r932b1845],
7	—	CD	NUMBER	—	dep	3	SENT_279	[p10l528t1797r932b1845],
8	41	CD	NUMBER	41	dep	7	SENT_279	[p10l528t1797r932b1845],
9	.	.	O	.	_	0	SENT_279	[p10l528t1797r932b1845],

1	[	NN	O	[	tmod	13	SENT_280	[p10l6t1861r98b1916],
2	23	CD	NUMBER	23	num	1	SENT_280	[p10l6t1861r98b1916],
3	]	CD	NUMBER	]	num	6	SENT_280	[p10l6t1861r98b1916],
4	Deng	NNP	PERSON	Deng	nn	6	SENT_280	[p10l132t1864r257b1916],
5	]	CD	NUMBER	]	num	6	SENT_280	[p10l274t1864r357b1916],
6	W	NNP	O	W	dep	1	SENT_280	[p10l274t1864r357b1916],
7	,	,	O	,	_	0	SENT_280	[p10l274t1864r357b1916],
8	Song	NN	O	song	nsubj	13	SENT_280	[p10l384t1864r502b1916],
9	IS	VBZ	O	be	cop	13	SENT_280	[p10l526t1864r577b1911],
10	,	,	O	,	_	0	SENT_280	[p10l526t1864r577b1911],
11	Shin	NNP	PERSON	Shin	nn	13	SENT_280	[p10l603t1861r708b1905],
12	H	NNP	PERSON	H	nn	13	SENT_280	[p10l734t1864r797b1916],
13	]	NN	O	]	_	0	SENT_280	[p10l734t1864r797b1916],
14	,	,	O	,	_	0	SENT_280	[p10l734t1864r797b1916],
15	et	FW	O	et	nn	16	SENT_280	[p10l823t1868r869b1905],
16	al.	FW	O	al.	appos	13	SENT_280	[p10l892t1861r943b1905],
17	.	.	O	.	_	0	SENT_280	[p10l892t1861r943b1905],

1	The	DT	O	the	det	2	SENT_281	[p10l967t1861r1055b1905],
2	effect	NN	O	effect	nsubj	16	SENT_281	[p10l1081t1861r1213b1905],
3	of	IN	O	of	_	0	SENT_281	[p10l1236t1861r1286b1905],
4	SLCO1B1	NN	O	slco1b1	prep_of	2	SENT_281	[p10l1306t1862r1601b1905],
5	*	CD	NUMBER	*	number	6	SENT_281	[p10l1306t1862r1601b1905],
6	15	CD	NUMBER	15	npadvmod	4	SENT_281	[p10l1306t1862r1601b1905],
7	on	IN	O	on	_	0	SENT_281	[p10l1628t1874r1689b1905],
8	the	DT	O	the	det	9	SENT_281	[p10l1713t1861r1790b1905],
9	disposition	NN	O	disposition	prep_on	4	SENT_281	[p10l1815t1861r2079b1916],
10	of	IN	O	of	_	0	SENT_281	[p10l2104t1861r2154b1905],
11	pravastatin	NN	O	pravastatin	prep_of	9	SENT_281	[p10l132t1928r399b1981],
12	and	CC	O	and	_	0	SENT_281	[p10l412t1927r500b1970],
13	pitavastatin	NN	O	pitavastatin	conj_and	11	SENT_281	[p10l516t1928r797b1981],
14	is	VBZ	O	be	cop	16	SENT_281	[p10l811t1928r846b1970],
15	substrate	JJ	O	substrate	amod	16	SENT_281	[p10l861t1927r1079b1970],
16	dependent	JJ	O	dependent	_	0	SENT_281	[p10l1095t1927r1367b1981],
17	:	:	O	:	_	0	SENT_281	[p10l1095t1927r1367b1981],
18	the	DT	O	the	det	19	SENT_281	[p10l1385t1927r1462b1970],
19	contribution	NN	O	contribution	dep	16	SENT_281	[p10l1477t1927r1776b1970],
20	of	IN	O	of	_	0	SENT_281	[p10l1790t1927r1842b1970],
21	transporting	VBG	O	transport	prepc_of	19	SENT_281	[p10l1850t1928r2149b1981],
22	activity	NN	O	activity	nn	23	SENT_281	[p10l131t1993r308b2047],
23	changes	NNS	O	change	dobj	21	SENT_281	[p10l323t1992r515b2047],
24	by	IN	O	by	_	0	SENT_281	[p10l532t1992r590b2047],
25	SLCO1B1	NN	O	slco1b1	prep_by	21	SENT_281	[p10l606t1993r915b2036],
26	*	CD	NUMBER	*	number	27	SENT_281	[p10l606t1993r915b2036],
27	15	CD	NUMBER	15	num	25	SENT_281	[p10l606t1993r915b2036],
28	.	.	O	.	_	0	SENT_281	[p10l606t1993r915b2036],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_282	[p10l933t1992r1308b2047],
2	Genomics	NNP	O	Genomics	_	0	SENT_282	[p10l1324t1993r1561b2036],
3	2008	CD	DATE	2008	num	2	SENT_282	[p10l1578t1995r1986b2043],
4	;	:	O	;	_	0	SENT_282	[p10l1578t1995r1986b2043],
5	18:424	CD	NUMBER	18:424	number	6	SENT_282	[p10l1578t1995r1986b2043],
6	—	CD	NUMBER	—	dep	2	SENT_282	[p10l1578t1995r1986b2043],
7	33	CD	NUMBER	33	dep	6	SENT_282	[p10l1578t1995r1986b2043],
8	.	.	O	.	_	0	SENT_282	[p10l1578t1995r1986b2043],

1	[	NN	O	[	_	0	SENT_283	[p10l6t2058r98b2113],
2	24	CD	NUMBER	24	num	1	SENT_283	[p10l6t2058r98b2113],
3	]	CD	NUMBER	]	num	5	SENT_283	[p10l6t2058r98b2113],
4	Gui	NN	O	guus	nn	5	SENT_283	[p10l131t2059r212b2102],
5	C	NN	O	c	dep	1	SENT_283	[p10l230t2061r271b2109],
6	,	,	O	,	_	0	SENT_283	[p10l230t2061r271b2109],
7	Miao	NNP	PERSON	Miao	nn	8	SENT_283	[p10l289t2059r408b2102],
8	Y	NN	PERSON	y	appos	5	SENT_283	[p10l424t2061r463b2109],
9	,	,	O	,	_	0	SENT_283	[p10l424t2061r463b2109],
10	Thompson	NNP	PERSON	Thompson	nn	11	SENT_283	[p10l479t2059r737b2113],
11	L	NNP	O	L	appos	5	SENT_283	[p10l755t2061r788b2109],
12	,	,	O	,	_	0	SENT_283	[p10l755t2061r788b2109],
13	et	FW	O	et	nn	14	SENT_283	[p10l807t2065r853b2102],
14	al.	FW	O	al.	appos	5	SENT_283	[p10l869t2059r919b2103],
15	.	.	O	.	_	0	SENT_283	[p10l869t2059r919b2103],

1	Effect	NN	O	effect	nsubj	9	SENT_284	[p10l938t2059r1073b2102],
2	of	IN	O	of	_	0	SENT_284	[p10l1088t2059r1139b2102],
3	pregnane	NN	O	pregnane	nn	6	SENT_284	[p10l1150t2071r1376b2113],
4	X	NN	O	x	nn	6	SENT_284	[p10l1391t2061r1427b2102],
5	receptor	NN	O	receptor	nn	6	SENT_284	[p10l1444t2065r1645b2113],
6	ligands	NNS	O	ligand	prep_of	1	SENT_284	[p10l1660t2059r1830b2113],
7	on	IN	O	on	_	0	SENT_284	[p10l1848t2071r1908b2102],
8	transport	NN	O	transport	prep_on	6	SENT_284	[p10l1925t2065r2149b2113],
9	mediated	VBN	O	mediate	_	0	SENT_284	[p10l131t2125r357b2169],
10	by	IN	O	by	_	0	SENT_284	[p10l374t2125r432b2180],
11	human	JJ	O	human	amod	12	SENT_284	[p10l448t2125r618b2169],
12	OATP1B1	NN	O	oatp1b1	prep_by	9	SENT_284	[p10l635t2127r848b2169],
13	and	CC	O	and	_	0	SENT_284	[p10l871t2125r959b2169],
14	OATP1	NN	O	oatp1	nn	15	SENT_284	[p10l977t2127r1127b2169],
15	B3	NN	O	b3	conj_and	12	SENT_284	[p10l1137t2127r1207b2169],
16	.	.	O	.	_	0	SENT_284	[p10l1137t2127r1207b2169],

1	Eur	NNP	MISC	Eur	nn	3	SENT_285	[p10l1225t2128r1336b2180],
2	]	NNP	O	]	nn	3	SENT_285	[p10l1225t2128r1336b2180],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_285	[p10l1353t2125r1607b2169],
4	2008	CD	DATE	2008	num	3	SENT_285	[p10l1624t2127r2035b2175],
5	;	:	O	;	_	0	SENT_285	[p10l1624t2127r2035b2175],
6	584:57	CD	NUMBER	584:57	number	7	SENT_285	[p10l1624t2127r2035b2175],
7	—	CD	NUMBER	—	dep	3	SENT_285	[p10l1624t2127r2035b2175],
8	65	CD	NUMBER	65	dep	7	SENT_285	[p10l1624t2127r2035b2175],
9	.	.	O	.	_	0	SENT_285	[p10l1624t2127r2035b2175],

1	[	NN	O	[	dep	6	SENT_286	[p10l6t2190r98b2245],
2	25	CD	NUMBER	25	dep	1	SENT_286	[p10l6t2190r98b2245],
3	]	CD	NUMBER	]	num	4	SENT_286	[p10l6t2190r98b2245],
4	]	NN	O	]	dep	6	SENT_286	[p10l125t2190r285b2245],
5	igore1	NN	O	igore1	nn	6	SENT_286	[p10l125t2190r285b2245],
6	E	NN	O	e	dep	34	SENT_286	[p10l323t2193r362b2241],
7	,	,	O	,	_	0	SENT_286	[p10l323t2193r362b2241],
8	Le	NNP	PERSON	Le	nn	10	SENT_286	[p10l399t2193r450b2234],
9	Vee	NNP	PERSON	Vee	nn	10	SENT_286	[p10l485t2193r576b2234],
10	M	NN	O	m	appos	6	SENT_286	[p10l614t2193r672b2241],
11	,	,	O	,	_	0	SENT_286	[p10l614t2193r672b2241],
12	Boursier-Neyret	JJ	O	boursier-neyret	amod	13	SENT_286	[p10l710t2191r1102b2245],
13	C	NN	O	c	appos	6	SENT_286	[p10l1137t2193r1177b2241],
14	,	,	O	,	_	0	SENT_286	[p10l1137t2193r1177b2241],
15	Parmentier	NNP	PERSON	Parmentier	nn	16	SENT_286	[p10l1215t2191r1491b2234],
16	Y	NN	PERSON	y	appos	6	SENT_286	[p10l1524t2193r1564b2241],
17	,	,	O	,	_	0	SENT_286	[p10l1524t2193r1564b2241],
18	Fardel	NNP	PERSON	Fardel	nn	21	SENT_286	[p10l1601t2190r1750b2234],
19	o.	NNP	O	o.	nn	21	SENT_286	[p10l1786t2193r1833b2234],
20	Differential	JJ	O	differential	amod	21	SENT_286	[p10l1871t2190r2147b2234],
21	regulation	NN	O	regulation	dep	29	SENT_286	[p10l132t2257r384b2311],
22	of	IN	O	of	_	0	SENT_286	[p10l408t2257r459b2301],
23	sinusoidal	JJ	O	sinusoidal	amod	27	SENT_286	[p10l478t2257r726b2301],
24	and	CC	O	and	_	0	SENT_286	[p10l751t2257r840b2301],
25	canalicular	JJ	O	canalicular	conj_and	23	SENT_286	[p10l866t2257r1134b2301],
26	hepatic	JJ	O	hepatic	amod	27	SENT_286	[p10l1157t2257r1337b2311],
27	drug	NN	O	drug	prep_of	21	SENT_286	[p10l1362t2257r1476b2311],
28	transporter	NN	O	transporter	dep	29	SENT_286	[p10l1499t2264r1780b2311],
29	expression	NN	O	expression	dep	34	SENT_286	[p10l1802t2258r2066b2311],
30	by	IN	O	by	_	0	SENT_286	[p10l2090t2257r2149b2311],
31	xenobiotics	NNS	O	xenobiotic	prep_by	29	SENT_286	[p10l130t2323r411b2366],
32	activating	VBG	O	activate	amod	34	SENT_286	[p10l443t2323r684b2377],
33	drug-sensing	JJ	O	drug-sensing	amod	34	SENT_286	[p10l715t2323r1039b2377],
34	receptors	NNS	O	receptor	_	0	SENT_286	[p10l1071t2329r1299b2377],
35	in	IN	O	in	_	0	SENT_286	[p10l1331t2323r1376b2366],
36	primary	JJ	O	primary	amod	38	SENT_286	[p10l1407t2323r1605b2377],
37	human	JJ	O	human	amod	38	SENT_286	[p10l1635t2323r1808b2366],
38	hepatocytes	NNS	O	hepatocyte	prep_in	34	SENT_286	[p10l1840t2323r2146b2377],
39	.	.	O	.	_	0	SENT_286	[p10l1840t2323r2146b2377],

1	Drug	NN	O	drug	nn	3	SENT_287	[p10l132t2392r252b2443],
2	Metab	NNP	O	Metab	nn	3	SENT_287	[p10l271t2389r425b2432],
3	Dispos	NNP	O	Dispos	_	0	SENT_287	[p10l445t2390r606b2443],
4	2006	CD	DATE	2006	num	3	SENT_287	[p10l627t2391r1076b2439],
5	;	:	O	;	_	0	SENT_287	[p10l627t2391r1076b2439],
6	34:1756	CD	NUMBER	34:1756	number	7	SENT_287	[p10l627t2391r1076b2439],
7	—	CD	NUMBER	—	dep	3	SENT_287	[p10l627t2391r1076b2439],
8	63	CD	NUMBER	63	dep	7	SENT_287	[p10l627t2391r1076b2439],
9	.	.	O	.	_	0	SENT_287	[p10l627t2391r1076b2439],

1	[	NN	O	[	nsubj	22	SENT_288	[p10l6t2454r98b2509],
2	26	CD	NUMBER	26	dep	1	SENT_288	[p10l6t2454r98b2509],
3	]	CD	NUMBER	]	num	5	SENT_288	[p10l6t2454r98b2509],
4	Kato	NNP	PERSON	Kato	nn	5	SENT_288	[p10l132t2457r241b2498],
5	M	NN	PERSON	m	dep	1	SENT_288	[p10l262t2457r320b2505],
6	,	,	O	,	_	0	SENT_288	[p10l262t2457r320b2505],
7	Chiba	NNP	LOCATION	Chiba	nn	8	SENT_288	[p10l342t2454r479b2498],
8	K	NNP	LOCATION	K	appos	5	SENT_288	[p10l500t2457r543b2505],
9	,	,	O	,	_	0	SENT_288	[p10l500t2457r543b2505],
10	Horikawa	NNP	PERSON	Horikawa	nn	11	SENT_288	[p10l564t2455r800b2498],
11	M	NNP	O	M	appos	5	SENT_288	[p10l821t2457r879b2505],
12	,	,	O	,	_	0	SENT_288	[p10l821t2457r879b2505],
13	Sugiyama	NNP	PERSON	Sugiyama	nn	17	SENT_288	[p10l901t2455r1138b2509],
14	Y.	NNP	O	Y.	nn	17	SENT_288	[p10l1156t2457r1196b2498],
15	The	NNP	O	The	nn	17	SENT_288	[p10l1215t2455r1305b2498],
16	quantitative	JJ	O	quantitative	amod	17	SENT_288	[p10l1325t2455r1622b2509],
17	prediction	NN	O	prediction	appos	5	SENT_288	[p10l1643t2454r1895b2509],
18	of	IN	O	of	prep	17	SENT_288	[p10l1916t2454r1967b2498],
19	in	FW	O	in	nn	20	SENT_288	[p10l1982t2455r2027b2498],
20	vivo	FW	O	vivo	dep	21	SENT_288	[p10l2045t2455r2148b2498],
21	enzyme-induction	NN	O	enzyme-induction	dep	18	SENT_288	[p10l131t2521r584b2575],
22	caused	VBN	O	cause	_	0	SENT_288	[p10l605t2521r771b2564],
23	by	IN	O	by	_	0	SENT_288	[p10l792t2521r851b2575],
24	drug	NN	O	drug	nn	25	SENT_288	[p10l869t2521r983b2575],
25	exposure	NN	O	exposure	prep_by	22	SENT_288	[p10l1002t2533r1225b2575],
26	from	IN	O	from	prep	22	SENT_288	[p10l1246t2521r1363b2564],
27	in	FW	O	in	nn	28	SENT_288	[p10l1382t2521r1427b2564],
28	vitro	FW	O	vitro	dep	29	SENT_288	[p10l1445t2521r1561b2564],
29	information	NN	O	information	dep	26	SENT_288	[p10l1582t2521r1874b2564],
30	on	IN	O	on	_	0	SENT_288	[p10l1894t2533r1955b2564],
31	human	JJ	O	human	amod	32	SENT_288	[p10l1975t2521r2148b2564],
32	hepatocytes	NNS	O	hepatocyte	prep_on	22	SENT_288	[p10l132t2587r438b2642],
33	.	.	O	.	_	0	SENT_288	[p10l132t2587r438b2642],

1	Drug	NN	O	drug	nn	3	SENT_289	[p10l459t2590r579b2642],
2	Metab	NNP	O	Metab	nn	3	SENT_289	[p10l598t2587r753b2631],
3	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_289	[p10l773t2587r1145b2631],
4	2005	CD	DATE	2005	num	3	SENT_289	[p10l1164t2589r1586b2637],
5	;	:	O	;	_	0	SENT_289	[p10l1164t2589r1586b2637],
6	20:236	CD	NUMBER	20:236	number	7	SENT_289	[p10l1164t2589r1586b2637],
7	—	CD	NUMBER	—	dep	3	SENT_289	[p10l1164t2589r1586b2637],
8	43	CD	NUMBER	43	dep	7	SENT_289	[p10l1164t2589r1586b2637],
9	.	.	O	.	_	0	SENT_289	[p10l1164t2589r1586b2637],

1	[	NN	O	[	_	0	SENT_290	[p10l6t2652r97b2707],
2	27	CD	NUMBER	27	num	1	SENT_290	[p10l6t2652r97b2707],
3	]	CD	NUMBER	]	num	5	SENT_290	[p10l6t2652r97b2707],
4	Fan	NN	O	fan	nn	5	SENT_290	[p10l130t2655r210b2696],
5	L	NN	O	l	dep	1	SENT_290	[p10l224t2655r257b2703],
6	,	,	O	,	_	0	SENT_290	[p10l224t2655r257b2703],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_290	[p10l270t2652r416b2707],
8	W	NNP	PERSON	W	appos	5	SENT_290	[p10l426t2655r489b2703],
9	,	,	O	,	_	0	SENT_290	[p10l426t2655r489b2703],
10	Guo	NNP	PERSON	Guo	nn	11	SENT_290	[p10l503t2655r597b2696],
11	D	NNP	O	D	appos	5	SENT_290	[p10l611t2655r656b2703],
12	,	,	O	,	_	0	SENT_290	[p10l611t2655r656b2703],
13	et	FW	O	et	nn	14	SENT_290	[p10l670t2659r715b2696],
14	al.	FW	O	al.	appos	5	SENT_290	[p10l727t2653r776b2696],
15	.	.	O	.	_	0	SENT_290	[p10l727t2653r776b2696],

1	The	DT	O	the	det	2	SENT_291	[p10l788t2653r875b2696],
2	effect	NN	O	effect	_	0	SENT_291	[p10l889t2652r1015b2696],
3	of	IN	O	of	_	0	SENT_291	[p10l1027t2652r1076b2696],
4	herbal	JJ	O	herbal	amod	6	SENT_291	[p10l1084t2652r1230b2696],
5	medicine	NN	O	medicine	nn	6	SENT_291	[p10l1244t2652r1458b2696],
6	baicalin	NN	O	baicalin	prep_of	2	SENT_291	[p10l1471t2652r1649b2696],
7	on	IN	O	on	_	0	SENT_291	[p10l1663t2665r1721b2696],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_291	[p10l1734t2652r2146b2707],
9	of	IN	O	of	_	0	SENT_291	[p10l130t2719r180b2763],
10	rosuvastatin	NN	O	rosuvastatin	prep_of	8	SENT_291	[p10l186t2720r479b2769],
11	,	,	O	,	_	0	SENT_291	[p10l186t2720r479b2769],
12	substrate	NN	O	substrate	appos	2	SENT_291	[p10l493t2719r702b2763],
13	of	IN	O	of	_	0	SENT_291	[p10l715t2719r764b2763],
14	organic	JJ	O	organic	amod	16	SENT_291	[p10l770t2720r942b2773],
15	anion	NN	O	anion	nn	16	SENT_291	[p10l953t2720r1394b2773],
16	—	NN	O	—	prep_of	12	SENT_291	[p10l953t2720r1394b2773],
17	transporting	VBG	O	transport	partmod	16	SENT_291	[p10l953t2720r1394b2773],
18	polypeptide	NN	O	polypeptide	nn	19	SENT_291	[p10l1405t2719r1682b2773],
19	1B1	NN	O	1b1	dobj	17	SENT_291	[p10l1697t2721r1787b2763],
20	.	.	O	.	_	0	SENT_291	[p10l1697t2721r1787b2763],

1	Clin	NNP	O	Clin	nn	3	SENT_292	[p10l1800t2719r1889b2763],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_292	[p10l1901t2719r2147b2763],
3	Ther	NNP	O	Ther	_	0	SENT_292	[p10l128t2785r237b2828],
4	2008	CD	DATE	2008	num	3	SENT_292	[p10l251t2787r541b2835],
5	;	:	O	;	_	0	SENT_292	[p10l251t2787r541b2835],
6	83:471	CD	NUMBER	83:471	number	7	SENT_292	[p10l251t2787r541b2835],
7	-6	CD	NUMBER	-6	dep	3	SENT_292	[p10l550t2787r617b2829],
8	.	.	O	.	_	0	SENT_292	[p10l550t2787r617b2829],

1	[	NN	O	[	_	0	SENT_293	[p10l6t2851r98b2905],
2	28	CD	NUMBER	28	number	3	SENT_293	[p10l6t2851r98b2905],
3	]	CD	NUMBER	]	dep	1	SENT_293	[p10l6t2851r98b2905],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_293	[p10l132t2852r230b2894],
5	RB	NN	O	rb	dep	3	SENT_293	[p10l245t2854r318b2895],
6	.	.	O	.	_	0	SENT_293	[p10l245t2854r318b2895],

1	Transporters	NNS	O	transporter	_	0	SENT_294	[p10l332t2854r646b2905],
2	and	CC	O	and	_	0	SENT_294	[p10l661t2851r750b2894],
3	xenobiotic	JJ	O	xenobiotic	amod	4	SENT_294	[p10l765t2851r1023b2894],
4	disposition	NN	O	disposition	conj_and	1	SENT_294	[p10l1037t2851r1320b2905],
5	.	.	O	.	_	0	SENT_294	[p10l1037t2851r1320b2905],

1	Toxicology	NN	O	toxicology	_	0	SENT_295	[p10l1334t2851r1599b2905],
2	2002	CD	DATE	2002	num	1	SENT_295	[p10l1613t2853r1838b2901],
3	;	:	O	;	_	0	SENT_295	[p10l1613t2853r1838b2901],
4	181	CD	NUMBER	181	number	5	SENT_295	[p10l1613t2853r1838b2901],
5	—	CD	NUMBER	—	dep	1	SENT_295	[p10l1849t2853r2070b2895],
6	182:291	CD	NUMBER	182:291	num	7	SENT_295	[p10l1849t2853r2070b2895],
7	-7	CD	NUMBER	-7	dep	5	SENT_295	[p10l2081t2854r2147b2895],
8	.	.	O	.	_	0	SENT_295	[p10l2081t2854r2147b2895],

1	[	NN	O	[	nn	4	SENT_296	[p10l6t2916r98b2971],
2	29	CD	NUMBER	29	num	4	SENT_296	[p10l6t2916r98b2971],
3	]	NN	O	]	nn	4	SENT_296	[p10l6t2916r98b2971],
4	Link	NN	O	link	_	0	SENT_296	[p10l132t2917r233b2960],
5	E	NN	O	e	dep	4	SENT_296	[p10l249t2919r287b2967],
6	,	,	O	,	_	0	SENT_296	[p10l249t2919r287b2967],
7	Parish	NNP	O	Parish	nn	8	SENT_296	[p10l305t2917r450b2960],
8	S	NNP	O	S	appos	5	SENT_296	[p10l467t2919r503b2967],
9	,	,	O	,	_	0	SENT_296	[p10l467t2919r503b2967],
10	Armitage	NNP	PERSON	Armitage	nn	11	SENT_296	[p10l518t2917r740b2971],
11	]	NNP	O	]	appos	5	SENT_296	[p10l751t2919r782b2971],
12	,	,	O	,	_	0	SENT_296	[p10l751t2919r782b2971],
13	et	FW	O	et	nn	14	SENT_296	[p10l800t2923r846b2960],
14	al.	FW	O	al.	appos	5	SENT_296	[p10l860t2916r911b2960],
15	.	.	O	.	_	0	SENT_296	[p10l860t2916r911b2960],

1	SLCO1	NN	O	slco1	nn	3	SENT_297	[p10l929t2919r1073b2960],
2	B1	NN	O	b1	nn	3	SENT_297	[p10l1083t2919r1135b2960],
3	variants	NNS	O	variant	nsubj	7	SENT_297	[p10l1157t2917r1348b2960],
4	and	CC	O	and	_	0	SENT_297	[p10l1365t2916r1453b2960],
5	statin-induced	JJ	O	statin-induced	amod	6	SENT_297	[p10l1471t2916r1820b2960],
6	myopathy	NN	O	myopathy	conj_and	3	SENT_297	[p10l1838t2916r2148b2971],
7	—	VBD	O	—	_	0	SENT_297	[p10l1838t2916r2148b2971],
8	a	DT	O	a	det	10	SENT_297	[p10l1838t2916r2148b2971],
9	genomewide	JJ	O	genomewide	amod	10	SENT_297	[p10l130t2983r444b3037],
10	study	NN	O	study	dobj	7	SENT_297	[p10l462t2983r601b3037],
11	.	.	O	.	_	0	SENT_297	[p10l462t2983r601b3037],

1	N	NN	O	n	nn	3	SENT_298	[p10l620t2985r656b3026],
2	Engl	NNP	O	Engl	nn	3	SENT_298	[p10l674t2983r807b3037],
3	]	NNP	O	]	nsubj	4	SENT_298	[p10l674t2983r807b3037],
4	Med	VBD	O	med	_	0	SENT_298	[p10l825t2983r931b3026],
5	2008	CD	DATE	2008	dobj	4	SENT_298	[p10l948t2985r1390b3033],
6	;	:	O	;	_	0	SENT_298	[p10l948t2985r1390b3033],
7	359:789	CD	NUMBER	359:789	number	8	SENT_298	[p10l948t2985r1390b3033],
8	—	CD	NUMBER	—	dep	5	SENT_298	[p10l948t2985r1390b3033],
9	99	CD	NUMBER	99	dep	8	SENT_298	[p10l948t2985r1390b3033],
10	.	.	O	.	_	0	SENT_298	[p10l948t2985r1390b3033],

